CINXE.COM
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model
<!DOCTYPE html> <html lang="en" xmlns:og="http://ogp.me/ns#" xmlns:fb="https://www.facebook.com/2008/fbml"> <head> <meta charset="utf-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"> <meta content="mdpi" name="sso-service" /> <meta content="width=device-width, initial-scale=1.0" name="viewport" /> <title>Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model</title><link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/font-awesome.min.css?eb190a3a77e5e1ee?1732884643"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/jquery.multiselect.css?f56c135cbf4d1483?1732884643"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/chosen.min.css?d7ca5ca9441ef9e1?1732884643"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/main2.css?69b39374e6b554b7?1732884643"> <link rel="mask-icon" href="https://pub.mdpi-res.com/img/mask-icon-128.svg?c1c7eca266cd7013?1732884643" color="#4f5671"> <link rel="apple-touch-icon" sizes="180x180" href="https://pub.mdpi-res.com/icon/apple-touch-icon-180x180.png?1732884643"> <link rel="apple-touch-icon" sizes="152x152" href="https://pub.mdpi-res.com/icon/apple-touch-icon-152x152.png?1732884643"> <link rel="apple-touch-icon" sizes="144x144" href="https://pub.mdpi-res.com/icon/apple-touch-icon-144x144.png?1732884643"> <link rel="apple-touch-icon" sizes="120x120" href="https://pub.mdpi-res.com/icon/apple-touch-icon-120x120.png?1732884643"> <link rel="apple-touch-icon" sizes="114x114" href="https://pub.mdpi-res.com/icon/apple-touch-icon-114x114.png?1732884643"> <link rel="apple-touch-icon" sizes="76x76" href="https://pub.mdpi-res.com/icon/apple-touch-icon-76x76.png?1732884643"> <link rel="apple-touch-icon" sizes="72x72" href="https://pub.mdpi-res.com/icon/apple-touch-icon-72x72.png?1732884643"> <link rel="apple-touch-icon" sizes="57x57" href="https://pub.mdpi-res.com/icon/apple-touch-icon-57x57.png?1732884643"> <link rel="apple-touch-icon" href="https://pub.mdpi-res.com/icon/apple-touch-icon-57x57.png?1732884643"> <link rel="apple-touch-icon-precomposed" href="https://pub.mdpi-res.com/icon/apple-touch-icon-57x57.png?1732884643"> <link rel="manifest" href="/manifest.json"> <meta name="theme-color" content="#ffffff"> <meta name="application-name" content=" "/> <link rel="apple-touch-startup-image" href="https://pub.mdpi-res.com/img/journals/cancers-logo-sq.png?8600e93ff98dbf14"> <link rel="apple-touch-icon" href="https://pub.mdpi-res.com/img/journals/cancers-logo-sq.png?8600e93ff98dbf14"> <meta name="msapplication-TileImage" content="https://pub.mdpi-res.com/img/journals/cancers-logo-sq.png?8600e93ff98dbf14"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/jquery-ui-1.10.4.custom.min.css?80647d88647bf347?1732884643"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/magnific-popup.min.css?04d343e036f8eecd?1732884643"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/xml2html/article-html.css?230b005b39af4260?1732884643"> <style> h2, #abstract .related_suggestion_title { } .batch_articles a { color: #000; } a, .batch_articles .authors a, a:focus, a:hover, a:active, .batch_articles a:focus, .batch_articles a:hover, li.side-menu-li a { } span.label a { color: #fff; } #main-content a.title-link:hover, #main-content a.title-link:focus, #main-content div.generic-item a.title-link:hover, #main-content div.generic-item a.title-link:focus { } #main-content #middle-column .generic-item.article-item a.title-link:hover, #main-content #middle-column .generic-item.article-item a.title-link:focus { } .art-authors a.toEncode { color: #333; font-weight: 700; } #main-content #middle-column ul li::before { } .accordion-navigation.active a.accordion__title, .accordion-navigation.active a.accordion__title::after { } .accordion-navigation li:hover::before, .accordion-navigation li:hover a, .accordion-navigation li:focus a { } .relative-size-container .relative-size-image .relative-size { } .middle-column__help__fixed a:hover i, } input[type="checkbox"]:checked:after { } input[type="checkbox"]:not(:disabled):hover:before { } #main-content .bolded-text { } #main-content .hypothesis-count-container { } #main-content .hypothesis-count-container:before { } .full-size-menu ul li.menu-item .dropdown-wrapper { } .full-size-menu ul li.menu-item > a.open::after { } #title-story .title-story-orbit .orbit-caption { #background: url('/img/design/000000_background.png') !important; background: url('/img/design/ffffff_background.png') !important; color: rgb(51, 51, 51) !important; } #main-content .content__container__orbit { background-color: #000 !important; } #main-content .content__container__journal { color: #fff; } .html-article-menu .row span { } .html-article-menu .row span.active { } .accordion-navigation__journal .side-menu-li.active::before, .accordion-navigation__journal .side-menu-li.active a { color: rgba(26,59,132,0.75) !important; font-weight: 700; } .accordion-navigation__journal .side-menu-li:hover::before , .accordion-navigation__journal .side-menu-li:hover a { color: rgba(26,59,132,0.75) !important; } .side-menu-ul li.active a, .side-menu-ul li.active, .side-menu-ul li.active::before { color: rgba(26,59,132,0.75) !important; } .side-menu-ul li.active a { } .result-selected, .active-result.highlighted, .active-result:hover, .result-selected, .active-result.highlighted, .active-result:focus { } .search-container.search-container__default-scheme { } nav.tab-bar .open-small-search.active:after { } .search-container.search-container__default-scheme .custom-accordion-for-small-screen-link::after { color: #fff; } @media only screen and (max-width: 50em) { #main-content .content__container.journal-info { color: #fff; } #main-content .content__container.journal-info a { color: #fff; } } .button.button--color { } .button.button--color:hover, .button.button--color:focus { } .button.button--color-journal { position: relative; background-color: rgba(26,59,132,0.75); border-color: #fff; color: #fff !important; } .button.button--color-journal:hover::before { content: ''; position: absolute; top: 0; left: 0; height: 100%; width: 100%; background-color: #ffffff; opacity: 0.2; } .button.button--color-journal:visited, .button.button--color-journal:hover, .button.button--color-journal:focus { background-color: rgba(26,59,132,0.75); border-color: #fff; color: #fff !important; } .button.button--color path { } .button.button--color:hover path { fill: #fff; } #main-content #search-refinements .ui-slider-horizontal .ui-slider-range { } .breadcrumb__element:last-of-type a { } #main-header { } #full-size-menu .top-bar, #full-size-menu li.menu-item span.user-email { } .top-bar-section li:not(.has-form) a:not(.button) { } #full-size-menu li.menu-item .dropdown-wrapper li a:hover { } #full-size-menu li.menu-item a:hover, #full-size-menu li.menu.item a:focus, nav.tab-bar a:hover { } #full-size-menu li.menu.item a:active, #full-size-menu li.menu.item a.active { } #full-size-menu li.menu-item a.open-mega-menu.active, #full-size-menu li.menu-item div.mega-menu, a.open-mega-menu.active { } #full-size-menu li.menu-item div.mega-menu li, #full-size-menu li.menu-item div.mega-menu a { border-color: #9a9a9a; } div.type-section h2 { font-size: 20px; line-height: 26px; font-weight: 300; } div.type-section h3 { margin-left: 15px; margin-bottom: 0px; font-weight: 300; } .journal-tabs .tab-title.active a { } </style> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/slick.css?f38b2db10e01b157?1732884643"> <meta name="title" content="Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model"> <meta name="description" content=" The TS/A cell line was established in 1983 from a spontaneous mammary tumor arisen in an inbred BALB/c female mouse. Its features (heterogeneity, low immunogenicity and metastatic ability) rendered the TS/A cell line suitable as a preclinical model for studies on tumor–host interactions and for gene therapy approaches. The integrated biological profile of TS/A resulting from the review of the literature could be a path towards the description of a precision experimental model of mammary cancer." > <link rel="image_src" href="https://pub.mdpi-res.com/img/journals/cancers-logo.png?8600e93ff98dbf14" > <meta name="dc.title" content="Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model"> <meta name="dc.creator" content="Carla De Giovanni"> <meta name="dc.creator" content="Giordano Nicoletti"> <meta name="dc.creator" content="Lorena Landuzzi"> <meta name="dc.creator" content="Arianna Palladini"> <meta name="dc.creator" content="Pier-Luigi Lollini"> <meta name="dc.creator" content="Patrizia Nanni"> <meta name="dc.type" content="Review"> <meta name="dc.source" content="Cancers 2019, Vol. 11, Page 1889"> <meta name="dc.date" content="2019-11-27"> <meta name ="dc.identifier" content="10.3390/cancers11121889"> <meta name="dc.publisher" content="Multidisciplinary Digital Publishing Institute"> <meta name="dc.rights" content="http://creativecommons.org/licenses/by/3.0/"> <meta name="dc.format" content="application/pdf" > <meta name="dc.language" content="en" > <meta name="dc.description" content=" The TS/A cell line was established in 1983 from a spontaneous mammary tumor arisen in an inbred BALB/c female mouse. Its features (heterogeneity, low immunogenicity and metastatic ability) rendered the TS/A cell line suitable as a preclinical model for studies on tumor–host interactions and for gene therapy approaches. The integrated biological profile of TS/A resulting from the review of the literature could be a path towards the description of a precision experimental model of mammary cancer." > <meta name="dc.subject" content="TS/A" > <meta name="dc.subject" content="murine mammary cancer" > <meta name="dc.subject" content="preclinical models" > <meta name="dc.subject" content="gene therapy" > <meta name="dc.subject" content="metastases" > <meta name="dc.subject" content="immunotherapy" > <meta name ="prism.issn" content="2072-6694"> <meta name ="prism.publicationName" content="Cancers"> <meta name ="prism.publicationDate" content="2019-11-27"> <meta name ="prism.volume" content="11"> <meta name ="prism.number" content="12"> <meta name ="prism.section" content="Review" > <meta name ="prism.startingPage" content="1889" > <meta name="citation_issn" content="2072-6694"> <meta name="citation_journal_title" content="Cancers"> <meta name="citation_publisher" content="Multidisciplinary Digital Publishing Institute"> <meta name="citation_title" content="Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model"> <meta name="citation_publication_date" content="2019/12"> <meta name="citation_online_date" content="2019/11/27"> <meta name="citation_volume" content="11"> <meta name="citation_issue" content="12"> <meta name="citation_firstpage" content="1889"> <meta name="citation_author" content="De Giovanni, Carla"> <meta name="citation_author" content="Nicoletti, Giordano"> <meta name="citation_author" content="Landuzzi, Lorena"> <meta name="citation_author" content="Palladini, Arianna"> <meta name="citation_author" content="Lollini, Pier-Luigi"> <meta name="citation_author" content="Nanni, Patrizia"> <meta name="citation_doi" content="10.3390/cancers11121889"> <meta name="citation_id" content="mdpi-cancers11121889"> <meta name="citation_abstract_html_url" content="https://www.mdpi.com/2072-6694/11/12/1889"> <meta name="citation_pdf_url" content="https://www.mdpi.com/2072-6694/11/12/1889/pdf?version=1576638352"> <link rel="alternate" type="application/pdf" title="PDF Full-Text" href="https://www.mdpi.com/2072-6694/11/12/1889/pdf?version=1576638352"> <meta name="fulltext_pdf" content="https://www.mdpi.com/2072-6694/11/12/1889/pdf?version=1576638352"> <meta name="citation_fulltext_html_url" content="https://www.mdpi.com/2072-6694/11/12/1889/htm"> <link rel="alternate" type="text/html" title="HTML Full-Text" href="https://www.mdpi.com/2072-6694/11/12/1889/htm"> <meta name="fulltext_html" content="https://www.mdpi.com/2072-6694/11/12/1889/htm"> <link rel="alternate" type="text/xml" title="XML Full-Text" href="https://www.mdpi.com/2072-6694/11/12/1889/xml"> <meta name="fulltext_xml" content="https://www.mdpi.com/2072-6694/11/12/1889/xml"> <meta name="citation_xml_url" content="https://www.mdpi.com/2072-6694/11/12/1889/xml"> <meta name="twitter:card" content="summary" /> <meta name="twitter:site" content="@MDPIOpenAccess" /> <meta name="twitter:image" content="https://pub.mdpi-res.com/img/journals/cancers-logo-social.png?8600e93ff98dbf14" /> <meta property="fb:app_id" content="131189377574"/> <meta property="og:site_name" content="MDPI"/> <meta property="og:type" content="article"/> <meta property="og:url" content="https://www.mdpi.com/2072-6694/11/12/1889" /> <meta property="og:title" content="Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model" /> <meta property="og:description" content=" The TS/A cell line was established in 1983 from a spontaneous mammary tumor arisen in an inbred BALB/c female mouse. Its features (heterogeneity, low immunogenicity and metastatic ability) rendered the TS/A cell line suitable as a preclinical model for studies on tumor–host interactions and for gene therapy approaches. The integrated biological profile of TS/A resulting from the review of the literature could be a path towards the description of a precision experimental model of mammary cancer." /> <meta property="og:image" content="https://pub.mdpi-res.com/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g001-550.jpg?1577711154" /> <link rel="alternate" type="application/rss+xml" title="MDPI Publishing - Latest articles" href="https://www.mdpi.com/rss"> <meta name="google-site-verification" content="PxTlsg7z2S00aHroktQd57fxygEjMiNHydKn3txhvwY"> <meta name="facebook-domain-verification" content="mcoq8dtq6sb2hf7z29j8w515jjoof7" /> <script id="Cookiebot" data-cfasync="false" src="https://consent.cookiebot.com/uc.js" data-cbid="51491ddd-fe7a-4425-ab39-69c78c55829f" type="text/javascript" async></script> <!--[if lt IE 9]> <script>var browserIe8 = true;</script> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/ie8foundationfix.css?50273beac949cbf0?1732884643"> <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script> <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.2/html5shiv.js"></script> <script src="//s3.amazonaws.com/nwapi/nwmatcher/nwmatcher-1.2.5-min.js"></script> <script src="//html5base.googlecode.com/svn-history/r38/trunk/js/selectivizr-1.0.3b.js"></script> <script src="//cdnjs.cloudflare.com/ajax/libs/respond.js/1.1.0/respond.min.js"></script> <script src="https://pub.mdpi-res.com/assets/js/ie8/ie8patch.js?9e1d3c689a0471df?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/ie8/rem.min.js?94b62787dcd6d2f2?1732884643"></script> <![endif]--> <script type="text/plain" data-cookieconsent="statistics"> (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-WPK7SW5'); </script> <script type="text/plain" data-cookieconsent="statistics"> _linkedin_partner_id = "2846186"; window._linkedin_data_partner_ids = window._linkedin_data_partner_ids || []; window._linkedin_data_partner_ids.push(_linkedin_partner_id); </script><script type="text/javascript"> (function(){var s = document.getElementsByTagName("script")[0]; var b = document.createElement("script"); b.type = "text/javascript";b.async = true; b.src = "https://snap.licdn.com/li.lms-analytics/insight.min.js"; s.parentNode.insertBefore(b, s);})(); </script> <script type="text/plain" data-cookieconsent="statistics" data-cfasync="false" src="//script.crazyegg.com/pages/scripts/0116/4951.js" async="async" ></script> </head> <body> <div class="direction direction_right" id="small_right" style="border-right-width: 0px; padding:0;"> <i class="fa fa-caret-right fa-2x"></i> </div> <div class="big_direction direction_right" id="big_right" style="border-right-width: 0px;"> <div style="text-align: right;"> Next Article in Journal<br> <div><a href="/2072-6694/11/12/1891">MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients with Stage II/III Colorectal Cancer</a></div> </div> </div> <div class="direction" id="small_left" style="border-left-width: 0px"> <i class="fa fa-caret-left fa-2x"></i> </div> <div class="big_direction" id="big_left" style="border-left-width: 0px;"> <div> Previous Article in Journal<br> <div><a href="/2072-6694/11/12/1888">Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in <i>STAT3/5A</i>-Addicted Glioblastoma</a></div> </div> </div> <div style="clear: both;"></div> <div id="menuModal" class="reveal-modal reveal-modal-new reveal-modal-menu" aria-hidden="true" data-reveal role="dialog"> <div class="menu-container"> <div class="UI_NavMenu"> <div class="content__container " > <div class="custom-accordion-for-small-screen-link " > <h2>Journals</h2> </div> <div class="target-item custom-accordion-for-small-screen-content show-for-medium-up"> <div class="menu-container__links"> <div style="width: 100%; float: left;"> <a href="/about/journals">Active Journals</a> <a href="/about/journalfinder">Find a Journal</a> <a href="/about/journals/proposal">Journal Proposal</a> <a href="/about/proceedings">Proceedings Series</a> </div> </div> </div> </div> <a href="/topics"> <h2>Topics</h2> </a> <div class="content__container " > <div class="custom-accordion-for-small-screen-link " > <h2>Information</h2> </div> <div class="target-item custom-accordion-for-small-screen-content show-for-medium-up"> <div class="menu-container__links"> <div style="width: 100%; max-width: 200px; float: left;"> <a href="/authors">For Authors</a> <a href="/reviewers">For Reviewers</a> <a href="/editors">For Editors</a> <a href="/librarians">For Librarians</a> <a href="/publishing_services">For Publishers</a> <a href="/societies">For Societies</a> <a href="/conference_organizers">For Conference Organizers</a> </div> <div style="width: 100%; max-width: 250px; float: left;"> <a href="/openaccess">Open Access Policy</a> <a href="/ioap">Institutional Open Access Program</a> <a href="/special_issues_guidelines">Special Issues Guidelines</a> <a href="/editorial_process">Editorial Process</a> <a href="/ethics">Research and Publication Ethics</a> <a href="/apc">Article Processing Charges</a> <a href="/awards">Awards</a> <a href="/testimonials">Testimonials</a> </div> </div> </div> </div> <a href="/authors/english"> <h2>Editing Services</h2> </a> <div class="content__container " > <div class="custom-accordion-for-small-screen-link " > <h2>Initiatives</h2> </div> <div class="target-item custom-accordion-for-small-screen-content show-for-medium-up"> <div class="menu-container__links"> <div style="width: 100%; float: left;"> <a href="https://sciforum.net" target="_blank" rel="noopener noreferrer">Sciforum</a> <a href="https://www.mdpi.com/books" target="_blank" rel="noopener noreferrer">MDPI Books</a> <a href="https://www.preprints.org" target="_blank" rel="noopener noreferrer">Preprints.org</a> <a href="https://www.scilit.net" target="_blank" rel="noopener noreferrer">Scilit</a> <a href="https://sciprofiles.com" target="_blank" rel="noopener noreferrer">SciProfiles</a> <a href="https://encyclopedia.pub" target="_blank" rel="noopener noreferrer">Encyclopedia</a> <a href="https://jams.pub" target="_blank" rel="noopener noreferrer">JAMS</a> <a href="/about/proceedings">Proceedings Series</a> </div> </div> </div> </div> <div class="content__container " > <div class="custom-accordion-for-small-screen-link " > <h2>About</h2> </div> <div class="target-item custom-accordion-for-small-screen-content show-for-medium-up"> <div class="menu-container__links"> <div style="width: 100%; float: left;"> <a href="/about">Overview</a> <a href="/about/contact">Contact</a> <a href="https://careers.mdpi.com" target="_blank" rel="noopener noreferrer">Careers</a> <a href="/about/announcements">News</a> <a href="/about/press">Press</a> <a href="http://blog.mdpi.com/" target="_blank" rel="noopener noreferrer">Blog</a> </div> </div> </div> </div> </div> <div class="menu-container__buttons"> <a class="button UA_SignInUpButton" href="/user/login">Sign In / Sign Up</a> </div> </div> </div> <div id="captchaModal" class="reveal-modal reveal-modal-new reveal-modal-new--small" data-reveal aria-label="Captcha" aria-hidden="true" role="dialog"></div> <div id="actionDisabledModal" class="reveal-modal" data-reveal aria-labelledby="actionDisableModalTitle" aria-hidden="true" role="dialog" style="width: 300px;"> <h2 id="actionDisableModalTitle">Notice</h2> <form action="/email/captcha" method="post" id="emailCaptchaForm"> <div class="row"> <div id="js-action-disabled-modal-text" class="small-12 columns"> </div> <div id="js-action-disabled-modal-submit" class="small-12 columns" style="margin-top: 10px; display: none;"> You can make submissions to other journals <a href="https://susy.mdpi.com/user/manuscripts/upload">here</a>. </div> </div> </form> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <div id="rssNotificationModal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="rssNotificationModalTitle" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 id="rssNotificationModalTitle">Notice</h2> <p> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div class="row"> <div class="small-12 columns"> <a class="button button--color js-rss-notification-confirm">Continue</a> <a class="button button--grey" onclick="$(this).closest('.reveal-modal').find('.close-reveal-modal').click(); return false;">Cancel</a> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <div id="drop-article-label-openaccess" class="f-dropdown medium" data-dropdown-content aria-hidden="true" tabindex="-1"> <p> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to <a href="https://www.mdpi.com/openaccess">https://www.mdpi.com/openaccess</a>. </p> </div> <div id="drop-article-label-feature" class="f-dropdown medium" data-dropdown-content aria-hidden="true" tabindex="-1"> <p> Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications. </p> <p> Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers. </p> </div> <div id="drop-article-label-choice" class="f-dropdown medium" data-dropdown-content aria-hidden="true" tabindex="-1"> <p> Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. <div style="margin-top: -10px;"> <div id="drop-article-label-choice-journal-link" style="display: none; margin-top: -10px; padding-top: 10px;"> </div> </div> </p> </div> <div id="drop-article-label-resubmission" class="f-dropdown medium" data-dropdown-content aria-hidden="true" tabindex="-1"> <p> Original Submission Date Received: <span id="drop-article-label-resubmission-date"></span>. </p> </div> <div id="container"> <noscript> <div id="no-javascript"> You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled. </div> </noscript> <div class="fixed"> <nav class="tab-bar show-for-medium-down"> <div class="row full-width collapse"> <div class="medium-3 small-4 columns"> <a href="/"> <img class="full-size-menu__mdpi-logo" src="https://pub.mdpi-res.com/img/design/mdpi-pub-logo-black-small1.svg?da3a8dcae975a41c?1732884643" style="width: 64px;" title="MDPI Open Access Journals"> </a> </div> <div class="medium-3 small-4 columns right-aligned"> <div class="show-for-medium-down"> <a href="#" style="display: none;"> <i class="material-icons" onclick="$('#menuModal').foundation('reveal', 'close'); return false;">clear</i> </a> <a class="js-toggle-desktop-layout-link" title="Toggle desktop layout" style="display: none;" href="/toggle_desktop_layout_cookie"> <i class="material-icons">zoom_out_map</i> </a> <a href="#" class="js-open-small-search open-small-search"> <i class="material-icons show-for-small only">search</i> </a> <a title="MDPI main page" class="js-open-menu" data-reveal-id="menuModal" href="#"> <i class="material-icons">menu</i> </a> </div> </div> </div> </nav> </div> <section class="main-section"> <header> <div class="full-size-menu show-for-large-up"> <div class="row full-width"> <div class="large-1 columns"> <a href="/"> <img class="full-size-menu__mdpi-logo" src="https://pub.mdpi-res.com/img/design/mdpi-pub-logo-black-small1.svg?da3a8dcae975a41c?1732884643" title="MDPI Open Access Journals"> </a> </div> <div class="large-8 columns text-right UI_NavMenu"> <ul> <li class="menu-item"> <a href="/about/journals" data-dropdown="journals-dropdown" aria-controls="journals-dropdown" aria-expanded="false" data-options="is_hover: true; hover_timeout: 200">Journals</a> <ul id="journals-dropdown" class="f-dropdown dropdown-wrapper dropdown-wrapper__small" data-dropdown-content aria-hidden="true" tabindex="-1"> <li> <div class="row"> <div class="small-12 columns"> <ul> <li> <a href="/about/journals"> Active Journals </a> </li> <li> <a href="/about/journalfinder"> Find a Journal </a> </li> <li> <a href="/about/journals/proposal"> Journal Proposal </a> </li> <li> <a href="/about/proceedings"> Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li class="menu-item"> <a href="/topics">Topics</a> </li> <li class="menu-item"> <a href="/authors" data-dropdown="information-dropdown" aria-controls="information-dropdown" aria-expanded="false" data-options="is_hover:true; hover_timeout:200">Information</a> <ul id="information-dropdown" class="f-dropdown dropdown-wrapper" data-dropdown-content aria-hidden="true" tabindex="-1"> <li> <div class="row"> <div class="small-5 columns right-border"> <ul> <li> <a href="/authors">For Authors</a> </li> <li> <a href="/reviewers">For Reviewers</a> </li> <li> <a href="/editors">For Editors</a> </li> <li> <a href="/librarians">For Librarians</a> </li> <li> <a href="/publishing_services">For Publishers</a> </li> <li> <a href="/societies">For Societies</a> </li> <li> <a href="/conference_organizers">For Conference Organizers</a> </li> </ul> </div> <div class="small-7 columns"> <ul> <li> <a href="/openaccess">Open Access Policy</a> </li> <li> <a href="/ioap">Institutional Open Access Program</a> </li> <li> <a href="/special_issues_guidelines">Special Issues Guidelines</a> </li> <li> <a href="/editorial_process">Editorial Process</a> </li> <li> <a href="/ethics">Research and Publication Ethics</a> </li> <li> <a href="/apc">Article Processing Charges</a> </li> <li> <a href="/awards">Awards</a> </li> <li> <a href="/testimonials">Testimonials</a> </li> </ul> </div> </div> </li> </ul> </li> <li class="menu-item"> <a href="/authors/english">Editing Services</a> </li> <li class="menu-item"> <a href="/about/initiatives" data-dropdown="initiatives-dropdown" aria-controls="initiatives-dropdown" aria-expanded="false" data-options="is_hover: true; hover_timeout: 200">Initiatives</a> <ul id="initiatives-dropdown" class="f-dropdown dropdown-wrapper dropdown-wrapper__small" data-dropdown-content aria-hidden="true" tabindex="-1"> <li> <div class="row"> <div class="small-12 columns"> <ul> <li> <a href="https://sciforum.net" target="_blank" rel="noopener noreferrer"> Sciforum </a> </li> <li> <a href="https://www.mdpi.com/books" target="_blank" rel="noopener noreferrer"> MDPI Books </a> </li> <li> <a href="https://www.preprints.org" target="_blank" rel="noopener noreferrer"> Preprints.org </a> </li> <li> <a href="https://www.scilit.net" target="_blank" rel="noopener noreferrer"> Scilit </a> </li> <li> <a href="https://sciprofiles.com" target="_blank" rel="noopener noreferrer"> SciProfiles </a> </li> <li> <a href="https://encyclopedia.pub" target="_blank" rel="noopener noreferrer"> Encyclopedia </a> </li> <li> <a href="https://jams.pub" target="_blank" rel="noopener noreferrer"> JAMS </a> </li> <li> <a href="/about/proceedings"> Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li class="menu-item"> <a href="/about" data-dropdown="about-dropdown" aria-controls="about-dropdown" aria-expanded="false" data-options="is_hover: true; hover_timeout: 200">About</a> <ul id="about-dropdown" class="f-dropdown dropdown-wrapper dropdown-wrapper__small" data-dropdown-content aria-hidden="true" tabindex="-1"> <li> <div class="row"> <div class="small-12 columns"> <ul> <li> <a href="/about"> Overview </a> </li> <li> <a href="/about/contact"> Contact </a> </li> <li> <a href="https://careers.mdpi.com" target="_blank" rel="noopener noreferrer"> Careers </a> </li> <li> <a href="/about/announcements"> News </a> </li> <li> <a href="/about/press"> Press </a> </li> <li> <a href="http://blog.mdpi.com/" target="_blank" rel="noopener noreferrer"> Blog </a> </li> </ul> </div> </div> </li> </ul> </li> </ul> </div> <div class="large-3 columns text-right full-size-menu__buttons"> <div> <a class="button button--default-inversed UA_SignInUpButton" href="/user/login">Sign In / Sign Up</a> <a class="button button--default js-journal-active-only-link js-journal-active-only-submit-link UC_NavSubmitButton" href=" https://susy.mdpi.com/user/manuscripts/upload?journal=cancers " data-disabledmessage="new submissions are not possible.">Submit</a> </div> </div> </div> </div> <div class="header-divider"> </div> <div class="search-container hide-for-small-down row search-container__homepage-scheme"> <form id="basic_search" style="background-color: inherit !important;" class="large-12 medium-12 columns " action="/search" method="get"> <div class="row search-container__main-elements"> <div class="large-2 medium-2 small-12 columns text-right1 small-only-text-left"> <div class="show-for-medium-up"> <div class="search-input-label"> </div> </div> <span class="search-container__title">Search<span class="hide-for-medium"> for Articles</span><span class="hide-for-small">:</span></span> </div> <div class="custom-accordion-for-small-screen-content"> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Title / Keyword</div> </div> <input type="text" placeholder="Title / Keyword" id="q" tabindex="1" name="q" value="" /> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Author / Affiliation / Email</div> </div> <input type="text" id="authors" placeholder="Author / Affiliation / Email" tabindex="2" name="authors" value="" /> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Journal</div> </div> <select id="journal" tabindex="3" name="journal" class="chosen-select"> <option value="">All Journals</option> <option value="acoustics" > Acoustics </option> <option value="amh" > Acta Microbiologica Hellenica (AMH) </option> <option value="actuators" > Actuators </option> <option value="admsci" > Administrative Sciences </option> <option value="adolescents" > Adolescents </option> <option value="arm" > Advances in Respiratory Medicine (ARM) </option> <option value="aerobiology" > Aerobiology </option> <option value="aerospace" > Aerospace </option> <option value="agriculture" > Agriculture </option> <option value="agriengineering" > AgriEngineering </option> <option value="agrochemicals" > Agrochemicals </option> <option value="agronomy" > Agronomy </option> <option value="ai" > AI </option> <option value="air" > Air </option> <option value="algorithms" > Algorithms </option> <option value="allergies" > Allergies </option> <option value="alloys" > Alloys </option> <option value="analytica" > Analytica </option> <option value="analytics" > Analytics </option> <option value="anatomia" > Anatomia </option> <option value="anesthres" > Anesthesia Research </option> <option value="animals" > Animals </option> <option value="antibiotics" > Antibiotics </option> <option value="antibodies" > Antibodies </option> <option value="antioxidants" > Antioxidants </option> <option value="applbiosci" > Applied Biosciences </option> <option value="applmech" > Applied Mechanics </option> <option value="applmicrobiol" > Applied Microbiology </option> <option value="applnano" > Applied Nano </option> <option value="applsci" > Applied Sciences </option> <option value="asi" > Applied System Innovation (ASI) </option> <option value="appliedchem" > AppliedChem </option> <option value="appliedmath" > AppliedMath </option> <option value="aquacj" > Aquaculture Journal </option> <option value="architecture" > Architecture </option> <option value="arthropoda" > Arthropoda </option> <option value="arts" > Arts </option> <option value="astronomy" > Astronomy </option> <option value="atmosphere" > Atmosphere </option> <option value="atoms" > Atoms </option> <option value="audiolres" > Audiology Research </option> <option value="automation" > Automation </option> <option value="axioms" > Axioms </option> <option value="bacteria" > Bacteria </option> <option value="batteries" > Batteries </option> <option value="behavsci" > Behavioral Sciences </option> <option value="beverages" > Beverages </option> <option value="BDCC" > Big Data and Cognitive Computing (BDCC) </option> <option value="biochem" > BioChem </option> <option value="bioengineering" > Bioengineering </option> <option value="biologics" > Biologics </option> <option value="biology" > Biology </option> <option value="blsf" > Biology and Life Sciences Forum </option> <option value="biomass" > Biomass </option> <option value="biomechanics" > Biomechanics </option> <option value="biomed" > BioMed </option> <option value="biomedicines" > Biomedicines </option> <option value="biomedinformatics" > BioMedInformatics </option> <option value="biomimetics" > Biomimetics </option> <option value="biomolecules" > Biomolecules </option> <option value="biophysica" > Biophysica </option> <option value="biosensors" > Biosensors </option> <option value="biotech" > BioTech </option> <option value="birds" > Birds </option> <option value="blockchains" > Blockchains </option> <option value="brainsci" > Brain Sciences </option> <option value="buildings" > Buildings </option> <option value="businesses" > Businesses </option> <option value="carbon" > C </option> <option value="cancers" selected='selected'> Cancers </option> <option value="cardiogenetics" > Cardiogenetics </option> <option value="catalysts" > Catalysts </option> <option value="cells" > Cells </option> <option value="ceramics" > Ceramics </option> <option value="challenges" > Challenges </option> <option value="ChemEngineering" > ChemEngineering </option> <option value="chemistry" > Chemistry </option> <option value="chemproc" > Chemistry Proceedings </option> <option value="chemosensors" > Chemosensors </option> <option value="children" > Children </option> <option value="chips" > Chips </option> <option value="civileng" > CivilEng </option> <option value="cleantechnol" > Clean Technologies (Clean Technol.) </option> <option value="climate" > Climate </option> <option value="ctn" > Clinical and Translational Neuroscience (CTN) </option> <option value="clinbioenerg" > Clinical Bioenergetics </option> <option value="clinpract" > Clinics and Practice </option> <option value="clockssleep" > Clocks & Sleep </option> <option value="coasts" > Coasts </option> <option value="coatings" > Coatings </option> <option value="colloids" > Colloids and Interfaces </option> <option value="colorants" > Colorants </option> <option value="commodities" > Commodities </option> <option value="complications" > Complications </option> <option value="compounds" > Compounds </option> <option value="computation" > Computation </option> <option value="csmf" > Computer Sciences & Mathematics Forum </option> <option value="computers" > Computers </option> <option value="condensedmatter" > Condensed Matter </option> <option value="conservation" > Conservation </option> <option value="constrmater" > Construction Materials </option> <option value="cmd" > Corrosion and Materials Degradation (CMD) </option> <option value="cosmetics" > Cosmetics </option> <option value="covid" > COVID </option> <option value="crops" > Crops </option> <option value="cryo" > Cryo </option> <option value="cryptography" > Cryptography </option> <option value="crystals" > Crystals </option> <option value="cimb" > Current Issues in Molecular Biology (CIMB) </option> <option value="curroncol" > Current Oncology </option> <option value="dairy" > Dairy </option> <option value="data" > Data </option> <option value="dentistry" > Dentistry Journal </option> <option value="dermato" > Dermato </option> <option value="dermatopathology" > Dermatopathology </option> <option value="designs" > Designs </option> <option value="diabetology" > Diabetology </option> <option value="diagnostics" > Diagnostics </option> <option value="dietetics" > Dietetics </option> <option value="digital" > Digital </option> <option value="disabilities" > Disabilities </option> <option value="diseases" > Diseases </option> <option value="diversity" > Diversity </option> <option value="dna" > DNA </option> <option value="drones" > Drones </option> <option value="ddc" > Drugs and Drug Candidates (DDC) </option> <option value="dynamics" > Dynamics </option> <option value="earth" > Earth </option> <option value="ecologies" > Ecologies </option> <option value="econometrics" > Econometrics </option> <option value="economies" > Economies </option> <option value="education" > Education Sciences </option> <option value="electricity" > Electricity </option> <option value="electrochem" > Electrochem </option> <option value="electronicmat" > Electronic Materials </option> <option value="electronics" > Electronics </option> <option value="ecm" > Emergency Care and Medicine </option> <option value="encyclopedia" > Encyclopedia </option> <option value="endocrines" > Endocrines </option> <option value="energies" > Energies </option> <option value="esa" > Energy Storage and Applications (ESA) </option> <option value="eng" > Eng </option> <option value="engproc" > Engineering Proceedings </option> <option value="entropy" > Entropy </option> <option value="environsciproc" > Environmental Sciences Proceedings </option> <option value="environments" > Environments </option> <option value="epidemiologia" > Epidemiologia </option> <option value="epigenomes" > Epigenomes </option> <option value="ebj" > European Burn Journal (EBJ) </option> <option value="ejihpe" > European Journal of Investigation in Health, Psychology and Education (EJIHPE) </option> <option value="fermentation" > Fermentation </option> <option value="fibers" > Fibers </option> <option value="fintech" > FinTech </option> <option value="fire" > Fire </option> <option value="fishes" > Fishes </option> <option value="fluids" > Fluids </option> <option value="foods" > Foods </option> <option value="forecasting" > Forecasting </option> <option value="forensicsci" > Forensic Sciences </option> <option value="forests" > Forests </option> <option value="fossstud" > Fossil Studies </option> <option value="foundations" > Foundations </option> <option value="fractalfract" > Fractal and Fractional (Fractal Fract) </option> <option value="fuels" > Fuels </option> <option value="future" > Future </option> <option value="futureinternet" > Future Internet </option> <option value="futurepharmacol" > Future Pharmacology </option> <option value="futuretransp" > Future Transportation </option> <option value="galaxies" > Galaxies </option> <option value="games" > Games </option> <option value="gases" > Gases </option> <option value="gastroent" > Gastroenterology Insights </option> <option value="gastrointestdisord" > Gastrointestinal Disorders </option> <option value="gastronomy" > Gastronomy </option> <option value="gels" > Gels </option> <option value="genealogy" > Genealogy </option> <option value="genes" > Genes </option> <option value="geographies" > Geographies </option> <option value="geohazards" > GeoHazards </option> <option value="geomatics" > Geomatics </option> <option value="geometry" > Geometry </option> <option value="geosciences" > Geosciences </option> <option value="geotechnics" > Geotechnics </option> <option value="geriatrics" > Geriatrics </option> <option value="glacies" > Glacies </option> <option value="gucdd" > Gout, Urate, and Crystal Deposition Disease (GUCDD) </option> <option value="grasses" > Grasses </option> <option value="hardware" > Hardware </option> <option value="healthcare" > Healthcare </option> <option value="hearts" > Hearts </option> <option value="hemato" > Hemato </option> <option value="hematolrep" > Hematology Reports </option> <option value="heritage" > Heritage </option> <option value="histories" > Histories </option> <option value="horticulturae" > Horticulturae </option> <option value="hospitals" > Hospitals </option> <option value="humanities" > Humanities </option> <option value="humans" > Humans </option> <option value="hydrobiology" > Hydrobiology </option> <option value="hydrogen" > Hydrogen </option> <option value="hydrology" > Hydrology </option> <option value="hygiene" > Hygiene </option> <option value="immuno" > Immuno </option> <option value="idr" > Infectious Disease Reports </option> <option value="informatics" > Informatics </option> <option value="information" > Information </option> <option value="infrastructures" > Infrastructures </option> <option value="inorganics" > Inorganics </option> <option value="insects" > Insects </option> <option value="instruments" > Instruments </option> <option value="iic" > Intelligent Infrastructure and Construction </option> <option value="ijerph" > International Journal of Environmental Research and Public Health (IJERPH) </option> <option value="ijfs" > International Journal of Financial Studies (IJFS) </option> <option value="ijms" > International Journal of Molecular Sciences (IJMS) </option> <option value="IJNS" > International Journal of Neonatal Screening (IJNS) </option> <option value="ijpb" > International Journal of Plant Biology (IJPB) </option> <option value="ijt" > International Journal of Topology </option> <option value="ijtm" > International Journal of Translational Medicine (IJTM) </option> <option value="ijtpp" > International Journal of Turbomachinery, Propulsion and Power (IJTPP) </option> <option value="ime" > International Medical Education (IME) </option> <option value="inventions" > Inventions </option> <option value="IoT" > IoT </option> <option value="ijgi" > ISPRS International Journal of Geo-Information (IJGI) </option> <option value="J" > J </option> <option value="jal" > Journal of Ageing and Longevity (JAL) </option> <option value="jcdd" > Journal of Cardiovascular Development and Disease (JCDD) </option> <option value="jcto" > Journal of Clinical & Translational Ophthalmology (JCTO) </option> <option value="jcm" > Journal of Clinical Medicine (JCM) </option> <option value="jcs" > Journal of Composites Science (J. Compos. Sci.) </option> <option value="jcp" > Journal of Cybersecurity and Privacy (JCP) </option> <option value="jdad" > Journal of Dementia and Alzheimer's Disease (JDAD) </option> <option value="jdb" > Journal of Developmental Biology (JDB) </option> <option value="jeta" > Journal of Experimental and Theoretical Analyses (JETA) </option> <option value="jfb" > Journal of Functional Biomaterials (JFB) </option> <option value="jfmk" > Journal of Functional Morphology and Kinesiology (JFMK) </option> <option value="jof" > Journal of Fungi (JoF) </option> <option value="jimaging" > Journal of Imaging (J. Imaging) </option> <option value="jintelligence" > Journal of Intelligence (J. Intell.) </option> <option value="jlpea" > Journal of Low Power Electronics and Applications (JLPEA) </option> <option value="jmmp" > Journal of Manufacturing and Materials Processing (JMMP) </option> <option value="jmse" > Journal of Marine Science and Engineering (JMSE) </option> <option value="jmahp" > Journal of Market Access & Health Policy (JMAHP) </option> <option value="jmp" > Journal of Molecular Pathology (JMP) </option> <option value="jnt" > Journal of Nanotheranostics (JNT) </option> <option value="jne" > Journal of Nuclear Engineering (JNE) </option> <option value="ohbm" > Journal of Otorhinolaryngology, Hearing and Balance Medicine (JOHBM) </option> <option value="jop" > Journal of Parks </option> <option value="jpm" > Journal of Personalized Medicine (JPM) </option> <option value="jpbi" > Journal of Pharmaceutical and BioTech Industry (JPBI) </option> <option value="jor" > Journal of Respiration (JoR) </option> <option value="jrfm" > Journal of Risk and Financial Management (JRFM) </option> <option value="jsan" > Journal of Sensor and Actuator Networks (JSAN) </option> <option value="joma" > Journal of the Oman Medical Association (JOMA) </option> <option value="jtaer" > Journal of Theoretical and Applied Electronic Commerce Research (JTAER) </option> <option value="jvd" > Journal of Vascular Diseases (JVD) </option> <option value="jox" > Journal of Xenobiotics (JoX) </option> <option value="jzbg" > Journal of Zoological and Botanical Gardens (JZBG) </option> <option value="journalmedia" > Journalism and Media </option> <option value="kidneydial" > Kidney and Dialysis </option> <option value="kinasesphosphatases" > Kinases and Phosphatases </option> <option value="knowledge" > Knowledge </option> <option value="labmed" > LabMed </option> <option value="laboratories" > Laboratories </option> <option value="land" > Land </option> <option value="languages" > Languages </option> <option value="laws" > Laws </option> <option value="life" > Life </option> <option value="limnolrev" > Limnological Review </option> <option value="lipidology" > Lipidology </option> <option value="liquids" > Liquids </option> <option value="literature" > Literature </option> <option value="livers" > Livers </option> <option value="logics" > Logics </option> <option value="logistics" > Logistics </option> <option value="lubricants" > Lubricants </option> <option value="lymphatics" > Lymphatics </option> <option value="make" > Machine Learning and Knowledge Extraction (MAKE) </option> <option value="machines" > Machines </option> <option value="macromol" > Macromol </option> <option value="magnetism" > Magnetism </option> <option value="magnetochemistry" > Magnetochemistry </option> <option value="marinedrugs" > Marine Drugs </option> <option value="materials" > Materials </option> <option value="materproc" > Materials Proceedings </option> <option value="mca" > Mathematical and Computational Applications (MCA) </option> <option value="mathematics" > Mathematics </option> <option value="medsci" > Medical Sciences </option> <option value="msf" > Medical Sciences Forum </option> <option value="medicina" > Medicina </option> <option value="medicines" > Medicines </option> <option value="membranes" > Membranes </option> <option value="merits" > Merits </option> <option value="metabolites" > Metabolites </option> <option value="metals" > Metals </option> <option value="meteorology" > Meteorology </option> <option value="methane" > Methane </option> <option value="mps" > Methods and Protocols (MPs) </option> <option value="metrics" > Metrics </option> <option value="metrology" > Metrology </option> <option value="micro" > Micro </option> <option value="microbiolres" > Microbiology Research </option> <option value="micromachines" > Micromachines </option> <option value="microorganisms" > Microorganisms </option> <option value="microplastics" > Microplastics </option> <option value="minerals" > Minerals </option> <option value="mining" > Mining </option> <option value="modelling" > Modelling </option> <option value="mmphys" > Modern Mathematical Physics </option> <option value="molbank" > Molbank </option> <option value="molecules" > Molecules </option> <option value="mti" > Multimodal Technologies and Interaction (MTI) </option> <option value="muscles" > Muscles </option> <option value="nanoenergyadv" > Nanoenergy Advances </option> <option value="nanomanufacturing" > Nanomanufacturing </option> <option value="nanomaterials" > Nanomaterials </option> <option value="ndt" > NDT </option> <option value="network" > Network </option> <option value="neuroglia" > Neuroglia </option> <option value="neurolint" > Neurology International </option> <option value="neurosci" > NeuroSci </option> <option value="nitrogen" > Nitrogen </option> <option value="ncrna" > Non-Coding RNA (ncRNA) </option> <option value="nursrep" > Nursing Reports </option> <option value="nutraceuticals" > Nutraceuticals </option> <option value="nutrients" > Nutrients </option> <option value="obesities" > Obesities </option> <option value="oceans" > Oceans </option> <option value="onco" > Onco </option> <option value="optics" > Optics </option> <option value="oral" > Oral </option> <option value="organics" > Organics </option> <option value="organoids" > Organoids </option> <option value="osteology" > Osteology </option> <option value="oxygen" > Oxygen </option> <option value="parasitologia" > Parasitologia </option> <option value="particles" > Particles </option> <option value="pathogens" > Pathogens </option> <option value="pathophysiology" > Pathophysiology </option> <option value="pediatrrep" > Pediatric Reports </option> <option value="pets" > Pets </option> <option value="pharmaceuticals" > Pharmaceuticals </option> <option value="pharmaceutics" > Pharmaceutics </option> <option value="pharmacoepidemiology" > Pharmacoepidemiology </option> <option value="pharmacy" > Pharmacy </option> <option value="philosophies" > Philosophies </option> <option value="photochem" > Photochem </option> <option value="photonics" > Photonics </option> <option value="phycology" > Phycology </option> <option value="physchem" > Physchem </option> <option value="psf" > Physical Sciences Forum </option> <option value="physics" > Physics </option> <option value="physiologia" > Physiologia </option> <option value="plants" > Plants </option> <option value="plasma" > Plasma </option> <option value="platforms" > Platforms </option> <option value="pollutants" > Pollutants </option> <option value="polymers" > Polymers </option> <option value="polysaccharides" > Polysaccharides </option> <option value="populations" > Populations </option> <option value="poultry" > Poultry </option> <option value="powders" > Powders </option> <option value="proceedings" > Proceedings </option> <option value="processes" > Processes </option> <option value="prosthesis" > Prosthesis </option> <option value="proteomes" > Proteomes </option> <option value="psychiatryint" > Psychiatry International </option> <option value="psychoactives" > Psychoactives </option> <option value="psycholint" > Psychology International </option> <option value="publications" > Publications </option> <option value="qubs" > Quantum Beam Science (QuBS) </option> <option value="quantumrep" > Quantum Reports </option> <option value="quaternary" > Quaternary </option> <option value="radiation" > Radiation </option> <option value="reactions" > Reactions </option> <option value="realestate" > Real Estate </option> <option value="receptors" > Receptors </option> <option value="recycling" > Recycling </option> <option value="rsee" > Regional Science and Environmental Economics (RSEE) </option> <option value="religions" > Religions </option> <option value="remotesensing" > Remote Sensing </option> <option value="reports" > Reports </option> <option value="reprodmed" > Reproductive Medicine (Reprod. Med.) </option> <option value="resources" > Resources </option> <option value="rheumato" > Rheumato </option> <option value="risks" > Risks </option> <option value="robotics" > Robotics </option> <option value="ruminants" > Ruminants </option> <option value="safety" > Safety </option> <option value="sci" > Sci </option> <option value="scipharm" > Scientia Pharmaceutica (Sci. Pharm.) </option> <option value="sclerosis" > Sclerosis </option> <option value="seeds" > Seeds </option> <option value="sensors" > Sensors </option> <option value="separations" > Separations </option> <option value="sexes" > Sexes </option> <option value="signals" > Signals </option> <option value="sinusitis" > Sinusitis </option> <option value="smartcities" > Smart Cities </option> <option value="socsci" > Social Sciences </option> <option value="siuj" > Société Internationale d’Urologie Journal (SIUJ) </option> <option value="societies" > Societies </option> <option value="software" > Software </option> <option value="soilsystems" > Soil Systems </option> <option value="solar" > Solar </option> <option value="solids" > Solids </option> <option value="spectroscj" > Spectroscopy Journal </option> <option value="sports" > Sports </option> <option value="standards" > Standards </option> <option value="stats" > Stats </option> <option value="stresses" > Stresses </option> <option value="surfaces" > Surfaces </option> <option value="surgeries" > Surgeries </option> <option value="std" > Surgical Techniques Development </option> <option value="sustainability" > Sustainability </option> <option value="suschem" > Sustainable Chemistry </option> <option value="symmetry" > Symmetry </option> <option value="synbio" > SynBio </option> <option value="systems" > Systems </option> <option value="targets" > Targets </option> <option value="taxonomy" > Taxonomy </option> <option value="technologies" > Technologies </option> <option value="telecom" > Telecom </option> <option value="textiles" > Textiles </option> <option value="thalassrep" > Thalassemia Reports </option> <option value="therapeutics" > Therapeutics </option> <option value="thermo" > Thermo </option> <option value="timespace" > Time and Space </option> <option value="tomography" > Tomography </option> <option value="tourismhosp" > Tourism and Hospitality </option> <option value="toxics" > Toxics </option> <option value="toxins" > Toxins </option> <option value="transplantology" > Transplantology </option> <option value="traumacare" > Trauma Care </option> <option value="higheredu" > Trends in Higher Education </option> <option value="tropicalmed" > Tropical Medicine and Infectious Disease (TropicalMed) </option> <option value="universe" > Universe </option> <option value="urbansci" > Urban Science </option> <option value="uro" > Uro </option> <option value="vaccines" > Vaccines </option> <option value="vehicles" > Vehicles </option> <option value="venereology" > Venereology </option> <option value="vetsci" > Veterinary Sciences </option> <option value="vibration" > Vibration </option> <option value="virtualworlds" > Virtual Worlds </option> <option value="viruses" > Viruses </option> <option value="vision" > Vision </option> <option value="waste" > Waste </option> <option value="water" > Water </option> <option value="wild" > Wild </option> <option value="wind" > Wind </option> <option value="women" > Women </option> <option value="world" > World </option> <option value="wevj" > World Electric Vehicle Journal (WEVJ) </option> <option value="youth" > Youth </option> <option value="zoonoticdis" > Zoonotic Diseases </option> </select> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Article Type</div> </div> <select id="article_type" tabindex="4" name="article_type" class="chosen-select"> <option value="">All Article Types</option> <option value="research-article">Article</option> <option value="review-article">Review</option> <option value="rapid-communication">Communication</option> <option value="editorial">Editorial</option> <option value="abstract">Abstract</option> <option value="book-review">Book Review</option> <option value="brief-communication">Brief Communication</option> <option value="brief-report">Brief Report</option> <option value="case-report">Case Report</option> <option value="clinicopathological-challenge">Clinicopathological Challenge</option> <option value="article-commentary">Comment</option> <option value="commentary">Commentary</option> <option value="concept-paper">Concept Paper</option> <option value="conference-report">Conference Report</option> <option value="correction">Correction</option> <option value="creative">Creative</option> <option value="data-descriptor">Data Descriptor</option> <option value="discussion">Discussion</option> <option value="Entry">Entry</option> <option value="essay">Essay</option> <option value="expression-of-concern">Expression of Concern</option> <option value="extended-abstract">Extended Abstract</option> <option value="field-guide">Field Guide</option> <option value="guidelines">Guidelines</option> <option value="hypothesis">Hypothesis</option> <option value="interesting-image">Interesting Images</option> <option value="letter">Letter</option> <option value="books-received">New Book Received</option> <option value="obituary">Obituary</option> <option value="opinion">Opinion</option> <option value="perspective">Perspective</option> <option value="proceedings">Proceeding Paper</option> <option value="project-report">Project Report</option> <option value="protocol">Protocol</option> <option value="registered-report">Registered Report</option> <option value="reply">Reply</option> <option value="retraction">Retraction</option> <option value="note">Short Note</option> <option value="study-protocol">Study Protocol</option> <option value="systematic_review">Systematic Review</option> <option value="technical-note">Technical Note</option> <option value="tutorial">Tutorial</option> <option value="viewpoint">Viewpoint</option> </select> </div> <div class="large-1 medium-1 small-6 end columns small-push-6 medium-reset-order large-reset-order js-search-collapsed-button-container"> <div class="search-input-label"> </div> <input type="submit" id="search" value="Search" class="button button--dark button--full-width searchButton1 US_SearchButton" tabindex="12"> </div> <div class="large-1 medium-1 small-6 end columns large-text-left small-only-text-center small-pull-6 medium-reset-order large-reset-order js-search-collapsed-link-container"> <div class="search-input-label"> </div> <a class="main-search-clear search-container__link" href="#" onclick="openAdvanced(''); return false;">Advanced<span class="show-for-small-only"> Search</span></a> </div> </div> </div> <div class="search-container__advanced" style="margin-top: 0; padding-top: 0px; background-color: inherit; color: inherit;"> <div class="row"> <div class="large-2 medium-2 columns show-for-medium-up"> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Section</div> </div> <select id="section" tabindex="5" name="section" class="chosen-select"> <option value=""></option> </select> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Special Issue</div> </div> <select id="special_issue" tabindex="6" name="special_issue" class="chosen-select"> <option value=""></option> </select> </div> <div class="large-1 medium-1 small-6 end columns "> <div class="search-input-label">Volume</div> <input type="text" id="volume" tabindex="7" name="volume" placeholder="..." value="11" /> </div> <div class="large-1 medium-1 small-6 end columns "> <div class="search-input-label">Issue</div> <input type="text" id="issue" tabindex="8" name="issue" placeholder="..." value="12" /> </div> <div class="large-1 medium-1 small-6 end columns "> <div class="search-input-label">Number</div> <input type="text" id="number" tabindex="9" name="number" placeholder="..." value="" /> </div> <div class="large-1 medium-1 small-6 end columns "> <div class="search-input-label">Page</div> <input type="text" id="page" tabindex="10" name="page" placeholder="..." value="" /> </div> <div class="large-1 medium-1 small-6 columns small-push-6 medium-reset order large-reset-order medium-reset-order js-search-expanded-button-container"></div> <div class="large-1 medium-1 small-6 columns large-text-left small-only-text-center small-pull-6 medium-reset-order large-reset-order js-search-expanded-link-container"></div> </div> </div> </form> <form id="advanced-search" class="large-12 medium-12 columns"> <div class="search-container__advanced"> <div id="advanced-search-template" class="row advanced-search-row"> <div class="large-2 medium-2 small-12 columns show-for-medium-up"> </div> <div class="large-2 medium-2 small-3 columns connector-div"> <div class="search-input-label"><span class="show-for-medium-up">Logical Operator</span><span class="show-for-small">Operator</span></div> <select class="connector"> <option value="and">AND</option> <option value="or">OR</option> </select> </div> <div class="large-3 medium-3 small-6 columns search-text-div"> <div class="search-input-label">Search Text</div> <input type="text" class="search-text" placeholder="Search text"> </div> <div class="large-2 medium-2 small-6 large-offset-0 medium-offset-0 small-offset-3 columns search-field-div"> <div class="search-input-label">Search Type</div> <select class="search-field"> <option value="all">All fields</option> <option value="title">Title</option> <option value="abstract">Abstract</option> <option value="keywords">Keywords</option> <option value="authors">Authors</option> <option value="affiliations">Affiliations</option> <option value="doi">Doi</option> <option value="full_text">Full Text</option> <option value="references">References</option> </select> </div> <div class="large-1 medium-1 small-3 columns"> <div class="search-input-label"> </div> <div class="search-action-div"> <div class="search-plus"> <i class="material-icons">add_circle_outline</i> </div> </div> <div class="search-action-div"> <div class="search-minus"> <i class="material-icons">remove_circle_outline</i> </div> </div> </div> <div class="large-1 medium-1 small-6 large-offset-0 medium-offset-0 small-offset-3 end columns"> <div class="search-input-label"> </div> <input class="advanced-search-button button button--dark search-submit" type="submit" value="Search"> </div> <div class="large-1 medium-1 small-6 end columns show-for-medium-up"></div> </div> </div> </form> </div> <div class="header-divider"> </div> <div class="breadcrumb row full-row"> <div class="breadcrumb__element"> <a href="/about/journals">Journals</a> </div> <div class="breadcrumb__element"> <a href="/journal/cancers">Cancers</a> </div> <div class="breadcrumb__element"> <a href="/2072-6694/11">Volume 11</a> </div> <div class="breadcrumb__element"> <a href="/2072-6694/11/12">Issue 12</a> </div> <div class="breadcrumb__element"> <a href="#">10.3390/cancers11121889</a> </div> </div> </header> <div id="main-content" class=""> <div class="row full-width row-fixed-left-column"> <div id="left-column" class="content__column large-3 medium-3 small-12 columns"> <div class="content__container"> <a href="/journal/cancers"> <img src="https://pub.mdpi-res.com/img/journals/cancers-logo.png?8600e93ff98dbf14" alt="cancers-logo" title="Cancers" style="max-height: 60px; margin: 0 0 0 0;"> </a> <div class="generic-item no-border"> <a class="button button--color button--full-width js-journal-active-only-link js-journal-active-only-submit-link UC_ArticleSubmitButton" href="https://susy.mdpi.com/user/manuscripts/upload?form%5Bjournal_id%5D%3D23" data-disabledmessage="creating new submissions is not possible."> Submit to this Journal </a> <a class="button button--color button--full-width js-journal-active-only-link UC_ArticleReviewButton" href="https://susy.mdpi.com/volunteer/journals/review" data-disabledmessage="volunteering as journal reviewer is not possible."> Review for this Journal </a> <a class="button button--color-inversed button--color-journal button--full-width js-journal-active-only-link UC_ArticleEditIssueButton" href="/journalproposal/sendproposalspecialissue/cancers" data-path="/2072-6694/11/12/1889" data-disabledmessage="proposing new special issue is not possible."> Propose a Special Issue </a> </div> <div class="generic-item link-article-menu show-for-small"> <a href="#" class="link-article-menu show-for-small"> <span class="closed">►</span> <span class="open" style="display: none;">▼</span> Article Menu </a> </div> <div class="hide-small-down-initially UI_ArticleMenu"> <div class="generic-item"> <h2>Article Menu</h2> </div> <ul class="accordion accordion__menu" data-accordion data-options="multi_expand:true;toggleable: true"> <li class="accordion-direct-link"> <a href="/2072-6694/11/12/1889/scifeed_display" data-reveal-id="scifeed-modal" data-reveal-ajax="true">Subscribe SciFeed</a> </li> <li class="accordion-direct-link js-article-similarity-container" style="display: none"> <a href="#" class="js-similarity-related-articles">Recommended Articles</a> </li> <li class="accordion-navigation"> <a href="#related" class="accordion__title">Related Info Links</a> <div id="related" class="content UI_ArticleMenu_RelatedLinks"> <ul> <li class="li-link"> <a href="http://www.ncbi.nlm.nih.gov/sites/entrez/31783695" target="_blank" rel="noopener noreferrer">PubMed/Medline</a> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Bioprofiling%20TS%2FA%20Murine%20Mammary%20Cancer%20for%20a%20Functional%20Precision%20Experimental%20Model" target="_blank" rel="noopener noreferrer">Google Scholar</a> </li> </ul> </div> </li> <li class="accordion-navigation"> <a href="#authors" class="accordion__title">More by Authors Links</a> <div id="authors" class="content UI_ArticleMenu_AuthorsLinks"> <ul class="side-menu-ul"> <li> <a class="expand" onclick='$(this).closest("li").next("div").toggle(); return false;'>on DOAJ</a> </li> <div id="AuthorDOAJExpand" style="display:none;"> <ul class="submenu"> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Carla%20De%20Giovanni%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">De Giovanni, C.</a> <li> </li> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Giordano%20Nicoletti%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Nicoletti, G.</a> <li> </li> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Lorena%20Landuzzi%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Landuzzi, L.</a> <li> </li> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Arianna%20Palladini%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Palladini, A.</a> <li> </li> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Pier-Luigi%20Lollini%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Lollini, P.</a> <li> </li> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Patrizia%20Nanni%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Nanni, P.</a> <li> </li> </ul> </div> <li> <a class="expand" onclick='$(this).closest("li").next("div").toggle(); return false;'>on Google Scholar</a> </li> <div id="AuthorGoogleExpand" style="display:none;"> <ul class="submenu"> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Carla%20De%20Giovanni" target="_blank" rel="noopener noreferrer">De Giovanni, C.</a> <li> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Giordano%20Nicoletti" target="_blank" rel="noopener noreferrer">Nicoletti, G.</a> <li> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Lorena%20Landuzzi" target="_blank" rel="noopener noreferrer">Landuzzi, L.</a> <li> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Arianna%20Palladini" target="_blank" rel="noopener noreferrer">Palladini, A.</a> <li> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Pier-Luigi%20Lollini" target="_blank" rel="noopener noreferrer">Lollini, P.</a> <li> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Patrizia%20Nanni" target="_blank" rel="noopener noreferrer">Nanni, P.</a> <li> </li> </ul> </div> <li> <a class="expand" onclick='$(this).closest("li").next("div").toggle(); return false;'>on PubMed</a> </li> <div id="AuthorPubMedExpand" style="display:none;"> <ul class="submenu"> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Carla%20De%20Giovanni" target="_blank" rel="noopener noreferrer">De Giovanni, C.</a> <li> </li> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Giordano%20Nicoletti" target="_blank" rel="noopener noreferrer">Nicoletti, G.</a> <li> </li> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Lorena%20Landuzzi" target="_blank" rel="noopener noreferrer">Landuzzi, L.</a> <li> </li> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Arianna%20Palladini" target="_blank" rel="noopener noreferrer">Palladini, A.</a> <li> </li> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Pier-Luigi%20Lollini" target="_blank" rel="noopener noreferrer">Lollini, P.</a> <li> </li> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Patrizia%20Nanni" target="_blank" rel="noopener noreferrer">Nanni, P.</a> <li> </li> </ul> </div> </ul> </div> </li> </ul> <span style="display:none" id="scifeed_hidden_flag"></span> <span style="display:none" id="scifeed_subscribe_url">/ajax/scifeed/subscribe</span> </div> </div> <div class="content__container responsive-moving-container large medium active hidden" data-id="article-counters"> <div id="counts-wrapper" class="row generic-item no-border" data-equalizer> <div id="js-counts-wrapper__views" class="small-12 hide columns count-div-container"> <a href="#metrics" > <div class="count-div" data-equalizer-watch> <span class="name">Article Views</span> <span class="count view-number"></span> </div> </a> </div> <div id="js-counts-wrapper__citations" class="small-12 columns hide count-div-container"> <a href="#metrics" > <div class="count-div" data-equalizer-watch> <span class="name">Citations</span> <span class="count citations-number Var_ArticleMaxCitations">-</span> </div> </a> </div> </div> </div> <div class="content__container"> <div class="hide-small-down-initially"> <ul class="accordion accordion__menu" data-accordion data-options="multi_expand:true;toggleable: true"> <li class="accordion-navigation"> <a href="#table_of_contents" class="accordion__title">Table of Contents</a> <div id="table_of_contents" class="content active"> <div class="menu-caption" id="html-quick-links-title"></div> </div> </li> </ul> </div> </div> <!-- PubGrade code --> <div id="pbgrd-sky"></div> <script src="https://cdn.pbgrd.com/core-mdpi.js"></script> <style>.content__container { min-width: 300px; }</style> <!-- PubGrade code --> </div> <div id="middle-column" class="content__column large-9 medium-9 small-12 columns end middle-bordered"> <div class="middle-column__help"> <div class="middle-column__help__fixed show-for-medium-up"> <span id="js-altmetrics-donut" href="#" target="_blank" rel="noopener noreferrer" style="display: none;"> <span data-badge-type='donut' class='altmetric-embed' data-doi='10.3390/cancers11121889'></span> <span>Altmetric</span> </span> <a href="#" class="UA_ShareButton" data-reveal-id="main-share-modal" title="Share"> <i class="material-icons">share</i> <span>Share</span> </a> <a href="#" data-reveal-id="main-help-modal" title="Help"> <i class="material-icons">announcement</i> <span>Help</span> </a> <a href="javascript:void(0);" data-reveal-id="cite-modal" data-counterslink = "https://www.mdpi.com/2072-6694/11/12/1889/cite" > <i class="material-icons">format_quote</i> <span>Cite</span> </a> <a href="https://sciprofiles.com/discussion-groups/public/10.3390/cancers11121889?utm_source=mpdi.com&utm_medium=publication&utm_campaign=discuss_in_sciprofiles" target="_blank" rel="noopener noreferrer" title="Discuss in Sciprofiles"> <i class="material-icons">question_answer</i> <span>Discuss in SciProfiles</span> </a> <a href="#" class="" data-hypothesis-trigger-endorses-tab title="Endorse"> <i data-hypothesis-endorse-trigger class="material-icons" >thumb_up</i> <div data-hypothesis-endorsement-count data-hypothesis-trigger-endorses-tab class="hypothesis-count-container"> ... </div> <span>Endorse</span> </a> <a href="#" data-hypothesis-trigger class="js-hypothesis-open UI_ArticleAnnotationsButton" title="Comment"> <i class="material-icons">textsms</i> <div data-hypothesis-annotation-count class="hypothesis-count-container"> ... </div> <span>Comment</span> </a> </div> <div id="main-help-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 style="margin: 0;">Need Help?</h2> </div> <div class="small-6 columns"> <h3>Support</h3> <p> Find support for a specific problem in the support section of our website. </p> <a target="_blank" href="/about/contactform" class="button button--color button--full-width"> Get Support </a> </div> <div class="small-6 columns"> <h3>Feedback</h3> <p> Please let us know what you think of our products and services. </p> <a target="_blank" href="/feedback/send" class="button button--color button--full-width"> Give Feedback </a> </div> <div class="small-6 columns end"> <h3>Information</h3> <p> Visit our dedicated information section to learn more about MDPI. </p> <a target="_blank" href="/authors" class="button button--color button--full-width"> Get Information </a> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> </div> <div class="middle-column__main "> <div class="page-highlight"> <style type="text/css"> img.review-status { width: 30px; } </style> <div id="jmolModal" class="reveal-modal" data-reveal aria-labelledby="Captcha" aria-hidden="true" role="dialog"> <h2>JSmol Viewer</h2> <div class="row"> <div class="small-12 columns text-center"> <iframe style="width: 520px; height: 520px;" frameborder="0" id="jsmol-content"></iframe> <div class="content"></div> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <div itemscope itemtype="http://schema.org/ScholarlyArticle" id="abstract" class="abstract_div"> <div class="js-check-update-container"></div> <div class="html-content__container content__container content__container__combined-for-large__first" style="overflow: auto; position: inherit;"> <div class='html-profile-nav'> <div class='top-bar'> <div class='nav-sidebar-btn show-for-large-up' data-status='opened' > <i class='material-icons'>first_page</i> </div> <a id="js-button-download" class="button button--color-inversed" style="display: none;" href="/2072-6694/11/12/1889/pdf?version=1576638352" data-name="Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model" data-journal="cancers"> <i class="material-icons custom-download"></i> Download PDF </a> <div class='nav-btn'> <i class='material-icons'>settings</i> </div> <a href="/2072-6694/11/12/1889/reprints" id="js-button-reprints" class="button button--color-inversed"> Order Article Reprints </a> </div> <div class='html-article-menu'> <div class='html-first-step row'> <div class='html-font-family large-6 medium-6 small-12 columns'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns'> Font Type: </div> <div class='large-8 medium-8 small-12 columns'> <span class="html-article-menu-option"><i style='font-family:Arial, Arial, Helvetica, sans-serif;' data-fontfamily='Arial, Arial, Helvetica, sans-serif'>Arial</i></span> <span class="html-article-menu-option"><i style='font-family:Georgia1, Georgia, serif;' data-fontfamily='Georgia1, Georgia, serif'>Georgia</i></span> <span class="html-article-menu-option"><i style='font-family:Verdana, Verdana, Geneva, sans-serif;' data-fontfamily='Verdana, Verdana, Geneva, sans-serif' >Verdana</i></span> </div> </div> </div> <div class='html-font-resize large-6 medium-6 small-12 columns'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns'>Font Size:</div> <div class='large-8 medium-8 small-12 columns'> <span class="html-article-menu-option a1" data-percent="100">Aa</span> <span class="html-article-menu-option a2" data-percent="120">Aa</span> <span class="html-article-menu-option a3" data-percent="160">Aa</span> </div> </div> </div> </div> <div class='row'> <div class='html-line-space large-6 medium-6 small-12 columns'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns' >Line Spacing:</div> <div class='large-8 medium-8 small-12 columns'> <span class="html-article-menu-option a1" data-line-height="1.5em"> <i class="fa"></i> </span> <span class="html-article-menu-option a2" data-line-height="1.8em"> <i class="fa"></i> </span> <span class="html-article-menu-option a3" data-line-height="2.1em"> <i class="fa"></i> </span> </div> </div> </div> <div class='html-column-width large-6 medium-6 small-12 columns'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns' >Column Width:</div> <div class='large-8 medium-8 small-12 columns'> <span class="html-article-menu-option a1" data-column-width="20%"> <i class="fa"></i> </span> <span class="html-article-menu-option a2" data-column-width="10%"> <i class="fa"></i> </span> <span class="html-article-menu-option a3" data-column-width="0%"> <i class="fa"></i> </span> </div> </div> </div> </div> <div class='row'> <div class='html-font-bg large-6 medium-6 small-12 columns end'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns'>Background:</div> <div class='large-8 medium-8 small-12 columns'> <div class="html-article-menu-option html-nav-bg html-nav-bright" data-bg="bright"> <i class="fa fa-file-text"></i> </div> <div class="html-article-menu-option html-nav-bg html-nav-dark" data-bg="dark"> <i class="fa fa-file-text-o"></i> </div> <div class="html-article-menu-option html-nav-bg html-nav-creme" data-bg="creme"> <i class="fa fa-file-text"></i> </div> </div> </div> </div> </div> </div> </div> <article ><div class='html-article-content'> <span itemprop="publisher" content="Multidisciplinary Digital Publishing Institute"></span><span itemprop="url" content="https://www.mdpi.com/2072-6694/11/12/1889"></span> <div class="article-icons"><span class="label openaccess" data-dropdown="drop-article-label-openaccess" aria-expanded="false">Open Access</span><span class="label articletype">Review</span></div> <h1 class="title hypothesis_container" itemprop="name"> Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model </h1> <div class="art-authors hypothesis_container"> by <span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop2285376' data-options='is_hover:true, hover_timeout:5000'> Carla De Giovanni</div><div id="profile-card-drop2285376" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Carla De Giovanni</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/887653?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Carla%20De%20Giovanni" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Carla%20De%20Giovanni&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Carla%20De%20Giovanni" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup> 1</sup><span style="display: inline; margin-left: 5px;"></span><a class="toEncode emailCaptcha visibility-hidden" data-author-id="2285376" href="/cdn-cgi/l/email-protection#88a7ebe6eca5ebefe1a7e4a7ede5e9e1e4a5f8fae7fcedebfce1e7e6abb8b8b8babebbb9b9b8eeb8babcecb8bfb8beb8bcb8e9b8ebb9bdb8bab8ecb8ecb8e9babbb9beb8ecb8e9b8b9b8ebbcecb8e9b9bf"><sup><i class="fa fa-envelope-o"></i></sup></a>, </span><span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop2285377' data-options='is_hover:true, hover_timeout:5000'> Giordano Nicoletti</div><div id="profile-card-drop2285377" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Giordano Nicoletti</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/1711191?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Giordano%20Nicoletti" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Giordano%20Nicoletti&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Giordano%20Nicoletti" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup> 2</sup><span style="display: inline; margin-left: 5px;"></span><a class="toEncode emailCaptcha visibility-hidden" data-author-id="2285377" href="/cdn-cgi/l/email-protection#be91ddd0da93ddd9d791d291dbd3dfd7d293ceccd1cadbddcad7d1d09d8e8e8edb88898e868f8b8e8d8e888e878e868a878e878edb8e8a8e868edc8e8c8f8d8f8d8edb8c898e8f8e888f8a8f8d8f8e8e8c8e8b8e878e8c8f8d8a878edb8f8d"><sup><i class="fa fa-envelope-o"></i></sup></a>, </span><span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop2285378' data-options='is_hover:true, hover_timeout:5000'> Lorena Landuzzi</div><div id="profile-card-drop2285378" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Lorena Landuzzi</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/1449551?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Lorena%20Landuzzi" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Lorena%20Landuzzi&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Lorena%20Landuzzi" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup> 2</sup><span style="display: inline; margin-left: 5px;"></span><a class="toEncode emailCaptcha visibility-hidden" data-author-id="2285378" href="/cdn-cgi/l/email-protection#c4eba7aaa0e9a7a3adeba8eba1a9a5ada8e9b4b6abb0a1a7b0adabaae7f4f4f4f7f2a7f5a1f4fdf4f6f4a0f0f6f4f4f4a0f4f6f4fcf5fdf5f2f5f2f4f1f6a7f4f1f4f7f5a1f0f6f4f1f5fc"><sup><i class="fa fa-envelope-o"></i></sup></a>, </span><span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop2285379' data-options='is_hover:true, hover_timeout:5000'> Arianna Palladini</div><div id="profile-card-drop2285379" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/profiles/588406/thumb/Arianna_Palladini.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Arianna Palladini</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/588406?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Arianna%20Palladini" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Arianna%20Palladini&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Arianna%20Palladini" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup> 1</sup><span style="display: inline; margin-left: 5px;"></span><a class="toEncode emailCaptcha visibility-hidden" data-author-id="2285379" href="/cdn-cgi/l/email-protection#d7f8b4b9b3fab4b0bef8bbf8b2bab6bebbfaa7a5b8a3b2b4a3beb8b9f4e7e7e6e4e1e6e7efe7e7e7b1e7b1e7e7e3b1e6e6e7e7e7b3e7b3e7e7e7e2e7efe7b1e7efe5e6e6e3e7b1e7efe7e4e7b2e3b1e7efe6e2"><sup><i class="fa fa-envelope-o"></i></sup></a>, </span><span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop2285380' data-options='is_hover:true, hover_timeout:5000'> Pier-Luigi Lollini</div><div id="profile-card-drop2285380" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Pier-Luigi Lollini</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/14361?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Pier-Luigi%20Lollini" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Pier-Luigi%20Lollini&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Pier-Luigi%20Lollini" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup> 1,*,†</sup><span style="display: inline; margin-left: 5px;"></span><a class="toEncode emailCaptcha visibility-hidden" data-author-id="2285380" href="/cdn-cgi/l/email-protection#a986cac7cd84cacec086c586ccc4c8c0c584d9dbc6ddcccaddc0c6c78a999998909e99989c999b98ca999c9890989e98909ccc98ca98cf98ca98ca989098cc98909a99999c98cc9890989b98cf9ccc9890999d"><sup><i class="fa fa-envelope-o"></i></sup></a> and </span><span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop2285381' data-options='is_hover:true, hover_timeout:5000'> Patrizia Nanni</div><div id="profile-card-drop2285381" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Patrizia Nanni</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/576363?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Patrizia%20Nanni" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Patrizia%20Nanni&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Patrizia%20Nanni" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup> 1,†</sup><span style="display: inline; margin-left: 5px;"></span><a class="toEncode emailCaptcha visibility-hidden" data-author-id="2285381" href="/cdn-cgi/l/email-protection#d9f6bab7bdf4babeb0f6b5f6bcb4b8b0b5f4a9abb6adbcbaadb0b6b7fae9e9e8e8eee9e9ede9ebe8e0e9b8e8e0e8e8ecbce8bce8e8e8bce8bce8e0eae9e9ece8bce8e0e8ebe8bfecbce8e0e9ed"><sup><i class="fa fa-envelope-o"></i></sup></a></span> </div> <div class="nrm"></div> <span style="display:block; height:6px;"></span> <div></div> <div style="margin: 5px 0 15px 0;" class="hypothesis_container"> <div class="art-affiliations"> <div class="affiliation "> <div class="affiliation-item"><sup>1</sup></div> <div class="affiliation-name ">Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum University of Bologna, Bologna I-40126, Italy</div> </div> <div class="affiliation "> <div class="affiliation-item"><sup>2</sup></div> <div class="affiliation-name ">Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna I-40136, Italy</div> </div> <div class="affiliation"> <div class="affiliation-item"><sup>*</sup></div> <div class="affiliation-name ">Author to whom correspondence should be addressed. </div> </div> <div class="affiliation"> <div class="affiliation-item"><sup>†</sup></div> <div class="affiliation-name ">These authors contributed equally to this paper.</div> </div> </div> </div> <div class="bib-identity" style="margin-bottom: 10px;"> <em>Cancers</em> <b>2019</b>, <em>11</em>(12), 1889; <a href="https://doi.org/10.3390/cancers11121889">https://doi.org/10.3390/cancers11121889</a> </div> <div class="pubhistory" style="font-weight: bold; padding-bottom: 10px;"> <span style="display: inline-block">Submission received: 23 October 2019</span> / <span style="display: inline-block">Revised: 20 November 2019</span> / <span style="display: inline-block">Accepted: 22 November 2019</span> / <span style="display: inline-block">Published: 27 November 2019</span> </div> <div class="highlight-box1"> <div class="download"> <a class="button button--color-inversed button--drop-down" data-dropdown="drop-download-291642" aria-controls="drop-supplementary-291642" aria-expanded="false"> Download <i class="material-icons">keyboard_arrow_down</i> </a> <div id="drop-download-291642" class="f-dropdown label__btn__dropdown label__btn__dropdown--button" data-dropdown-content aria-hidden="true" tabindex="-1"> <a class="UD_ArticlePDF" href="/2072-6694/11/12/1889/pdf?version=1576638352" data-name="Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model" data-journal="cancers">Download PDF</a> <br/> <a id="js-pdf-with-cover-access-captcha" href="#" data-target="/2072-6694/11/12/1889/pdf-with-cover" class="accessCaptcha">Download PDF with Cover</a> <br/> <a id="js-xml-access-captcha" href="#" data-target="/2072-6694/11/12/1889/xml" class="accessCaptcha">Download XML</a> <br/> <a href="/2072-6694/11/12/1889/epub" id="epub_link">Download Epub</a> <br/> <a href="javascript:void(0);" data-reveal-id="supplementaryModal">Download Supplementary Material</a> <br/> </div> <div class="js-browse-figures" style="display: inline-block;"> <a href="#" class="button button--color-inversed margin-bottom-10 openpopupgallery UI_BrowseArticleFigures" data-target='article-popup' data-counterslink = "https://www.mdpi.com/2072-6694/11/12/1889/browse" >Browse Figures</a> </div> <div id="article-popup" class="popupgallery" style="display: inline; line-height: 200%"> <a href="https://pub.mdpi-res.com/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g001.png?1577711154" title=" <strong>Figure 1</strong><br/> <p>Origin of the TS/A cell line and variants. For pictures see [<a href="#B51-cancers-11-01889" class="html-bibr">51</a>].</p> "> </a> <a href="https://pub.mdpi-res.com/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g002.png?1577711154" title=" <strong>Figure 2</strong><br/> <p>Morphology of the TS/A cell line in adherent culture (phase contrast, ×100).</p> "> </a> </div> <a class="button button--color-inversed" href="/2072-6694/11/12/1889/notes">Versions Notes</a> </div> </div> <div class="responsive-moving-container small hidden" data-id="article-counters" style="margin-top: 15px;"></div> <div class="html-dynamic"> <section> <div class="art-abstract art-abstract-new in-tab hypothesis_container"> <p> <div><section class="html-abstract" id="html-abstract"> <h2 id="html-abstract-title">Abstract</h2><b>:</b> <div class="html-p">The TS/A cell line was established in 1983 from a spontaneous mammary tumor arisen in an inbred BALB/c female mouse. Its features (heterogeneity, low immunogenicity and metastatic ability) rendered the TS/A cell line suitable as a preclinical model for studies on tumor–host interactions and for gene therapy approaches. The integrated biological profile of TS/A resulting from the review of the literature could be a path towards the description of a precision experimental model of mammary cancer.</div> </section> <div id="html-keywords"> <div class="html-gwd-group"><div id="html-keywords-title">Keywords: </div><a href="/search?q=TS%2FA">TS/A</a>; <a href="/search?q=murine+mammary+cancer">murine mammary cancer</a>; <a href="/search?q=preclinical+models">preclinical models</a>; <a href="/search?q=gene+therapy">gene therapy</a>; <a href="/search?q=metastases">metastases</a>; <a href="/search?q=immunotherapy">immunotherapy</a></div> <div> </div> </div> </div> </p> </div> </section> </div> <div class="hypothesis_container"> <ul class="menu html-nav" data-prev-node="#html-quick-links-title"> </ul> <div class="html-body"> <section id='sec1-cancers-11-01889' type='intro'><h2 data-nested='1'> 1. Introduction</h2><div class='html-p'>Precision medicine in clinics is an evolving concept which goes beyond mere genomic medicine and means matching individual patients with medicine [<a href="#B1-cancers-11-01889" class="html-bibr">1</a>]. According to these premises, in an experimental environment a precision cancer model should mean matching the appropriate preclinical model with target biology study [<a href="#B2-cancers-11-01889" class="html-bibr">2</a>]. Preclinical models of mammary cancer of increasing complexity have been proposed, including transplantable murine tumors, gene-driven mammary carcinogenic models, human cell lines grown in vitro or in vivo as xenografts and patient-derived xenografts and organoids (see <a href="#sec6-cancers-11-01889" class="html-sec">Section 6</a> for a comparative discussion) [<a href="#B3-cancers-11-01889" class="html-bibr">3</a>,<a href="#B4-cancers-11-01889" class="html-bibr">4</a>]. Each model remains an approximation [<a href="#B2-cancers-11-01889" class="html-bibr">2</a>], with advantages and disadvantages depending on the specific aim of the study. The main advantage of transplantable murine mammary tumors consists of allowing mechanistic studies on tumor–host interactions, like those focusing on the role of microenvironment, the metastatic process and the immune response. A deep knowledge of a preclinical model, where literature studies are collected and retrospectively examined as a whole, like an individual patient’s medical record, can help in a better design of experimental approaches. The aim of this review is the biological profiling of a popular model of murine mammary cancer (TS/A) for a better understanding and modeling of a complex pathology like human breast cancer [<a href="#B5-cancers-11-01889" class="html-bibr">5</a>].</div></section><section id='sec2-cancers-11-01889' type=''><h2 data-nested='1'> 2. The Dawn of Murine Models for Tumor–Host Interactions</h2><div class='html-p'>At the beginning of the 1980s, metastases and tumor–host interaction studies mostly took advantage of a few tumor cell lines, established and subcultured for many years, such as 3LL Lewis lung carcinoma and B16 murine spontaneous melanoma [<a href="#B6-cancers-11-01889" class="html-bibr">6</a>]. Through the intravenous injection of B16 cells, metastatic deposits to lungs and other organs could be easily obtained, allowing for important advancements in understanding post-intravasation late phases of the metastatic process. However, the B16 parental cell line was almost incapable of disseminating from a locally-growing tumor, and therefore it did not adequately model the invasion and intravasation phases. Moreover, the non-epithelial origin of B16 melanoma impeded inferences about the behavior of epithelial tumors. At the same time, some rodent cell lines were already being used as models for mammary cancer, but most of them were either carcinogen- or virus-induced [<a href="#B7-cancers-11-01889" class="html-bibr">7</a>,<a href="#B8-cancers-11-01889" class="html-bibr">8</a>]. These models did not undergo a long natural history in the host, in which they arose, and generally had a high immunogenicity due to the expression of strong tumor-associated antigens. Likely due to these features, they generally gave too optimistic results when used to study antitumor immune responses or immunotherapeutic approaches [<a href="#B9-cancers-11-01889" class="html-bibr">9</a>].</div><div class='html-p'>In this landscape, in 1983 we described a new cell line, TS/A, derived from a mammary tumor spontaneously arisen in a 20 month-old BALB/c inbred mouse strain [<a href="#B10-cancers-11-01889" class="html-bibr">10</a>]. The TS/A cell line exhibited some features typical of human breast cancer, which prompted its use as a preclinical model, such as the low immunogenicity, the ability of local tumors to give rise to distant metastases and the heterogeneity, well evident both of morphology and metastatic ability. The TS/A cell line (also referred to as TSA or TS/A-pc, see [<a href="#B11-cancers-11-01889" class="html-bibr">11</a>,<a href="#B12-cancers-11-01889" class="html-bibr">12</a>] and below) and its clones were distributed to many laboratories worldwide and were employed for different applications, such as studies on malignant phenotype, pharmacologic therapeutic approaches, antitumor immune response and as a gene therapy model.</div><div class='html-p'>A list of research studies exploiting the TS/A cell line or its cell variants is reported in the <a href="#app1-cancers-11-01889" class="html-app">Supplementary Table S1</a>. It includes (up to 2018) 276 research papers where TS/A was used as model system and 19 papers where it was a control model. Reviews reporting results obtained with TS/A and citations of the TS/A paper are also listed in the <a href="#app1-cancers-11-01889" class="html-app">Supplementary Table S1</a>.</div><div class='html-p'>This review aims at profiling the main biological features of the TS/A model system resulting from literature research papers (<a href="#cancers-11-01889-t001" class="html-table">Table 1</a>). The two research areas where TS/A-based models yielded important results will be discussed in depth: tumor–host interactions and experimental gene therapy.</div></section><section id='sec3-cancers-11-01889' type=''><h2 data-nested='1'> 3. Bioprofiling TS/A Cell Line</h2><div class='html-p'>The mammary tumor originating the TS/A cell line was isolated in a 20 months-old BALB/c female retired breeder and was described as a moderately differentiated adenocarcinoma [<a href="#B10-cancers-11-01889" class="html-bibr">10</a>]. Its first in vivo passage into a healthy BALB/c female was adapted to in vitro culture and named TS/A (<a href="#cancers-11-01889-f001" class="html-fig">Figure 1</a>). Several clones and cell variants were derived from TS/A and distributed worldwide. In particular, a TS/A subline was chosen by Guido Forni (University of Turin) for a large collaborative endeavor as the recipient cell for the systematic transduction of a large series of genes coding for immune modulators; such subline was referred to as TS/A-pc (from “parental cells”). TS/A and TS/A-pc share most features reviewed here, and some kind of drift occurred during the extensive amplification of TS/A-pc. Throughout this review, we will refer to the TS/A model system on the whole, and therefore incorrect terminology (such as TSA, TS/a, and so on) has been systematically corrected to “TS/A”. However, the <a href="#app1-cancers-11-01889" class="html-app">Supplementary Table reports</a> exactly the TS/A cell variant used in each referenced paper.</div><div class='html-p'>The tumor from which the TS/A cell line was derived likely had a long natural history in its host of origin. When tested in a growth-excision test, TS/A cells did not confer protection against a second challenge, thus showing a low immunogenicity [<a href="#B10-cancers-11-01889" class="html-bibr">10</a>], thereafter confirmed in other studies (see, for example, [<a href="#B23-cancers-11-01889" class="html-bibr">23</a>]). Such a low immunogenicity was the basis for a huge number of immunopotentiation studies, most of which exploiting gene therapy approaches (see next section).</div><div class='html-p'>TS/A cells express the gp70env product of an endogenous retrovirus whose AH1 immunodominant class I epitope could be recognized by cytotoxic T lymphocytes through presentation by H-2L<sup>d</sup> [<a href="#B25-cancers-11-01889" class="html-bibr">25</a>]. Gp70env antigen is shared by other murine cell lines, such as the colorectal cancer cell line CT26. The down-regulation of the L<sup>d</sup> observed in TS/A cells [<a href="#B52-cancers-11-01889" class="html-bibr">52</a>] is likely due to the immunoediting process leading to evasion from the host immune response.</div><div class='html-p'>TS/A exerts a suppressive effect on the host immune response through several mechanisms, such as a selective loss of STAT5a/b expression in T and B lymphocytes [<a href="#B26-cancers-11-01889" class="html-bibr">26</a>], the production of transforming growth factor β1 (TGF-β1) [<a href="#B18-cancers-11-01889" class="html-bibr">18</a>], the induction of regulatory T cells [<a href="#B27-cancers-11-01889" class="html-bibr">27</a>], natural killer resistance [<a href="#B36-cancers-11-01889" class="html-bibr">36</a>] and the production of colony stimulating factors (CSFs) that deeply subvert hematopoiesis [<a href="#B14-cancers-11-01889" class="html-bibr">14</a>,<a href="#B15-cancers-11-01889" class="html-bibr">15</a>], giving rise to splenomegaly, leucocytosis and to tumor-infiltrating myeloid-derived suppressor cells (MDSC) [<a href="#B29-cancers-11-01889" class="html-bibr">29</a>,<a href="#B33-cancers-11-01889" class="html-bibr">33</a>,<a href="#B53-cancers-11-01889" class="html-bibr">53</a>].</div><div class='html-p'>When injected subcutaneously into syngeneic BALB/c mice, TS/A cells gave rise to local tumors rapidly disseminating to the lungs. Metastases could also be obtained after injection of TS/A cells by the intravenous route, thus allowing a comparison between the dynamics of the early and late phases of the metastatic process [<a href="#B10-cancers-11-01889" class="html-bibr">10</a>,<a href="#B41-cancers-11-01889" class="html-bibr">41</a>]. Metastases to lungs and liver have also been obtained by orthotopic cell injection [<a href="#B54-cancers-11-01889" class="html-bibr">54</a>]. Like other mammary carcinoma cell lines, the growth of micrometastases at distant organs was found to involve the formation of filopodium-like protrusions mediated by FAK/ERK and Rif/mDia2 signaling [<a href="#B54-cancers-11-01889" class="html-bibr">54</a>].</div><div class='html-p'>Heterogeneity of TS/A cells was observed in adherent cultures, with areas of epithelial-like and fibroblast-like morphology (<a href="#cancers-11-01889-f002" class="html-fig">Figure 2</a>), and in anchorage-independent cultures [<a href="#B10-cancers-11-01889" class="html-bibr">10</a>,<a href="#B40-cancers-11-01889" class="html-bibr">40</a>]. Subcloning from agar cultures allowed the isolation of two types of cell clones, both tumorigenic and metastatic, but with markedly different metastatic power [<a href="#B40-cancers-11-01889" class="html-bibr">40</a>]. Unexpectedly high-metastatic clones had a prevalent epithelial morphology, compared to the fibroblast-like pattern of low-metastatic clones. Gene expression profiling of several murine mammary cancer cell lines showed clustering of TS/A-E1 (a high-metastatic clone) with high-claudin expressors [<a href="#B13-cancers-11-01889" class="html-bibr">13</a>]. Our data on gene expression profiling of TS/A clones showed that claudin-3 was the top overexpressed gene in high-metastatic clones (about 90-fold expression over low-metastatic clones), while low-metastatic clones overexpressed nme4 and necdin, two putative metastasis suppressor genes (our unpublished results). These data suggest that metastatic ability is not always a consequence of epithelial–mesenchymal transition but can also be acquired in an epithelial-like differentiation context.</div><div class='html-p'>The TS/A cell line has a triploid karyotype [<a href="#B20-cancers-11-01889" class="html-bibr">20</a>] and carries a mutated p53 at codon 270 [<a href="#B21-cancers-11-01889" class="html-bibr">21</a>]. About a third of the cells express the cancer stem cell marker Sca-1 [<a href="#B43-cancers-11-01889" class="html-bibr">43</a>]. In our laboratory, the expression of Sca-1 (also known as Ly6A) was almost negative, but inducible by IFN-γ [<a href="#B12-cancers-11-01889" class="html-bibr">12</a>]. TS/A cells express estrogen receptor [<a href="#B10-cancers-11-01889" class="html-bibr">10</a>] and endogenous murine p185-erbB2 product [<a href="#B39-cancers-11-01889" class="html-bibr">39</a>]. Its use as a negative HER2/neu mammary cancer cell line in studies on HER2/neu transgenic models relies upon the negativity to the reagent specifically recognizing rat HER2/neu.</div></section><section id='sec4-cancers-11-01889' type=''><h2 data-nested='1'> 4. Tumor–Host Interaction Studies</h2><div class='html-p'>TS/A-induced tumors have a rich and heterogeneous infiltrate comprising granulocyte and monocyte/macrophage subpopulations, whose relative proportions change during tumor progression [<a href="#B55-cancers-11-01889" class="html-bibr">55</a>], in agreement with the known plasticity of myeloid cells. Several subpopulations contribute to maintainance of a tumor-promoting microenvironment in TS/A, as well as in many other murine and human tumors [<a href="#B56-cancers-11-01889" class="html-bibr">56</a>], with a variety of mechanisms. Alternatively-activated M2 macrophages are strong producer of the immunosuppressive cytokine IL10 and of several chemokines recruiting Treg, Th2, eosinophils and basophils [<a href="#B56-cancers-11-01889" class="html-bibr">56</a>]. MDSC are heterogeneous immature CD11b+/Gr-1+ populations [<a href="#B57-cancers-11-01889" class="html-bibr">57</a>], with immunosuppressive function. Both M2-polarized macrophages and MDSC have been investigated in the TS/A model system, along with strategies to circumvent tumor promotion, pushing infiltrate cells towards more differentiated, activated cells.</div><div class='html-p'>In the TS/A model, the induction of M2 tumor-associated macrophages was mediated by the expression of the CD20 homolog <span class='html-italic'>MS4A8A</span> gene [<a href="#B58-cancers-11-01889" class="html-bibr">58</a>]. In TS/A tumors, M2-polarized macrophages were more abundant and more proangiogenic in hypoxic tumor areas [<a href="#B55-cancers-11-01889" class="html-bibr">55</a>]. The M2 immune suppressing phenotype was switched to an anti-tumor M1 phenotype through the in vivo adenoviral gene transfer of the chemokine CCL16 [<a href="#B59-cancers-11-01889" class="html-bibr">59</a>]. Alternatively-activated M2 macrophages expressed highly restricted, individual-specific, combinatorial T cell receptor-αβ immunoreceptors, suggestive of an adaptive response of macrophages to the tumor [<a href="#B60-cancers-11-01889" class="html-bibr">60</a>]. In TS/A, as well as in a variety of other murine and human tumors, alternatively-activated M2 tumor-associated macrophages expressed a multifunctional scavenger receptor named stabilin-1 involved in endocytic and phagocytic clearance of “unwanted-self” components, including soluble component of extracellular matrix SPARC (a tumor-inhibiting agent). Stabilin-1 was found to play a tumor promoting role in the TS/A model likely through enhanced clearance of SPARC [<a href="#B61-cancers-11-01889" class="html-bibr">61</a>].</div><div class='html-p'>A major component of TS/A infiltrate consisted of MDSC [<a href="#B53-cancers-11-01889" class="html-bibr">53</a>], which correlated with the production of CSFs by TS/A cells [<a href="#B14-cancers-11-01889" class="html-bibr">14</a>,<a href="#B29-cancers-11-01889" class="html-bibr">29</a>]. Immature myeloid progenitors can be released in the bloodstream, giving rise to peripheral leukocytosis and splenomegaly [<a href="#B14-cancers-11-01889" class="html-bibr">14</a>,<a href="#B15-cancers-11-01889" class="html-bibr">15</a>]. MDSC suppressed antigen-activated T lymphocytes through apoptosis induction [<a href="#B28-cancers-11-01889" class="html-bibr">28</a>,<a href="#B29-cancers-11-01889" class="html-bibr">29</a>], and suppressed NK cytotoxicity [<a href="#B62-cancers-11-01889" class="html-bibr">62</a>], with mechanisms involving nitric oxide [<a href="#B30-cancers-11-01889" class="html-bibr">30</a>]. Impaired anti-tumor immune response in aging can take advantage of an increased MDSC infiltrate [<a href="#B32-cancers-11-01889" class="html-bibr">32</a>]. MDSC expressed Fas–FasL and caspases, suggesting that Fas–FasL apoptosis regulated MDSC survival [<a href="#B33-cancers-11-01889" class="html-bibr">33</a>,<a href="#B34-cancers-11-01889" class="html-bibr">34</a>] and proposing new potential therapeutic options. MDSCs are key drivers of resistance to antiangiogenic therapy, but all-trans retinoic acid was able to induce differentiation of MDSC into mature cells, thus increasing the efficacy of the antiangiogenic therapy [<a href="#B63-cancers-11-01889" class="html-bibr">63</a>].</div><div class='html-p'>In the TS/A microenvironment, other non-tumoral cell types can play a tumor-promoting role, such as tumor-associated fibroblasts and adipocytes. Through a tumor-stromal cell co-injection model, novel candidate tumor-associated genes were identified in tumor-associated fibroblasts. The most studied gene was tubulin tyrosine ligase: its downregulation in tumor-associated fibroblasts promoted TS/A tumor growth [<a href="#B64-cancers-11-01889" class="html-bibr">64</a>]. Co-culture of TS/A cells with adipocytes caused an increased lipid content in TS/A cells and an increased lung colonization ability [<a href="#B65-cancers-11-01889" class="html-bibr">65</a>]. The release of free fatty acids from lipid droplets is mediated by an adipose triglyceride lipase-dependent lipolytic pathway, that was proposed as a potential therapeutic target. The metabolic cross-talk between tumor cells and tumor-associated adipocytes could favor epithelial-mesenchymal transition and increase tumor invasiveness.</div><div class='html-p'>TS/A cells, like other tumor cell lines, secrete membrane vesicles of endosomal origin called “exosomes”, with contradictory roles in tumor biology. Exosomes could have some immunostimulatory effect, since they carry tumor antigens which can be transferred to dendritic cells and cross-prime cytotoxic T lymphocytes [<a href="#B66-cancers-11-01889" class="html-bibr">66</a>]. However, exosomes mainly exerted a potent immunosuppressive anti-tumor immune response through suppression of NK cell function [<a href="#B67-cancers-11-01889" class="html-bibr">67</a>] and inhibition of differentiation of bone marrow dendritic cells [<a href="#B68-cancers-11-01889" class="html-bibr">68</a>]. Tumor-derived exosomes released from irradiated TS/A cells showed an altered molecular composition and were able to transfer dsDNA to dendritic cells and stimulate upregulation of costimulatory molecules and STING-dependent activation of IFN-I [<a href="#B69-cancers-11-01889" class="html-bibr">69</a>].</div></section><section id='sec5-cancers-11-01889' type=''><h2 data-nested='1'> 5. Gene Therapy Studies</h2><div class='html-p'>TS/A cells were easily transduced both with naked DNA and viral systems, generating good and stable transgene expression of secreted factors or membrane molecules. Most gene therapy approaches were performed to directly increase TS/A immunogenicity with the purpose to use engineered cells as anticancer vaccines (<a href="#cancers-11-01889-t002" class="html-table">Table 2</a>).</div><div class='html-p'>Genes for a variety of cytokines, costimulatory molecules and major histocompatibility complex (MHC) antigens were inserted and stably expressed in TS/A cells. Cytokine transduction in TS/A cells was often performed isolating clones with different levels of cytokine production, and this allowed to study the dose-related effects, such as the minimal cytokine release level required to significantly impact on tumor growth and immunogenicity and the potential side effects of highly-releasing cells. As an example, IFN-γ transduction led to isolate clones with cytokine production ranging from a few IU/ml up to a very high expressor clone (releasing 6000 IU/mL), likely the highest transduced expression ever obtained. Such a panel of IFN-γ releasing clones showed a dose-related growth inhibition and immunogenicity, but also showed potentially important side effects, such as increased lung colonizing ability and other systemic effects [<a href="#B12-cancers-11-01889" class="html-bibr">12</a>,<a href="#B136-cancers-11-01889" class="html-bibr">136</a>].</div><div class='html-p'>The wide portfolio of TS/A cells transduced with different cytokine genes allowed to understand the role played by each cytokine in the modulation of tumor infiltrate composition and its impact on tumor growth [<a href="#B137-cancers-11-01889" class="html-bibr">137</a>]. A major role for granulocytes in cytokine-induced tumor debulking was unexpectedly found, along with a continuous cross-talk between leukocytes and lymphocytes. The transduced cytokine drove the composition of the reactive cells elicited, the efficacy of the anti-tumor reaction and the immune memory against the non-transduced tumor. The increased memory reaction is the basis for the use of gene-engineered cells as anticancer vaccines. On the whole, data obtained with engineered TS/A vaccines (<a href="#cancers-11-01889-t002" class="html-table">Table 2</a>) showed that the most effective cytokines were IFN-γ and IL-12.</div><div class='html-p'>TS/A transduction with GM-CSF was performed only once [<a href="#B74-cancers-11-01889" class="html-bibr">74</a>], with almost no effect on tumor growth or immunogenicity. On the contrary, GM-CSF engineering of another murine model (B16 melanoma) gave good results [<a href="#B138-cancers-11-01889" class="html-bibr">138</a>] and prompted clinical studies. B16 melanoma did not produce spontaneously GM-CSF whereas TS/A abundantly secreted CSFs [<a href="#B16-cancers-11-01889" class="html-bibr">16</a>]. The spontaneous CSF production in TS/A did not hamper tumor growth but likely contributed to the tumor-promoting environment, showing that similar cytokines could play opposite roles in tumors of different origin.</div><div class='html-p'>Transduction of genes coding for activating pro-drug enzymes (suicide genes) was performed with the main aim to obtain more immunogenic cancer cell vaccines. It was reported that replicating cells were more immunogenic than dead cells [<a href="#B74-cancers-11-01889" class="html-bibr">74</a>], so prodrug activation by suicide gene products could switch off partially replicating cell vaccines after the start of the immune response. However, prodrug-induced cancer cell death itself was found to increase the specific immune response [<a href="#B125-cancers-11-01889" class="html-bibr">125</a>]. Suicide genes were also included in oncolytic viruses, to enhance their safety profile [<a href="#B128-cancers-11-01889" class="html-bibr">128</a>].</div><div class='html-p'>Gene therapy approaches to obtain increased TS/A cancer cell immunogenicity gave interesting but, at the same time, unsatisfactory results. Most approaches actually showed increased immunogenicity, but when challenged in therapeutic set up, a minority of mice could be cured, and only when therapy started at the very early phases of metastatic growth [<a href="#B106-cancers-11-01889" class="html-bibr">106</a>,<a href="#B112-cancers-11-01889" class="html-bibr">112</a>]. Similar conclusions could be drawn for the variety of gene therapy trials conducted in the last three decades with the purpose of increasing tumor immunogenicity through cytokine or costimulatory gene transduction. Therefore, results obtained with TS/A as well as with other experimental gene therapy models predicted the low efficacy found in trials. Combined gene therapy approaches showed better therapeutic activity and prompted new combination immune-gene therapy approaches [<a href="#B99-cancers-11-01889" class="html-bibr">99</a>,<a href="#B111-cancers-11-01889" class="html-bibr">111</a>].</div><div class='html-p'>Gene transduction was applied to the TS/A model to study cancer biology and cancer gene therapy (<a href="#cancers-11-01889-t003" class="html-table">Table 3</a>). Transduction of the wild-type p53 gene (p53wt), aiming to restore a correct p53 signaling, was performed in vitro and in vivo with a Canarypox vector carrying p53wt, leading to downstream p21 expression with a proapoptotic effect that caused tumor growth inhibition [<a href="#B21-cancers-11-01889" class="html-bibr">21</a>]. Tumor rejection was associated with the generation of a specific antitumor immune response in a sarcoma model but not in TS/A, thus confirming the low immunogenicity of the TS/A model system.</div><div class='html-p'>TS/A cells were transduced with luciferase gene and green fluorescent protein (GFP) variants and used in studies on imaging techniques (<a href="#cancers-11-01889-t003" class="html-table">Table 3</a>). TS/A cells were used as recipient for genes coding exogenous antigens as a surrogate to study features of the corresponding immune response (<a href="#cancers-11-01889-t003" class="html-table">Table 3</a>).</div><div class='html-p'>Silencing approaches were performed with retro- and lenti-viral vectors and recently with CRISPR-Cas9 technology. Through silencing, TGF-β1 released by TS/A cells was found to play a suppressive role on graft-versus-tumor reaction [<a href="#B18-cancers-11-01889" class="html-bibr">18</a>].</div><div class='html-p'>In search of new genes potentially involved in metastasis of mammary cancer, along with data from human histopathological samples, some studies used TS/A cells for a mechanistic demonstration through silencing approaches. These studies were sometimes performed in parallel with another popular model of murine mammary cancer (4T1), which is more metastatic than TS/A cells (see <a href="#sec6-cancers-11-01889" class="html-sec">Section 6</a>). The overexpression of Fragile X mental retardation protein (FMRP) was concordantly related to lung metastases in both models [<a href="#B46-cancers-11-01889" class="html-bibr">46</a>]. On the contrary, some disagreement between TS/A and 4T1 was reported concerning the role of the small GTPase Rab27a [<a href="#B146-cancers-11-01889" class="html-bibr">146</a>]. Rab27a was involved in exosome secretion. Its silencing inhibited tumor growth and lung metastases in the 4T1 model, but not in TS/A. It should be noted that the authors described TS/A as a non-metastatic tumor model. Since TS/A is actually able to metastasize to lungs, two explanations are possible for such discrepancy: a) Rab27a is not an on/off determinant of metastatic power, but rather a quantitative modulator; b) 4T1 is a clone while TS/A is a polyclonal and heterogeneous cell line. TS/A extensive subculture can have led to drift phenomena with oligoclonal dominance of less metastatic cells, which are well represented in the cell line of origin.</div><div class='html-p'>Genetic inactivation through CRISPR/CAS9 technology of the DNA mismatched repair gene <span class='html-italic'>MutL</span> homologue 1 (MLH1) in TS/A cells, as well as in other non-mammary murine cancer models, led to increased immunogenicity due to accumulation of neoantigens [<a href="#B147-cancers-11-01889" class="html-bibr">147</a>]. MLH1-inactivated cells acquired sensitivity to antibodies against checkpoint inhibitors, which now represent the forefront of cancer immunotherapy.</div><div class='html-p'>The expression of murine ErbB2 in TS/A cells was exploited to provide experimental evidence of the oncosuppressor role of FoxP3 in mammary cancers, that downmodulated the expression of the ErbB2 oncogene [<a href="#B44-cancers-11-01889" class="html-bibr">44</a>]. TS/A cells was also used as a model to study optimization of parameters of gene electrotransfer [<a href="#B50-cancers-11-01889" class="html-bibr">50</a>].</div></section><section id='sec6-cancers-11-01889' type=''><h2 data-nested='1'> 6. Comparison with Other Mammary Cancer Models</h2><div class='html-p'>Modeling mammary cancer in mouse to study tumor–host interactions took advantage of several model systems [<a href="#B3-cancers-11-01889" class="html-bibr">3</a>,<a href="#B4-cancers-11-01889" class="html-bibr">4</a>,<a href="#B166-cancers-11-01889" class="html-bibr">166</a>]. Reordering models according to their intrinsic complexity, we can mention transplantable murine tumors, gene-driven mammary carcinogenic models, human cell lines grown in vitro or in vivo as xenografts and patient-derived xenografts and organoids.</div><div class='html-p'>Concerning transplantable murine mammary cancer, the most popular cell line is 4T1, derived from a spontaneous mammary cancer arisen in a BALB/cfC3H female [<a href="#B167-cancers-11-01889" class="html-bibr">167</a>,<a href="#B168-cancers-11-01889" class="html-bibr">168</a>,<a href="#B169-cancers-11-01889" class="html-bibr">169</a>]. 4T1 share several features with TS/A and with human mammary cancers, such as low immunogenicity and tumor–host interactions. In fact, several studies were performed using in parallel 4T1 and TS/A (see for example <a href="#app1-cancers-11-01889" class="html-app">Supplementary Table S1</a>, column N), which were considered as biological replicates and generally gave concordant results. We can focus here on the main differences between the two models. 4T1 is a thioguanine-resistant clone derived from a heterogeneous mammary cancer cell line [<a href="#B167-cancers-11-01889" class="html-bibr">167</a>,<a href="#B168-cancers-11-01889" class="html-bibr">168</a>]. TS/A is a cell line with heterogeneity spanning from morphology to metastatic ability and to CSF production (and therefore tumor–host interactions), as proven by the in vitro isolation of clones with markedly different features [<a href="#B14-cancers-11-01889" class="html-bibr">14</a>,<a href="#B40-cancers-11-01889" class="html-bibr">40</a>]. Populations with different abilities to metastasize were also isolated from TS/A through in vivo selection procedures [<a href="#B41-cancers-11-01889" class="html-bibr">41</a>]. Heterogeneity is a hallmark of mammary cancer, which comprises morphology, differentiation and metastatic ability, but cloned populations at least partially lose such heterogeneity. 4T1 is a highly aggressive clone, with the ability to give rise to a high number of lung metastases following subcutaneous, intravenous or orthotopic cell injections (see for example [<a href="#B146-cancers-11-01889" class="html-bibr">146</a>]). Moreover, 4T1 can metastasize to other organs (such as liver and bone) [<a href="#B170-cancers-11-01889" class="html-bibr">170</a>]. TS/A is a cell line provided with metastatic ability but giving rise to moderate number of lung metastases following local growth, subcutaneous and intravenous injections or orthotopic administration [<a href="#B10-cancers-11-01889" class="html-bibr">10</a>,<a href="#B54-cancers-11-01889" class="html-bibr">54</a>]. The lower metastatic ability of the TS/A model can allow to study a wider range of metastasis modulators.</div><div class='html-p'>In the last three decades the research on mammary tumor development and malignancy took advantage of transgenic models. One of the most studied models of gene-driven mammary carcinogenesis was that based on the rat HER2/neu oncogene under the transcriptional control of the Mouse Mammary Tumor Virus (MMTV) promoter [<a href="#B171-cancers-11-01889" class="html-bibr">171</a>,<a href="#B172-cancers-11-01889" class="html-bibr">172</a>]. Transgenic models recapitulated all the transitions from the normal mammary gland to mammary cancer, both from morphological and molecular points of view, and led to essential advancement in comprehension of the carcinogenic process and development of new therapeutic approaches. The reproducible carcinogenic process observed in transgenic models was exploited to study the prevention of tumor progression, including approaches based on immune strategies [<a href="#B173-cancers-11-01889" class="html-bibr">173</a>]. Transgene expression is somewhat artificial, concerning both the xenogeneic origin of the oncogene (rat HER2/neu) and the expression driven by a viral promoter. From an immunological point of view, the fast carcinogenesis and the altered immunoreactivity of mice being tolerant to transgene can be significant differences from the human pathogenetic development of mammary cancer. However, the main problems of transgenic models are time-consuming procedures and costs. Cell lines from spontaneous mammary cancer such as TS/A therefore are still widely employed in studies on biological features and new therapeutic approaches.</div><div class='html-p'>Human models for mammary cancer comprise cell lines and xenografts [<a href="#B4-cancers-11-01889" class="html-bibr">4</a>,<a href="#B166-cancers-11-01889" class="html-bibr">166</a>]. Human breast cancer is a heterogeneous disease that, thanks to biomarkers, can be subdivided in different subtypes with prognostic significance [<a href="#B174-cancers-11-01889" class="html-bibr">174</a>,<a href="#B175-cancers-11-01889" class="html-bibr">175</a>] and subjected to appropriate treatments. The main advantage of human models is that they can reproduce the heterogeneity among tumors, giving researchers the possibility to choose the correct subtype depending on the aim of the research, while the main constraint of human cell lines and xenografts is the lack of immune tumor–host interactions. To identify which subtypes can be modeled by the different murine mammary cancers, a comparison among gene expression profiles of a panel of murine mammary cancer cell lines including a TS/A variant (clone E1) and profiles of the different human subtypes was performed [<a href="#B13-cancers-11-01889" class="html-bibr">13</a>]. E1 showed a non-basal profile, with prevalent features of luminal A and HER2 subtypes (about 50% and 20%–30% probability, respectively). Therefore, a single murine model can mimic a peculiar human subtype, but obviously is limited to the fixed genetic setting of the cell line and does not reflect diverse spectrum of personalized genetic and/or epigenetic alterations of human breast cancers.</div><div class='html-p'>To better depict individual mammary cancers, patient-derived xenografts (PDX) [<a href="#B176-cancers-11-01889" class="html-bibr">176</a>] and patient-derived organoids (PDO) were proposed [<a href="#B177-cancers-11-01889" class="html-bibr">177</a>,<a href="#B178-cancers-11-01889" class="html-bibr">178</a>,<a href="#B179-cancers-11-01889" class="html-bibr">179</a>]. Such approaches are more compatible with the need of precision oncology and without concern of species difference. PDX do not allow to study immune interactions (since they are grown in immunodeficient mice), and also present other disadvantages such as the low frequency of tumor take, with a bias toward more aggressive subtypes [<a href="#B180-cancers-11-01889" class="html-bibr">180</a>], the cost and the time-consuming procedure. PDO are 3D cultures obtained by dissociated tumor tissue which can be co-cultured with human lymphocytes, thus allowing to investigate tumor microenvironment, anticancer immunotherapy, and other aspects including development of novel therapeutics [<a href="#B181-cancers-11-01889" class="html-bibr">181</a>,<a href="#B182-cancers-11-01889" class="html-bibr">182</a>].</div><div class='html-p'>In conclusion, preclinical models of murine mammary cancer cell lines are still widely used thanks to their possibility to focus on tumor–host interactions comprising the role of stroma, the metastatic process and immune responses. The recent burst of immune-based anti-cancer therapies (see for example checkpoint inhibitors [<a href="#B133-cancers-11-01889" class="html-bibr">133</a>,<a href="#B147-cancers-11-01889" class="html-bibr">147</a>] and CAR-T [<a href="#B183-cancers-11-01889" class="html-bibr">183</a>]) likely will take advantage of murine models comprising mammary cancer cell lines. Other advantages are the low cost and time to obtain results. The possibility to study in parallel several cancer cell lines mimicking different breast cancer subtypes could remain a first-line means to study innovative molecular and therapeutic approaches, which will be then tested in individually precise, more complex human models.</div></section><section id='sec7-cancers-11-01889' type='conclusions'><h2 data-nested='1'> 7. Conclusions</h2><div class='html-p'>The analysis of the main studies exploiting TS/A as a pre-clinical model of mammary cancer allows to draft a profile spanning from molecular alterations to malignant phenotype and immune interactions. This profile should be considered when designing experiments based on TS/A model. Knowledge of this profile can allow inference about the complexity of human breast cancer.</div></section> </div> <div class="html-back"> <section><section id='app1-cancers-11-01889' type=''><h2 data-nested='1'> Supplementary Materials</h2><div class='html-p'>The following are available online at <a href='https://www.mdpi.com/2072-6694/11/12/1889/s1' target='_blank' rel="noopener noreferrer">https://www.mdpi.com/2072-6694/11/12/1889/s1</a>, Table S1: Comprehensive list of papers using TS/A cell variants.</div></section></section><section class='html-notes'><h2 >Author Contributions</h2><div class='html-p'>Conceptualization: C.D.G., P.-L.L. and P.N.; Data collection and writing-original draft preparation: C.D.G. and A.P.; Discussion, writing-review and editing: C.D.G., G.N., L.L., A.P., P.-L.L. and P.N.</div></section><section class='html-notes'><h2 >Funding</h2><div class='html-p'>This research was funded by grants from the Italian Association for Cancer Research (AIRC) (IG15324 to P-L. Lollini), the Department of Experimental, Diagnostic and Specialty Medicine of the University of Bologna (DIMES) (“Pallotti” Fund) and the University of Bologna.</div></section><section class='html-notes'><h2 >Conflicts of Interest</h2><div class='html-p'>The University of Bologna granted to EMD Millipore license for TS/A distribution worldwide. Royalties are destined for oncological research.</div></section><section id='html-references_list'><h2>References</h2><ol class='html-xxx'><li id='B1-cancers-11-01889' class='html-x' data-content='1.'>Letai, A. Functional precision cancer medicine-moving beyond pure genomics. <span class='html-italic'>Nat. Med.</span> <b>2017</b>, <span class='html-italic'>23</span>, 1028–1035. [<a href="https://scholar.google.com/scholar_lookup?title=Functional+precision+cancer+medicine-moving+beyond+pure+genomics&author=Letai,+A.&publication_year=2017&journal=Nat.+Med.&volume=23&pages=1028%E2%80%931035&doi=10.1038/nm.4389&pmid=28886003" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/nm.4389" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/28886003" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B2-cancers-11-01889' class='html-x' data-content='2.'>Gould, S.E.; Junttila, M.R.; De Sauvage, F.J. Translational value of mouse models in oncology drug development. <span class='html-italic'>Nat. Med.</span> <b>2015</b>, <span class='html-italic'>21</span>, 431–439. [<a href="https://scholar.google.com/scholar_lookup?title=Translational+value+of+mouse+models+in+oncology+drug+development&author=Gould,+S.E.&author=Junttila,+M.R.&author=De+Sauvage,+F.J.&publication_year=2015&journal=Nat.+Med.&volume=21&pages=431%E2%80%93439&doi=10.1038/nm.3853&pmid=25951530" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/nm.3853" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/25951530" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B3-cancers-11-01889' class='html-x' data-content='3.'>Heppner, G.H.; Miller, F.R.; Shekhar, P.V.M. Nontransgenic models of breast cancer. <span class='html-italic'>Breast Cancer Res.</span> <b>2000</b>, <span class='html-italic'>2</span>, 331–334. [<a href="https://scholar.google.com/scholar_lookup?title=Nontransgenic+models+of+breast+cancer&author=Heppner,+G.H.&author=Miller,+F.R.&author=Shekhar,+P.V.M.&publication_year=2000&journal=Breast+Cancer+Res.&volume=2&pages=331%E2%80%93334&doi=10.1186/bcr77&pmid=11250725" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1186/bcr77" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/11250725" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B4-cancers-11-01889' class='html-x' data-content='4.'>Gengenbacher, N.; Singhal, M.; Augustin, H.G. Preclinical mouse solid tumour models: Status quo, challenges and perspectives. <span class='html-italic'>Nat. Rev. Cancer</span> <b>2017</b>, <span class='html-italic'>17</span>, 751–765. [<a href="https://scholar.google.com/scholar_lookup?title=Preclinical+mouse+solid+tumour+models:+Status+quo,+challenges+and+perspectives&author=Gengenbacher,+N.&author=Singhal,+M.&author=Augustin,+H.G.&publication_year=2017&journal=Nat.+Rev.+Cancer&volume=17&pages=751%E2%80%93765&doi=10.1038/nrc.2017.92" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/nrc.2017.92" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B5-cancers-11-01889' class='html-x' data-content='5.'>Haynes, B.; Sarma, A.; Nangia-Makker, P.; Shekhar, M.P. Breast cancer complexity: Implications of intratumoral heterogeneity in clinical management. <span class='html-italic'>Cancer Metastasis Rev.</span> <b>2017</b>, <span class='html-italic'>36</span>, 547–555. [<a href="https://scholar.google.com/scholar_lookup?title=Breast+cancer+complexity:+Implications+of+intratumoral+heterogeneity+in+clinical+management&author=Haynes,+B.&author=Sarma,+A.&author=Nangia-Makker,+P.&author=Shekhar,+M.P.&publication_year=2017&journal=Cancer+Metastasis+Rev.&volume=36&pages=547%E2%80%93555&doi=10.1007/s10555-017-9684-y&pmid=28752247" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/s10555-017-9684-y" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/28752247" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B6-cancers-11-01889' class='html-x' data-content='6.'>Poste, G.; Doll, J.; Fidler, I.J. Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. <span class='html-italic'>Proc. Natl. Acad. Sci. USA</span> <b>1981</b>, <span class='html-italic'>78</span>, 6226–6230. [<a href="https://scholar.google.com/scholar_lookup?title=Interactions+among+clonal+subpopulations+affect+stability+of+the+metastatic+phenotype+in+polyclonal+populations+of+B16+melanoma+cells&author=Poste,+G.&author=Doll,+J.&author=Fidler,+I.J.&publication_year=1981&journal=Proc.+Natl.+Acad.+Sci.+USA&volume=78&pages=6226%E2%80%936230&doi=10.1073/pnas.78.10.6226" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1073/pnas.78.10.6226" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B7-cancers-11-01889' class='html-x' data-content='7.'>Ramshaw, I.A.; Badenoch-Jones, P. Studies on rat mammary adenocarcinomas: A model for metastasis. <span class='html-italic'>Cancer Metastasis Rev.</span> <b>1985</b>, <span class='html-italic'>4</span>, 195–208. [<a href="https://scholar.google.com/scholar_lookup?title=Studies+on+rat+mammary+adenocarcinomas:+A+model+for+metastasis&author=Ramshaw,+I.A.&author=Badenoch-Jones,+P.&publication_year=1985&journal=Cancer+Metastasis+Rev.&volume=4&pages=195%E2%80%93208&doi=10.1007/BF00048095" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/BF00048095" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B8-cancers-11-01889' class='html-x' data-content='8.'>Price, J.E.; Carr, D.; Tarin, D. Spontaneous and induced metastasis of naturally occurring tumors in mice: Analysis of cell shedding into the blood. <span class='html-italic'>J. Natl. Cancer Inst.</span> <b>1984</b>, <span class='html-italic'>73</span>, 1319–1326. [<a href="https://scholar.google.com/scholar_lookup?title=Spontaneous+and+induced+metastasis+of+naturally+occurring+tumors+in+mice:+Analysis+of+cell+shedding+into+the+blood&author=Price,+J.E.&author=Carr,+D.&author=Tarin,+D.&publication_year=1984&journal=J.+Natl.+Cancer+Inst.&volume=73&pages=1319%E2%80%931326" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B9-cancers-11-01889' class='html-x' data-content='9.'>Hewitt, H.B. Second point: Animal tumor models and their relevance to human tumor immunology. <span class='html-italic'>J. Biol. Response Mod.</span> <b>1983</b>, <span class='html-italic'>2</span>, 210–216. [<a href="https://scholar.google.com/scholar_lookup?title=Second+point:+Animal+tumor+models+and+their+relevance+to+human+tumor+immunology&author=Hewitt,+H.B.&publication_year=1983&journal=J.+Biol.+Response+Mod.&volume=2&pages=210%E2%80%93216" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B10-cancers-11-01889' class='html-xx' data-content='10.'>Nanni, P.; De Giovanni, C.; Lollini, P.L.; Nicoletti, G.; Prodi, G. TS/A: A new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma. <span class='html-italic'>Clin. Exp. Metastasis</span> <b>1983</b>, <span class='html-italic'>1</span>, 373–380. [<a href="https://scholar.google.com/scholar_lookup?title=TS/A:+A+new+metastasizing+cell+line+from+a+BALB/c+spontaneous+mammary+adenocarcinoma&author=Nanni,+P.&author=De+Giovanni,+C.&author=Lollini,+P.L.&author=Nicoletti,+G.&author=Prodi,+G.&publication_year=1983&journal=Clin.+Exp.+Metastasis&volume=1&pages=373%E2%80%93380&doi=10.1007/BF00121199" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/BF00121199" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B11-cancers-11-01889' class='html-xx' data-content='11.'>Cavallo, F.; Di Pierre, F.; Giovarelli, M.; Gulino, A.; Vacca, A.; Stoppacciaro, A.; Forni, M.; Modesti, A.; Forni, G. Protective and Curative Potential of Vaccination with Interleukin-2-Gene-transfected Cells from a Spontaneous Mouse Mammary Adenocarcinoma. <span class='html-italic'>Cancer Res.</span> <b>1993</b>, <span class='html-italic'>53</span>, 5067–5070. [<a href="https://scholar.google.com/scholar_lookup?title=Protective+and+Curative+Potential+of+Vaccination+with+Interleukin-2-Gene-transfected+Cells+from+a+Spontaneous+Mouse+Mammary+Adenocarcinoma&author=Cavallo,+F.&author=Di+Pierre,+F.&author=Giovarelli,+M.&author=Gulino,+A.&author=Vacca,+A.&author=Stoppacciaro,+A.&author=Forni,+M.&author=Modesti,+A.&author=Forni,+G.&publication_year=1993&journal=Cancer+Res.&volume=53&pages=5067%E2%80%935070&pmid=8221636" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/8221636" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B12-cancers-11-01889' class='html-xx' data-content='12.'>Lollini, P.-L.; Bosco, M.C.; Cavallo, F.; De Giovanni, C.; Giovarelli, M.; Landuzzi, L.; Musiani, P.; Modesti, A.; Nicoletti, G.; Palmieri, G.; et al. Inhibition of tumor growth and enhancement of metastasis after transfection of the γ-interferon gene. <span class='html-italic'>Int. J. Cancer</span> <b>1993</b>, <span class='html-italic'>55</span>, 320–329. [<a href="https://scholar.google.com/scholar_lookup?title=Inhibition+of+tumor+growth+and+enhancement+of+metastasis+after+transfection+of+the+%CE%B3-interferon+gene&author=Lollini,+P.-L.&author=Bosco,+M.C.&author=Cavallo,+F.&author=De+Giovanni,+C.&author=Giovarelli,+M.&author=Landuzzi,+L.&author=Musiani,+P.&author=Modesti,+A.&author=Nicoletti,+G.&author=Palmieri,+G.&publication_year=1993&journal=Int.+J.+Cancer&volume=55&pages=320%E2%80%93329&doi=10.1002/ijc.2910550224&pmid=8370628" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/ijc.2910550224" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/8370628" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B13-cancers-11-01889' class='html-xx' data-content='13.'>Yang, Y.; Yang, H.H.; Hu, Y.; Watson, P.H.; Liu, H.; Geiger, T.R.; Anver, M.R.; Haines, D.C.; Martin, P.; Green, J.E.; et al. Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis. <span class='html-italic'>Oncotarget</span> <b>2017</b>, <span class='html-italic'>8</span>, 30621–30643. [<a href="https://scholar.google.com/scholar_lookup?title=Immunocompetent+mouse+allograft+models+for+development+of+therapies+to+target+breast+cancer+metastasis&author=Yang,+Y.&author=Yang,+H.H.&author=Hu,+Y.&author=Watson,+P.H.&author=Liu,+H.&author=Geiger,+T.R.&author=Anver,+M.R.&author=Haines,+D.C.&author=Martin,+P.&author=Green,+J.E.&publication_year=2017&journal=Oncotarget&volume=8&pages=30621%E2%80%9330643&doi=10.18632/oncotarget.15695&pmid=28430642" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.18632/oncotarget.15695" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/28430642" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B14-cancers-11-01889' class='html-xx' data-content='14.'>Nicoletti, G.; Brambilla, P.; De Giovanni, C.; Lollini, P.L.; Del Re, B.; Marocchi, A.; Mocarelli, P.; Prodi, G.; Nanni, P. Colony-stimulating activity from the new metastatic TS/A cell line and its high- and low-metastatic clonal derivatives. <span class='html-italic'>Br. J. Cancer</span> <b>1985</b>, <span class='html-italic'>52</span>, 215–222. [<a href="https://scholar.google.com/scholar_lookup?title=Colony-stimulating+activity+from+the+new+metastatic+TS/A+cell+line+and+its+high-+and+low-metastatic+clonal+derivatives&author=Nicoletti,+G.&author=Brambilla,+P.&author=De+Giovanni,+C.&author=Lollini,+P.L.&author=Del+Re,+B.&author=Marocchi,+A.&author=Mocarelli,+P.&author=Prodi,+G.&author=Nanni,+P.&publication_year=1985&journal=Br.+J.+Cancer&volume=52&pages=215%E2%80%93222&doi=10.1038/bjc.1985.180" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/bjc.1985.180" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B15-cancers-11-01889' class='html-xx' data-content='15.'>Nicoletti, G.; Lollini, P.L.; Bagnara, G.P.; De Giovanni, C.; Del Re, B.; Bons, L.; Prodi, G.; Nanni, P. Are colony-stimulating factor-producing cells facilitated in the metastatic process? <span class='html-italic'>Anticancer Res.</span> <b>1987</b>, <span class='html-italic'>7</span>, 695–700. [<a href="https://scholar.google.com/scholar_lookup?title=Are+colony-stimulating+factor-producing+cells+facilitated+in+the+metastatic+process?&author=Nicoletti,+G.&author=Lollini,+P.L.&author=Bagnara,+G.P.&author=De+Giovanni,+C.&author=Del+Re,+B.&author=Bons,+L.&author=Prodi,+G.&author=Nanni,+P.&publication_year=1987&journal=Anticancer+Res.&volume=7&pages=695%E2%80%93700&pmid=3314670" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/3314670" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B16-cancers-11-01889' class='html-xx' data-content='16.'>Nicoletti, G.; De Giovanni, C.; Lollini, P.L.; Bagnara, G.P.; Scotlandi, K.; Landuzzi, L.; Del Re, B.; Zauli, G.; Prodi, G.; Nanni, P. In vivo and in vitro production of haemopoietic colony-stimulating activity by murine cell lines of different origin: A frequent finding. <span class='html-italic'>Eur. J. Cancer Clin. Oncol.</span> <b>1989</b>, <span class='html-italic'>25</span>, 1281–1286. [<a href="https://scholar.google.com/scholar_lookup?title=In+vivo+and+in+vitro+production+of+haemopoietic+colony-stimulating+activity+by+murine+cell+lines+of+different+origin:+A+frequent+finding&author=Nicoletti,+G.&author=De+Giovanni,+C.&author=Lollini,+P.L.&author=Bagnara,+G.P.&author=Scotlandi,+K.&author=Landuzzi,+L.&author=Del+Re,+B.&author=Zauli,+G.&author=Prodi,+G.&author=Nanni,+P.&publication_year=1989&journal=Eur.+J.+Cancer+Clin.+Oncol.&volume=25&pages=1281%E2%80%931286&doi=10.1016/0277-5379(89)90074-6" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/0277-5379(89)90074-6" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B17-cancers-11-01889' class='html-xx' data-content='17.'>Bronte, V.; Chappell, D.B.; Apolloni, E.; Cabrelle, A.; Wang, M.; Hwu, P.; Restifo, N.P. Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. <span class='html-italic'>J. Immunol.</span> <b>1999</b>, <span class='html-italic'>162</span>, 5728–5737. [<a href="https://scholar.google.com/scholar_lookup?title=Unopposed+production+of+granulocyte-macrophage+colony-stimulating+factor+by+tumors+inhibits+CD8++T+cell+responses+by+dysregulating+antigen-presenting+cell+maturation&author=Bronte,+V.&author=Chappell,+D.B.&author=Apolloni,+E.&author=Cabrelle,+A.&author=Wang,+M.&author=Hwu,+P.&author=Restifo,+N.P.&publication_year=1999&journal=J.+Immunol.&volume=162&pages=5728%E2%80%935737" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B18-cancers-11-01889' class='html-xx' data-content='18.'>Kummar, S.; Ishii, A.; Yang, H.K.; Venzon, D.J.; Kim, S.J.; Gress, R.E. Modulation of graft-versus-tumor effects in a murine allogeneic bone marrow transplantation model by tumor-derived transforming growth factor-β1. <span class='html-italic'>Biol. Blood Marrow Transplant.</span> <b>2001</b>, <span class='html-italic'>7</span>, 25–31. [<a href="https://scholar.google.com/scholar_lookup?title=Modulation+of+graft-versus-tumor+effects+in+a+murine+allogeneic+bone+marrow+transplantation+model+by+tumor-derived+transforming+growth+factor-%CE%B21&author=Kummar,+S.&author=Ishii,+A.&author=Yang,+H.K.&author=Venzon,+D.J.&author=Kim,+S.J.&author=Gress,+R.E.&publication_year=2001&journal=Biol.+Blood+Marrow+Transplant.&volume=7&pages=25%E2%80%9331&doi=10.1053/bbmt.2001.v7.pm11215695" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1053/bbmt.2001.v7.pm11215695" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B19-cancers-11-01889' class='html-xx' data-content='19.'>Cofano, F.; Fassio, A.; Cavallo, G.; Landolfo, S. Binding of murine 125I-labelled natural interferon-gamma to murine cell receptors. <span class='html-italic'>J. Gen. Virol.</span> <b>1986</b>, <span class='html-italic'>67</span>, 1205–1206. [<a href="https://scholar.google.com/scholar_lookup?title=Binding+of+murine+125I-labelled+natural+interferon-gamma+to+murine+cell+receptors&author=Cofano,+F.&author=Fassio,+A.&author=Cavallo,+G.&author=Landolfo,+S.&publication_year=1986&journal=J.+Gen.+Virol.&volume=67&pages=1205%E2%80%931206&doi=10.1099/0022-1317-67-6-1205" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1099/0022-1317-67-6-1205" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B20-cancers-11-01889' class='html-xx' data-content='20.'>Jentsch, I.; Geigl, J.; Klein, C.A.; Speicher, M.R. Seven-fluorochrome mouse M-FISH for high-resolution analysis of interchromosomal rearrangements. <span class='html-italic'>Cytogenet. Genome Res.</span> <b>2003</b>, <span class='html-italic'>103</span>, 84–88. [<a href="https://scholar.google.com/scholar_lookup?title=Seven-fluorochrome+mouse+M-FISH+for+high-resolution+analysis+of+interchromosomal+rearrangements&author=Jentsch,+I.&author=Geigl,+J.&author=Klein,+C.A.&author=Speicher,+M.R.&publication_year=2003&journal=Cytogenet.+Genome+Res.&volume=103&pages=84%E2%80%9388&doi=10.1159/000076294" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1159/000076294" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B21-cancers-11-01889' class='html-xx' data-content='21.'>Odin, L.; Favrot, M.; Poujol, D.; Michot, J.P.; Moingeon, P.; Tartaglia, J.; Puisieux, I. Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53. <span class='html-italic'>Cancer Gene Ther.</span> <b>2001</b>, <span class='html-italic'>8</span>, 87–98. [<a href="https://scholar.google.com/scholar_lookup?title=Canarypox+virus+expressing+wild+type+p53+for+gene+therapy+in+murine+tumors+mutated+in+p53&author=Odin,+L.&author=Favrot,+M.&author=Poujol,+D.&author=Michot,+J.P.&author=Moingeon,+P.&author=Tartaglia,+J.&author=Puisieux,+I.&publication_year=2001&journal=Cancer+Gene+Ther.&volume=8&pages=87%E2%80%9398&doi=10.1038/sj.cgt.7700279&pmid=11263530" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/sj.cgt.7700279" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/11263530" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B22-cancers-11-01889' class='html-xx' data-content='22.'>Yamano, T.; Kaneda, Y.; Hiramatsu, S.H.; Huang, S.; Tran, A.N.; Giuliano, A.E.; Hoon, D.S.B. Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21. <span class='html-italic'>Cancer Gene Ther.</span> <b>2007</b>, <span class='html-italic'>14</span>, 451–459. [<a href="https://scholar.google.com/scholar_lookup?title=Immunity+against+breast+cancer+by+TERT+DNA+vaccine+primed+with+chemokine+CCL21&author=Yamano,+T.&author=Kaneda,+Y.&author=Hiramatsu,+S.H.&author=Huang,+S.&author=Tran,+A.N.&author=Giuliano,+A.E.&author=Hoon,+D.S.B.&publication_year=2007&journal=Cancer+Gene+Ther.&volume=14&pages=451%E2%80%93459&doi=10.1038/sj.cgt.7701035&pmid=17318199" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/sj.cgt.7701035" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/17318199" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B23-cancers-11-01889' class='html-xx' data-content='23.'>Cavallo, F.; Giovarelli, M.; Gulino, A.; Vacca, A.; Stoppacciaro, A.; Modesti, A.; Forni, G. Role of neutrophils and CD4+T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. <span class='html-italic'>J. Immunol.</span> <b>1992</b>, <span class='html-italic'>149</span>, 3627–3635. [<a href="https://scholar.google.com/scholar_lookup?title=Role+of+neutrophils+and+CD4+T+lymphocytes+in+the+primary+and+memory+response+to+nonimmunogenic+murine+mammary+adenocarcinoma+made+immunogenic+by+IL-2+gene&author=Cavallo,+F.&author=Giovarelli,+M.&author=Gulino,+A.&author=Vacca,+A.&author=Stoppacciaro,+A.&author=Modesti,+A.&author=Forni,+G.&publication_year=1992&journal=J.+Immunol.&volume=149&pages=3627%E2%80%933635" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B24-cancers-11-01889' class='html-xx' data-content='24.'>Rakhmilevich, A.L.; Janssen, K.; Hao, Z.; Sondel, P.M.; Yang, N.S. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell- independent mechanism. <span class='html-italic'>Cancer Gene Ther.</span> <b>2000</b>, <span class='html-italic'>7</span>, 826–838. [<a href="https://scholar.google.com/scholar_lookup?title=Interleukin-12+gene+therapy+of+a+weakly+immunogenic+mouse+mammary+carcinoma+results+in+reduction+of+spontaneous+lung+metastases+via+a+T-cell-+independent+mechanism&author=Rakhmilevich,+A.L.&author=Janssen,+K.&author=Hao,+Z.&author=Sondel,+P.M.&author=Yang,+N.S.&publication_year=2000&journal=Cancer+Gene+Ther.&volume=7&pages=826%E2%80%93838&doi=10.1038/sj.cgt.7700176&pmid=10880012" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/sj.cgt.7700176" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/10880012" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B25-cancers-11-01889' class='html-xx' data-content='25.'>Rosato, A.; Dalla Santa, S.; Zoso, A.; Giacomelli, S.; Milan, G.; Macino, B.; Tosello, V.; Dellabona, P.; Lollini, P.L.; De Giovanni, C.; et al. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus. <span class='html-italic'>Cancer Res.</span> <b>2003</b>, <span class='html-italic'>63</span>, 2158–2163. [<a href="https://scholar.google.com/scholar_lookup?title=The+cytotoxic+T-lymphocyte+response+against+a+poorly+immunogenic+mammary+adenocarcinoma+is+focused+on+a+single+immunodominant+class+I+epitope+derived+from+the+gp70+Env+product+of+an+endogenous+retrovirus&author=Rosato,+A.&author=Dalla+Santa,+S.&author=Zoso,+A.&author=Giacomelli,+S.&author=Milan,+G.&author=Macino,+B.&author=Tosello,+V.&author=Dellabona,+P.&author=Lollini,+P.L.&author=De+Giovanni,+C.&publication_year=2003&journal=Cancer+Res.&volume=63&pages=2158%E2%80%932163&pmid=12727834" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/12727834" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B26-cancers-11-01889' class='html-xx' data-content='26.'>Pericle, F.; Sconocchia, G.; Segal, D.M.; Bronte, V.; Kirken, R.A.; Dasilva, L. Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes. <span class='html-italic'>J. Immunol.</span> <b>1997</b>, <span class='html-italic'>159</span>, 2580–2585. [<a href="https://scholar.google.com/scholar_lookup?title=Immunocompromised+tumor-bearing+mice+show+a+selective+loss+of+STAT5a/b+expression+in+T+and+B+lymphocytes&author=Pericle,+F.&author=Sconocchia,+G.&author=Segal,+D.M.&author=Bronte,+V.&author=Kirken,+R.A.&author=Dasilva,+L.&publication_year=1997&journal=J.+Immunol.&volume=159&pages=2580%E2%80%932585&pmid=9300676" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/9300676" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B27-cancers-11-01889' class='html-xx' data-content='27.'>Piconese, S.; Valzasina, B.; Colombo, M.P. OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection. <span class='html-italic'>J. Exp. Med.</span> <b>2008</b>, <span class='html-italic'>205</span>, 825–839. [<a href="https://scholar.google.com/scholar_lookup?title=OX40+triggering+blocks+suppression+by+regulatory+T+cells+and+facilitates+tumor+rejection&author=Piconese,+S.&author=Valzasina,+B.&author=Colombo,+M.P.&publication_year=2008&journal=J.+Exp.+Med.&volume=205&pages=825%E2%80%93839&doi=10.1084/jem.20071341" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1084/jem.20071341" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B28-cancers-11-01889' class='html-xx' data-content='28.'>Apolloni, E.; Bronte, V.; Mazzoni, A.; Serafini, P.; Cabrelle, A.; Segal, D.M.; Young, H.A.; Zanovello, P. Immortalized Myeloid Suppressor Cells Trigger Apoptosis in Antigen-Activated T Lymphocytes. <span class='html-italic'>J. Immunol.</span> <b>2000</b>, <span class='html-italic'>165</span>, 6723–6730. [<a href="https://scholar.google.com/scholar_lookup?title=Immortalized+Myeloid+Suppressor+Cells+Trigger+Apoptosis+in+Antigen-Activated+T+Lymphocytes&author=Apolloni,+E.&author=Bronte,+V.&author=Mazzoni,+A.&author=Serafini,+P.&author=Cabrelle,+A.&author=Segal,+D.M.&author=Young,+H.A.&author=Zanovello,+P.&publication_year=2000&journal=J.+Immunol.&volume=165&pages=6723%E2%80%936730&doi=10.4049/jimmunol.165.12.6723" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.4049/jimmunol.165.12.6723" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B29-cancers-11-01889' class='html-xx' data-content='29.'>Bronte, V.; Apolloni, E.; Cabrelle, A.; Ronca, R.; Serafini, P.; Zamboni, P.; Restifo, N.P.; Zanovello, P. Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+ T cells. <span class='html-italic'>Blood</span> <b>2000</b>, <span class='html-italic'>96</span>, 3838–3846. [<a href="https://scholar.google.com/scholar_lookup?title=Identification+of+a+CD11b+/Gr-1+/CD31++myeloid+progenitor+capable+of+activating+or+suppressing+CD8++T+cells&author=Bronte,+V.&author=Apolloni,+E.&author=Cabrelle,+A.&author=Ronca,+R.&author=Serafini,+P.&author=Zamboni,+P.&author=Restifo,+N.P.&author=Zanovello,+P.&publication_year=2000&journal=Blood&volume=96&pages=3838%E2%80%933846&doi=10.1182/blood.V96.12.3838" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1182/blood.V96.12.3838" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B30-cancers-11-01889' class='html-xx' data-content='30.'>Mazzoni, A.; Bronte, V.; Visintin, A.; Spitzer, J.H.; Apolloni, E.; Serafini, P.; Zanovello, P.; Segal, D.M. Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism. <span class='html-italic'>J. Immunol.</span> <b>2002</b>, <span class='html-italic'>168</span>, 689–695. [<a href="https://scholar.google.com/scholar_lookup?title=Myeloid+Suppressor+Lines+Inhibit+T+Cell+Responses+by+an+NO-Dependent+Mechanism&author=Mazzoni,+A.&author=Bronte,+V.&author=Visintin,+A.&author=Spitzer,+J.H.&author=Apolloni,+E.&author=Serafini,+P.&author=Zanovello,+P.&author=Segal,+D.M.&publication_year=2002&journal=J.+Immunol.&volume=168&pages=689%E2%80%93695&doi=10.4049/jimmunol.168.2.689" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.4049/jimmunol.168.2.689" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B31-cancers-11-01889' class='html-xx' data-content='31.'>Serafini, P.; Meckel, K.; Kelso, M.; Noonan, K.; Califano, J.; Koch, W.; Dolcetti, L.; Bronte, V.; Borrello, I. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. <span class='html-italic'>J. Exp. Med.</span> <b>2006</b>, <span class='html-italic'>203</span>, 2691–2702. [<a href="https://scholar.google.com/scholar_lookup?title=Phosphodiesterase-5+inhibition+augments+endogenous+antitumor+immunity+by+reducing+myeloid-derived+suppressor+cell+function&author=Serafini,+P.&author=Meckel,+K.&author=Kelso,+M.&author=Noonan,+K.&author=Califano,+J.&author=Koch,+W.&author=Dolcetti,+L.&author=Bronte,+V.&author=Borrello,+I.&publication_year=2006&journal=J.+Exp.+Med.&volume=203&pages=2691%E2%80%932702&doi=10.1084/jem.20061104&pmid=17101732" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1084/jem.20061104" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/17101732" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B32-cancers-11-01889' class='html-xx' data-content='32.'>Grizzle, W.E.; Xu, X.; Zhang, S.; Stockard, C.R.; Liu, C.; Yu, S.; Wang, J.; Mountz, J.D.; Zhang, H.G. Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice. <span class='html-italic'>Mech. Ageing Dev.</span> <b>2007</b>, <span class='html-italic'>128</span>, 672–680. [<a href="https://scholar.google.com/scholar_lookup?title=Age-related+increase+of+tumor+susceptibility+is+associated+with+myeloid-derived+suppressor+cell+mediated+suppression+of+T+cell+cytotoxicity+in+recombinant+inbred+BXD12+mice&author=Grizzle,+W.E.&author=Xu,+X.&author=Zhang,+S.&author=Stockard,+C.R.&author=Liu,+C.&author=Yu,+S.&author=Wang,+J.&author=Mountz,+J.D.&author=Zhang,+H.G.&publication_year=2007&journal=Mech.+Ageing+Dev.&volume=128&pages=672%E2%80%93680&doi=10.1016/j.mad.2007.10.003&pmid=18036633" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.mad.2007.10.003" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/18036633" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B33-cancers-11-01889' class='html-xx' data-content='33.'>Sinha, P.; Chornoguz, O.; Clements, V.K.; Artemenko, K.A.; Zubarev, R.A.; Ostrand-Rosenberg, S. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. <span class='html-italic'>Blood</span> <b>2011</b>, <span class='html-italic'>117</span>, 5381–5390. [<a href="https://scholar.google.com/scholar_lookup?title=Myeloid-derived+suppressor+cells+express+the+death+receptor+Fas+and+apoptose+in+response+to+T+cell-expressed+FasL&author=Sinha,+P.&author=Chornoguz,+O.&author=Clements,+V.K.&author=Artemenko,+K.A.&author=Zubarev,+R.A.&author=Ostrand-Rosenberg,+S.&publication_year=2011&journal=Blood&volume=117&pages=5381%E2%80%935390&doi=10.1182/blood-2010-11-321752&pmid=21450901" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1182/blood-2010-11-321752" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/21450901" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B34-cancers-11-01889' class='html-xx' data-content='34.'>Ostrand-Rosenberg, S.; Sinha, P.; Chornoguz, O.; Ecker, C. Regulating the suppressors: Apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC). <span class='html-italic'>Cancer Immunol. Immunother.</span> <b>2012</b>, <span class='html-italic'>61</span>, 1319–1325. [<a href="https://scholar.google.com/scholar_lookup?title=Regulating+the+suppressors:+Apoptosis+and+inflammation+govern+the+survival+of+tumor-induced+myeloid-derived+suppressor+cells+(MDSC)&author=Ostrand-Rosenberg,+S.&author=Sinha,+P.&author=Chornoguz,+O.&author=Ecker,+C.&publication_year=2012&journal=Cancer+Immunol.+Immunother.&volume=61&pages=1319%E2%80%931325&doi=10.1007/s00262-012-1269-6" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/s00262-012-1269-6" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B35-cancers-11-01889' class='html-xx' data-content='35.'>Sinha, P.; Parker, K.H.; Horn, L.; Ostrand-Rosenberg, S. Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4Rα. <span class='html-italic'>Eur. J. Immunol.</span> <b>2012</b>, <span class='html-italic'>42</span>, 2052–2059. [<a href="https://scholar.google.com/scholar_lookup?title=Tumor-induced+myeloid-derived+suppressor+cell+function+is+independent+of+IFN-%CE%B3+and+IL-4R%CE%B1&author=Sinha,+P.&author=Parker,+K.H.&author=Horn,+L.&author=Ostrand-Rosenberg,+S.&publication_year=2012&journal=Eur.+J.+Immunol.&volume=42&pages=2052%E2%80%932059&doi=10.1002/eji.201142230" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/eji.201142230" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://europepmc.org/articles/pmc3673533?pdf=render" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B36-cancers-11-01889' class='html-xx' data-content='36.'>Morandi, B.; Mortara, L.; Chiossone, L.; Accolla, R.S.; Mingari, M.C.; Moretta, L.; Moretta, A.; Ferlazzo, G. Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. <span class='html-italic'>PLoS ONE</span> <b>2012</b>, <span class='html-italic'>7</span>, e39170. [<a href="https://scholar.google.com/scholar_lookup?title=Dendritic+cell+editing+by+activated+natural+killer+cells+results+in+a+more+protective+cancer-specific+immune+response&author=Morandi,+B.&author=Mortara,+L.&author=Chiossone,+L.&author=Accolla,+R.S.&author=Mingari,+M.C.&author=Moretta,+L.&author=Moretta,+A.&author=Ferlazzo,+G.&publication_year=2012&journal=PLoS+ONE&volume=7&pages=e39170&doi=10.1371/journal.pone.0039170&pmid=22723958" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1371/journal.pone.0039170" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/22723958" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="https://core.ac.uk/reader/53556251" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B37-cancers-11-01889' class='html-xx' data-content='37.'>Mirshahidi, S.; Kramer, V.G.; Whitney, J.B.; Essono, S.; Lee, S.; Dranoff, G.; Anderson, K.S.; Ruprecht, R.M. Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: Prolonged survival. <span class='html-italic'>Vaccine</span> <b>2009</b>, <span class='html-italic'>27</span>, 1825–1833. [<a href="https://scholar.google.com/scholar_lookup?title=Overlapping+synthetic+peptides+encoding+TPD52+as+breast+cancer+vaccine+in+mice:+Prolonged+survival&author=Mirshahidi,+S.&author=Kramer,+V.G.&author=Whitney,+J.B.&author=Essono,+S.&author=Lee,+S.&author=Dranoff,+G.&author=Anderson,+K.S.&author=Ruprecht,+R.M.&publication_year=2009&journal=Vaccine&volume=27&pages=1825%E2%80%931833&doi=10.1016/j.vaccine.2009.01.089&pmid=19201387" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.vaccine.2009.01.089" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/19201387" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="http://europepmc.org/articles/pmc4477950?pdf=render" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B38-cancers-11-01889' class='html-xx' data-content='38.'>Clément, M.; Rocher, J.; Loirand, G.; Le Pendu, J. Expression of sialyl-Tn epitopes on β1 integrin alters epithelial cell phenotype, proliferation and haptotaxis. <span class='html-italic'>J. Cell Sci.</span> <b>2004</b>, <span class='html-italic'>117</span>, 5059–5069. [<a href="https://scholar.google.com/scholar_lookup?title=Expression+of+sialyl-Tn+epitopes+on+%CE%B21+integrin+alters+epithelial+cell+phenotype,+proliferation+and+haptotaxis&author=Cl%C3%A9ment,+M.&author=Rocher,+J.&author=Loirand,+G.&author=Le+Pendu,+J.&publication_year=2004&journal=J.+Cell+Sci.&volume=117&pages=5059%E2%80%935069&doi=10.1242/jcs.01350" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1242/jcs.01350" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://jcs.biologists.org/content/117/21/5059.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B39-cancers-11-01889' class='html-xx' data-content='39.'>Hsu, H.C.; Li, L.; Zhang, H.G.; Mountz, J.D. Genetic regulation of thymic involution. <span class='html-italic'>Mech. Ageing Dev.</span> <b>2005</b>, <span class='html-italic'>126</span>, 87–97. [<a href="https://scholar.google.com/scholar_lookup?title=Genetic+regulation+of+thymic+involution&author=Hsu,+H.C.&author=Li,+L.&author=Zhang,+H.G.&author=Mountz,+J.D.&publication_year=2005&journal=Mech.+Ageing+Dev.&volume=126&pages=87%E2%80%9397&doi=10.1016/j.mad.2004.09.016" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.mad.2004.09.016" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B40-cancers-11-01889' class='html-xx' data-content='40.'>Lollini, P.L.; De Giovanni, C.; Eusebi, V.; Nicoletti, G.; Prodi, G.; Nanni, P. High-metastatic clones selected in vitro from a recent spontaneous BALB/c mammary adenocarcinoma cell line. <span class='html-italic'>Clin. Exp. Metastasis</span> <b>1984</b>, <span class='html-italic'>2</span>, 251–259. [<a href="https://scholar.google.com/scholar_lookup?title=High-metastatic+clones+selected+in+vitro+from+a+recent+spontaneous+BALB/c+mammary+adenocarcinoma+cell+line&author=Lollini,+P.L.&author=De+Giovanni,+C.&author=Eusebi,+V.&author=Nicoletti,+G.&author=Prodi,+G.&author=Nanni,+P.&publication_year=1984&journal=Clin.+Exp.+Metastasis&volume=2&pages=251%E2%80%93259&doi=10.1007/BF00132932" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/BF00132932" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B41-cancers-11-01889' class='html-xx' data-content='41.'>Nanni, P.; De Giovanni, C.; Lollini, P.L.; Nicoletti, G.; Prodi, G. Clones with different metastatic capacity and variant selection during metastasis: A problematic relationship. <span class='html-italic'>J. Natl. Cancer Inst.</span> <b>1986</b>, <span class='html-italic'>76</span>, 87–93. [<a href="https://scholar.google.com/scholar_lookup?title=Clones+with+different+metastatic+capacity+and+variant+selection+during+metastasis:+A+problematic+relationship&author=Nanni,+P.&author=De+Giovanni,+C.&author=Lollini,+P.L.&author=Nicoletti,+G.&author=Prodi,+G.&publication_year=1986&journal=J.+Natl.+Cancer+Inst.&volume=76&pages=87%E2%80%9393&pmid=3455746" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/3455746" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B42-cancers-11-01889' class='html-xx' data-content='42.'>Lollini, P.L.; Landuzzi, L.; Nlcoletti, G.; De Giovanni, C.; Glovarelli, M.; Lalli, E.; Facchini, A.; Nanni, P. <span class='html-italic'>LY-6A/E</span> gene is widely expressed among transformed nonhematopoietic cells. Autocrine modulation by interferon. <span class='html-italic'>Anticancer Res.</span> <b>1992</b>, <span class='html-italic'>12</span>, 2245–2252. [<a href="https://scholar.google.com/scholar_lookup?title=LY-6A/E+gene+is+widely+expressed+among+transformed+nonhematopoietic+cells.+Autocrine+modulation+by+interferon&author=Lollini,+P.L.&author=Landuzzi,+L.&author=Nlcoletti,+G.&author=De+Giovanni,+C.&author=Glovarelli,+M.&author=Lalli,+E.&author=Facchini,+A.&author=Nanni,+P.&publication_year=1992&journal=Anticancer+Res.&volume=12&pages=2245%E2%80%932252&pmid=1295472" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/1295472" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B43-cancers-11-01889' class='html-xx' data-content='43.'>Kim, R.J.; Kim, S.R.; Roh, K.J.; Park, S.B.; Park, J.R.; Kang, K.S.; Kong, G.; Tang, B.; Yang, Y.A.; Kohn, E.A.; et al. Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer. <span class='html-italic'>Cancer Lett.</span> <b>2010</b>, <span class='html-italic'>287</span>, 172–181. [<a href="https://scholar.google.com/scholar_lookup?title=Ras+activation+contributes+to+the+maintenance+and+expansion+of+Sca-1pos+cells+in+a+mouse+model+of+breast+cancer&author=Kim,+R.J.&author=Kim,+S.R.&author=Roh,+K.J.&author=Park,+S.B.&author=Park,+J.R.&author=Kang,+K.S.&author=Kong,+G.&author=Tang,+B.&author=Yang,+Y.A.&author=Kohn,+E.A.&publication_year=2010&journal=Cancer+Lett.&volume=287&pages=172%E2%80%93181&doi=10.1016/j.canlet.2009.06.010&pmid=19586713" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.canlet.2009.06.010" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/19586713" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B44-cancers-11-01889' class='html-xx' data-content='44.'>Zuo, T.; Wang, L.; Morrison, C.; Chang, X.; Zhang, H.; Li, W.; Liu, Y.; Wang, Y.; Liu, X.; Chan, M.W.Y.; et al. FOXP3 Is an X-Linked Breast Cancer Suppressor Gene and an Important Repressor of the HER-2/ErbB2 Oncogene. <span class='html-italic'>Cell</span> <b>2007</b>, <span class='html-italic'>129</span>, 1275–1286. [<a href="https://scholar.google.com/scholar_lookup?title=FOXP3+Is+an+X-Linked+Breast+Cancer+Suppressor+Gene+and+an+Important+Repressor+of+the+HER-2/ErbB2+Oncogene&author=Zuo,+T.&author=Wang,+L.&author=Morrison,+C.&author=Chang,+X.&author=Zhang,+H.&author=Li,+W.&author=Liu,+Y.&author=Wang,+Y.&author=Liu,+X.&author=Chan,+M.W.Y.&publication_year=2007&journal=Cell&volume=129&pages=1275%E2%80%931286&doi=10.1016/j.cell.2007.04.034" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.cell.2007.04.034" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://core.ac.uk/download/pdf/82521654.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B45-cancers-11-01889' class='html-xx' data-content='45.'>Dolinsek, T.; Markelc, B.; Bosnjak, M.; Blagus, T.; Prosen, L.; Kranjc, S.; Stimac, M.; Lampreht, U.; Sersa, G.; Cemazar, M. Endoglin Silencing has Significant Antitumor Effect on Murine Mammary Adenocarcinoma Mediated by Vascular Targeted Effect. <span class='html-italic'>Curr. Gene Ther.</span> <b>2015</b>, <span class='html-italic'>15</span>, 228–244. [<a href="https://scholar.google.com/scholar_lookup?title=Endoglin+Silencing+has+Significant+Antitumor+Effect+on+Murine+Mammary+Adenocarcinoma+Mediated+by+Vascular+Targeted+Effect&author=Dolinsek,+T.&author=Markelc,+B.&author=Bosnjak,+M.&author=Blagus,+T.&author=Prosen,+L.&author=Kranjc,+S.&author=Stimac,+M.&author=Lampreht,+U.&author=Sersa,+G.&author=Cemazar,+M.&publication_year=2015&journal=Curr.+Gene+Ther.&volume=15&pages=228%E2%80%93244&doi=10.2174/1566523215666150126115501" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.2174/1566523215666150126115501" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B46-cancers-11-01889' class='html-xx' data-content='46.'>Lucá, R.; Averna, M.; Zalfa, F.; Vecchi, M.; Bianchi, F.; La Fata, G.; Del Nonno, F.; Nardacci, R.; Bianchi, M.; Nuciforo, P.; et al. The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation. <span class='html-italic'>EMBO Mol. Med.</span> <b>2013</b>, <span class='html-italic'>5</span>, 1523–1536. [<a href="https://scholar.google.com/scholar_lookup?title=The+Fragile+X+Protein+binds+mRNAs+involved+in+cancer+progression+and+modulates+metastasis+formation&author=Luc%C3%A1,+R.&author=Averna,+M.&author=Zalfa,+F.&author=Vecchi,+M.&author=Bianchi,+F.&author=La+Fata,+G.&author=Del+Nonno,+F.&author=Nardacci,+R.&author=Bianchi,+M.&author=Nuciforo,+P.&publication_year=2013&journal=EMBO+Mol.+Med.&volume=5&pages=1523%E2%80%931536&doi=10.1002/emmm.201302847" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/emmm.201302847" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://core.ac.uk/download/pdf/34578931.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B47-cancers-11-01889' class='html-xx' data-content='47.'>Cottone, L.; Capobianco, A.; Gualteroni, C.; Monno, A.; Raccagni, I.; Valtorta, S.; Canu, T.; Di Tomaso, T.; Lombardo, A.; Esposito, A.; et al. Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis. <span class='html-italic'>Oncoimmunology</span> <b>2016</b>, <span class='html-italic'>5</span>, e1122860. [<a href="https://scholar.google.com/scholar_lookup?title=Leukocytes+recruited+by+tumor-derived+HMGB1+sustain+peritoneal+carcinomatosis&author=Cottone,+L.&author=Capobianco,+A.&author=Gualteroni,+C.&author=Monno,+A.&author=Raccagni,+I.&author=Valtorta,+S.&author=Canu,+T.&author=Di+Tomaso,+T.&author=Lombardo,+A.&author=Esposito,+A.&publication_year=2016&journal=Oncoimmunology&volume=5&pages=e1122860&doi=10.1080/2162402X.2015.1122860" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1080/2162402X.2015.1122860" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1122860?needAccess=true" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B48-cancers-11-01889' class='html-xx' data-content='48.'>Li, W.; Wang, L.; Katoh, H.; Liu, R.; Zheng, P.; Liu, Y. Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers. <span class='html-italic'>Cancer Res.</span> <b>2011</b>, <span class='html-italic'>71</span>, 2162–2171. [<a href="https://scholar.google.com/scholar_lookup?title=Identification+of+a+tumor+suppressor+relay+between+the+FOXP3+and+the+Hippo+pathways+in+breast+and+prostate+cancers&author=Li,+W.&author=Wang,+L.&author=Katoh,+H.&author=Liu,+R.&author=Zheng,+P.&author=Liu,+Y.&publication_year=2011&journal=Cancer+Res.&volume=71&pages=2162%E2%80%932171&doi=10.1158/0008-5472.CAN-10-3268" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/0008-5472.CAN-10-3268" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B49-cancers-11-01889' class='html-xx' data-content='49.'>Dalziel, M.; Yeahuang, R.; Dall’Olio, F.; Morris, J.R.; Taylor-Papadimitriou, J.; Lau, J.T.Y. Mouse ST6Gal sialyltransferase gene expression during mammary gland lactation. <span class='html-italic'>Glycobiology</span> <b>2001</b>, <span class='html-italic'>11</span>, 407–412. [<a href="https://scholar.google.com/scholar_lookup?title=Mouse+ST6Gal+sialyltransferase+gene+expression+during+mammary+gland+lactation&author=Dalziel,+M.&author=Yeahuang,+R.&author=Dall%E2%80%99Olio,+F.&author=Morris,+J.R.&author=Taylor-Papadimitriou,+J.&author=Lau,+J.T.Y.&publication_year=2001&journal=Glycobiology&volume=11&pages=407%E2%80%93412&doi=10.1093/glycob/11.5.407" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1093/glycob/11.5.407" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://academic.oup.com/glycob/article-pdf/11/5/407/9806246/110407.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B50-cancers-11-01889' class='html-xx' data-content='50.'>Znidar, K.; Bosnjak, M.; Semenova, N.; Pakhomova, O.; Heller, L.; Cemazar, M. Tumor cell death after electrotransfer of plasmid DNA is associated with cytosolic DNA sensor upregulation. <span class='html-italic'>Oncotarget</span> <b>2018</b>, <span class='html-italic'>9</span>, 18665–18681. [<a href="https://scholar.google.com/scholar_lookup?title=Tumor+cell+death+after+electrotransfer+of+plasmid+DNA+is+associated+with+cytosolic+DNA+sensor+upregulation&author=Znidar,+K.&author=Bosnjak,+M.&author=Semenova,+N.&author=Pakhomova,+O.&author=Heller,+L.&author=Cemazar,+M.&publication_year=2018&journal=Oncotarget&volume=9&pages=18665%E2%80%9318681&doi=10.18632/oncotarget.24816" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.18632/oncotarget.24816" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=24816&path%5B%5D=77821" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B51-cancers-11-01889' class='html-xx' data-content='51.'>Servier Medical Art. Licensed under a Creative Commons Attribution 3.0 Unported License. Available online: <a href='http://smart.servier.com' target='_blank' rel="noopener noreferrer" >http://smart.servier.com</a> (accessed on 24 October 2019).</li><li id='B52-cancers-11-01889' class='html-xx' data-content='52.'>Schirmbeck, R.; Riedl, P.; Kupferschmitt, M.; Wegenka, U.; Hauser, H.; Rice, J.; Kröger, A.; Reimann, J. Priming Protective CD8 T Cell Immunity by DNA Vaccines Encoding Chimeric, Stress Protein-Capturing Tumor-Associated Antigen. <span class='html-italic'>J. Immunol.</span> <b>2006</b>, <span class='html-italic'>177</span>, 1534–1542. [<a href="https://scholar.google.com/scholar_lookup?title=Priming+Protective+CD8+T+Cell+Immunity+by+DNA+Vaccines+Encoding+Chimeric,+Stress+Protein-Capturing+Tumor-Associated+Antigen&author=Schirmbeck,+R.&author=Riedl,+P.&author=Kupferschmitt,+M.&author=Wegenka,+U.&author=Hauser,+H.&author=Rice,+J.&author=Kr%C3%B6ger,+A.&author=Reimann,+J.&publication_year=2006&journal=J.+Immunol.&volume=177&pages=1534%E2%80%931542&doi=10.4049/jimmunol.177.3.1534&pmid=16849460" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.4049/jimmunol.177.3.1534" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/16849460" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="http://www.jimmunol.org/content/177/3/1534.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B53-cancers-11-01889' class='html-xx' data-content='53.'>Serafini, P.; De Santo, C.; Marigo, I.; Cingarlini, S.; Dolcetti, L.; Gallina, G.; Zanovello, P.; Bronte, V. Derangement of immune responses by myeloid suppressor cells. <span class='html-italic'>Cancer Immunol. Immunother.</span> <b>2004</b>, <span class='html-italic'>53</span>, 64–72. [<a href="https://scholar.google.com/scholar_lookup?title=Derangement+of+immune+responses+by+myeloid+suppressor+cells&author=Serafini,+P.&author=De+Santo,+C.&author=Marigo,+I.&author=Cingarlini,+S.&author=Dolcetti,+L.&author=Gallina,+G.&author=Zanovello,+P.&author=Bronte,+V.&publication_year=2004&journal=Cancer+Immunol.+Immunother.&volume=53&pages=64%E2%80%9372&doi=10.1007/s00262-003-0443-2&pmid=14593498" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/s00262-003-0443-2" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/14593498" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B54-cancers-11-01889' class='html-xx' data-content='54.'>Shibue, T.; Brooks, M.W.; Fatih Inan, M.; Reinhardt, F.; Weinberg, R.A. The outgrowth of micrometastases is enabled by the formation of filopodium-like protrusions. <span class='html-italic'>Cancer Discov.</span> <b>2012</b>, <span class='html-italic'>2</span>, 706–721. [<a href="https://scholar.google.com/scholar_lookup?title=The+outgrowth+of+micrometastases+is+enabled+by+the+formation+of+filopodium-like+protrusions&author=Shibue,+T.&author=Brooks,+M.W.&author=Fatih+Inan,+M.&author=Reinhardt,+F.&author=Weinberg,+R.A.&publication_year=2012&journal=Cancer+Discov.&volume=2&pages=706%E2%80%93721&doi=10.1158/2159-8290.CD-11-0239" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/2159-8290.CD-11-0239" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B55-cancers-11-01889' class='html-xx' data-content='55.'>Movahedi, K.; Laoui, D.; Gysemans, C.; Baeten, M.; Stangé, G.; Van Den Bossche, J.; Mack, M.; Pipeleers, D.; In’t Veld, P.; De Baetselier, P.; et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. <span class='html-italic'>Cancer Res.</span> <b>2010</b>, <span class='html-italic'>70</span>, 5728–5739. [<a href="https://scholar.google.com/scholar_lookup?title=Different+tumor+microenvironments+contain+functionally+distinct+subsets+of+macrophages+derived+from+Ly6C(high)+monocytes&author=Movahedi,+K.&author=Laoui,+D.&author=Gysemans,+C.&author=Baeten,+M.&author=Stang%C3%A9,+G.&author=Van+Den+Bossche,+J.&author=Mack,+M.&author=Pipeleers,+D.&author=In%E2%80%99t+Veld,+P.&author=De+Baetselier,+P.&publication_year=2010&journal=Cancer+Res.&volume=70&pages=5728%E2%80%935739&doi=10.1158/0008-5472.CAN-09-4672&pmid=20570887" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/0008-5472.CAN-09-4672" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20570887" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B56-cancers-11-01889' class='html-xx' data-content='56.'>Galdiero, M.R.; Bonavita, E.; Barajon, I.; Garlanda, C.; Mantovani, A.; Jaillon, S. Tumor associated macrophages and neutrophils in cancer. <span class='html-italic'>Immunobiology</span> <b>2013</b>, <span class='html-italic'>218</span>, 1402–1410. [<a href="https://scholar.google.com/scholar_lookup?title=Tumor+associated+macrophages+and+neutrophils+in+cancer&author=Galdiero,+M.R.&author=Bonavita,+E.&author=Barajon,+I.&author=Garlanda,+C.&author=Mantovani,+A.&author=Jaillon,+S.&publication_year=2013&journal=Immunobiology&volume=218&pages=1402%E2%80%931410&doi=10.1016/j.imbio.2013.06.003" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.imbio.2013.06.003" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B57-cancers-11-01889' class='html-xx' data-content='57.'>Bronte, V.; Brandau, S.; Chen, S.H.; Colombo, M.P.; Frey, A.B.; Greten, T.F.; Mandruzzato, S.; Murray, P.J.; Ochoa, A.; Ostrand-Rosenberg, S.; et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. <span class='html-italic'>Nat. Commun.</span> <b>2016</b>, <span class='html-italic'>7</span>, 12150. [<a href="https://scholar.google.com/scholar_lookup?title=Recommendations+for+myeloid-derived+suppressor+cell+nomenclature+and+characterization+standards&author=Bronte,+V.&author=Brandau,+S.&author=Chen,+S.H.&author=Colombo,+M.P.&author=Frey,+A.B.&author=Greten,+T.F.&author=Mandruzzato,+S.&author=Murray,+P.J.&author=Ochoa,+A.&author=Ostrand-Rosenberg,+S.&publication_year=2016&journal=Nat.+Commun.&volume=7&pages=12150&doi=10.1038/ncomms12150" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/ncomms12150" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://www.nature.com/articles/ncomms12150.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B58-cancers-11-01889' class='html-xx' data-content='58.'>Schmieder, A.; Schledzewski, K.; Michel, J.; Tuckermann, J.P.; Tome, L.; Sticht, C.; Gkaniatsou, C.; Nicolay, J.P.; Demory, A.; Faulhaber, J.; et al. Synergistic activation by p38MAPK and glucocorticoid signaling mediates induction of M2-like tumor-associated macrophages expressing the novel CD20 homolog MS4A8A. <span class='html-italic'>Int. J. Cancer</span> <b>2011</b>, <span class='html-italic'>129</span>, 122–132. [<a href="https://scholar.google.com/scholar_lookup?title=Synergistic+activation+by+p38MAPK+and+glucocorticoid+signaling+mediates+induction+of+M2-like+tumor-associated+macrophages+expressing+the+novel+CD20+homolog+MS4A8A&author=Schmieder,+A.&author=Schledzewski,+K.&author=Michel,+J.&author=Tuckermann,+J.P.&author=Tome,+L.&author=Sticht,+C.&author=Gkaniatsou,+C.&author=Nicolay,+J.P.&author=Demory,+A.&author=Faulhaber,+J.&publication_year=2011&journal=Int.+J.+Cancer&volume=129&pages=122%E2%80%93132&doi=10.1002/ijc.25657" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/ijc.25657" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B59-cancers-11-01889' class='html-xx' data-content='59.'>Guiducci, C.; Vicari, A.P.; Sangaletti, S.; Trinchieri, G.; Colombo, M.P. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. <span class='html-italic'>Cancer Res.</span> <b>2005</b>, <span class='html-italic'>65</span>, 3437–3446. [<a href="https://scholar.google.com/scholar_lookup?title=Redirecting+in+vivo+elicited+tumor+infiltrating+macrophages+and+dendritic+cells+towards+tumor+rejection&author=Guiducci,+C.&author=Vicari,+A.P.&author=Sangaletti,+S.&author=Trinchieri,+G.&author=Colombo,+M.P.&publication_year=2005&journal=Cancer+Res.&volume=65&pages=3437%E2%80%933446&doi=10.1158/0008-5472.CAN-04-4262" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/0008-5472.CAN-04-4262" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://cancerres.aacrjournals.org/content/65/8/3437.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B60-cancers-11-01889' class='html-xx' data-content='60.'>Fuchs, T.; Hahn, M.; Riabov, V.; Yin, S.; Kzhyshkowska, J.; Busch, S.; Püllmann, K.; Beham, A.W.; Neumaier, M.; Kaminski, W.E. A combinatorial αβ T cell receptor expressed by macrophages in the tumor microenvironment. <span class='html-italic'>Immunobiology</span> <b>2017</b>, <span class='html-italic'>222</span>, 39–44. [<a href="https://scholar.google.com/scholar_lookup?title=A+combinatorial+%CE%B1%CE%B2+T+cell+receptor+expressed+by+macrophages+in+the+tumor+microenvironment&author=Fuchs,+T.&author=Hahn,+M.&author=Riabov,+V.&author=Yin,+S.&author=Kzhyshkowska,+J.&author=Busch,+S.&author=P%C3%BCllmann,+K.&author=Beham,+A.W.&author=Neumaier,+M.&author=Kaminski,+W.E.&publication_year=2017&journal=Immunobiology&volume=222&pages=39%E2%80%9344&doi=10.1016/j.imbio.2015.09.022" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.imbio.2015.09.022" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B61-cancers-11-01889' class='html-xx' data-content='61.'>Riabov, V.; Yin, S.; Song, B.; Avdic, A.; Schledzewski, K.; Ovsiy, I.; Gratchev, A.; Verdiell, M.L.; Sticht, C.; Schmuttermaier, C.; et al. Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary adenocarcinoma mouse model. <span class='html-italic'>Oncotarget</span> <b>2016</b>, <span class='html-italic'>7</span>, 31097–31110. [<a href="https://scholar.google.com/scholar_lookup?title=Stabilin-1+is+expressed+in+human+breast+cancer+and+supports+tumor+growth+in+mammary+adenocarcinoma+mouse+model&author=Riabov,+V.&author=Yin,+S.&author=Song,+B.&author=Avdic,+A.&author=Schledzewski,+K.&author=Ovsiy,+I.&author=Gratchev,+A.&author=Verdiell,+M.L.&author=Sticht,+C.&author=Schmuttermaier,+C.&publication_year=2016&journal=Oncotarget&volume=7&pages=31097%E2%80%9331110&doi=10.18632/oncotarget.8857" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.18632/oncotarget.8857" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=8857&path%5B%5D=27271" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B62-cancers-11-01889' class='html-xx' data-content='62.'>Liu, C.; Yu, S.; Kappes, J.; Wang, J.; Grizzle, W.E.; Zinn, K.R.; Zhang, H.G. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. <span class='html-italic'>Blood</span> <b>2007</b>, <span class='html-italic'>109</span>, 4336–4342. [<a href="https://scholar.google.com/scholar_lookup?title=Expansion+of+spleen+myeloid+suppressor+cells+represses+NK+cell+cytotoxicity+in+tumor-bearing+host&author=Liu,+C.&author=Yu,+S.&author=Kappes,+J.&author=Wang,+J.&author=Grizzle,+W.E.&author=Zinn,+K.R.&author=Zhang,+H.G.&publication_year=2007&journal=Blood&volume=109&pages=4336%E2%80%934342&doi=10.1182/blood-2006-09-046201&pmid=17244679" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1182/blood-2006-09-046201" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/17244679" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B63-cancers-11-01889' class='html-xx' data-content='63.'>Bauer, R.; Udonta, F.; Wroblewski, M.; Ben-Batalla, I.; Santos, I.M.; Taverna, F.; Kuhlencord, M.; Gensch, V.; Päsler, S.; Vinckier, S.; et al. Blockade of myeloid-derived suppressor cell expansion with all-trans retinoic acid increases the efficacy of antiangiogenic therapy. <span class='html-italic'>Cancer Res.</span> <b>2018</b>, <span class='html-italic'>78</span>, 3220–3232. [<a href="https://scholar.google.com/scholar_lookup?title=Blockade+of+myeloid-derived+suppressor+cell+expansion+with+all-trans+retinoic+acid+increases+the+efficacy+of+antiangiogenic+therapy&author=Bauer,+R.&author=Udonta,+F.&author=Wroblewski,+M.&author=Ben-Batalla,+I.&author=Santos,+I.M.&author=Taverna,+F.&author=Kuhlencord,+M.&author=Gensch,+V.&author=P%C3%A4sler,+S.&author=Vinckier,+S.&publication_year=2018&journal=Cancer+Res.&volume=78&pages=3220%E2%80%933232&pmid=29674477" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/29674477" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="https://cancerres.aacrjournals.org/content/canres/78/12/3220.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B64-cancers-11-01889' class='html-xx' data-content='64.'>Rong, L.; Bian, Y.; Liu, S.; Liu, X.; Li, X.; Liu, H.; Zhou, J.; Peng, J.; Zhang, H.; Chen, H.; et al. Identifying tumor promoting genomic alterations in tumorassociated fibroblasts via retrovirus-insertional mutagenesis. <span class='html-italic'>Oncotarget</span> <b>2017</b>, <span class='html-italic'>8</span>, 97231–97245. [<a href="https://scholar.google.com/scholar_lookup?title=Identifying+tumor+promoting+genomic+alterations+in+tumorassociated+fibroblasts+via+retrovirus-insertional+mutagenesis&author=Rong,+L.&author=Bian,+Y.&author=Liu,+S.&author=Liu,+X.&author=Li,+X.&author=Liu,+H.&author=Zhou,+J.&author=Peng,+J.&author=Zhang,+H.&author=Chen,+H.&publication_year=2017&journal=Oncotarget&volume=8&pages=97231%E2%80%9397245&doi=10.18632/oncotarget.21881" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.18632/oncotarget.21881" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=21881&path%5B%5D=69395" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B65-cancers-11-01889' class='html-xx' data-content='65.'>Wang, Y.Y.; Attané, C.; Milhas, D.; Dirat, B.; Dauvillier, S.; Guerard, A.; Gilhodes, J.; Lazar, I.; Alet, N.; Laurent, V.; et al. Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells. <span class='html-italic'>JCI Insight</span> <b>2017</b>, <span class='html-italic'>2</span>, e87489. [<a href="https://scholar.google.com/scholar_lookup?title=Mammary+adipocytes+stimulate+breast+cancer+invasion+through+metabolic+remodeling+of+tumor+cells&author=Wang,+Y.Y.&author=Attan%C3%A9,+C.&author=Milhas,+D.&author=Dirat,+B.&author=Dauvillier,+S.&author=Guerard,+A.&author=Gilhodes,+J.&author=Lazar,+I.&author=Alet,+N.&author=Laurent,+V.&publication_year=2017&journal=JCI+Insight&volume=2&pages=e87489&doi=10.1172/jci.insight.87489&pmid=28239646" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1172/jci.insight.87489" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/28239646" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="http://insight.jci.org/articles/view/87489/files/pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B66-cancers-11-01889' class='html-xx' data-content='66.'>Wolfers, J.; Lozier, A.; Raposo, G.; Regnault, A.; Théry, C.; Masurier, C.; Flament, C.; Pouzieux, S.; Faure, F.; Tursz, T.; et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. <span class='html-italic'>Nat. Med.</span> <b>2001</b>, <span class='html-italic'>7</span>, 297–303. [<a href="https://scholar.google.com/scholar_lookup?title=Tumor-derived+exosomes+are+a+source+of+shared+tumor+rejection+antigens+for+CTL+cross-priming&author=Wolfers,+J.&author=Lozier,+A.&author=Raposo,+G.&author=Regnault,+A.&author=Th%C3%A9ry,+C.&author=Masurier,+C.&author=Flament,+C.&author=Pouzieux,+S.&author=Faure,+F.&author=Tursz,+T.&publication_year=2001&journal=Nat.+Med.&volume=7&pages=297%E2%80%93303&doi=10.1038/85438&pmid=11231627" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/85438" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/11231627" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B67-cancers-11-01889' class='html-xx' data-content='67.'>Liu, C.; Yu, S.; Zinn, K.; Wang, J.; Zhang, L.; Jia, Y.; Kappes, J.C.; Barnes, S.; Kimberly, R.P.; Grizzle, W.E.; et al. Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function. <span class='html-italic'>J. Immunol.</span> <b>2006</b>, <span class='html-italic'>176</span>, 1375–1385. [<a href="https://scholar.google.com/scholar_lookup?title=Murine+Mammary+Carcinoma+Exosomes+Promote+Tumor+Growth+by+Suppression+of+NK+Cell+Function&author=Liu,+C.&author=Yu,+S.&author=Zinn,+K.&author=Wang,+J.&author=Zhang,+L.&author=Jia,+Y.&author=Kappes,+J.C.&author=Barnes,+S.&author=Kimberly,+R.P.&author=Grizzle,+W.E.&publication_year=2006&journal=J.+Immunol.&volume=176&pages=1375%E2%80%931385&doi=10.4049/jimmunol.176.3.1375" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.4049/jimmunol.176.3.1375" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://www.jimmunol.org/content/jimmunol/176/3/1375.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B68-cancers-11-01889' class='html-xx' data-content='68.'>Yu, S.; Liu, C.; Su, K.; Wang, J.; Liu, Y.; Zhang, L.; Li, C.; Cong, Y.; Kimberly, R.; Grizzle, W.E.; et al. Tumor Exosomes Inhibit Differentiation of Bone Marrow Dendritic Cells. <span class='html-italic'>J. Immunol.</span> <b>2007</b>, <span class='html-italic'>178</span>, 6867–6875. [<a href="https://scholar.google.com/scholar_lookup?title=Tumor+Exosomes+Inhibit+Differentiation+of+Bone+Marrow+Dendritic+Cells&author=Yu,+S.&author=Liu,+C.&author=Su,+K.&author=Wang,+J.&author=Liu,+Y.&author=Zhang,+L.&author=Li,+C.&author=Cong,+Y.&author=Kimberly,+R.&author=Grizzle,+W.E.&publication_year=2007&journal=J.+Immunol.&volume=178&pages=6867%E2%80%936875&doi=10.4049/jimmunol.178.11.6867" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.4049/jimmunol.178.11.6867" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://www.jimmunol.org/content/jimmunol/178/11/6867.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B69-cancers-11-01889' class='html-xx' data-content='69.'>Diamond, J.M.; Vanpouille-Box, C.; Spada, S.; Rudqvist, N.P.; Chapman, J.R.; Ueberheide, B.M.; Pilones, K.A.; Sarfraz, Y.; Formenti, S.C.; Demaria, S. Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs. <span class='html-italic'>Cancer Immunol. Res.</span> <b>2018</b>, <span class='html-italic'>6</span>, 910–920. [<a href="https://scholar.google.com/scholar_lookup?title=Exosomes+Shuttle+TREX1-Sensitive+IFN-Stimulatory+dsDNA+from+Irradiated+Cancer+Cells+to+DCs&author=Diamond,+J.M.&author=Vanpouille-Box,+C.&author=Spada,+S.&author=Rudqvist,+N.P.&author=Chapman,+J.R.&author=Ueberheide,+B.M.&author=Pilones,+K.A.&author=Sarfraz,+Y.&author=Formenti,+S.C.&author=Demaria,+S.&publication_year=2018&journal=Cancer+Immunol.+Res.&volume=6&pages=910%E2%80%93920&doi=10.1158/2326-6066.CIR-17-0581" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/2326-6066.CIR-17-0581" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://cancerimmunolres.aacrjournals.org/content/canimm/6/8/910.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B70-cancers-11-01889' class='html-xx' data-content='70.'>Giovarelli, M.; Cappello, P.; Forni, G.; Salcedo, T.; Moore, P.A.; LeFleur, D.W.; Nardelli, B.; Di Carlo, E.; Lollini, P.-L.; Ruben, S.; et al. Tumor Rejection and Immune Memory Elicited by Locally Released LEC Chemokine Are Associated with an Impressive Recruitment of APCs, Lymphocytes, and Granulocytes. <span class='html-italic'>J. Immunol.</span> <b>2000</b>, <span class='html-italic'>164</span>, 3200–3206. [<a href="https://scholar.google.com/scholar_lookup?title=Tumor+Rejection+and+Immune+Memory+Elicited+by+Locally+Released+LEC+Chemokine+Are+Associated+with+an+Impressive+Recruitment+of+APCs,+Lymphocytes,+and+Granulocytes&author=Giovarelli,+M.&author=Cappello,+P.&author=Forni,+G.&author=Salcedo,+T.&author=Moore,+P.A.&author=LeFleur,+D.W.&author=Nardelli,+B.&author=Di+Carlo,+E.&author=Lollini,+P.-L.&author=Ruben,+S.&publication_year=2000&journal=J.+Immunol.&volume=164&pages=3200%E2%80%933206&doi=10.4049/jimmunol.164.6.3200" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.4049/jimmunol.164.6.3200" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.jimmunol.org/content/jimmunol/164/6/3200.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B71-cancers-11-01889' class='html-xx' data-content='71.'>Cappello, P.; Caorsi, C.; Bosticardo, M.; De Angelis, S.; Novelli, F.; Forni, G.; Giovarelli, M. CCL16/LEC powerfully triggers effector and antigen-presenting functions of macrophages and enhances T cell cytotoxicity. <span class='html-italic'>J. Leukoc. Biol.</span> <b>2004</b>, <span class='html-italic'>75</span>, 135–142. [<a href="https://scholar.google.com/scholar_lookup?title=CCL16/LEC+powerfully+triggers+effector+and+antigen-presenting+functions+of+macrophages+and+enhances+T+cell+cytotoxicity&author=Cappello,+P.&author=Caorsi,+C.&author=Bosticardo,+M.&author=De+Angelis,+S.&author=Novelli,+F.&author=Forni,+G.&author=Giovarelli,+M.&publication_year=2004&journal=J.+Leukoc.+Biol.&volume=75&pages=135%E2%80%93142&doi=10.1189/jlb.0403146" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1189/jlb.0403146" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://pdfs.semanticscholar.org/0588/562c6ccb84b2c9276d359e45fd4ba1b714d9.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B72-cancers-11-01889' class='html-xx' data-content='72.'>Guiducci, C.; Di Carlo, E.; Parenza, M.; Hitt, M.; Giovarelli, M.; Musiani, P.; Colombo, M.P. Intralesional Injection of Adenovirus Encoding CC Chemokine Ligand 16 Inhibits Mammary Tumor Growth and Prevents Metastatic-Induced Death after Surgical Removal of the Treated Primary Tumor. <span class='html-italic'>J. Immunol.</span> <b>2004</b>, <span class='html-italic'>172</span>, 4026–4036. [<a href="https://scholar.google.com/scholar_lookup?title=Intralesional+Injection+of+Adenovirus+Encoding+CC+Chemokine+Ligand+16+Inhibits+Mammary+Tumor+Growth+and+Prevents+Metastatic-Induced+Death+after+Surgical+Removal+of+the+Treated+Primary+Tumor&author=Guiducci,+C.&author=Di+Carlo,+E.&author=Parenza,+M.&author=Hitt,+M.&author=Giovarelli,+M.&author=Musiani,+P.&author=Colombo,+M.P.&publication_year=2004&journal=J.+Immunol.&volume=172&pages=4026%E2%80%934036&doi=10.4049/jimmunol.172.7.4026&pmid=15034014" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.4049/jimmunol.172.7.4026" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/15034014" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B73-cancers-11-01889' class='html-xx' data-content='73.'>Musiani, P.; Modesti, A.; Brunetti, M.; Modica, A.; Vitullo, P.; Gulino, A.; Bosco, M.C.; Colombo, M.P.; Nanni, P.; Cavallo, F.; et al. Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-γ genes. <span class='html-italic'>Nat. Immun.</span> <b>1994</b>, <span class='html-italic'>13</span>, 93–101. [<a href="https://scholar.google.com/scholar_lookup?title=Nature+and+potential+of+the+reactive+response+to+mouse+mammary+adenocarcinoma+cells+engineered+with+interleukin-2,+interleukin-4+or+interferon-%CE%B3+genes&author=Musiani,+P.&author=Modesti,+A.&author=Brunetti,+M.&author=Modica,+A.&author=Vitullo,+P.&author=Gulino,+A.&author=Bosco,+M.C.&author=Colombo,+M.P.&author=Nanni,+P.&author=Cavallo,+F.&publication_year=1994&journal=Nat.+Immun.&volume=13&pages=93%E2%80%93101&pmid=8173240" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/8173240" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B74-cancers-11-01889' class='html-xx' data-content='74.'>Allione, A.; Consalvo, M.; Nanni, P.; Lollini, P.L.; Cavallo, F.; Giovarelli, M.; Forni, M.; Gulino, A.; Colombo, M.P.; Dellabona, P.; et al. Immunizing and Curative Potential of Replicating and Nonreplicating Murine Mammary Adenocarcinoma Cells Engineered with Interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, Tumor Necrosis Factor a, Granulocyte-Macrophage Colony-stimulating Factor, and y-Interfero. <span class='html-italic'>Cancer Res.</span> <b>1994</b>, <span class='html-italic'>54</span>, 6022–6026. [<a href="https://scholar.google.com/scholar_lookup?title=Immunizing+and+Curative+Potential+of+Replicating+and+Nonreplicating+Murine+Mammary+Adenocarcinoma+Cells+Engineered+with+Interleukin+(IL)-2,+IL-4,+IL-6,+IL-7,+IL-10,+Tumor+Necrosis+Factor+a,+Granulocyte-Macrophage+Colony-stimulating+Factor,+and+y-Interfero&author=Allione,+A.&author=Consalvo,+M.&author=Nanni,+P.&author=Lollini,+P.L.&author=Cavallo,+F.&author=Giovarelli,+M.&author=Forni,+M.&author=Gulino,+A.&author=Colombo,+M.P.&author=Dellabona,+P.&publication_year=1994&journal=Cancer+Res.&volume=54&pages=6022%E2%80%936026&pmid=7954438" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/7954438" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B75-cancers-11-01889' class='html-xx' data-content='75.'>Pericle, F.; Kirken, R.A.; Epling-Burnette, P.K.; Blanchard, D.K.; Djeu, J.Y. Direct killing of interleukin-2-transfected tumor cells by human neutrophils. <span class='html-italic'>Int. J. Cancer</span> <b>1996</b>, <span class='html-italic'>66</span>, 367–373. [<a href="https://scholar.google.com/scholar_lookup?title=Direct+killing+of+interleukin-2-transfected+tumor+cells+by+human+neutrophils&author=Pericle,+F.&author=Kirken,+R.A.&author=Epling-Burnette,+P.K.&author=Blanchard,+D.K.&author=Djeu,+J.Y.&publication_year=1996&journal=Int.+J.+Cancer&volume=66&pages=367%E2%80%93373&doi=10.1002/(SICI)1097-0215(19960503)66:3%3C367::AID-IJC17%3E3.0.CO;2-8" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/(SICI)1097-0215(19960503)66:3<367::AID-IJC17>3.0.CO;2-8" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B76-cancers-11-01889' class='html-xx' data-content='76.'>Vagliani, M.; Rodolfo, M.; Cavallo, F.; Parenza, M.; Melani, C.; Parmiani, G.; Forni, G.; Colombo, M.P. Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells. <span class='html-italic'>Cancer Res.</span> <b>1996</b>, <span class='html-italic'>56</span>, 467–470. [<a href="https://scholar.google.com/scholar_lookup?title=Interleukin+12+potentiates+the+curative+effect+of+a+vaccine+based+on+interleukin+2-transduced+tumor+cells&author=Vagliani,+M.&author=Rodolfo,+M.&author=Cavallo,+F.&author=Parenza,+M.&author=Melani,+C.&author=Parmiani,+G.&author=Forni,+G.&author=Colombo,+M.P.&publication_year=1996&journal=Cancer+Res.&volume=56&pages=467%E2%80%93470" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B77-cancers-11-01889' class='html-xx' data-content='77.'>Provinciali, M.; Argentati, K.; Tibaldi, A. Efficacy of cancer gene therapy in aging adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice. <span class='html-italic'>Gene Ther.</span> <b>2000</b>, <span class='html-italic'>7</span>, 624–632. [<a href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+cancer+gene+therapy+in+aging+adenocarcinoma+cells+engineered+to+release+IL-2+are+rejected+but+do+not+induce+tumor+specific+immune+memory+in+old+mice&author=Provinciali,+M.&author=Argentati,+K.&author=Tibaldi,+A.&publication_year=2000&journal=Gene+Ther.&volume=7&pages=624%E2%80%93632&doi=10.1038/sj.gt.3301131" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/sj.gt.3301131" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://www.nature.com/articles/3301131.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B78-cancers-11-01889' class='html-xx' data-content='78.'>Modesti, A.; D’Orazi, G.; Masuelli, L.; Modica, A.; Scarpa, S.; Bosco, M.C.; Forni, G. Ultrastructural evidence of the mechanisms responsible for interleukin-4-activated rejection of a spontaneous murine adenocarcinoma. <span class='html-italic'>Int. J. Cancer</span> <b>1993</b>, <span class='html-italic'>53</span>, 988–993. [<a href="https://scholar.google.com/scholar_lookup?title=Ultrastructural+evidence+of+the+mechanisms+responsible+for+interleukin-4-activated+rejection+of+a+spontaneous+murine+adenocarcinoma&author=Modesti,+A.&author=D%E2%80%99Orazi,+G.&author=Masuelli,+L.&author=Modica,+A.&author=Scarpa,+S.&author=Bosco,+M.C.&author=Forni,+G.&publication_year=1993&journal=Int.+J.+Cancer&volume=53&pages=988%E2%80%93993&doi=10.1002/ijc.2910530622" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/ijc.2910530622" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B79-cancers-11-01889' class='html-xx' data-content='79.'>Pericle, F.; Giovarelli, M.; Cavallo, F.; Di Pierro, F.; Novelli, F.; Forni, G.; Colombo, M.P.; Ferrari, G.; Musiani, P.; Modesti, A. An efficient Th2-type memory follows CD8+lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. <span class='html-italic'>J. Immunol.</span> <b>1994</b>, <span class='html-italic'>153</span>, 5659–5673. [<a href="https://scholar.google.com/scholar_lookup?title=An+efficient+Th2-type+memory+follows+CD8+lymphocyte-driven+and+eosinophil-mediated+rejection+of+a+spontaneous+mouse+mammary+adenocarcinoma+engineered+to+release+IL-4&author=Pericle,+F.&author=Giovarelli,+M.&author=Cavallo,+F.&author=Di+Pierro,+F.&author=Novelli,+F.&author=Forni,+G.&author=Colombo,+M.P.&author=Ferrari,+G.&author=Musiani,+P.&author=Modesti,+A.&publication_year=1994&journal=J.+Immunol.&volume=153&pages=5659%E2%80%935673" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B80-cancers-11-01889' class='html-xx' data-content='80.'>Musiani, P.; Allione, A.; Modica, A.; Lollini, P.L.; Giovarelli, M.; Cavallo, F.; Belardelli, F.; Forni, G.; Modesti, A. Role of Neutrophils and Lymphocytes in Inhibition of a Mouse Mammary Adenocarcinoma Engineered to Release IL-2, IL-4, IL-7, IL-10, IFN-α, IFN-γ, and TNF-α. <span class='html-italic'>Lab. Investig.</span> <b>1996</b>, <span class='html-italic'>74</span>, 146–157. [<a href="https://scholar.google.com/scholar_lookup?title=Role+of+Neutrophils+and+Lymphocytes+in+Inhibition+of+a+Mouse+Mammary+Adenocarcinoma+Engineered+to+Release+IL-2,+IL-4,+IL-7,+IL-10,+IFN-%CE%B1,+IFN-%CE%B3,+and+TNF-%CE%B1&author=Musiani,+P.&author=Allione,+A.&author=Modica,+A.&author=Lollini,+P.L.&author=Giovarelli,+M.&author=Cavallo,+F.&author=Belardelli,+F.&author=Forni,+G.&author=Modesti,+A.&publication_year=1996&journal=Lab.+Investig.&volume=74&pages=146%E2%80%93157" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B81-cancers-11-01889' class='html-xx' data-content='81.'>Cayeux, S.; Richter, G.; Noffz, G.; Dörken, B.; Blankenstein, T. Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation. <span class='html-italic'>J. Immunol.</span> <b>1997</b>, <span class='html-italic'>158</span>, 2834–2841. [<a href="https://scholar.google.com/scholar_lookup?title=Influence+of+gene-modified+(IL-7,+IL-4,+and+B7)+tumor+cell+vaccines+on+tumor+antigen+presentation&author=Cayeux,+S.&author=Richter,+G.&author=Noffz,+G.&author=D%C3%B6rken,+B.&author=Blankenstein,+T.&publication_year=1997&journal=J.+Immunol.&volume=158&pages=2834%E2%80%932841" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B82-cancers-11-01889' class='html-xx' data-content='82.'>Belardelli, F.; Ferrantini, M.; Santini, S.M.; Baccarini, S.; Proietti, E.; Colombo, M.P.; Sprent, J.; Tough, D.F. The induction of in vivo proliferation of long-lived CD44(hi) CD8+ T cells after the injection of tumor cells expressing IFN-α1 into syngeneic mice. <span class='html-italic'>Cancer Res.</span> <b>1998</b>, <span class='html-italic'>58</span>, 5795–5802. [<a href="https://scholar.google.com/scholar_lookup?title=The+induction+of+in+vivo+proliferation+of+long-lived+CD44(hi)+CD8++T+cells+after+the+injection+of+tumor+cells+expressing+IFN-%CE%B11+into+syngeneic+mice&author=Belardelli,+F.&author=Ferrantini,+M.&author=Santini,+S.M.&author=Baccarini,+S.&author=Proietti,+E.&author=Colombo,+M.P.&author=Sprent,+J.&author=Tough,+D.F.&publication_year=1998&journal=Cancer+Res.&volume=58&pages=5795%E2%80%935802&pmid=9865738" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/9865738" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B83-cancers-11-01889' class='html-xx' data-content='83.'>Di Carlo, E.; Modesti, A.; Coletti, A.; Colombo, M.P.; Giovarelli, M.; Forni, G.; Diodoro, M.G.; Musiani, P. Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumour. <span class='html-italic'>J. Pathol.</span> <b>1998</b>, <span class='html-italic'>186</span>, 390–397. [<a href="https://scholar.google.com/scholar_lookup?title=Interaction+between+endothelial+cells+and+the+secreted+cytokine+drives+the+fate+of+an+IL4-+or+an+IL5-transduced+tumour&author=Di+Carlo,+E.&author=Modesti,+A.&author=Coletti,+A.&author=Colombo,+M.P.&author=Giovarelli,+M.&author=Forni,+G.&author=Diodoro,+M.G.&author=Musiani,+P.&publication_year=1998&journal=J.+Pathol.&volume=186&pages=390%E2%80%93397&doi=10.1002/(SICI)1096-9896(199812)186:4%3C390::AID-PATH194%3E3.0.CO;2-Z" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/(SICI)1096-9896(199812)186:4<390::AID-PATH194>3.0.CO;2-Z" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B84-cancers-11-01889' class='html-xx' data-content='84.'>Pacor, S.; Gagliardi, R.; Di Daniel, E.; Vadori, M.; Sava, G. In vitro down regulation of ICAM-1 and E-cadherin and in vivo reduction of lung metastases of TS/A adenocarcinoma by a lysozyme derivative. <span class='html-italic'>Int. J. Mol. Med.</span> <b>1999</b>, <span class='html-italic'>4</span>, 369–375. [<a href="https://scholar.google.com/scholar_lookup?title=In+vitro+down+regulation+of+ICAM-1+and+E-cadherin+and+in+vivo+reduction+of+lung+metastases+of+TS/A+adenocarcinoma+by+a+lysozyme+derivative&author=Pacor,+S.&author=Gagliardi,+R.&author=Di+Daniel,+E.&author=Vadori,+M.&author=Sava,+G.&publication_year=1999&journal=Int.+J.+Mol.+Med.&volume=4&pages=369%E2%80%93375&doi=10.3892/ijmm.4.4.369&pmid=10493977" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.3892/ijmm.4.4.369" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/10493977" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B85-cancers-11-01889' class='html-xx' data-content='85.'>Pacor, S.; Magnarin, M.; Carotenuto, M.E.; Spessotto, P.; Zabucchi, G.; Sava, G. In vitro growth of TS/A adenocarcinoma and of the gene transfected TS/A-IL4 line on biological substrates. <span class='html-italic'>Anticancer Res.</span> <b>2000</b>, <span class='html-italic'>20</span>, 191–196. [<a href="https://scholar.google.com/scholar_lookup?title=In+vitro+growth+of+TS/A+adenocarcinoma+and+of+the+gene+transfected+TS/A-IL4+line+on+biological+substrates&author=Pacor,+S.&author=Magnarin,+M.&author=Carotenuto,+M.E.&author=Spessotto,+P.&author=Zabucchi,+G.&author=Sava,+G.&publication_year=2000&journal=Anticancer+Res.&volume=20&pages=191%E2%80%93196" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B86-cancers-11-01889' class='html-xx' data-content='86.'>Krüger-Krasagakes, S.; Li, W.; Richter, G.; Diamantstein, T.; Blankenstein, T. Eosinophils infiltrating interleukin-5 gene-transfected tumors do not suppress tumor growth. <span class='html-italic'>Eur. J. Immunol.</span> <b>1993</b>, <span class='html-italic'>23</span>, 992–995. [<a href="https://scholar.google.com/scholar_lookup?title=Eosinophils+infiltrating+interleukin-5+gene-transfected+tumors+do+not+suppress+tumor+growth&author=Kr%C3%BCger-Krasagakes,+S.&author=Li,+W.&author=Richter,+G.&author=Diamantstein,+T.&author=Blankenstein,+T.&publication_year=1993&journal=Eur.+J.+Immunol.&volume=23&pages=992%E2%80%93995&doi=10.1002/eji.1830230438" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/eji.1830230438" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B87-cancers-11-01889' class='html-xx' data-content='87.'>Di Carlo, E.; Coletti, A.; Modesti, A.; Giovarelli, M.; Forni, G.; Musiani, P. Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection. <span class='html-italic'>Eur. Cytokine Netw.</span> <b>1998</b>, <span class='html-italic'>9</span>, 61–68. [<a href="https://scholar.google.com/scholar_lookup?title=Local+release+of+interleukin-10+by+transfected+mouse+adenocarcinoma+cells+exhibits+pro-+and+anti-inflammatory+activity+and+results+in+a+delayed+tumor+rejection&author=Di+Carlo,+E.&author=Coletti,+A.&author=Modesti,+A.&author=Giovarelli,+M.&author=Forni,+G.&author=Musiani,+P.&publication_year=1998&journal=Eur.+Cytokine+Netw.&volume=9&pages=61%E2%80%9368" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B88-cancers-11-01889' class='html-xx' data-content='88.'>Hock, H.; Dorsch, M.; Diamantstein, T.; Blankenstein, T. Interleukin 7 induces CD4 + T cell-dependent tumor rejection. <span class='html-italic'>J. Exp. Med.</span> <b>1991</b>, <span class='html-italic'>174</span>, 1291–1298. [<a href="https://scholar.google.com/scholar_lookup?title=Interleukin+7+induces+CD4+++T+cell-dependent+tumor+rejection&author=Hock,+H.&author=Dorsch,+M.&author=Diamantstein,+T.&author=Blankenstein,+T.&publication_year=1991&journal=J.+Exp.+Med.&volume=174&pages=1291%E2%80%931298&doi=10.1084/jem.174.6.1291" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1084/jem.174.6.1291" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://jem.rupress.org/content/174/6/1291.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B89-cancers-11-01889' class='html-xx' data-content='89.'>Cayeux, S.; Beck, C.; Aicher, A.; Dörken, B.; Blankenstein, T. Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines. <span class='html-italic'>Eur. J. Immunol.</span> <b>1995</b>, <span class='html-italic'>25</span>, 2325–2331. [<a href="https://scholar.google.com/scholar_lookup?title=Tumor+cells+cotransfected+with+interleukin-7+and+B7.1+genes+induce+CD25+and+CD28+on+tumor-infiltrating+T+lymphocytes+and+are+strong+vaccines&author=Cayeux,+S.&author=Beck,+C.&author=Aicher,+A.&author=D%C3%B6rken,+B.&author=Blankenstein,+T.&publication_year=1995&journal=Eur.+J.+Immunol.&volume=25&pages=2325%E2%80%932331&doi=10.1002/eji.1830250831" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/eji.1830250831" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B90-cancers-11-01889' class='html-xx' data-content='90.'>Willimsky, G.; Blankenstein, T. Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors. <span class='html-italic'>Cancer Res.</span> <b>2000</b>, <span class='html-italic'>60</span>, 685–692. [<a href="https://scholar.google.com/scholar_lookup?title=Interleukin-7/B7.1-encoding+adenoviruses+induce+rejection+of+transplanted+but+not+nontransplanted+tumors&author=Willimsky,+G.&author=Blankenstein,+T.&publication_year=2000&journal=Cancer+Res.&volume=60&pages=685%E2%80%93692" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B91-cancers-11-01889' class='html-xx' data-content='91.'>Giovarelli, M.; Musiani, P.; Modesti, A.; Dellabona, P.; Casorati, G.; Allione, A.; Consalvo, M.; Cavallo, F.; di Pierro, F.; De Giovanni, C. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. <span class='html-italic'>J. Immunol.</span> <b>1995</b>, <span class='html-italic'>155</span>, 3112–3123. [<a href="https://scholar.google.com/scholar_lookup?title=Local+release+of+IL-10+by+transfected+mouse+mammary+adenocarcinoma+cells+does+not+suppress+but+enhances+antitumor+reaction+and+elicits+a+strong+cytotoxic+lymphocyte+and+antibody-dependent+immune+memory&author=Giovarelli,+M.&author=Musiani,+P.&author=Modesti,+A.&author=Dellabona,+P.&author=Casorati,+G.&author=Allione,+A.&author=Consalvo,+M.&author=Cavallo,+F.&author=di+Pierro,+F.&author=De+Giovanni,+C.&publication_year=1995&journal=J.+Immunol.&volume=155&pages=3112%E2%80%933123" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B92-cancers-11-01889' class='html-xx' data-content='92.'>Morini, M.; Albini, A.; Lorusso, G.; Moelling, K.; Lu, B.; Cilli, M.; Ferrini, S.; Noonan, D.M. Prevention of angiogenesis by naked DNA IL-12 gene transfer: Angioprevention by immunogene therapy. <span class='html-italic'>Gene Ther.</span> <b>2004</b>, <span class='html-italic'>11</span>, 284–291. [<a href="https://scholar.google.com/scholar_lookup?title=Prevention+of+angiogenesis+by+naked+DNA+IL-12+gene+transfer:+Angioprevention+by+immunogene+therapy&author=Morini,+M.&author=Albini,+A.&author=Lorusso,+G.&author=Moelling,+K.&author=Lu,+B.&author=Cilli,+M.&author=Ferrini,+S.&author=Noonan,+D.M.&publication_year=2004&journal=Gene+Ther.&volume=11&pages=284%E2%80%93291&doi=10.1038/sj.gt.3302175" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/sj.gt.3302175" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://www.nature.com/articles/3302175.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B93-cancers-11-01889' class='html-xx' data-content='93.'>Weber, S.M.; Qi, C.; Neal, Z.; Sondel, P.; Mahvi, D.M. IL-12 cDNA direct injection: Antimetastatic effect from a single injection in a murine hepatic metastases model. <span class='html-italic'>J. Surg. Res.</span> <b>2004</b>, <span class='html-italic'>122</span>, 210–217. [<a href="https://scholar.google.com/scholar_lookup?title=IL-12+cDNA+direct+injection:+Antimetastatic+effect+from+a+single+injection+in+a+murine+hepatic+metastases+model&author=Weber,+S.M.&author=Qi,+C.&author=Neal,+Z.&author=Sondel,+P.&author=Mahvi,+D.M.&publication_year=2004&journal=J.+Surg.+Res.&volume=122&pages=210%E2%80%93217&doi=10.1016/j.jss.2004.04.021" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.jss.2004.04.021" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B94-cancers-11-01889' class='html-xx' data-content='94.'>Oshikawa, K.; Shi, F.; Rakhmilevich, A.L.; Sondel, P.M.; Mahvi, D.M.; Yang, N.S. Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1β converting enzyme cDNA. <span class='html-italic'>Proc. Natl. Acad. Sci. USA</span> <b>1999</b>, <span class='html-italic'>96</span>, 13351–13356. [<a href="https://scholar.google.com/scholar_lookup?title=Synergistic+inhibition+of+tumor+growth+in+a+murine+mammary+adenocarcinoma+model+by+combinational+gene+therapy+using+IL-12,+pro-IL-18,+and+IL-1%CE%B2+converting+enzyme+cDNA&author=Oshikawa,+K.&author=Shi,+F.&author=Rakhmilevich,+A.L.&author=Sondel,+P.M.&author=Mahvi,+D.M.&author=Yang,+N.S.&publication_year=1999&journal=Proc.+Natl.+Acad.+Sci.+USA&volume=96&pages=13351%E2%80%9313356&doi=10.1073/pnas.96.23.13351" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1073/pnas.96.23.13351" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.pnas.org/content/96/23/13351.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B95-cancers-11-01889' class='html-xx' data-content='95.'>Comes, A.; Di Carlo, E.; Musiani, P.; Rosso, O.; Meazza, R.; Chiodoni, C.; Colombo, M.P.; Ferrini, S. IFN-γ-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice. <span class='html-italic'>Eur. J. Immunol.</span> <b>2002</b>, <span class='html-italic'>32</span>, 1914–1923. [<a href="https://scholar.google.com/scholar_lookup?title=IFN-%CE%B3-independent+synergistic+effects+of+IL-12+and+IL-15+induce+anti-tumor+immune+responses+in+syngeneic+mice&author=Comes,+A.&author=Di+Carlo,+E.&author=Musiani,+P.&author=Rosso,+O.&author=Meazza,+R.&author=Chiodoni,+C.&author=Colombo,+M.P.&author=Ferrini,+S.&publication_year=2002&journal=Eur.+J.+Immunol.&volume=32&pages=1914%E2%80%931923&doi=10.1002/1521-4141(200207)32:7%3C1914::AID-IMMU1914%3E3.0.CO;2-P" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/1521-4141(200207)32:7<1914::AID-IMMU1914>3.0.CO;2-P" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B96-cancers-11-01889' class='html-xx' data-content='96.'>Cavallo, F.; Signorelli, P.; Giovarelli, M.; Musiani, P.; Modesti, A.; Brunda, M.J.; Colombo, M.P.; Forni, G. Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. <span class='html-italic'>J. Natl. Cancer Inst.</span> <b>1997</b>, <span class='html-italic'>89</span>, 1049–1058. [<a href="https://scholar.google.com/scholar_lookup?title=Antitumor+efficacy+of+adenocarcinoma+cells+engineered+to+produce+interleukin+12+(IL-12)+or+other+cytokines+compared+with+exogenous+IL-12&author=Cavallo,+F.&author=Signorelli,+P.&author=Giovarelli,+M.&author=Musiani,+P.&author=Modesti,+A.&author=Brunda,+M.J.&author=Colombo,+M.P.&author=Forni,+G.&publication_year=1997&journal=J.+Natl.+Cancer+Inst.&volume=89&pages=1049%E2%80%931058&doi=10.1093/jnci/89.14.1049&pmid=9230887" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1093/jnci/89.14.1049" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/9230887" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="https://academic.oup.com/jnci/article-pdf/89/14/1049/7707551/89-14-1049.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B97-cancers-11-01889' class='html-xx' data-content='97.'>Gri, G.; Chiodoni, C.; Gallo, E.; Stoppacciaro, A.; Liew, F.Y.; Colombo, M.P. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-γ: A role for intrinsic tumor immunogenicity and IL-15. <span class='html-italic'>Cancer Res.</span> <b>2002</b>, <span class='html-italic'>62</span>, 4390–4397. [<a href="https://scholar.google.com/scholar_lookup?title=Antitumor+effect+of+interleukin+(IL)-12+in+the+absence+of+endogenous+IFN-%CE%B3:+A+role+for+intrinsic+tumor+immunogenicity+and+IL-15&author=Gri,+G.&author=Chiodoni,+C.&author=Gallo,+E.&author=Stoppacciaro,+A.&author=Liew,+F.Y.&author=Colombo,+M.P.&publication_year=2002&journal=Cancer+Res.&volume=62&pages=4390%E2%80%934397" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B98-cancers-11-01889' class='html-xx' data-content='98.'>Puisieux, I.; Odin, L.; Poujol, D.; Moingeon, P.; Tartaglia, J.; Cox, W.; Favrot, M. Canarypox virus-mediated interleukin 12 gene transfer into murine mammary adenocarcinoma induces tumor suppression and long-term antitumoral immunity. <span class='html-italic'>Hum. Gene Ther.</span> <b>1998</b>, <span class='html-italic'>9</span>, 2481–2492. [<a href="https://scholar.google.com/scholar_lookup?title=Canarypox+virus-mediated+interleukin+12+gene+transfer+into+murine+mammary+adenocarcinoma+induces+tumor+suppression+and+long-term+antitumoral+immunity&author=Puisieux,+I.&author=Odin,+L.&author=Poujol,+D.&author=Moingeon,+P.&author=Tartaglia,+J.&author=Cox,+W.&author=Favrot,+M.&publication_year=1998&journal=Hum.+Gene+Ther.&volume=9&pages=2481%E2%80%932492&doi=10.1089/hum.1998.9.17-2481" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1089/hum.1998.9.17-2481" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B99-cancers-11-01889' class='html-xx' data-content='99.'>De Giovanni, C.; Nicoletti, G.; Landuzzi, L.; Rossi, I.; Astolfi, A.; Ricci, C.; Di Carlo, E.; Musiani, P.; Forni, G.; Fradelizi, D.; et al. Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-γ. <span class='html-italic'>Gene Ther.</span> <b>2001</b>, <span class='html-italic'>8</span>, 1698–1704. [<a href="https://scholar.google.com/scholar_lookup?title=Therapy+of+lung+metastases+through+combined+vaccination+with+carcinoma+cells+engineered+to+release+IL-13+and+IFN-%CE%B3&author=De+Giovanni,+C.&author=Nicoletti,+G.&author=Landuzzi,+L.&author=Rossi,+I.&author=Astolfi,+A.&author=Ricci,+C.&author=Di+Carlo,+E.&author=Musiani,+P.&author=Forni,+G.&author=Fradelizi,+D.&publication_year=2001&journal=Gene+Ther.&volume=8&pages=1698%E2%80%931704&doi=10.1038/sj.gt.3301584" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/sj.gt.3301584" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B100-cancers-11-01889' class='html-xxx' data-content='100.'>Morris, J.C.; Ramlogan-Steel, C.A.; Yu, P.; Black, B.A.; Mannan, P.; Allison, J.P.; Waldmann, T.A.; Steel, J.C. Vaccination with tumor cells expressing IL-15 and IL-15R inhibits murine breast and prostate cancer. <span class='html-italic'>Gene Ther.</span> <b>2014</b>, <span class='html-italic'>21</span>, 393–401. [<a href="https://scholar.google.com/scholar_lookup?title=Vaccination+with+tumor+cells+expressing+IL-15+and+IL-15R+inhibits+murine+breast+and+prostate+cancer&author=Morris,+J.C.&author=Ramlogan-Steel,+C.A.&author=Yu,+P.&author=Black,+B.A.&author=Mannan,+P.&author=Allison,+J.P.&author=Waldmann,+T.A.&author=Steel,+J.C.&publication_year=2014&journal=Gene+Ther.&volume=21&pages=393%E2%80%93401&doi=10.1038/gt.2014.10" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/gt.2014.10" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B101-cancers-11-01889' class='html-xxx' data-content='101.'>Meazza, R.; Lollini, P.L.; Nanni, P.; De Giovanni, C.; Gaggero, A.; Comes, A.; Cilli, M.; Di Carlo, E.; Ferrini, S.; Musiani, P. Gene transfer of a secretable form of IL-15 in murine adenocarcinoma cells: Effects on tumorigenicity, metastatic potential and immune response. <span class='html-italic'>Int. J. Cancer</span> <b>2000</b>, <span class='html-italic'>87</span>, 574–581. [<a href="https://scholar.google.com/scholar_lookup?title=Gene+transfer+of+a+secretable+form+of+IL-15+in+murine+adenocarcinoma+cells:+Effects+on+tumorigenicity,+metastatic+potential+and+immune+response&author=Meazza,+R.&author=Lollini,+P.L.&author=Nanni,+P.&author=De+Giovanni,+C.&author=Gaggero,+A.&author=Comes,+A.&author=Cilli,+M.&author=Di+Carlo,+E.&author=Ferrini,+S.&author=Musiani,+P.&publication_year=2000&journal=Int.+J.+Cancer&volume=87&pages=574%E2%80%93581&doi=10.1002/1097-0215(20000815)87:4%3C574::AID-IJC18%3E3.0.CO;2-T" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/1097-0215(20000815)87:4<574::AID-IJC18>3.0.CO;2-T" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B102-cancers-11-01889' class='html-xxx' data-content='102.'>Di Carlo, E.; Comes, A.; Orengo, A.M.; Rosso, O.; Meazza, R.; Musiani, P.; Colombo, M.P.; Ferrini, S. IL-21 Induces Tumor Rejection by Specific CTL and IFN-γ-Dependent CXC Chemokines in Syngeneic Mice. <span class='html-italic'>J. Immunol.</span> <b>2004</b>, <span class='html-italic'>172</span>, 1540–1547. [<a href="https://scholar.google.com/scholar_lookup?title=IL-21+Induces+Tumor+Rejection+by+Specific+CTL+and+IFN-%CE%B3-Dependent+CXC+Chemokines+in+Syngeneic+Mice&author=Di+Carlo,+E.&author=Comes,+A.&author=Orengo,+A.M.&author=Rosso,+O.&author=Meazza,+R.&author=Musiani,+P.&author=Colombo,+M.P.&author=Ferrini,+S.&publication_year=2004&journal=J.+Immunol.&volume=172&pages=1540%E2%80%931547&doi=10.4049/jimmunol.172.3.1540&pmid=14734732" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.4049/jimmunol.172.3.1540" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/14734732" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B103-cancers-11-01889' class='html-xxx' data-content='103.'>Ferrantini, M.; Giovarelli, M.; Modesti, A.; Musiani, P.; Modica, A.; Venditti, M.; Peretti, E.; Lollini, P.L.; Nanni, P.; Forni, G.; et al. IFN-α1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+T cell-mediated tumor rejection and development of antitumor immunity: Comparative studies with IFN-γ-producing TS/A cells. <span class='html-italic'>J. Immunol.</span> <b>1994</b>, <span class='html-italic'>153</span>, 4604–4615. [<a href="https://scholar.google.com/scholar_lookup?title=IFN-%CE%B11+gene+expression+into+a+metastatic+murine+adenocarcinoma+(TS/A)+results+in+CD8+T+cell-mediated+tumor+rejection+and+development+of+antitumor+immunity:+Comparative+studies+with+IFN-%CE%B3-producing+TS/A+cells&author=Ferrantini,+M.&author=Giovarelli,+M.&author=Modesti,+A.&author=Musiani,+P.&author=Modica,+A.&author=Venditti,+M.&author=Peretti,+E.&author=Lollini,+P.L.&author=Nanni,+P.&author=Forni,+G.&publication_year=1994&journal=J.+Immunol.&volume=153&pages=4604%E2%80%934615" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B104-cancers-11-01889' class='html-xxx' data-content='104.'>Santodonato, L.; D’Agostino, G.; Santini, S.M.; Carlei, D.; Musiani, P.; Modesti, A.; Signorelli, P.; Belardelli, F.; Ferrantini, M. Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-α and HSVtk: Perspectives for the generation of cancer vaccines. <span class='html-italic'>Gene Ther.</span> <b>1997</b>, <span class='html-italic'>4</span>, 1246–1255. [<a href="https://scholar.google.com/scholar_lookup?title=Local+and+systemic+antitumor+response+after+combined+therapy+of+mouse+metastatic+tumors+with+tumor+cells+expressing+IFN-%CE%B1+and+HSVtk:+Perspectives+for+the+generation+of+cancer+vaccines&author=Santodonato,+L.&author=D%E2%80%99Agostino,+G.&author=Santini,+S.M.&author=Carlei,+D.&author=Musiani,+P.&author=Modesti,+A.&author=Signorelli,+P.&author=Belardelli,+F.&author=Ferrantini,+M.&publication_year=1997&journal=Gene+Ther.&volume=4&pages=1246%E2%80%931255&doi=10.1038/sj.gt.3300518" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/sj.gt.3300518" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://www.nature.com/articles/3300518.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B105-cancers-11-01889' class='html-xxx' data-content='105.'>Scarpa, S.; Giuffrida, A.; Palumbo, C.; Vasaturo, F.; Signorelli, P.; Forni, G.; Modesti, M.; Ferrantini, M.; Belardelli, F.; Musiani, P.; et al. Extracellular matrix remodelling in a murine mammary adenocarcinoma transfected with the interferon-alpha1 gene. <span class='html-italic'>J. Pathol.</span> <b>1997</b>, <span class='html-italic'>181</span>, 116–123. [<a href="https://scholar.google.com/scholar_lookup?title=Extracellular+matrix+remodelling+in+a+murine+mammary+adenocarcinoma+transfected+with+the+interferon-alpha1+gene&author=Scarpa,+S.&author=Giuffrida,+A.&author=Palumbo,+C.&author=Vasaturo,+F.&author=Signorelli,+P.&author=Forni,+G.&author=Modesti,+M.&author=Ferrantini,+M.&author=Belardelli,+F.&author=Musiani,+P.&publication_year=1997&journal=J.+Pathol.&volume=181&pages=116%E2%80%93123&doi=10.1002/(SICI)1096-9896(199701)181:1%3C116::AID-PATH116%3E3.0.CO;2-X" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/(SICI)1096-9896(199701)181:1<116::AID-PATH116>3.0.CO;2-X" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B106-cancers-11-01889' class='html-xxx' data-content='106.'>Rossi, I.; Nicoletti, G.; Landuzzi, L.; Frabetti, F.; De Giovanni, C.; Nanni, P.; Musiani, P.; Ferrantini, M.; Belardelli, F.; Lollini, P.L. Inhibition of lung colonisation of a mouse mammary carcinoma by therapeutic vaccination with interferon-α gene-transduced tumor cells. <span class='html-italic'>Clin. Exp. Metastasis</span> <b>1998</b>, <span class='html-italic'>16</span>, 123–128. [<a href="https://scholar.google.com/scholar_lookup?title=Inhibition+of+lung+colonisation+of+a+mouse+mammary+carcinoma+by+therapeutic+vaccination+with+interferon-%CE%B1+gene-transduced+tumor+cells&author=Rossi,+I.&author=Nicoletti,+G.&author=Landuzzi,+L.&author=Frabetti,+F.&author=De+Giovanni,+C.&author=Nanni,+P.&author=Musiani,+P.&author=Ferrantini,+M.&author=Belardelli,+F.&author=Lollini,+P.L.&publication_year=1998&journal=Clin.+Exp.+Metastasis&volume=16&pages=123%E2%80%93128&doi=10.1023/A:1021980818017" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1023/A:1021980818017" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B107-cancers-11-01889' class='html-xxx' data-content='107.'>Tüting, T.; Gambotto, A.; Baar, J.; Davis, I.D.; Storkus, W.J.; Zavodny, P.J.; Narula, S.; Tahara, H.; Robbins, P.D.; Lotze, M.T. Interferon-α gene therapy for cancer: Retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models. <span class='html-italic'>Gene Ther.</span> <b>1997</b>, <span class='html-italic'>4</span>, 1053–1060. [<a href="https://scholar.google.com/scholar_lookup?title=Interferon-%CE%B1+gene+therapy+for+cancer:+Retroviral+transduction+of+fibroblasts+and+particle-mediated+transfection+of+tumor+cells+are+both+effective+strategies+for+gene+delivery+in+murine+tumor+models&author=T%C3%BCting,+T.&author=Gambotto,+A.&author=Baar,+J.&author=Davis,+I.D.&author=Storkus,+W.J.&author=Zavodny,+P.J.&author=Narula,+S.&author=Tahara,+H.&author=Robbins,+P.D.&author=Lotze,+M.T.&publication_year=1997&journal=Gene+Ther.&volume=4&pages=1053%E2%80%931060&doi=10.1038/sj.gt.3300509" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/sj.gt.3300509" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://www.nature.com/articles/3300509.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B108-cancers-11-01889' class='html-xxx' data-content='108.'>Coleman, M.; Muller, S.; Quezada, A.; Mendiratta, S.K.; Wang, J.; Thull, N.M.; Bishop, J.; Matar, M.; Mester, J.; Pericle, F. Nonviral interferon α gene therapy inhibits growth of established tumors by eliciting a systemic immune response. <span class='html-italic'>Hum. Gene Ther.</span> <b>1998</b>, <span class='html-italic'>9</span>, 2223–2230. [<a href="https://scholar.google.com/scholar_lookup?title=Nonviral+interferon+%CE%B1+gene+therapy+inhibits+growth+of+established+tumors+by+eliciting+a+systemic+immune+response&author=Coleman,+M.&author=Muller,+S.&author=Quezada,+A.&author=Mendiratta,+S.K.&author=Wang,+J.&author=Thull,+N.M.&author=Bishop,+J.&author=Matar,+M.&author=Mester,+J.&author=Pericle,+F.&publication_year=1998&journal=Hum.+Gene+Ther.&volume=9&pages=2223%E2%80%932230&doi=10.1089/hum.1998.9.15-2223" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1089/hum.1998.9.15-2223" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B109-cancers-11-01889' class='html-xxx' data-content='109.'>Rozera, C.; Carlei, D.; Lollini, P.L.; De Giovanni, C.; Musiani, P.; Di Carlo, E.; Belardelli, F.; Ferrantini, M. Interferon (IFN)-β gene transfer into TS/A adenocarcinoma cells and comparison with IFN-α. Differential effects on tumorigenicity and host response. <span class='html-italic'>Am. J. Pathol.</span> <b>1999</b>, <span class='html-italic'>154</span>, 1211–1222. [<a href="https://scholar.google.com/scholar_lookup?title=Interferon+(IFN)-%CE%B2+gene+transfer+into+TS/A+adenocarcinoma+cells+and+comparison+with+IFN-%CE%B1.+Differential+effects+on+tumorigenicity+and+host+response&author=Rozera,+C.&author=Carlei,+D.&author=Lollini,+P.L.&author=De+Giovanni,+C.&author=Musiani,+P.&author=Di+Carlo,+E.&author=Belardelli,+F.&author=Ferrantini,+M.&publication_year=1999&journal=Am.+J.+Pathol.&volume=154&pages=1211%E2%80%931222&doi=10.1016/S0002-9440(10)65373-4" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/S0002-9440(10)65373-4" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B110-cancers-11-01889' class='html-xxx' data-content='110.'>Lollini, P.L.; Nanni, P. Minimal requirements for characterization of cytokine gene-transduced tumor cells: A proposal. <span class='html-italic'>J. Natl. Cancer Inst.</span> <b>1995</b>, <span class='html-italic'>87</span>, 1717–1718. [<a href="https://scholar.google.com/scholar_lookup?title=Minimal+requirements+for+characterization+of+cytokine+gene-transduced+tumor+cells:+A+proposal&author=Lollini,+P.L.&author=Nanni,+P.&publication_year=1995&journal=J.+Natl.+Cancer+Inst.&volume=87&pages=1717%E2%80%931718&doi=10.1093/jnci/87.22.1717" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1093/jnci/87.22.1717" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B111-cancers-11-01889' class='html-xxx' data-content='111.'>Nanni, P.; De Giovanni, C.; Landuzzi, L.; Nicoletti, G.; Frabetti, F.; Rossi, I.; Cavallo, F.; Giovarelli, M.; Forni, G.; Lollini, P.L. Therapy of murine mammary carcinoma metastasis with interferon γ and MHC gene-transduced tumour cells. <span class='html-italic'>Br. J. Cancer</span> <b>1996</b>, <span class='html-italic'>74</span>, 1564–1569. [<a href="https://scholar.google.com/scholar_lookup?title=Therapy+of+murine+mammary+carcinoma+metastasis+with+interferon+%CE%B3+and+MHC+gene-transduced+tumour+cells&author=Nanni,+P.&author=De+Giovanni,+C.&author=Landuzzi,+L.&author=Nicoletti,+G.&author=Frabetti,+F.&author=Rossi,+I.&author=Cavallo,+F.&author=Giovarelli,+M.&author=Forni,+G.&author=Lollini,+P.L.&publication_year=1996&journal=Br.+J.+Cancer&volume=74&pages=1564%E2%80%931569&doi=10.1038/bjc.1996.590" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/bjc.1996.590" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://www.nature.com/articles/bjc1996590.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B112-cancers-11-01889' class='html-xxx' data-content='112.'>Nanni, P.; De Giovanni, C.; Nicoletti, G.; Landuzzi, L.; Rossi, I.; Frabetti, F.; Giovarelli, M.; Forni, G.; Cavallo, F.; Di Carlo, E.; et al. The immune response elicited by mammary adenocarcinoma cells transduced with interferon-γ and cytosine deaminase genes cures lung metastases by parental cells. <span class='html-italic'>Hum. Gene Ther.</span> <b>1998</b>, <span class='html-italic'>9</span>, 217–224. [<a href="https://scholar.google.com/scholar_lookup?title=The+immune+response+elicited+by+mammary+adenocarcinoma+cells+transduced+with+interferon-%CE%B3+and+cytosine+deaminase+genes+cures+lung+metastases+by+parental+cells&author=Nanni,+P.&author=De+Giovanni,+C.&author=Nicoletti,+G.&author=Landuzzi,+L.&author=Rossi,+I.&author=Frabetti,+F.&author=Giovarelli,+M.&author=Forni,+G.&author=Cavallo,+F.&author=Di+Carlo,+E.&publication_year=1998&journal=Hum.+Gene+Ther.&volume=9&pages=217%E2%80%93224&doi=10.1089/hum.1998.9.2-217&pmid=9472781" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1089/hum.1998.9.2-217" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/9472781" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B113-cancers-11-01889' class='html-xxx' data-content='113.'>Sacchi, A.; Gasparri, A.; Curnis, F.; Bellone, M.; Corti, A. Crucial role for interferon γ in the synergism between tumor vasculature-targeted tumor necrosis factor α (NGR-TNF) and doxorubicin. <span class='html-italic'>Cancer Res.</span> <b>2004</b>, <span class='html-italic'>64</span>, 7150–7155. [<a href="https://scholar.google.com/scholar_lookup?title=Crucial+role+for+interferon+%CE%B3+in+the+synergism+between+tumor+vasculature-targeted+tumor+necrosis+factor+%CE%B1+(NGR-TNF)+and+doxorubicin&author=Sacchi,+A.&author=Gasparri,+A.&author=Curnis,+F.&author=Bellone,+M.&author=Corti,+A.&publication_year=2004&journal=Cancer+Res.&volume=64&pages=7150%E2%80%937155&doi=10.1158/0008-5472.CAN-04-1445" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/0008-5472.CAN-04-1445" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B114-cancers-11-01889' class='html-xxx' data-content='114.'>Cavallo, F.; Martin-Fontecha, A.; Bellone, M.; Heltai, S.; Gatti, E.; Tornaghi, P.; Freschi, M.; Forni, G.; Dellabona, P.; Casorati, G. Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. <span class='html-italic'>Eur. J. Immunol.</span> <b>1995</b>, <span class='html-italic'>25</span>, 1154–1162. [<a href="https://scholar.google.com/scholar_lookup?title=Co-expression+of+B7-1+and+ICAM-1+on+tumors+is+required+for+rejection+and+the+establishment+of+a+memory+response&author=Cavallo,+F.&author=Martin-Fontecha,+A.&author=Bellone,+M.&author=Heltai,+S.&author=Gatti,+E.&author=Tornaghi,+P.&author=Freschi,+M.&author=Forni,+G.&author=Dellabona,+P.&author=Casorati,+G.&publication_year=1995&journal=Eur.+J.+Immunol.&volume=25&pages=1154%E2%80%931162&doi=10.1002/eji.1830250504" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/eji.1830250504" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B115-cancers-11-01889' class='html-xxx' data-content='115.'>Martin-Fontecha, A.; Cavallo, F.; Bellone, M.; Heltai, S.; Lezzi, G.; Tornaghi, P.; Nabavi, N.; Forni, G.; Dellabona, P.; Casorati, G. Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic antitumor immunity against different mouse tumors. <span class='html-italic'>Eur. J. Immunol.</span> <b>1996</b>, <span class='html-italic'>26</span>, 1851–1859. [<a href="https://scholar.google.com/scholar_lookup?title=Heterogeneous+effects+of+B7-1+and+B7-2+in+the+induction+of+both+protective+and+therapeutic+antitumor+immunity+against+different+mouse+tumors&author=Martin-Fontecha,+A.&author=Cavallo,+F.&author=Bellone,+M.&author=Heltai,+S.&author=Lezzi,+G.&author=Tornaghi,+P.&author=Nabavi,+N.&author=Forni,+G.&author=Dellabona,+P.&author=Casorati,+G.&publication_year=1996&journal=Eur.+J.+Immunol.&volume=26&pages=1851%E2%80%931859&doi=10.1002/eji.1830260828&pmid=8765031" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/eji.1830260828" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/8765031" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B116-cancers-11-01889' class='html-xxx' data-content='116.'>Martín-Fontecha, A.; Moro, M.; Crosti, M.C.; Veglia, F.; Casorati, G.; Dellabona, P. Vaccination with Mouse Mammary Adenocarcinoma Cells Coexpressing B7-1 (CD80) and B7-2 (CD86) Discloses the Dominant Effect of B7-1 in the Induction of Antitumor Immunity. <span class='html-italic'>J. Immunol.</span> <b>2000</b>, <span class='html-italic'>164</span>, 698–704. [<a href="https://scholar.google.com/scholar_lookup?title=Vaccination+with+Mouse+Mammary+Adenocarcinoma+Cells+Coexpressing+B7-1+(CD80)+and+B7-2+(CD86)+Discloses+the+Dominant+Effect+of+B7-1+in+the+Induction+of+Antitumor+Immunity&author=Mart%C3%ADn-Fontecha,+A.&author=Moro,+M.&author=Crosti,+M.C.&author=Veglia,+F.&author=Casorati,+G.&author=Dellabona,+P.&publication_year=2000&journal=J.+Immunol.&volume=164&pages=698%E2%80%93704&doi=10.4049/jimmunol.164.2.698" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.4049/jimmunol.164.2.698" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.jimmunol.org/content/164/2/698.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B117-cancers-11-01889' class='html-xxx' data-content='117.'>Lollini, P.L.; De Giovanni, C.; Landuzzi, L.; Nicoletti, G.; Frabetti, F.; Nanni, P.; Landuzzi, L.; Nicoletti, G.; Cavallo, F.; Giovarelli, M.; et al. Transduction of Genes Coding for a Histocompatibility (MHC) Antigen and for Its Physiological Inducer Interferon-γ in the Same Cell: Efficient MHC Expression and Inhibition of Tumor and Metastasis Growth. <span class='html-italic'>Hum. Gene Ther.</span> <b>1995</b>, <span class='html-italic'>6</span>, 743–752. [<a href="https://scholar.google.com/scholar_lookup?title=Transduction+of+Genes+Coding+for+a+Histocompatibility+(MHC)+Antigen+and+for+Its+Physiological+Inducer+Interferon-%CE%B3+in+the+Same+Cell:+Efficient+MHC+Expression+and+Inhibition+of+Tumor+and+Metastasis+Growth&author=Lollini,+P.L.&author=De+Giovanni,+C.&author=Landuzzi,+L.&author=Nicoletti,+G.&author=Frabetti,+F.&author=Nanni,+P.&author=Landuzzi,+L.&author=Nicoletti,+G.&author=Cavallo,+F.&author=Giovarelli,+M.&publication_year=1995&journal=Hum.+Gene+Ther.&volume=6&pages=743%E2%80%93752&doi=10.1089/hum.1995.6.6-743" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1089/hum.1995.6.6-743" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B118-cancers-11-01889' class='html-xxx' data-content='118.'>Couderc, B.; Zitvogel, L.; Douin-Echinard, V.; Djennane, L.; Tahara, H.; Favre, G.; Lotze, M.T.; Robbins, P.D. Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells. <span class='html-italic'>Cancer Gene Ther.</span> <b>1998</b>, <span class='html-italic'>5</span>, 163–175. [<a href="https://scholar.google.com/scholar_lookup?title=Enhancement+of+antitumor+immunity+by+expression+of+CD70+(CD27+ligand)+or+CD154+(CD40+ligand)+costimulatory+molecules+in+tumor+cells&author=Couderc,+B.&author=Zitvogel,+L.&author=Douin-Echinard,+V.&author=Djennane,+L.&author=Tahara,+H.&author=Favre,+G.&author=Lotze,+M.T.&author=Robbins,+P.D.&publication_year=1998&journal=Cancer+Gene+Ther.&volume=5&pages=163%E2%80%93175" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B119-cancers-11-01889' class='html-xxx' data-content='119.'>Douin-Echinard, V.; Bornes, S.; Rochaix, P.; Tilkin, A.F.; Peron, J.M.; Bonnet, J.; Favre, G.; Couderc, B. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status. <span class='html-italic'>Cancer Gene Ther.</span> <b>2000</b>, <span class='html-italic'>7</span>, 1543–1556. [<a href="https://scholar.google.com/scholar_lookup?title=The+expression+of+CD70+and+CD80+by+gene-modified+tumor+cells+induces+an+antitumor+response+depending+on+the+MHC+status&author=Douin-Echinard,+V.&author=Bornes,+S.&author=Rochaix,+P.&author=Tilkin,+A.F.&author=Peron,+J.M.&author=Bonnet,+J.&author=Favre,+G.&author=Couderc,+B.&publication_year=2000&journal=Cancer+Gene+Ther.&volume=7&pages=1543%E2%80%931556&doi=10.1038/sj.cgt.7700268" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/sj.cgt.7700268" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://www.nature.com/articles/7700268.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B120-cancers-11-01889' class='html-xxx' data-content='120.'>Grangeon, C.; Cormary, C.; Douin-Echinard, V.; Favre, G.; Couderc, B.; Tilkin-Mariamé, A.F. In vivo induction of antitumor immunity and protection against tumor growth by injection of CD154-expressing tumor cells. <span class='html-italic'>Cancer Gene Ther.</span> <b>2002</b>, <span class='html-italic'>9</span>, 282–288. [<a href="https://scholar.google.com/scholar_lookup?title=In+vivo+induction+of+antitumor+immunity+and+protection+against+tumor+growth+by+injection+of+CD154-expressing+tumor+cells&author=Grangeon,+C.&author=Cormary,+C.&author=Douin-Echinard,+V.&author=Favre,+G.&author=Couderc,+B.&author=Tilkin-Mariam%C3%A9,+A.F.&publication_year=2002&journal=Cancer+Gene+Ther.&volume=9&pages=282%E2%80%93288&doi=10.1038/sj.cgt.7700439" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/sj.cgt.7700439" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.nature.com/cgt/journal/v9/n3/pdf/7700439a.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B121-cancers-11-01889' class='html-xxx' data-content='121.'>Giovarelli, M.; Cappello, P.; Rigamonti, L.; Bernabei, P.; Novelli, F.; Lollini, P.L.; Forni, G.; Musiani, P.; Di Carlo, E.; Garotta, G.; et al. A “stealth effect”: Adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. <span class='html-italic'>J. Immunol.</span> <b>1999</b>, <span class='html-italic'>163</span>, 4886–4893. [<a href="https://scholar.google.com/scholar_lookup?title=A+%E2%80%9Cstealth+effect%E2%80%9D:+Adenocarcinoma+cells+engineered+to+express+TRAIL+elude+tumor-specific+and+allogeneic+T+cell+reactions&author=Giovarelli,+M.&author=Cappello,+P.&author=Rigamonti,+L.&author=Bernabei,+P.&author=Novelli,+F.&author=Lollini,+P.L.&author=Forni,+G.&author=Musiani,+P.&author=Di+Carlo,+E.&author=Garotta,+G.&publication_year=1999&journal=J.+Immunol.&volume=163&pages=4886%E2%80%934893" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B122-cancers-11-01889' class='html-xxx' data-content='122.'>Prigent, P.; El Mir, S.; Dréano, M.; Triebel, F. Lymphocyte activation gene-3 induces tumor regression and antitumor immune responses. <span class='html-italic'>Eur. J. Immunol.</span> <b>1999</b>, <span class='html-italic'>29</span>, 3867–3876. [<a href="https://scholar.google.com/scholar_lookup?title=Lymphocyte+activation+gene-3+induces+tumor+regression+and+antitumor+immune+responses&author=Prigent,+P.&author=El+Mir,+S.&author=Dr%C3%A9ano,+M.&author=Triebel,+F.&publication_year=1999&journal=Eur.+J.+Immunol.&volume=29&pages=3867%E2%80%933876&doi=10.1002/(SICI)1521-4141(199912)29:12%3C3867::AID-IMMU3867%3E3.0.CO;2-E" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/(SICI)1521-4141(199912)29:12<3867::AID-IMMU3867>3.0.CO;2-E" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B123-cancers-11-01889' class='html-xxx' data-content='123.'>Di Carlo, E.; Cappello, P.; Sorrentino, C.; D’Antuono, T.; Pellicciotta, A.; Giovarelli, M.; Forni, G.; Musiani, P.; Triebel, F. Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: Sharing a common Th1 anti-tumour immune pathway. <span class='html-italic'>J. Pathol.</span> <b>2005</b>, <span class='html-italic'>205</span>, 82–91. [<a href="https://scholar.google.com/scholar_lookup?title=Immunological+mechanisms+elicited+at+the+tumour+site+by+lymphocyte+activation+gene-3+(LAG-3)+versus+IL-12:+Sharing+a+common+Th1+anti-tumour+immune+pathway&author=Di+Carlo,+E.&author=Cappello,+P.&author=Sorrentino,+C.&author=D%E2%80%99Antuono,+T.&author=Pellicciotta,+A.&author=Giovarelli,+M.&author=Forni,+G.&author=Musiani,+P.&author=Triebel,+F.&publication_year=2005&journal=J.+Pathol.&volume=205&pages=82%E2%80%9391&doi=10.1002/path.1679" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/path.1679" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B124-cancers-11-01889' class='html-xxx' data-content='124.'>Croci, S.; Nicoletti, G.; Landuzzi, L.; Palladini, A.; Chiarini, F.; Nanni, P.; Lollini, P.L.; De Giovanni, C. Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells. <span class='html-italic'>Oncol. Rep.</span> <b>2007</b>, <span class='html-italic'>18</span>, 451–456. [<a href="https://scholar.google.com/scholar_lookup?title=Expression+of+a+functional+CCR7+chemokine+receptor+inhibits+the+post-intravasation+steps+of+metastasis+in+malignant+murine+mammary+cancer+cells&author=Croci,+S.&author=Nicoletti,+G.&author=Landuzzi,+L.&author=Palladini,+A.&author=Chiarini,+F.&author=Nanni,+P.&author=Lollini,+P.L.&author=De+Giovanni,+C.&publication_year=2007&journal=Oncol.+Rep.&volume=18&pages=451%E2%80%93456&doi=10.3892/or.18.2.451&pmid=17611670" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.3892/or.18.2.451" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/17611670" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="http://www.spandidos-publications.com/or/18/2/451/download" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B125-cancers-11-01889' class='html-xxx' data-content='125.'>Consalvo, M.; Mullen, C.A.; Modesti, A.; Musiani, P.; Allione, A.; Cavallo, F.; Giovarelli, M.; Forni, G. 5-Fluorocytosine-Induced Eradication of Murine Adenocarcinomas Engineered To Express the Cytosine Deaminase Suicide Gene Requires Host Immune Competence and Leaves an Efficient Memory. <span class='html-italic'>J. Immunol.</span> <b>1995</b>, <span class='html-italic'>154</span>, 5302–5312. [<a href="https://scholar.google.com/scholar_lookup?title=5-Fluorocytosine-Induced+Eradication+of+Murine+Adenocarcinomas+Engineered+To+Express+the+Cytosine+Deaminase+Suicide+Gene+Requires+Host+Immune+Competence+and+Leaves+an+Efficient+Memory&author=Consalvo,+M.&author=Mullen,+C.A.&author=Modesti,+A.&author=Musiani,+P.&author=Allione,+A.&author=Cavallo,+F.&author=Giovarelli,+M.&author=Forni,+G.&publication_year=1995&journal=J.+Immunol.&volume=154&pages=5302%E2%80%935312" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B126-cancers-11-01889' class='html-xxx' data-content='126.'>Uckert, W.; Kammertöns, T.; Haack, K.; Qin, Z.; Gebert, J.; Schendel, D.J.; Blankenstein, T. Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo. <span class='html-italic'>Hum. Gene Ther.</span> <b>1998</b>, <span class='html-italic'>9</span>, 855–865. [<a href="https://scholar.google.com/scholar_lookup?title=Double+suicide+gene+(cytosine+deaminase+and+herpes+simplex+virus+thymidine+kinase)+but+not+single+gene+transfer+allows+reliable+elimination+of+tumor+cells+in+vivo&author=Uckert,+W.&author=Kammert%C3%B6ns,+T.&author=Haack,+K.&author=Qin,+Z.&author=Gebert,+J.&author=Schendel,+D.J.&author=Blankenstein,+T.&publication_year=1998&journal=Hum.+Gene+Ther.&volume=9&pages=855%E2%80%93865&doi=10.1089/hum.1998.9.6-855" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1089/hum.1998.9.6-855" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B127-cancers-11-01889' class='html-xxx' data-content='127.'>Porosnicu, M.; Mian, A.; Barber, G.N. The Oncolytic Effect of Recombinant Vesicular Stomatitis Virus Is Enhanced by Expression of the Fusion Cytosine Deaminase/Uracil Phosphoribosyltransferase Suicide Gene. <span class='html-italic'>Cancer Res.</span> <b>2003</b>, <span class='html-italic'>63</span>, 8366–8376. [<a href="https://scholar.google.com/scholar_lookup?title=The+Oncolytic+Effect+of+Recombinant+Vesicular+Stomatitis+Virus+Is+Enhanced+by+Expression+of+the+Fusion+Cytosine+Deaminase/Uracil+Phosphoribosyltransferase+Suicide+Gene&author=Porosnicu,+M.&author=Mian,+A.&author=Barber,+G.N.&publication_year=2003&journal=Cancer+Res.&volume=63&pages=8366%E2%80%938376" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B128-cancers-11-01889' class='html-xxx' data-content='128.'>Leveille, S.; Goulet, M.-L.; Lichty, B.D.; Hiscott, J. Vesicular Stomatitis Virus Oncolytic Treatment Interferes with Tumor-Associated Dendritic Cell Functions and Abrogates Tumor Antigen Presentation. <span class='html-italic'>J. Virol.</span> <b>2011</b>, <span class='html-italic'>85</span>, 12160–12169. [<a href="https://scholar.google.com/scholar_lookup?title=Vesicular+Stomatitis+Virus+Oncolytic+Treatment+Interferes+with+Tumor-Associated+Dendritic+Cell+Functions+and+Abrogates+Tumor+Antigen+Presentation&author=Leveille,+S.&author=Goulet,+M.-L.&author=Lichty,+B.D.&author=Hiscott,+J.&publication_year=2011&journal=J.+Virol.&volume=85&pages=12160%E2%80%9312169&doi=10.1128/JVI.05703-11" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1128/JVI.05703-11" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://jvi.asm.org/content/85/23/12160.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B129-cancers-11-01889' class='html-xxx' data-content='129.'>Chen, X.; Zhang, D.; Dennert, G.; Hung, G.; Lee, A.S. Eradication of murine mammary adenocarcinoma through HSVtk expression directed by the glucose-starvation inducible grp78 promoter. <span class='html-italic'>Breast Cancer Res. Treat.</span> <b>2000</b>, <span class='html-italic'>59</span>, 81–90. [<a href="https://scholar.google.com/scholar_lookup?title=Eradication+of+murine+mammary+adenocarcinoma+through+HSVtk+expression+directed+by+the+glucose-starvation+inducible+grp78+promoter&author=Chen,+X.&author=Zhang,+D.&author=Dennert,+G.&author=Hung,+G.&author=Lee,+A.S.&publication_year=2000&journal=Breast+Cancer+Res.+Treat.&volume=59&pages=81%E2%80%9390&doi=10.1023/A:1006398918227" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1023/A:1006398918227" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B130-cancers-11-01889' class='html-xxx' data-content='130.'>Faneca, H.; Cabrita, A.S.; Simões, S.; Pedroso de Lima, M.C. Evaluation of the antitumoral effect mediated by IL-12 and HSV-tk genes when delivered by a novel lipid-based system. <span class='html-italic'>Biochim. Biophys. Acta Biomembr.</span> <b>2007</b>, <span class='html-italic'>1768</span>, 1093–1102. [<a href="https://scholar.google.com/scholar_lookup?title=Evaluation+of+the+antitumoral+effect+mediated+by+IL-12+and+HSV-tk+genes+when+delivered+by+a+novel+lipid-based+system&author=Faneca,+H.&author=Cabrita,+A.S.&author=Sim%C3%B5es,+S.&author=Pedroso+de+Lima,+M.C.&publication_year=2007&journal=Biochim.+Biophys.+Acta+Biomembr.&volume=1768&pages=1093%E2%80%931102&doi=10.1016/j.bbamem.2006.12.017" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.bbamem.2006.12.017" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://estudogeral.sib.uc.pt/bitstream/10316/4720/1/file4e13d68bfdb645a3a6a16feab7dcf0eb.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B131-cancers-11-01889' class='html-xxx' data-content='131.'>Meazza, R.; Comes, A.; Orengo, A.M.; Ferrini, S.; Accolla, R.S. Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells. <span class='html-italic'>Eur. J. Immunol.</span> <b>2003</b>, <span class='html-italic'>33</span>, 1183–1192. [<a href="https://scholar.google.com/scholar_lookup?title=Tumor+rejection+by+gene+transfer+of+the+MHC+class+II+transactivator+in+murine+mammary+adenocarcinoma+cells&author=Meazza,+R.&author=Comes,+A.&author=Orengo,+A.M.&author=Ferrini,+S.&author=Accolla,+R.S.&publication_year=2003&journal=Eur.+J.+Immunol.&volume=33&pages=1183%E2%80%931192&doi=10.1002/eji.200323712" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/eji.200323712" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B132-cancers-11-01889' class='html-xxx' data-content='132.'>Mortara, L.; Frangione, V.; Castellani, P.; De Lerma Barbaro, A.; Accolla, R.S. Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions. <span class='html-italic'>Int. Immunol.</span> <b>2009</b>, <span class='html-italic'>21</span>, 655–665. [<a href="https://scholar.google.com/scholar_lookup?title=Irradiated+CIITA-positive+mammary+adenocarcinoma+cells+act+as+a+potent+anti-tumor-preventive+vaccine+by+inducing+tumor-specific+CD4++T+cell+priming+and+CD8++T+cell+effector+functions&author=Mortara,+L.&author=Frangione,+V.&author=Castellani,+P.&author=De+Lerma+Barbaro,+A.&author=Accolla,+R.S.&publication_year=2009&journal=Int.+Immunol.&volume=21&pages=655%E2%80%93665&doi=10.1093/intimm/dxp034" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1093/intimm/dxp034" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://academic.oup.com/intimm/article-pdf/21/6/655/2068886/dxp034.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B133-cancers-11-01889' class='html-xxx' data-content='133.'>McCaw, T.R.; Li, M.; Starenki, D.; Cooper, S.J.; Liu, M.; Meza-Perez, S.; Arend, R.C.; Buchsbaum, D.J.; Forero, A.; Randall, T.D. The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth. <span class='html-italic'>Cancer Immunol. Immunother.</span> <b>2019</b>, <span class='html-italic'>68</span>, 175–188. [<a href="https://scholar.google.com/scholar_lookup?title=The+expression+of+MHC+class+II+molecules+on+murine+breast+tumors+delays+T-cell+exhaustion,+expands+the+T-cell+repertoire,+and+slows+tumor+growth&author=McCaw,+T.R.&author=Li,+M.&author=Starenki,+D.&author=Cooper,+S.J.&author=Liu,+M.&author=Meza-Perez,+S.&author=Arend,+R.C.&author=Buchsbaum,+D.J.&author=Forero,+A.&author=Randall,+T.D.&publication_year=2019&journal=Cancer+Immunol.+Immunother.&volume=68&pages=175%E2%80%93188&doi=10.1007/s00262-018-2262-5&pmid=30334128" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/s00262-018-2262-5" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/30334128" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B134-cancers-11-01889' class='html-xxx' data-content='134.'>Lipnik, K.; Naschberger, E.; Gonin-Laurent, N.; Kodajova, P.; Petznek, H.; Rungaldier, S.; Astigiano, S.; Ferrini, S.; Stürz, M.; Hohenadl, C. Interferon γ-Induced human guanylate binding protein 1 inhibits mammary tumor growth in mice. <span class='html-italic'>Mol. Med.</span> <b>2010</b>, <span class='html-italic'>16</span>, 177–187. [<a href="https://scholar.google.com/scholar_lookup?title=Interferon+%CE%B3-Induced+human+guanylate+binding+protein+1+inhibits+mammary+tumor+growth+in+mice&author=Lipnik,+K.&author=Naschberger,+E.&author=Gonin-Laurent,+N.&author=Kodajova,+P.&author=Petznek,+H.&author=Rungaldier,+S.&author=Astigiano,+S.&author=Ferrini,+S.&author=St%C3%BCrz,+M.&author=Hohenadl,+C.&publication_year=2010&journal=Mol.+Med.&volume=16&pages=177%E2%80%93187&doi=10.2119/molmed.2009.00172&pmid=20454519" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.2119/molmed.2009.00172" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20454519" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B135-cancers-11-01889' class='html-xxx' data-content='135.'>Kim, P.K.M.; Armstrong, M.; Liu, Y.; Yan, P.; Bucher, B.; Zuckerbraun, B.S.; Gambotto, A.; Billiar, T.R.; Yim, J.H. IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo. <span class='html-italic'>Oncogene</span> <b>2004</b>, <span class='html-italic'>23</span>, 1125–1135. [<a href="https://scholar.google.com/scholar_lookup?title=IRF-1+expression+induces+apoptosis+and+inhibits+tumor+growth+in+mouse+mammary+cancer+cells+in+vitro+and+in+vivo&author=Kim,+P.K.M.&author=Armstrong,+M.&author=Liu,+Y.&author=Yan,+P.&author=Bucher,+B.&author=Zuckerbraun,+B.S.&author=Gambotto,+A.&author=Billiar,+T.R.&author=Yim,+J.H.&publication_year=2004&journal=Oncogene&volume=23&pages=1125%E2%80%931135&doi=10.1038/sj.onc.1207023&pmid=14762441" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/sj.onc.1207023" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/14762441" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="https://www.nature.com/articles/1207023.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B136-cancers-11-01889' class='html-xxx' data-content='136.'>Lollini, P.-L.; D’Errico, A.; De Giovanni, C.; Landuzzi, L.; Frabetti, F.; Nicoletti, G.; Cavallo, F.; Giovarelli, M.; Grigioni, W.F.; Nanni, P. Systemic effects of cytokines released by gene-transduced tumor cells: Marked hyperplasia induced in small bowel by γ-interferon transfectants through host lymphocytes. <span class='html-italic'>Int. J. Cancer</span> <b>1995</b>, <span class='html-italic'>61</span>, 425–430. [<a href="https://scholar.google.com/scholar_lookup?title=Systemic+effects+of+cytokines+released+by+gene-transduced+tumor+cells:+Marked+hyperplasia+induced+in+small+bowel+by+%CE%B3-interferon+transfectants+through+host+lymphocytes&author=Lollini,+P.-L.&author=D%E2%80%99Errico,+A.&author=De+Giovanni,+C.&author=Landuzzi,+L.&author=Frabetti,+F.&author=Nicoletti,+G.&author=Cavallo,+F.&author=Giovarelli,+M.&author=Grigioni,+W.F.&author=Nanni,+P.&publication_year=1995&journal=Int.+J.+Cancer&volume=61&pages=425%E2%80%93430&doi=10.1002/ijc.2910610325" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/ijc.2910610325" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B137-cancers-11-01889' class='html-xxx' data-content='137.'>Musiani, P.; Modesti, A.; Giovarelli, M.; Cavallo, F.; Forni, G.; Lollini, P.L.; Colombo, M.P. Cytokines, tumour-cell death and immunogenicity: A question of choice. <span class='html-italic'>Immunol. Today</span> <b>1997</b>, <span class='html-italic'>18</span>, 32–36. [<a href="https://scholar.google.com/scholar_lookup?title=Cytokines,+tumour-cell+death+and+immunogenicity:+A+question+of+choice&author=Musiani,+P.&author=Modesti,+A.&author=Giovarelli,+M.&author=Cavallo,+F.&author=Forni,+G.&author=Lollini,+P.L.&author=Colombo,+M.P.&publication_year=1997&journal=Immunol.+Today&volume=18&pages=32%E2%80%9336&doi=10.1016/S0167-5699(97)80012-6" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/S0167-5699(97)80012-6" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B138-cancers-11-01889' class='html-xxx' data-content='138.'>Dranoff, G.; Jaffee, E.; Lazenby, A.; Golumbek, P.; Levitsky, H.; Brose, K.; Jackson, V.; Hamada, H.; Pardoll, D.; Mulligan, R.C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. <span class='html-italic'>Proc. Natl. Acad. Sci. USA</span> <b>1993</b>, <span class='html-italic'>90</span>, 3539–3543. [<a href="https://scholar.google.com/scholar_lookup?title=Vaccination+with+irradiated+tumor+cells+engineered+to+secrete+murine+granulocyte-macrophage+colony-stimulating+factor+stimulates+potent,+specific,+and+long-lasting+anti-tumor+immunity&author=Dranoff,+G.&author=Jaffee,+E.&author=Lazenby,+A.&author=Golumbek,+P.&author=Levitsky,+H.&author=Brose,+K.&author=Jackson,+V.&author=Hamada,+H.&author=Pardoll,+D.&author=Mulligan,+R.C.&publication_year=1993&journal=Proc.+Natl.+Acad.+Sci.+USA&volume=90&pages=3539%E2%80%933543&doi=10.1073/pnas.90.8.3539" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1073/pnas.90.8.3539" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.pnas.org/content/90/8/3539.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B139-cancers-11-01889' class='html-xxx' data-content='139.'>Heiber, J.F.; Barber, G.N. Vesicular Stomatitis Virus Expressing Tumor Suppressor p53 Is a Highly Attenuated, Potent Oncolytic Agent. <span class='html-italic'>J. Virol.</span> <b>2011</b>, <span class='html-italic'>85</span>, 10440–10450. [<a href="https://scholar.google.com/scholar_lookup?title=Vesicular+Stomatitis+Virus+Expressing+Tumor+Suppressor+p53+Is+a+Highly+Attenuated,+Potent+Oncolytic+Agent&author=Heiber,+J.F.&author=Barber,+G.N.&publication_year=2011&journal=J.+Virol.&volume=85&pages=10440%E2%80%9310450&doi=10.1128/JVI.05408-11" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1128/JVI.05408-11" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://jvi.asm.org/content/jvi/85/20/10440.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B140-cancers-11-01889' class='html-xxx' data-content='140.'>Bonnet, M.E.; Gossart, J.B.; Benoit, E.; Messmer, M.; Zounib, O.; Moreau, V.; Behr, J.P.; Lenne-Samuel, N.; Kedinger, V.; Meulle, A.; et al. Systemic delivery of sticky siRNAs targeting the cell cycle for lung tumor metastasis inhibition. <span class='html-italic'>J. Control. Release</span> <b>2013</b>, <span class='html-italic'>170</span>, 183–190. [<a href="https://scholar.google.com/scholar_lookup?title=Systemic+delivery+of+sticky+siRNAs+targeting+the+cell+cycle+for+lung+tumor+metastasis+inhibition&author=Bonnet,+M.E.&author=Gossart,+J.B.&author=Benoit,+E.&author=Messmer,+M.&author=Zounib,+O.&author=Moreau,+V.&author=Behr,+J.P.&author=Lenne-Samuel,+N.&author=Kedinger,+V.&author=Meulle,+A.&publication_year=2013&journal=J.+Control.+Release&volume=170&pages=183%E2%80%93190&doi=10.1016/j.jconrel.2013.05.015" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.jconrel.2013.05.015" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B141-cancers-11-01889' class='html-xxx' data-content='141.'>Kéramidas, M.; De Fraipont, F.; Karageorgis, A.; Moisan, A.; Persoons, V.; Richard, M.J.; Coll, J.L.; Rome, C. The dual effect of mscs on tumour growth and tumour angiogenesis. <span class='html-italic'>Stem Cell Res. Ther.</span> <b>2013</b>, <span class='html-italic'>4</span>, 41. [<a href="https://scholar.google.com/scholar_lookup?title=The+dual+effect+of+mscs+on+tumour+growth+and+tumour+angiogenesis&author=K%C3%A9ramidas,+M.&author=De+Fraipont,+F.&author=Karageorgis,+A.&author=Moisan,+A.&author=Persoons,+V.&author=Richard,+M.J.&author=Coll,+J.L.&author=Rome,+C.&publication_year=2013&journal=Stem+Cell+Res.+Ther.&volume=4&pages=41&doi=10.1186/scrt195" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1186/scrt195" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://stemcellres.biomedcentral.com/track/pdf/10.1186/scrt195" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B142-cancers-11-01889' class='html-xxx' data-content='142.'>Josserand, V.; Texier-Nogues, I.; Huber, P.; Favrot, M.C.; Coll, J.L. Non-invasive in vivo optical imaging of the lacZ and luc gene expression in mice. <span class='html-italic'>Gene Ther.</span> <b>2007</b>, <span class='html-italic'>14</span>, 1587–1593. [<a href="https://scholar.google.com/scholar_lookup?title=Non-invasive+in+vivo+optical+imaging+of+the+lacZ+and+luc+gene+expression+in+mice&author=Josserand,+V.&author=Texier-Nogues,+I.&author=Huber,+P.&author=Favrot,+M.C.&author=Coll,+J.L.&publication_year=2007&journal=Gene+Ther.&volume=14&pages=1587%E2%80%931593&doi=10.1038/sj.gt.3303028&pmid=17882264" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/sj.gt.3303028" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/17882264" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B143-cancers-11-01889' class='html-xxx' data-content='143.'>Steel, J.C.; Morrison, B.J.; Mannan, P.; Abu-Asab, M.S.; Wildner, O.; Miles, B.K.; Yim, K.C.; Ramanan, V.; Prince, G.A.; Morris, J.C. Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus. <span class='html-italic'>Virology</span> <b>2007</b>, <span class='html-italic'>369</span>, 131–142. [<a href="https://scholar.google.com/scholar_lookup?title=Immunocompetent+syngeneic+cotton+rat+tumor+models+for+the+assessment+of+replication-competent+oncolytic+adenovirus&author=Steel,+J.C.&author=Morrison,+B.J.&author=Mannan,+P.&author=Abu-Asab,+M.S.&author=Wildner,+O.&author=Miles,+B.K.&author=Yim,+K.C.&author=Ramanan,+V.&author=Prince,+G.A.&author=Morris,+J.C.&publication_year=2007&journal=Virology&volume=369&pages=131%E2%80%93142&doi=10.1016/j.virol.2007.07.022&pmid=17727912" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.virol.2007.07.022" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/17727912" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="http://europepmc.org/articles/pmc2104792?pdf=render" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B144-cancers-11-01889' class='html-xxx' data-content='144.'>Kamensek, U.; Sersa, G.; Vidic, S.; Tevz, G.; Kranjc, S.; Cemazar, M. Irradiation, cisplatin, and 5-azacytidine upregulate cytomegalovirus promoter in tumors and muscles: Implementation of non-invasive fluorescence imaging. <span class='html-italic'>Mol. Imaging Biol.</span> <b>2011</b>, <span class='html-italic'>13</span>, 43–52. [<a href="https://scholar.google.com/scholar_lookup?title=Irradiation,+cisplatin,+and+5-azacytidine+upregulate+cytomegalovirus+promoter+in+tumors+and+muscles:+Implementation+of+non-invasive+fluorescence+imaging&author=Kamensek,+U.&author=Sersa,+G.&author=Vidic,+S.&author=Tevz,+G.&author=Kranjc,+S.&author=Cemazar,+M.&publication_year=2011&journal=Mol.+Imaging+Biol.&volume=13&pages=43%E2%80%9352&doi=10.1007/s11307-010-0300-6&pmid=20396957" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/s11307-010-0300-6" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20396957" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="https://link.springer.com/content/pdf/10.1007/s11307-010-0300-6.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B145-cancers-11-01889' class='html-xxx' data-content='145.'>Kamensek, U.; Sersa, G.; Cemazar, M. Evaluation of p21 promoter for interleukin 12 radiation induced transcriptional targeting in a mouse tumor model. <span class='html-italic'>Mol. Cancer</span> <b>2013</b>, <span class='html-italic'>12</span>, 136. [<a href="https://scholar.google.com/scholar_lookup?title=Evaluation+of+p21+promoter+for+interleukin+12+radiation+induced+transcriptional+targeting+in+a+mouse+tumor+model&author=Kamensek,+U.&author=Sersa,+G.&author=Cemazar,+M.&publication_year=2013&journal=Mol.+Cancer&volume=12&pages=136&doi=10.1186/1476-4598-12-136" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1186/1476-4598-12-136" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://molecular-cancer.biomedcentral.com/track/pdf/10.1186/1476-4598-12-136" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B146-cancers-11-01889' class='html-xxx' data-content='146.'>Bobrie, A.; Krumeich, S.; Reyal, F.; Recchi, C.; Moita, L.F.; Seabra, M.C.; Ostrowski, M.; Théry, C. Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. <span class='html-italic'>Cancer Res.</span> <b>2012</b>, <span class='html-italic'>72</span>, 4920–4930. [<a href="https://scholar.google.com/scholar_lookup?title=Rab27a+supports+exosome-dependent+and+-independent+mechanisms+that+modify+the+tumor+microenvironment+and+can+promote+tumor+progression&author=Bobrie,+A.&author=Krumeich,+S.&author=Reyal,+F.&author=Recchi,+C.&author=Moita,+L.F.&author=Seabra,+M.C.&author=Ostrowski,+M.&author=Th%C3%A9ry,+C.&publication_year=2012&journal=Cancer+Res.&volume=72&pages=4920%E2%80%934930&doi=10.1158/0008-5472.CAN-12-0925" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/0008-5472.CAN-12-0925" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B147-cancers-11-01889' class='html-xxx' data-content='147.'>Germano, G.; Lamba, S.; Rospo, G.; Barault, L.; Magri, A.; Maione, F.; Russo, M.; Crisafulli, G.; Bartolini, A.; Lerda, G.; et al. Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth. <span class='html-italic'>Nature</span> <b>2017</b>, <span class='html-italic'>552</span>, 1–5. [<a href="https://scholar.google.com/scholar_lookup?title=Inactivation+of+DNA+repair+triggers+neoantigen+generation+and+impairs+tumour+growth&author=Germano,+G.&author=Lamba,+S.&author=Rospo,+G.&author=Barault,+L.&author=Magri,+A.&author=Maione,+F.&author=Russo,+M.&author=Crisafulli,+G.&author=Bartolini,+A.&author=Lerda,+G.&publication_year=2017&journal=Nature&volume=552&pages=1%E2%80%935&doi=10.1038/nature24673" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/nature24673" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B148-cancers-11-01889' class='html-xxx' data-content='148.'>Cayeux, S.; Richter, G.; Becker, C.; Pezzutto, A.; Dörken, B.; Blankenstein, T. Direct and indirect T cell priming by dendritic cell vaccines. <span class='html-italic'>Eur. J. Immunol.</span> <b>1999</b>, <span class='html-italic'>29</span>, 225–234. [<a href="https://scholar.google.com/scholar_lookup?title=Direct+and+indirect+T+cell+priming+by+dendritic+cell+vaccines&author=Cayeux,+S.&author=Richter,+G.&author=Becker,+C.&author=Pezzutto,+A.&author=D%C3%B6rken,+B.&author=Blankenstein,+T.&publication_year=1999&journal=Eur.+J.+Immunol.&volume=29&pages=225%E2%80%93234&doi=10.1002/(SICI)1521-4141(199901)29:01%3C225::AID-IMMU225%3E3.0.CO;2-W" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/(SICI)1521-4141(199901)29:01<225::AID-IMMU225>3.0.CO;2-W" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B149-cancers-11-01889' class='html-xxx' data-content='149.'>Cayeux, S.; Qin, Z.; Dörken, B.; Blankenstein, T. Decreased generation of anti-tumor immunity after intrasplenic immunization. <span class='html-italic'>Eur. J. Immunol.</span> <b>2001</b>, <span class='html-italic'>31</span>, 1392–1399. [<a href="https://scholar.google.com/scholar_lookup?title=Decreased+generation+of+anti-tumor+immunity+after+intrasplenic+immunization&author=Cayeux,+S.&author=Qin,+Z.&author=D%C3%B6rken,+B.&author=Blankenstein,+T.&publication_year=2001&journal=Eur.+J.+Immunol.&volume=31&pages=1392%E2%80%931399&doi=10.1002/1521-4141(200105)31:5%3C1392::AID-IMMU1392%3E3.0.CO;2-W" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/1521-4141(200105)31:5<1392::AID-IMMU1392>3.0.CO;2-W" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B150-cancers-11-01889' class='html-xxx' data-content='150.'>Preiss, S.; Kammertoens, T.; Lampert, C.; Willimsky, G.; Blankenstein, T. Tumor-induced antibodies resemble the response to tissue damage. <span class='html-italic'>Int. J. Cancer</span> <b>2005</b>, <span class='html-italic'>115</span>, 456–462. [<a href="https://scholar.google.com/scholar_lookup?title=Tumor-induced+antibodies+resemble+the+response+to+tissue+damage&author=Preiss,+S.&author=Kammertoens,+T.&author=Lampert,+C.&author=Willimsky,+G.&author=Blankenstein,+T.&publication_year=2005&journal=Int.+J.+Cancer&volume=115&pages=456%E2%80%93462&doi=10.1002/ijc.20914" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/ijc.20914" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B151-cancers-11-01889' class='html-xxx' data-content='151.'>Dobrzanski, M.J.; Reome, J.B.; Hylind, J.C.; Rewers-Felkins, K.A. CD8-Mediated Type 1 Antitumor Responses Selectively Modulate Endogenous Differentiated and Nondifferentiated T Cell Localization, Activation, and Function in Progressive Breast Cancer. <span class='html-italic'>J. Immunol.</span> <b>2006</b>, <span class='html-italic'>177</span>, 8191–8201. [<a href="https://scholar.google.com/scholar_lookup?title=CD8-Mediated+Type+1+Antitumor+Responses+Selectively+Modulate+Endogenous+Differentiated+and+Nondifferentiated+T+Cell+Localization,+Activation,+and+Function+in+Progressive+Breast+Cancer&author=Dobrzanski,+M.J.&author=Reome,+J.B.&author=Hylind,+J.C.&author=Rewers-Felkins,+K.A.&publication_year=2006&journal=J.+Immunol.&volume=177&pages=8191%E2%80%938201&doi=10.4049/jimmunol.177.11.8191" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.4049/jimmunol.177.11.8191" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B152-cancers-11-01889' class='html-xxx' data-content='152.'>Dobrzanski, M.J.; Reome, J.B.; Hylind, J.C.; Rewers-Felkins, K.A.; Abdulsamad, K.; Adams, S.L. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10. <span class='html-italic'>Immunol. Investig.</span> <b>2008</b>, <span class='html-italic'>37</span>, 315–338. [<a href="https://scholar.google.com/scholar_lookup?title=Ag-specific+type+1+CD8+effector+cells+enhance+methotrexate-mediated+antitumor+responses+by+modulating+endogenous+CD49b-expressing+CD4+and+CD8+T+effector+cell+subpopulations+producing+IL-10&author=Dobrzanski,+M.J.&author=Reome,+J.B.&author=Hylind,+J.C.&author=Rewers-Felkins,+K.A.&author=Abdulsamad,+K.&author=Adams,+S.L.&publication_year=2008&journal=Immunol.+Investig.&volume=37&pages=315%E2%80%93338&doi=10.1080/08820130802083762&pmid=18569073" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1080/08820130802083762" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/18569073" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B153-cancers-11-01889' class='html-xxx' data-content='153.'>Benigni, F.; Zimmermann, V.S.; Hugues, S.; Caserta, S.; Basso, V.; Rivino, L.; Ingulli, E.; Malherbe, L.; Glaichenhaus, N.; Mondino, A. Phenotype and Homing of CD4 Tumor-Specific T Cells Is Modulated by Tumor Bulk. <span class='html-italic'>J. Immunol.</span> <b>2005</b>, <span class='html-italic'>175</span>, 739–748. [<a href="https://scholar.google.com/scholar_lookup?title=Phenotype+and+Homing+of+CD4+Tumor-Specific+T+Cells+Is+Modulated+by+Tumor+Bulk&author=Benigni,+F.&author=Zimmermann,+V.S.&author=Hugues,+S.&author=Caserta,+S.&author=Basso,+V.&author=Rivino,+L.&author=Ingulli,+E.&author=Malherbe,+L.&author=Glaichenhaus,+N.&author=Mondino,+A.&publication_year=2005&journal=J.+Immunol.&volume=175&pages=739%E2%80%93748&doi=10.4049/jimmunol.175.2.739&pmid=16002669" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.4049/jimmunol.175.2.739" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/16002669" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="http://www.jimmunol.org/content/jimmunol/175/2/739.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B154-cancers-11-01889' class='html-xxx' data-content='154.'>Zimmermann, V.S.; Casati, A.; Schiering, C.; Caserta, S.; Hess, M.R.; Basso, V.; Mondino, A. Tumors hamper the immunogenic competence of CD4+ T cell-directed dendritic cell vaccination. <span class='html-italic'>J. Immunol.</span> <b>2007</b>, <span class='html-italic'>179</span>, 2899–2909. [<a href="https://scholar.google.com/scholar_lookup?title=Tumors+hamper+the+immunogenic+competence+of+CD4++T+cell-directed+dendritic+cell+vaccination&author=Zimmermann,+V.S.&author=Casati,+A.&author=Schiering,+C.&author=Caserta,+S.&author=Hess,+M.R.&author=Basso,+V.&author=Mondino,+A.&publication_year=2007&journal=J.+Immunol.&volume=179&pages=2899%E2%80%932909&doi=10.4049/jimmunol.179.5.2899&pmid=17709504" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.4049/jimmunol.179.5.2899" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/17709504" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="http://www.jimmunol.org/content/179/5/2899.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B155-cancers-11-01889' class='html-xxx' data-content='155.'>Schiering, C.; Guarnerio, J.; Basso, V.; Muzio, L.; Mondino, A. Antigen-experienced CD4+ T cells limit naïve T-cell priming in response to therapeutic vaccination in vivo. <span class='html-italic'>Cancer Res.</span> <b>2010</b>, <span class='html-italic'>70</span>, 6161–6170. [<a href="https://scholar.google.com/scholar_lookup?title=Antigen-experienced+CD4++T+cells+limit+na%C3%AFve+T-cell+priming+in+response+to+therapeutic+vaccination+in+vivo&author=Schiering,+C.&author=Guarnerio,+J.&author=Basso,+V.&author=Muzio,+L.&author=Mondino,+A.&publication_year=2010&journal=Cancer+Res.&volume=70&pages=6161%E2%80%936170&doi=10.1158/0008-5472.CAN-09-4398" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/0008-5472.CAN-09-4398" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://cancerres.aacrjournals.org/content/70/15/6161.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B156-cancers-11-01889' class='html-xxx' data-content='156.'>Martino, A.; Vismara, D.; Cicconi, R.; Delpino, A.; Ivanyi, J.; Colizzi, V.; Cassol, M.; Fraziano, M.; Piselli, P. Effective anti-tumor immunity induced in mice by a two-step vaccination protocol. <span class='html-italic'>In Vivo</span> <b>2001</b>, <span class='html-italic'>15</span>, 425–428. [<a href="https://scholar.google.com/scholar_lookup?title=Effective+anti-tumor+immunity+induced+in+mice+by+a+two-step+vaccination+protocol&author=Martino,+A.&author=Vismara,+D.&author=Cicconi,+R.&author=Delpino,+A.&author=Ivanyi,+J.&author=Colizzi,+V.&author=Cassol,+M.&author=Fraziano,+M.&author=Piselli,+P.&publication_year=2001&journal=In+Vivo&volume=15&pages=425%E2%80%93428" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B157-cancers-11-01889' class='html-xxx' data-content='157.'>Li, Z.; Pradera, F.; Kammertoens, T.; Li, B.; Liu, S.; Qin, Z. Cross-Talk between T Cells and Innate Immune Cells Is Crucial for IFN-γ-Dependent Tumor Rejection. <span class='html-italic'>J. Immunol.</span> <b>2007</b>, <span class='html-italic'>179</span>, 1568–1576. [<a href="https://scholar.google.com/scholar_lookup?title=Cross-Talk+between+T+Cells+and+Innate+Immune+Cells+Is+Crucial+for+IFN-%CE%B3-Dependent+Tumor+Rejection&author=Li,+Z.&author=Pradera,+F.&author=Kammertoens,+T.&author=Li,+B.&author=Liu,+S.&author=Qin,+Z.&publication_year=2007&journal=J.+Immunol.&volume=179&pages=1568%E2%80%931576&doi=10.4049/jimmunol.179.3.1568" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.4049/jimmunol.179.3.1568" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.jimmunol.org/content/179/3/1568.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B158-cancers-11-01889' class='html-xxx' data-content='158.'>Ghiringhelli, F.; Apetoh, L.; Tesniere, A.; Aymeric, L.; Ma, Y.; Ortiz, C.; Vermaelen, K.; Panaretakis, T.; Mignot, G.; Ullrich, E.; et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1Β-dependent adaptive immunity against tumors. <span class='html-italic'>Nat. Med.</span> <b>2009</b>, <span class='html-italic'>15</span>, 1170–1178. [<a href="https://scholar.google.com/scholar_lookup?title=Activation+of+the+NLRP3+inflammasome+in+dendritic+cells+induces+IL-1%CE%92-dependent+adaptive+immunity+against+tumors&author=Ghiringhelli,+F.&author=Apetoh,+L.&author=Tesniere,+A.&author=Aymeric,+L.&author=Ma,+Y.&author=Ortiz,+C.&author=Vermaelen,+K.&author=Panaretakis,+T.&author=Mignot,+G.&author=Ullrich,+E.&publication_year=2009&journal=Nat.+Med.&volume=15&pages=1170%E2%80%931178&doi=10.1038/nm.2028" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/nm.2028" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B159-cancers-11-01889' class='html-xxx' data-content='159.'>Colombo, B.; Curnis, F.; Foglieni, C.; Monno, A.; Arrigoni, G.; Corti, A. Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models. <span class='html-italic'>Cancer Res.</span> <b>2002</b>, <span class='html-italic'>62</span>, 941–946. [<a href="https://scholar.google.com/scholar_lookup?title=Chromogranin+A+expression+in+neoplastic+cells+affects+tumor+growth+and+morphogenesis+in+mouse+models&author=Colombo,+B.&author=Curnis,+F.&author=Foglieni,+C.&author=Monno,+A.&author=Arrigoni,+G.&author=Corti,+A.&publication_year=2002&journal=Cancer+Res.&volume=62&pages=941%E2%80%93946" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B160-cancers-11-01889' class='html-xxx' data-content='160.'>Malosio, M.L.; Giordano, T.; Laslop, A.; Meldolesi, J. Dense-core granules: A specific hallmark of the neuronal/neurosecretory cell phenotype. <span class='html-italic'>J. Cell Sci.</span> <b>2004</b>, <span class='html-italic'>117</span>, 743–749. [<a href="https://scholar.google.com/scholar_lookup?title=Dense-core+granules:+A+specific+hallmark+of+the+neuronal/neurosecretory+cell+phenotype&author=Malosio,+M.L.&author=Giordano,+T.&author=Laslop,+A.&author=Meldolesi,+J.&publication_year=2004&journal=J.+Cell+Sci.&volume=117&pages=743%E2%80%93749&doi=10.1242/jcs.00934" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1242/jcs.00934" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://jcs.biologists.org/content/joces/117/5/743.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B161-cancers-11-01889' class='html-xxx' data-content='161.'>Veschini, L.; Crippa, L.; Dondossola, E.; Doglioni, C.; Corti, A.; Ferrero, E. The vasostatin-1 fragment of chromogranin A preserves a quiescent phenotype in hypoxia-driven endothelial cells and regulates tumor neovascularization. <span class='html-italic'>FASEB J.</span> <b>2011</b>, <span class='html-italic'>25</span>, 3906–3914. [<a href="https://scholar.google.com/scholar_lookup?title=The+vasostatin-1+fragment+of+chromogranin+A+preserves+a+quiescent+phenotype+in+hypoxia-driven+endothelial+cells+and+regulates+tumor+neovascularization&author=Veschini,+L.&author=Crippa,+L.&author=Dondossola,+E.&author=Doglioni,+C.&author=Corti,+A.&author=Ferrero,+E.&publication_year=2011&journal=FASEB+J.&volume=25&pages=3906%E2%80%933914&doi=10.1096/fj.11-182410" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1096/fj.11-182410" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B162-cancers-11-01889' class='html-xxx' data-content='162.'>Melani, C.; Stoppacciaro, A.; Foroni, C.; Felicetti, F.; Caré, A.; Colombo, M.P. Angiopoietin decoy secreted at tumor site impairs tumor growth and metastases by inducing local inflammation and altering neoangiogenesis. <span class='html-italic'>Cancer Immunol. Immunother.</span> <b>2004</b>, <span class='html-italic'>53</span>, 600–608. [<a href="https://scholar.google.com/scholar_lookup?title=Angiopoietin+decoy+secreted+at+tumor+site+impairs+tumor+growth+and+metastases+by+inducing+local+inflammation+and+altering+neoangiogenesis&author=Melani,+C.&author=Stoppacciaro,+A.&author=Foroni,+C.&author=Felicetti,+F.&author=Car%C3%A9,+A.&author=Colombo,+M.P.&publication_year=2004&journal=Cancer+Immunol.+Immunother.&volume=53&pages=600%E2%80%93608&doi=10.1007/s00262-004-0500-5&pmid=14985859" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/s00262-004-0500-5" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/14985859" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B163-cancers-11-01889' class='html-xxx' data-content='163.'>Sorli, S.C.; Le Gonidec, S.; Knibiehler, B.; Audigier, Y. Apelin is a potent activator of tumour neoangiogenesis. <span class='html-italic'>Oncogene</span> <b>2007</b>, <span class='html-italic'>26</span>, 7692–7699. [<a href="https://scholar.google.com/scholar_lookup?title=Apelin+is+a+potent+activator+of+tumour+neoangiogenesis&author=Sorli,+S.C.&author=Le+Gonidec,+S.&author=Knibiehler,+B.&author=Audigier,+Y.&publication_year=2007&journal=Oncogene&volume=26&pages=7692%E2%80%937699&doi=10.1038/sj.onc.1210573&pmid=17563744" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/sj.onc.1210573" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/17563744" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="https://www.nature.com/articles/1210573.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B164-cancers-11-01889' class='html-xxx' data-content='164.'>Marionneau, S.; Ruvoën, N.; Le MoullacVaidye, B.; Clement, M.; CailleauThomas, A.; RuizPalacois, G.; Huang, P.; Jiang, X.; Le Pendu, J. Norwalk Virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. <span class='html-italic'>Gastroenterology</span> <b>2002</b>, <span class='html-italic'>122</span>, 1967–1977. [<a href="https://scholar.google.com/scholar_lookup?title=Norwalk+Virus+binds+to+histo-blood+group+antigens+present+on+gastroduodenal+epithelial+cells+of+secretor+individuals&author=Marionneau,+S.&author=Ruvo%C3%ABn,+N.&author=Le+MoullacVaidye,+B.&author=Clement,+M.&author=CailleauThomas,+A.&author=RuizPalacois,+G.&author=Huang,+P.&author=Jiang,+X.&author=Le+Pendu,+J.&publication_year=2002&journal=Gastroenterology&volume=122&pages=1967%E2%80%931977&doi=10.1053/gast.2002.33661&pmid=12055602" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1053/gast.2002.33661" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/12055602" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B165-cancers-11-01889' class='html-xxx' data-content='165.'>Zavaglia, D.; Favrot, M.C.; Eymin, B.; Tenaud, C.; Coll, J.L. Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein. <span class='html-italic'>Gene Ther.</span> <b>2003</b>, <span class='html-italic'>10</span>, 314–325. [<a href="https://scholar.google.com/scholar_lookup?title=Intercellular+trafficking+and+enhanced+in+vivo+antitumour+activity+of+a+non-virally+delivered+P27-VP22+fusion+protein&author=Zavaglia,+D.&author=Favrot,+M.C.&author=Eymin,+B.&author=Tenaud,+C.&author=Coll,+J.L.&publication_year=2003&journal=Gene+Ther.&volume=10&pages=314%E2%80%93325&doi=10.1038/sj.gt.3301904&pmid=12595890" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/sj.gt.3301904" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/12595890" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B166-cancers-11-01889' class='html-xxx' data-content='166.'>Zitvogel, L.; Pitt, J.M.; Daillere, R.; Smyth, M.J.; Kroemer, G. Mouse models in oncoimmunology. <span class='html-italic'>Nat. Rev. Cancer</span> <b>2016</b>, <span class='html-italic'>16</span>, 759–773. [<a href="https://scholar.google.com/scholar_lookup?title=Mouse+models+in+oncoimmunology&author=Zitvogel,+L.&author=Pitt,+J.M.&author=Daillere,+R.&author=Smyth,+M.J.&author=Kroemer,+G.&publication_year=2016&journal=Nat.+Rev.+Cancer&volume=16&pages=759%E2%80%93773&doi=10.1038/nrc.2016.91" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/nrc.2016.91" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B167-cancers-11-01889' class='html-xxx' data-content='167.'>Dexter, D.L.; Kowalski, H.M.; Blazar, B.A.; Fligiel, Z.; Vogel, R.; Gloria, H.; Heppner, H. Heterogeneity of Tumor Cells from a Single Mouse Mammary Tumor. <span class='html-italic'>Cancer Res.</span> <b>1978</b>, <span class='html-italic'>38</span>, 3174–3181. [<a href="https://scholar.google.com/scholar_lookup?title=Heterogeneity+of+Tumor+Cells+from+a+Single+Mouse+Mammary+Tumor&author=Dexter,+D.L.&author=Kowalski,+H.M.&author=Blazar,+B.A.&author=Fligiel,+Z.&author=Vogel,+R.&author=Gloria,+H.&author=Heppner,+H.&publication_year=1978&journal=Cancer+Res.&volume=38&pages=3174%E2%80%933181" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B168-cancers-11-01889' class='html-xxx' data-content='168.'>Heppner, G.H.; Dexter, D.L.; DeNucci, T.; Miller, F.R.; Calabresi, P. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor. <span class='html-italic'>Cancer Res.</span> <b>1978</b>, <span class='html-italic'>38</span>, 3758–3763. [<a href="https://scholar.google.com/scholar_lookup?title=Heterogeneity+in+drug+sensitivity+among+tumor+cell+subpopulations+of+a+single+mammary+tumor&author=Heppner,+G.H.&author=Dexter,+D.L.&author=DeNucci,+T.&author=Miller,+F.R.&author=Calabresi,+P.&publication_year=1978&journal=Cancer+Res.&volume=38&pages=3758%E2%80%933763" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B169-cancers-11-01889' class='html-xxx' data-content='169.'>Aslakson, C.J.; Miller, F.R. Selective Events in the Metastatic Process Defined by Analysis of the Sequential Dissemination of Subpopulations of a Mouse Mammary Tumor. <span class='html-italic'>Cancer Res.</span> <b>1992</b>, <span class='html-italic'>52</span>, 1399–1405. [<a href="https://scholar.google.com/scholar_lookup?title=Selective+Events+in+the+Metastatic+Process+Defined+by+Analysis+of+the+Sequential+Dissemination+of+Subpopulations+of+a+Mouse+Mammary+Tumor&author=Aslakson,+C.J.&author=Miller,+F.R.&publication_year=1992&journal=Cancer+Res.&volume=52&pages=1399%E2%80%931405" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>]</li><li id='B170-cancers-11-01889' class='html-xxx' data-content='170.'>Yoneda, T.; Michigami, T.; Yi, B.; Williams, P.J.; Niewolna, M.; Hiraga, T. Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma. <span class='html-italic'>Cancer</span> <b>2000</b>, <span class='html-italic'>88</span>, 2979–2988. [<a href="https://scholar.google.com/scholar_lookup?title=Actions+of+bisphosphonate+on+bone+metastasis+in+animal+models+of+breast+carcinoma&author=Yoneda,+T.&author=Michigami,+T.&author=Yi,+B.&author=Williams,+P.J.&author=Niewolna,+M.&author=Hiraga,+T.&publication_year=2000&journal=Cancer&volume=88&pages=2979%E2%80%932988&doi=10.1002/1097-0142(20000615)88:12+%3C2979::AID-CNCR13%3E3.0.CO;2-U" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/1097-0142(20000615)88:12+<2979::AID-CNCR13>3.0.CO;2-U" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B171-cancers-11-01889' class='html-xxx' data-content='171.'>Guy, C.T.; Webster, M.A.; Schaller, M.; Parsons, T.J.; Cardiff, R.D.; Muller, W.J. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. <span class='html-italic'>Proc. Natl. Acad. Sci. USA</span> <b>1992</b>, <span class='html-italic'>89</span>, 10578–10582. [<a href="https://scholar.google.com/scholar_lookup?title=Expression+of+the+neu+protooncogene+in+the+mammary+epithelium+of+transgenic+mice+induces+metastatic+disease&author=Guy,+C.T.&author=Webster,+M.A.&author=Schaller,+M.&author=Parsons,+T.J.&author=Cardiff,+R.D.&author=Muller,+W.J.&publication_year=1992&journal=Proc.+Natl.+Acad.+Sci.+USA&volume=89&pages=10578%E2%80%9310582&doi=10.1073/pnas.89.22.10578" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1073/pnas.89.22.10578" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.pnas.org/content/89/22/10578.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B172-cancers-11-01889' class='html-xxx' data-content='172.'>Lollini, P.L.; De Giovanni, C.; Nanni, P. Preclinical HER-2 vaccines: From rodent to human HER-2. <span class='html-italic'>Front. Oncol.</span> <b>2013</b>, <span class='html-italic'>3</span>, 151. [<a href="https://scholar.google.com/scholar_lookup?title=Preclinical+HER-2+vaccines:+From+rodent+to+human+HER-2&author=Lollini,+P.L.&author=De+Giovanni,+C.&author=Nanni,+P.&publication_year=2013&journal=Front.+Oncol.&volume=3&pages=151&doi=10.3389/fonc.2013.00151" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.3389/fonc.2013.00151" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://core.ac.uk/download/pdf/82863835.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B173-cancers-11-01889' class='html-xxx' data-content='173.'>Lollini, P.L.; Cavallo, F.; Nanni, P.; Forni, G. Vaccines for tumour prevention. <span class='html-italic'>Nat. Rev. Cancer</span> <b>2006</b>, <span class='html-italic'>6</span>, 204–216. [<a href="https://scholar.google.com/scholar_lookup?title=Vaccines+for+tumour+prevention&author=Lollini,+P.L.&author=Cavallo,+F.&author=Nanni,+P.&author=Forni,+G.&publication_year=2006&journal=Nat.+Rev.+Cancer&volume=6&pages=204%E2%80%93216&doi=10.1038/nrc1815" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/nrc1815" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B174-cancers-11-01889' class='html-xxx' data-content='174.'>Sørlie, T.; Perou, C.M.; Tibshirani, R.; Aas, T.; Geisler, S.; Johnsen, H.; Hastie, T.; Eisen, M.B.; Van De Rijn, M.; Jeffrey, S.S.; et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. <span class='html-italic'>Proc. Natl. Acad. Sci. USA</span> <b>2001</b>, <span class='html-italic'>98</span>, 10869–10874. [<a href="https://scholar.google.com/scholar_lookup?title=Gene+expression+patterns+of+breast+carcinomas+distinguish+tumor+subclasses+with+clinical+implications&author=S%C3%B8rlie,+T.&author=Perou,+C.M.&author=Tibshirani,+R.&author=Aas,+T.&author=Geisler,+S.&author=Johnsen,+H.&author=Hastie,+T.&author=Eisen,+M.B.&author=Van+De+Rijn,+M.&author=Jeffrey,+S.S.&publication_year=2001&journal=Proc.+Natl.+Acad.+Sci.+USA&volume=98&pages=10869%E2%80%9310874&doi=10.1073/pnas.191367098" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1073/pnas.191367098" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.pnas.org/content/98/19/10869.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B175-cancers-11-01889' class='html-xxx' data-content='175.'>Russnes, H.G.; Lingjærde, O.C.; Børresen-Dale, A.L.; Caldas, C. Breast Cancer Molecular Stratification: From Intrinsic Subtypes to Integrative Clusters. <span class='html-italic'>Am. J. Pathol.</span> <b>2017</b>, <span class='html-italic'>187</span>, 2152–2162. [<a href="https://scholar.google.com/scholar_lookup?title=Breast+Cancer+Molecular+Stratification:+From+Intrinsic+Subtypes+to+Integrative+Clusters&author=Russnes,+H.G.&author=Lingj%C3%A6rde,+O.C.&author=B%C3%B8rresen-Dale,+A.L.&author=Caldas,+C.&publication_year=2017&journal=Am.+J.+Pathol.&volume=187&pages=2152%E2%80%932162&doi=10.1016/j.ajpath.2017.04.022" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.ajpath.2017.04.022" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B176-cancers-11-01889' class='html-xxx' data-content='176.'>Dobrolecki, L.E.; Airhart, S.D.; Alferez, D.G.; Aparicio, S.; Behbod, F.; Bentires-Alj, M.; Brisken, C.; Bult, C.J.; Cai, S.; Clarke, R.B.; et al. Patient-derived xenograft (PDX) models in basic and translational breast cancer research. <span class='html-italic'>Cancer Metastasis Rev.</span> <b>2016</b>, <span class='html-italic'>35</span>, 547–573. [<a href="https://scholar.google.com/scholar_lookup?title=Patient-derived+xenograft+(PDX)+models+in+basic+and+translational+breast+cancer+research&author=Dobrolecki,+L.E.&author=Airhart,+S.D.&author=Alferez,+D.G.&author=Aparicio,+S.&author=Behbod,+F.&author=Bentires-Alj,+M.&author=Brisken,+C.&author=Bult,+C.J.&author=Cai,+S.&author=Clarke,+R.B.&publication_year=2016&journal=Cancer+Metastasis+Rev.&volume=35&pages=547%E2%80%93573&doi=10.1007/s10555-016-9653-x" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/s10555-016-9653-x" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://europepmc.org/articles/pmc5396460?pdf=render" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B177-cancers-11-01889' class='html-xxx' data-content='177.'>Baker, K. Organoids provide an important window on inflammation in cancer. <span class='html-italic'>Cancers</span> <b>2018</b>, <span class='html-italic'>10</span>, 151. [<a href="https://scholar.google.com/scholar_lookup?title=Organoids+provide+an+important+window+on+inflammation+in+cancer&author=Baker,+K.&publication_year=2018&journal=Cancers&volume=10&pages=151&doi=10.3390/cancers10050151" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.3390/cancers10050151" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://www.mdpi.com/2072-6694/10/5/151/pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B178-cancers-11-01889' class='html-xxx' data-content='178.'>Sachs, N.; de Ligt, J.; Kopper, O.; Gogola, E.; Bounova, G.; Weeber, F.; Balgobind, A.V.; Wind, K.; Gracanin, A.; Begthel, H.; et al. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity. <span class='html-italic'>Cell</span> <b>2018</b>, <span class='html-italic'>172</span>, 373–386. [<a href="https://scholar.google.com/scholar_lookup?title=A+Living+Biobank+of+Breast+Cancer+Organoids+Captures+Disease+Heterogeneity&author=Sachs,+N.&author=de+Ligt,+J.&author=Kopper,+O.&author=Gogola,+E.&author=Bounova,+G.&author=Weeber,+F.&author=Balgobind,+A.V.&author=Wind,+K.&author=Gracanin,+A.&author=Begthel,+H.&publication_year=2018&journal=Cell&volume=172&pages=373%E2%80%93386&doi=10.1016/j.cell.2017.11.010" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.cell.2017.11.010" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.cell.com/article/S0092867417313193/pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B179-cancers-11-01889' class='html-xxx' data-content='179.'>Tuveson, D.; Clevers, H. Cancer modeling meets human organoid technology. <span class='html-italic'>Science</span> <b>2019</b>, <span class='html-italic'>364</span>, 952–955. [<a href="https://scholar.google.com/scholar_lookup?title=Cancer+modeling+meets+human+organoid+technology&author=Tuveson,+D.&author=Clevers,+H.&publication_year=2019&journal=Science&volume=364&pages=952%E2%80%93955&doi=10.1126/science.aaw6985" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1126/science.aaw6985" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B180-cancers-11-01889' class='html-xxx' data-content='180.'>Du Manoir, S.; Orsetti, B.; Bras-Gonçalves, R.; Nguyen, T.T.; Lasorsa, L.; Boissière, F.; Massemin, B.; Colombo, P.E.; Bibeau, F.; Jacot, W.; et al. Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse. <span class='html-italic'>Mol. Oncol.</span> <b>2014</b>, <span class='html-italic'>8</span>, 431–443. [<a href="https://scholar.google.com/scholar_lookup?title=Breast+tumor+PDXs+are+genetically+plastic+and+correspond+to+a+subset+of+aggressive+cancers+prone+to+relapse&author=Du+Manoir,+S.&author=Orsetti,+B.&author=Bras-Gon%C3%A7alves,+R.&author=Nguyen,+T.T.&author=Lasorsa,+L.&author=Boissi%C3%A8re,+F.&author=Massemin,+B.&author=Colombo,+P.E.&author=Bibeau,+F.&author=Jacot,+W.&publication_year=2014&journal=Mol.+Oncol.&volume=8&pages=431%E2%80%93443&doi=10.1016/j.molonc.2013.11.010" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.molonc.2013.11.010" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B181-cancers-11-01889' class='html-xxx' data-content='181.'>Dijkstra, K.K.; Cattaneo, C.M.; Weeber, F.; Chalabi, M.; van de Haar, J.; Fanchi, L.F.; Slagter, M.; van der Velden, D.L.; Kaing, S.; Kelderman, S.; et al. Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids. <span class='html-italic'>Cell</span> <b>2018</b>, <span class='html-italic'>174</span>, 1586–1598. [<a href="https://scholar.google.com/scholar_lookup?title=Generation+of+Tumor-Reactive+T+Cells+by+Co-culture+of+Peripheral+Blood+Lymphocytes+and+Tumor+Organoids&author=Dijkstra,+K.K.&author=Cattaneo,+C.M.&author=Weeber,+F.&author=Chalabi,+M.&author=van+de+Haar,+J.&author=Fanchi,+L.F.&author=Slagter,+M.&author=van+der+Velden,+D.L.&author=Kaing,+S.&author=Kelderman,+S.&publication_year=2018&journal=Cell&volume=174&pages=1586%E2%80%931598&doi=10.1016/j.cell.2018.07.009" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.cell.2018.07.009" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.cell.com/article/S0092867418309036/pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B182-cancers-11-01889' class='html-xxx' data-content='182.'>Neal, J.T.; Li, X.; Zhu, J.; Giangarra, V.; Grzeskowiak, C.L.; Ju, J.; Liu, I.H.; Chiou, S.H.; Salahudeen, A.A.; Smith, A.R.; et al. Organoid Modeling of the Tumor Immune Microenvironment. <span class='html-italic'>Cell</span> <b>2018</b>, <span class='html-italic'>175</span>, 1972–1988. [<a href="https://scholar.google.com/scholar_lookup?title=Organoid+Modeling+of+the+Tumor+Immune+Microenvironment&author=Neal,+J.T.&author=Li,+X.&author=Zhu,+J.&author=Giangarra,+V.&author=Grzeskowiak,+C.L.&author=Ju,+J.&author=Liu,+I.H.&author=Chiou,+S.H.&author=Salahudeen,+A.A.&author=Smith,+A.R.&publication_year=2018&journal=Cell&volume=175&pages=1972%E2%80%931988&doi=10.1016/j.cell.2018.11.021" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.cell.2018.11.021" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.cell.com/article/S0092867418315137/pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B183-cancers-11-01889' class='html-xxx' data-content='183.'>Hu, J.; Sun, C.; Bernatchez, C.; Xia, X.; Hwu, P.; Dotti, G.; Li, S. T-cell homing therapy for reducing regulatory T cells and preserving effector T-cell function in large solid tumors. <span class='html-italic'>Clin. Cancer Res.</span> <b>2018</b>, <span class='html-italic'>24</span>, 2920–2934. [<a href="https://scholar.google.com/scholar_lookup?title=T-cell+homing+therapy+for+reducing+regulatory+T+cells+and+preserving+effector+T-cell+function+in+large+solid+tumors&author=Hu,+J.&author=Sun,+C.&author=Bernatchez,+C.&author=Xia,+X.&author=Hwu,+P.&author=Dotti,+G.&author=Li,+S.&publication_year=2018&journal=Clin.+Cancer+Res.&volume=24&pages=2920%E2%80%932934&doi=10.1158/1078-0432.CCR-17-1365" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/1078-0432.CCR-17-1365" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://clincancerres.aacrjournals.org/content/clincanres/24/12/2920.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li></ol></section><section id='FiguresandTables' type='display-objects'><div class="html-fig-wrap" id="cancers-11-01889-f001"> <div class='html-fig_img'> <div class="html-figpopup html-figpopup-link" data-counterslinkmanual = "https://www.mdpi.com/2072-6694/11/12/1889/display" href="#fig_body_display_cancers-11-01889-f001"> <img alt="Cancers 11 01889 g001 550" data-large="/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g001.png" data-original="/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g001.png" data-lsrc="/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g001-550.jpg" /> <a class="html-expand html-figpopup" data-counterslinkmanual = "https://www.mdpi.com/2072-6694/11/12/1889/display" href="#fig_body_display_cancers-11-01889-f001"></a> </div> </div> <div class="html-fig_description"> <b>Figure 1.</b> Origin of the TS/A cell line and variants. For pictures see [<a href="#B51-cancers-11-01889" class="html-bibr">51</a>]. <!-- <p><a class="html-figpopup" href="#fig_body_display_cancers-11-01889-f001"> Click here to enlarge figure </a></p> --> </div> </div> <div class="html-fig_show mfp-hide" id ="fig_body_display_cancers-11-01889-f001" > <div class="html-caption" > <b>Figure 1.</b> Origin of the TS/A cell line and variants. For pictures see [<a href="#B51-cancers-11-01889" class="html-bibr">51</a>].</div> <div class="html-img"><img alt="Cancers 11 01889 g001" data-large="/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g001.png" data-original="/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g001.png" data-lsrc="/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g001.png" /></div> </div><div class="html-fig-wrap" id="cancers-11-01889-f002"> <div class='html-fig_img'> <div class="html-figpopup html-figpopup-link" data-counterslinkmanual = "https://www.mdpi.com/2072-6694/11/12/1889/display" href="#fig_body_display_cancers-11-01889-f002"> <img alt="Cancers 11 01889 g002 550" data-large="/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g002.png" data-original="/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g002.png" data-lsrc="/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g002-550.jpg" /> <a class="html-expand html-figpopup" data-counterslinkmanual = "https://www.mdpi.com/2072-6694/11/12/1889/display" href="#fig_body_display_cancers-11-01889-f002"></a> </div> </div> <div class="html-fig_description"> <b>Figure 2.</b> Morphology of the TS/A cell line in adherent culture (phase contrast, ×100). <!-- <p><a class="html-figpopup" href="#fig_body_display_cancers-11-01889-f002"> Click here to enlarge figure </a></p> --> </div> </div> <div class="html-fig_show mfp-hide" id ="fig_body_display_cancers-11-01889-f002" > <div class="html-caption" > <b>Figure 2.</b> Morphology of the TS/A cell line in adherent culture (phase contrast, ×100).</div> <div class="html-img"><img alt="Cancers 11 01889 g002" data-large="/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g002.png" data-original="/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g002.png" data-lsrc="/cancers/cancers-11-01889/article_deploy/html/images/cancers-11-01889-g002.png" /></div> </div><div class="html-table-wrap" id="cancers-11-01889-t001"> <div class="html-table_wrap_td" > <div class="html-tablepopup html-tablepopup-link" data-counterslinkmanual = "https://www.mdpi.com/2072-6694/11/12/1889/display" href='#table_body_display_cancers-11-01889-t001'> <img alt="Table" data-lsrc="https://www.mdpi.com/img/table.png" /> <a class="html-expand html-tablepopup" data-counterslinkmanual = "https://www.mdpi.com/2072-6694/11/12/1889/display" href="#table_body_display_cancers-11-01889-t001"></a> </div> </div> <div class="html-table_wrap_discription"> <b>Table 1.</b> TS/A model: main features. </div> </div> <div class="html-table_show mfp-hide " id ="table_body_display_cancers-11-01889-t001" > <div class="html-caption" ><b>Table 1.</b> TS/A model: main features.</div> <table > <thead ><tr ><th align='left' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-left' >Topics</th><th align='left' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-left' >Cell Variants</th><th align='left' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-left' >Features</th><th align='left' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-left' >Refs</th></tr></thead><tbody ><tr ><td align='left' valign='middle' class='html-align-left' >Cytoskeletal markers</td><td align='left' valign='middle' class='html-align-left' >E1</td><td align='left' valign='middle' class='html-align-left' >CK8-positive</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B13-cancers-11-01889" class="html-bibr">13</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Cytokine production </td><td align='left' valign='middle' class='html-align-left' >TS/A, clones and variants</td><td align='left' valign='middle' class='html-align-left' >CSF</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B14-cancers-11-01889" class="html-bibr">14</a>,<a href="#B15-cancers-11-01889" class="html-bibr">15</a>,<a href="#B16-cancers-11-01889" class="html-bibr">16</a>,<a href="#B17-cancers-11-01889" class="html-bibr">17</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >TGF-β1 production (about 4 ng/mL)</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B18-cancers-11-01889" class="html-bibr">18</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Cytokine receptors</td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >IFN-γ receptor (1000/cell)</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B19-cancers-11-01889" class="html-bibr">19</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Gene alterations</td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >Karyotype</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B20-cancers-11-01889" class="html-bibr">20</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >TS/A and E1</td><td align='left' valign='middle' class='html-align-left' >p53 mutated (codon 270 Arg to His)</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B13-cancers-11-01889" class="html-bibr">13</a>,<a href="#B21-cancers-11-01889" class="html-bibr">21</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Gene expression</td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >TERT (11,000 RNA copies)</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B22-cancers-11-01889" class="html-bibr">22</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Hormone sensitivity</td><td align='left' valign='middle' class='html-align-left' >TS/A and E1</td><td align='left' valign='middle' class='html-align-left' >Estrogen receptor positive</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B10-cancers-11-01889" class="html-bibr">10</a>,<a href="#B13-cancers-11-01889" class="html-bibr">13</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Immunity</td><td align='left' valign='middle' class='html-align-left' >TS/A </td><td align='left' valign='middle' class='html-align-left' >Low immunogenicity</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B10-cancers-11-01889" class="html-bibr">10</a>,<a href="#B23-cancers-11-01889" class="html-bibr">23</a>,<a href="#B24-cancers-11-01889" class="html-bibr">24</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >TS/A and engineered variants</td><td align='left' valign='middle' class='html-align-left' >Tumor associated antigen gp70env</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B25-cancers-11-01889" class="html-bibr">25</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >TS/A </td><td align='left' valign='middle' class='html-align-left' >Suppressor activity</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B26-cancers-11-01889" class="html-bibr">26</a>,<a href="#B27-cancers-11-01889" class="html-bibr">27</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >Myeloid-derived suppressor cells (MDSC)</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B28-cancers-11-01889" class="html-bibr">28</a>,<a href="#B29-cancers-11-01889" class="html-bibr">29</a>,<a href="#B30-cancers-11-01889" class="html-bibr">30</a>,<a href="#B31-cancers-11-01889" class="html-bibr">31</a>,<a href="#B32-cancers-11-01889" class="html-bibr">32</a>,<a href="#B33-cancers-11-01889" class="html-bibr">33</a>,<a href="#B34-cancers-11-01889" class="html-bibr">34</a>,<a href="#B35-cancers-11-01889" class="html-bibr">35</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >NK resistance</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B36-cancers-11-01889" class="html-bibr">36</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >mD52 antigen</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B37-cancers-11-01889" class="html-bibr">37</a>] </td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Membrane molecules</td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >Core 1 O-glycans</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B38-cancers-11-01889" class="html-bibr">38</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >Muc-1</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B39-cancers-11-01889" class="html-bibr">39</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >Tag72</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B39-cancers-11-01889" class="html-bibr">39</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Phenotype</td><td align='left' valign='middle' class='html-align-left' >TS/A, clones and variants</td><td align='left' valign='middle' class='html-align-left' >Heterogeneity (morphology, metastasis)</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B10-cancers-11-01889" class="html-bibr">10</a>,<a href="#B40-cancers-11-01889" class="html-bibr">40</a>,<a href="#B41-cancers-11-01889" class="html-bibr">41</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Stem cell markers</td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >Sca-1 (Ly6A/E)</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B42-cancers-11-01889" class="html-bibr">42</a>,<a href="#B43-cancers-11-01889" class="html-bibr">43</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Tyrosine Kinase membrane receptors</td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >p185erbB2</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B39-cancers-11-01889" class="html-bibr">39</a>,<a href="#B44-cancers-11-01889" class="html-bibr">44</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Others</td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >Endoglin-negative</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B45-cancers-11-01889" class="html-bibr">45</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >Fragile X mental retardation protein (FMRP), low expression</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B46-cancers-11-01889" class="html-bibr">46</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >High Mobility Group Box1 (HMGB1)-positive</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B47-cancers-11-01889" class="html-bibr">47</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >Lats2</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B48-cancers-11-01889" class="html-bibr">48</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >TS/A</td><td align='left' valign='middle' class='html-align-left' >ST6Gal activity (present, low)</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B49-cancers-11-01889" class="html-bibr">49</a>]</td></tr><tr ><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' > </td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >TS/A</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >TLR9-negative</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >[<a href="#B50-cancers-11-01889" class="html-bibr">50</a>]</td></tr></tbody> </table> </div><div class="html-table-wrap" id="cancers-11-01889-t002"> <div class="html-table_wrap_td" > <div class="html-tablepopup html-tablepopup-link" data-counterslinkmanual = "https://www.mdpi.com/2072-6694/11/12/1889/display" href='#table_body_display_cancers-11-01889-t002'> <img alt="Table" data-lsrc="https://www.mdpi.com/img/table.png" /> <a class="html-expand html-tablepopup" data-counterslinkmanual = "https://www.mdpi.com/2072-6694/11/12/1889/display" href="#table_body_display_cancers-11-01889-t002"></a> </div> </div> <div class="html-table_wrap_discription"> <b>Table 2.</b> TS/A in gene therapy studies aiming to increase tumor immunogenicity. </div> </div> <div class="html-table_show mfp-hide " id ="table_body_display_cancers-11-01889-t002" > <div class="html-caption" ><b>Table 2.</b> TS/A in gene therapy studies aiming to increase tumor immunogenicity.</div> <table > <thead ><tr ><th align='left' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-left' >Immune Categories</th><th align='left' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-left' >Transgenes</th><th align='left' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-left' >Vector/Transfer Methods</th><th align='left' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-left' >Refs</th></tr></thead><tbody ><tr ><td align='left' valign='middle' class='html-align-left' >Chemokines</td><td align='left' valign='middle' class='html-align-left' >h-CCL16/LEC</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + lipofection</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B70-cancers-11-01889" class="html-bibr">70</a>,<a href="#B71-cancers-11-01889" class="html-bibr">71</a>]</td></tr><tr ><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' > </td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' > </td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >Adenoviral, in vivo</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >[<a href="#B59-cancers-11-01889" class="html-bibr">59</a>,<a href="#B72-cancers-11-01889" class="html-bibr">72</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Cytokines</td><td align='left' valign='middle' class='html-align-left' >m-IL2</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + electroporation</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B11-cancers-11-01889" class="html-bibr">11</a>,<a href="#B23-cancers-11-01889" class="html-bibr">23</a>,<a href="#B73-cancers-11-01889" class="html-bibr">73</a>,<a href="#B74-cancers-11-01889" class="html-bibr">74</a>,<a href="#B75-cancers-11-01889" class="html-bibr">75</a>,<a href="#B76-cancers-11-01889" class="html-bibr">76</a>,<a href="#B77-cancers-11-01889" class="html-bibr">77</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-IL4</td><td align='left' valign='middle' class='html-align-left' >Retroviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B73-cancers-11-01889" class="html-bibr">73</a>,<a href="#B74-cancers-11-01889" class="html-bibr">74</a>,<a href="#B78-cancers-11-01889" class="html-bibr">78</a>,<a href="#B79-cancers-11-01889" class="html-bibr">79</a>,<a href="#B80-cancers-11-01889" class="html-bibr">80</a>,<a href="#B81-cancers-11-01889" class="html-bibr">81</a>,<a href="#B82-cancers-11-01889" class="html-bibr">82</a>,<a href="#B83-cancers-11-01889" class="html-bibr">83</a>,<a href="#B84-cancers-11-01889" class="html-bibr">84</a>,<a href="#B85-cancers-11-01889" class="html-bibr">85</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-IL5</td><td align='left' valign='middle' class='html-align-left' >Retroviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B86-cancers-11-01889" class="html-bibr">86</a>,<a href="#B87-cancers-11-01889" class="html-bibr">87</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-IL6</td><td align='left' valign='middle' class='html-align-left' >Retroviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B74-cancers-11-01889" class="html-bibr">74</a>,<a href="#B80-cancers-11-01889" class="html-bibr">80</a>,<a href="#B87-cancers-11-01889" class="html-bibr">87</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-IL7</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + electroporation</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B73-cancers-11-01889" class="html-bibr">73</a>,<a href="#B74-cancers-11-01889" class="html-bibr">74</a>,<a href="#B80-cancers-11-01889" class="html-bibr">80</a>,<a href="#B81-cancers-11-01889" class="html-bibr">81</a>,<a href="#B88-cancers-11-01889" class="html-bibr">88</a>,<a href="#B89-cancers-11-01889" class="html-bibr">89</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-IL7</td><td align='left' valign='middle' class='html-align-left' >Adenoviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B90-cancers-11-01889" class="html-bibr">90</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-IL10</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + electroporation</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B74-cancers-11-01889" class="html-bibr">74</a>,<a href="#B91-cancers-11-01889" class="html-bibr">91</a>] </td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-IL12 p35 and p40</td><td align='left' valign='middle' class='html-align-left' >Naked DNA, in vivo</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B92-cancers-11-01889" class="html-bibr">92</a>,<a href="#B93-cancers-11-01889" class="html-bibr">93</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Naked DNA + gene gun</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B94-cancers-11-01889" class="html-bibr">94</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Naked DNA + lipofection</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B95-cancers-11-01889" class="html-bibr">95</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Retroviral </td><td align='left' valign='middle' class='html-align-left' >[<a href="#B96-cancers-11-01889" class="html-bibr">96</a>,<a href="#B97-cancers-11-01889" class="html-bibr">97</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Canarypox</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B98-cancers-11-01889" class="html-bibr">98</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Naked DNA + gene gun, in vivo</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B24-cancers-11-01889" class="html-bibr">24</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >h-IL13</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + calcium phosphate</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B99-cancers-11-01889" class="html-bibr">99</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-IL15</td><td align='left' valign='middle' class='html-align-left' >Adenoviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B100-cancers-11-01889" class="html-bibr">100</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >IL15</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + lipofection</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B95-cancers-11-01889" class="html-bibr">95</a>,<a href="#B101-cancers-11-01889" class="html-bibr">101</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Pro-IL18 and ICE</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + gene gun</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B94-cancers-11-01889" class="html-bibr">94</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-IL21</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + lipofection</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B102-cancers-11-01889" class="html-bibr">102</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-IFNα1</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + electroporation</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B80-cancers-11-01889" class="html-bibr">80</a>,<a href="#B82-cancers-11-01889" class="html-bibr">82</a>,<a href="#B103-cancers-11-01889" class="html-bibr">103</a>,<a href="#B104-cancers-11-01889" class="html-bibr">104</a>,<a href="#B105-cancers-11-01889" class="html-bibr">105</a>,<a href="#B106-cancers-11-01889" class="html-bibr">106</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-IFNα1</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + gene gun</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B107-cancers-11-01889" class="html-bibr">107</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-IFNα4</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + polymer</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B108-cancers-11-01889" class="html-bibr">108</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-IFNβ</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + calcium phosphate</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B109-cancers-11-01889" class="html-bibr">109</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-IFNγ</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + lipofection</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B12-cancers-11-01889" class="html-bibr">12</a>,<a href="#B74-cancers-11-01889" class="html-bibr">74</a>,<a href="#B80-cancers-11-01889" class="html-bibr">80</a>,<a href="#B99-cancers-11-01889" class="html-bibr">99</a>,<a href="#B110-cancers-11-01889" class="html-bibr">110</a>,<a href="#B111-cancers-11-01889" class="html-bibr">111</a>,<a href="#B112-cancers-11-01889" class="html-bibr">112</a>,<a href="#B113-cancers-11-01889" class="html-bibr">113</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >m-GMCSF</td><td align='left' valign='middle' class='html-align-left' >Retroviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B74-cancers-11-01889" class="html-bibr">74</a>]</td></tr><tr ><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' > </td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >m-TNFα</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >Retroviral</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >[<a href="#B74-cancers-11-01889" class="html-bibr">74</a>,<a href="#B80-cancers-11-01889" class="html-bibr">80</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Membrane molecules</td><td align='left' valign='middle' class='html-align-left' >B7-1/CD80</td><td align='left' valign='middle' class='html-align-left' >Naked DNA</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B114-cancers-11-01889" class="html-bibr">114</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Naked DNA + electroporation</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B115-cancers-11-01889" class="html-bibr">115</a>,<a href="#B116-cancers-11-01889" class="html-bibr">116</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Retroviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B81-cancers-11-01889" class="html-bibr">81</a>,<a href="#B89-cancers-11-01889" class="html-bibr">89</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >B7-2/CD86</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + electroporation</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B115-cancers-11-01889" class="html-bibr">115</a>,<a href="#B116-cancers-11-01889" class="html-bibr">116</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Allogeneic MHC</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + calcium phosphate</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B111-cancers-11-01889" class="html-bibr">111</a>,<a href="#B117-cancers-11-01889" class="html-bibr">117</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >CD70 (CD27L)</td><td align='left' valign='middle' class='html-align-left' >Retroviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B118-cancers-11-01889" class="html-bibr">118</a>,<a href="#B119-cancers-11-01889" class="html-bibr">119</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >CD153 (CD30L)</td><td align='left' valign='middle' class='html-align-left' >Retroviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B118-cancers-11-01889" class="html-bibr">118</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >CD154 (CD40L)</td><td align='left' valign='middle' class='html-align-left' >Retroviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B118-cancers-11-01889" class="html-bibr">118</a>,<a href="#B120-cancers-11-01889" class="html-bibr">120</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >TRAIL/APO2L</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + lipofection</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B121-cancers-11-01889" class="html-bibr">121</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >LAG-3 and LAG5</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + electroporation</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B122-cancers-11-01889" class="html-bibr">122</a>,<a href="#B123-cancers-11-01889" class="html-bibr">123</a>]</td></tr><tr ><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' > </td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >CCR7</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >Naked DNA + calcium phosphate</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >[<a href="#B124-cancers-11-01889" class="html-bibr">124</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Suicide genes</td><td align='left' valign='middle' class='html-align-left' >Cytosine deaminase</td><td align='left' valign='middle' class='html-align-left' >Retroviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B112-cancers-11-01889" class="html-bibr">112</a>,<a href="#B125-cancers-11-01889" class="html-bibr">125</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Naked DNA</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B126-cancers-11-01889" class="html-bibr">126</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >VSV (oncolytic)</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B127-cancers-11-01889" class="html-bibr">127</a>,<a href="#B128-cancers-11-01889" class="html-bibr">128</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >HSV-Thymidine kinase</td><td align='left' valign='middle' class='html-align-left' >Naked DNA</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B104-cancers-11-01889" class="html-bibr">104</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Retroviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B129-cancers-11-01889" class="html-bibr">129</a>]</td></tr><tr ><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' > </td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' > </td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >Naked DNA + lipofection</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >[<a href="#B130-cancers-11-01889" class="html-bibr">130</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Others</td><td align='left' valign='middle' class='html-align-left' >CIITA</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + lipofection</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B131-cancers-11-01889" class="html-bibr">131</a>,<a href="#B132-cancers-11-01889" class="html-bibr">132</a>,<a href="#B133-cancers-11-01889" class="html-bibr">133</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >GBP1</td><td align='left' valign='middle' class='html-align-left' >Retroviral (conditional) + naked DNA</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B134-cancers-11-01889" class="html-bibr">134</a>]</td></tr><tr ><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' > </td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >m-IRF1</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >Adenoviral</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >[<a href="#B135-cancers-11-01889" class="html-bibr">135</a>]</td></tr></tbody> </table> </div><div class="html-table-wrap" id="cancers-11-01889-t003"> <div class="html-table_wrap_td" > <div class="html-tablepopup html-tablepopup-link" data-counterslinkmanual = "https://www.mdpi.com/2072-6694/11/12/1889/display" href='#table_body_display_cancers-11-01889-t003'> <img alt="Table" data-lsrc="https://www.mdpi.com/img/table.png" /> <a class="html-expand html-tablepopup" data-counterslinkmanual = "https://www.mdpi.com/2072-6694/11/12/1889/display" href="#table_body_display_cancers-11-01889-t003"></a> </div> </div> <div class="html-table_wrap_discription"> <b>Table 3.</b> TS/A in transduction studies of cancer biology. </div> </div> <div class="html-table_show mfp-hide " id ="table_body_display_cancers-11-01889-t003" > <div class="html-caption" ><b>Table 3.</b> TS/A in transduction studies of cancer biology.</div> <table > <thead ><tr ><th align='left' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-left' >Gene Categories</th><th align='left' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-left' >Transgenes</th><th align='left' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-left' >Vector/Transfer Methods</th><th align='left' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-left' >Refs</th></tr></thead><tbody ><tr ><td align='left' valign='middle' class='html-align-left' >Oncosuppressors</td><td align='left' valign='middle' class='html-align-left' >m-p53wt</td><td align='left' valign='middle' class='html-align-left' >Canarypox</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B21-cancers-11-01889" class="html-bibr">21</a>]</td></tr><tr ><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' > </td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >m-p53wt/mut</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >VSV (oncolytic)</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >[<a href="#B139-cancers-11-01889" class="html-bibr">139</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Reporter genes</td><td align='left' valign='middle' class='html-align-left' >Luciferase</td><td align='left' valign='middle' class='html-align-left' >Naked DNA</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B140-cancers-11-01889" class="html-bibr">140</a>,<a href="#B141-cancers-11-01889" class="html-bibr">141</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >β-galactosidase</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + polyfection</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B142-cancers-11-01889" class="html-bibr">142</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >GFP</td><td align='left' valign='middle' class='html-align-left' >Adenoviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B143-cancers-11-01889" class="html-bibr">143</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >GFP</td><td align='left' valign='middle' class='html-align-left' >Lentiviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B46-cancers-11-01889" class="html-bibr">46</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >EGFP</td><td align='left' valign='middle' class='html-align-left' >Lentiviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B54-cancers-11-01889" class="html-bibr">54</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >EGFP</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + electroporation</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B50-cancers-11-01889" class="html-bibr">50</a>]</td></tr><tr ><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' > </td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >EGFP (driven by p21 or CMV promoter)</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >Naked DNA + electroporation</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >[<a href="#B144-cancers-11-01889" class="html-bibr">144</a>,<a href="#B145-cancers-11-01889" class="html-bibr">145</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Silencing </td><td align='left' valign='middle' class='html-align-left' >antisense m-TGF-β1</td><td align='left' valign='middle' class='html-align-left' >Retroviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B18-cancers-11-01889" class="html-bibr">18</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Rab27a</td><td align='left' valign='middle' class='html-align-left' >Lentiviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B146-cancers-11-01889" class="html-bibr">146</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Mlh1</td><td align='left' valign='middle' class='html-align-left' >CRISPR-Cas9</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B147-cancers-11-01889" class="html-bibr">147</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >FoxP3</td><td align='left' valign='middle' class='html-align-left' >Lentiviral siRNA</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B44-cancers-11-01889" class="html-bibr">44</a>]</td></tr><tr ><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' > </td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >fragile X mental retardation protein (FMRP)</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >Lentiviral shRNA</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >[<a href="#B46-cancers-11-01889" class="html-bibr">46</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Surrogate antigens</td><td align='left' valign='middle' class='html-align-left' >β-galactosidase</td><td align='left' valign='middle' class='html-align-left' >Retroviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B81-cancers-11-01889" class="html-bibr">81</a>,<a href="#B148-cancers-11-01889" class="html-bibr">148</a>,<a href="#B149-cancers-11-01889" class="html-bibr">149</a>,<a href="#B150-cancers-11-01889" class="html-bibr">150</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Hemagglutinin</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + lipofection</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B151-cancers-11-01889" class="html-bibr">151</a>,<a href="#B152-cancers-11-01889" class="html-bibr">152</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Leishmania receptor for activated C kinase (LACK)</td><td align='left' valign='middle' class='html-align-left' >Naked DNA</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B153-cancers-11-01889" class="html-bibr">153</a>,<a href="#B154-cancers-11-01889" class="html-bibr">154</a>,<a href="#B155-cancers-11-01889" class="html-bibr">155</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Mycobacterial cell wall-associated 19-kDa lipoprotein</td><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >[<a href="#B156-cancers-11-01889" class="html-bibr">156</a>]</td></tr><tr ><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' > </td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >Ovalbumin</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >Naked DNA </td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >[<a href="#B157-cancers-11-01889" class="html-bibr">157</a>,<a href="#B158-cancers-11-01889" class="html-bibr">158</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >Others</td><td align='left' valign='middle' class='html-align-left' >Chromogranin A (Vasostatin-1 fragment)</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + electroporation</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B159-cancers-11-01889" class="html-bibr">159</a>,<a href="#B160-cancers-11-01889" class="html-bibr">160</a>,<a href="#B161-cancers-11-01889" class="html-bibr">161</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Extracellular domain of receptor tyrosine kinase Tie2/TEK (ex-TEK)</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + calcium phosphate precipitation</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B162-cancers-11-01889" class="html-bibr">162</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Apelin</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + polyfection</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B163-cancers-11-01889" class="html-bibr">163</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >Interferon-regulatory factor-1 (IRF-1)</td><td align='left' valign='middle' class='html-align-left' >Adenoviral</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B43-cancers-11-01889" class="html-bibr">43</a>]</td></tr><tr ><td align='left' valign='middle' class='html-align-left' > </td><td align='left' valign='middle' class='html-align-left' >α1,2fucosyltransferase</td><td align='left' valign='middle' class='html-align-left' >Naked DNA + lipofection</td><td align='left' valign='middle' class='html-align-left' >[<a href="#B164-cancers-11-01889" class="html-bibr">164</a>]</td></tr><tr ><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' > </td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >P27VP22</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >Naked DNA + polyfection</td><td align='left' valign='middle' style='border-bottom:solid thin' class='html-align-left' >[<a href="#B165-cancers-11-01889" class="html-bibr">165</a>]</td></tr></tbody> </table> </div></section> <section id="html-copyright"><br>© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href='http://creativecommons.org/licenses/by/4.0/' target='_blank' rel="noopener noreferrer" >http://creativecommons.org/licenses/by/4.0/</a>).</section> </div> </div> <div class="additional-content"> <h2><a name="cite"></a>Share and Cite</h2> <div class="social-media-links" style="text-align: left;"> <a href="/cdn-cgi/l/email-protection#cbf4edaaa6bbf0b8bea9a1aea8bff68db9a4a6eef9fb868f9b82eef88aeef9fbeef9f989a2a4bbb9a4ada2a7a2a5aceef9fb9f98eef98d8aeef9fb86beb9a2a5aeeef9fb86aaa6a6aab9b2eef9fb88aaa5a8aeb9eef9fbada4b9eef9fbaaeef9fb8dbea5a8bfa2a4a5aaa7eef9fb9bb9aea8a2b8a2a4a5eef9fb8eb3bbaeb9a2a6aea5bfaaa7eef9fb86a4afaea7edbabea4bff0edaaa6bbf0a9a4afb2f6a3bfbfbbb8f1e4e4bcbcbce5a6afbba2e5a8a4a6e4fef3f8f9f3ffeef88aeefb8aeefb8a89a2a4bbb9a4ada2a7a2a5aceef9fb9f98eef98d8aeef9fb86beb9a2a5aeeef9fb86aaa6a6aab9b2eef9fb88aaa5a8aeb9eef9fbada4b9eef9fbaaeef9fb8dbea5a8bfa2a4a5aaa7eef9fb9bb9aea8a2b8a2a4a5eef9fb8eb3bbaeb9a2a6aea5bfaaa7eef9fb86a4afaea7eefb8aeefb8a8aa9b8bfb9aaa8bfeef88aeef9fbeef9fb9fa3aeeef9fb9f98eef98d8aeef9fba8aea7a7eef9fba7a2a5aeeef9fbbcaab8eef9fbaeb8bfaaa9a7a2b8a3aeafeef9fba2a5eef9fbfaf2f3f8eef9fbadb9a4a6eef9fbaaeef9fbb8bba4a5bfaaa5aea4beb8eef9fba6aaa6a6aab9b2eef9fbbfbea6a4b9eef9fbaab9a2b8aea5eef9fba2a5eef9fbaaa5eef9fba2a5a9b9aeafeef9fb898a8789eef98da8eef9fbadaea6aaa7aeeef9fba6a4beb8aee5eef9fb82bfb8eef9fbadaeaabfbeb9aeb8eef9fbeef9f3a3aebfaeb9a4acaea5aea2bfb2eef988eef9fba7a4bceef9fba2a6a6bea5a4acaea5a2a8a2bfb2eef9fbaaa5afeef9fba6aebfaab8bfaabfa2a8eef9fbaaa9a2a7a2bfb2eef9f2eef9fbb9aea5afaeb9aeafeef9fbbfa3aeeef9fb9f98eef98d8aeef9fba8aea7a7eef9fba7a2a5aeeef9fbb8bea2bfaaa9a7aeeef9fbaab8eef9fbaaeef9fbbbb9aea8a7a2a5a2a8aaa7eef9fba6a4afaea7eef9fbada4b9eef9fbb8bfbeafa2aeb8eef9fba4a5eef9fbbfbea6a4b9eef9fda5afaab8a3eef889a3a4b8bfeef9fba2a5bfaeb9aaa8bfa2a4a5b8eef9fbaaa5afeef9fbada4b9eef9fbacaea5aeeef9fbbfa3aeb9aabbb2eef9fbaabbbbb9a4aaa8a3aeb8e5eef9fb9fa3aeeef9fba2a5bfaeacb9aabfaeafeef9fba9a2a4a7a4aca2a8aaa7eef9fbbbb9a4ada2a7aeeef9fba4adeef9fb9f98eef98d8aeef9fbb9aeb8bea7bfa2a5aceef9fbadb9a4a6eef9fbbfa3aeeef9fbb9aebda2aebceef9fba4adeef9fbbfa3aeeef9fba7a2bfaeb9aabfbeb9aeeef9fba8a4bea7afeef9fba9aeeef9fbaaeef9fbbbaabfa3eef9fbbfa4bcaab9afb8eef9fbbfa3aeeef9fbafaeb8a8b9a2bbbfa2a4a5eef9fba4adeef9fbaaeef9fbbbb9aea8a2b8a2a4a5eef9fbaeb3bbaeb9a2a6aea5bfaaa7eef9fba6a4afaea7eef9fba4adeef9fba6aaa6a6aab9b2eef9fba8aaa5a8aeb9e5" title="Email"> <i class="fa fa-envelope-square" style="font-size: 30px;"></i> </a> <a href="https://twitter.com/intent/tweet?text=Bioprofiling+TS%2FA+Murine+Mammary+Cancer+for+a+Functional+Precision+Experimental+Model&hashtags=mdpicancers&url=https%3A%2F%2Fwww.mdpi.com%2F583284&via=Cancers_MDPI" onclick="windowOpen(this.href,600,800); return false" target="_blank" rel="noopener noreferrer"> <i class="fa fa-twitter-x-square" style="font-size: 30px;"></i> </a> <a href=" http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.mdpi.com%2F583284&title=Bioprofiling%20TS%2FA%20Murine%20Mammary%20Cancer%20for%20a%20Functional%20Precision%20Experimental%20Model%26source%3Dhttps%3A%2F%2Fwww.mdpi.com%26summary%3D%20The%20TS%2FA%20cell%20line%20was%20established%20in%201983%20from%20a%20spontaneous%20mammary%20tumor%20arisen%20in%20an%20inbred%20BALB%2Fc%20female%20mouse.%20Its%20features%20%28heterogeneity%2C%20low%20immunogenicity%20and%20metastatic%20ability%29%20rendered%20the%20TS%2FA%20cell%20line%20suitable%20as%20a%20preclinical%20model%20%5B...%5D" onclick="windowOpen(this.href,600,800); return false" title="LinkedIn" target="_blank" rel="noopener noreferrer"> <i class="fa fa-linkedin-square" style="font-size: 30px;"></i> </a> <a href="https://www.facebook.com/sharer.php?u=https://www.mdpi.com/583284" title="facebook" target="_blank" rel="noopener noreferrer"> <i class="fa fa-facebook-square" style="font-size: 30px;"></i> </a> <a href="javascript:void(0);" title="Wechat" data-reveal-id="weixin-share-modal"> <i class="fa fa-weixin-square" style="font-size: 26px;"></i> </a> <a href="http://www.reddit.com/submit?url=https://www.mdpi.com/583284" title="Reddit" target="_blank" rel="noopener noreferrer"> <i class="fa fa-reddit-square" style="font-size: 30px;"></i> </a> <a href="http://www.mendeley.com/import/?url=https://www.mdpi.com/583284" title="Mendeley" target="_blank" rel="noopener noreferrer"> <i class="fa fa-mendeley-square" style="font-size: 30px;"></i> </a> </div> <div class="in-tab" style="padding-top: 0px!important; margin-top: 15px;"> <div><b>MDPI and ACS Style</b></div> <p> De Giovanni, C.; Nicoletti, G.; Landuzzi, L.; Palladini, A.; Lollini, P.-L.; Nanni, P. Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model. <em>Cancers</em> <b>2019</b>, <em>11</em>, 1889. https://doi.org/10.3390/cancers11121889 </p> <div style="display: block"> <b>AMA Style</b><br> <p> De Giovanni C, Nicoletti G, Landuzzi L, Palladini A, Lollini P-L, Nanni P. Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model. <em>Cancers</em>. 2019; 11(12):1889. https://doi.org/10.3390/cancers11121889 </p> <b>Chicago/Turabian Style</b><br> <p> De Giovanni, Carla, Giordano Nicoletti, Lorena Landuzzi, Arianna Palladini, Pier-Luigi Lollini, and Patrizia Nanni. 2019. "Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model" <em>Cancers</em> 11, no. 12: 1889. https://doi.org/10.3390/cancers11121889 </p> <b>APA Style</b><br> <p> De Giovanni, C., Nicoletti, G., Landuzzi, L., Palladini, A., Lollini, P. -L., & Nanni, P. (2019). Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model. <em>Cancers</em>, <em>11</em>(12), 1889. https://doi.org/10.3390/cancers11121889 </p> </div> </div> <div class="info-box no-margin"> Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details <a target="_blank" href="https://www.mdpi.com/about/announcements/784">here</a>. </div> <h2><a name="metrics"></a>Article Metrics</h2> <div class="row"> <div class="small-12 columns"> <div id="loaded_cite_count" style="display:none">No</div> <div id="framed_div_cited_count" class="in-tab" style="display: none; overflow: auto;"></div> <div id="loaded" style="display:none">No</div> <div id="framed_div" class="in-tab" style="display: none; margin-top: 10px;"></div> </div> <div class="small-12 columns"> <div id="article_stats_div" style="display: none; margin-bottom: 1em;"> <h3>Article Access Statistics</h3> <div id="article_stats_swf" ></div> For more information on the journal statistics, click <a href="/journal/cancers/stats">here</a>. <div class="info-box"> Multiple requests from the same IP address are counted as one view. </div> </div> </div> </div> </div> </div> </article> </div> <div id="supplementaryModal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="Captcha" aria-hidden="true" role="dialog"> <div class="row"> <div class="large-12 medium-12 small-12 columns"> <h2>Supplementary Material</h2> <div class="custom-accordion-for-small-screen-content show-for-medium-up"> <div class="in-tab"> <ul style="margin:0; list-style: none; overflow: auto;"> <li><a name="supplementary_file1"></a><b>Supplementary File 1:</b> <p> <a href="/2072-6694/11/12/1889/s1?version=1574869627"> ZIP-Document </a> (ZIP, 57 KiB) </p> </li> </ul> </div> </div> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> </div></div> <div class="webpymol-controls webpymol-controls-template" style="margin-top: 10px; display: none;"> <a class="bzoom">Zoom</a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="borient"> Orient </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="blines"> As Lines </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bsticks"> As Sticks </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bcartoon"> As Cartoon </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bsurface"> As Surface </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bprevscene">Previous Scene</a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bnextscene">Next Scene</a> </div> <div id="scifeed-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> </div> <div id="recommended-articles-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> </div> <div id="author-biographies-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> </div> <div id="cite-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="Captcha" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 style="margin: 0;">Cite</h2> </div> <div class="small-12 columns"> <!-- BibTeX --> <form style="margin:0; padding:0; display:inline;" name="export-bibtex" method="POST" action="/export"> <input type="hidden" name="articles_ids[]" value="291642"> <input type="hidden" name="export_format_top" value="bibtex"> <input type="hidden" name="export_submit_top" value=""> </form> <!-- EndNote --> <form style="margin:0; padding:0; display:inline;" name="export-endnote" method="POST" action="/export"> <input type="hidden" name="articles_ids[]" value="291642"> <input type="hidden" name="export_format_top" value="endnote_no_abstract"> <input type="hidden" name="export_submit_top" value=""> </form> <!-- RIS --> <form style="margin:0; padding:0; display:inline;" name="export-ris" method="POST" action="/export"> <input type="hidden" name="articles_ids[]" value="291642"> <input type="hidden" name="export_format_top" value="ris"> <input type="hidden" name="export_submit_top" value=""> </form> <div> Export citation file: <a href="javascript:window.document.forms['export-bibtex'].submit()">BibTeX</a> | <a href="javascript:window.document.forms['export-endnote'].submit()">EndNote</a> | <a href="javascript:window.document.forms['export-ris'].submit()">RIS</a> </div> </div> <div class="small-12 columns"> <div class="in-tab"> <div><b>MDPI and ACS Style</b></div> <p> De Giovanni, C.; Nicoletti, G.; Landuzzi, L.; Palladini, A.; Lollini, P.-L.; Nanni, P. Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model. <em>Cancers</em> <b>2019</b>, <em>11</em>, 1889. https://doi.org/10.3390/cancers11121889 </p> <div style="display: block"> <b>AMA Style</b><br> <p> De Giovanni C, Nicoletti G, Landuzzi L, Palladini A, Lollini P-L, Nanni P. Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model. <em>Cancers</em>. 2019; 11(12):1889. https://doi.org/10.3390/cancers11121889 </p> <b>Chicago/Turabian Style</b><br> <p> De Giovanni, Carla, Giordano Nicoletti, Lorena Landuzzi, Arianna Palladini, Pier-Luigi Lollini, and Patrizia Nanni. 2019. "Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model" <em>Cancers</em> 11, no. 12: 1889. https://doi.org/10.3390/cancers11121889 </p> <b>APA Style</b><br> <p> De Giovanni, C., Nicoletti, G., Landuzzi, L., Palladini, A., Lollini, P. -L., & Nanni, P. (2019). Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model. <em>Cancers</em>, <em>11</em>(12), 1889. https://doi.org/10.3390/cancers11121889 </p> </div> </div> <div class="info-box no-margin"> Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details <a target="_blank" href="https://www.mdpi.com/about/announcements/784">here</a>. </div> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> </div> </div> </div> </div> </section> <div id="footer"> <div class="journal-info"> <span> <em><a class="Var_JournalInfo" href="/journal/cancers">Cancers</a></em>, EISSN 2072-6694, Published by MDPI </span> <div class="large-right"> <span> <a href="/rss/journal/cancers" class="rss-link">RSS</a> </span> <span> <a href="/journal/cancers/toc-alert">Content Alert</a> </span> </div> </div> <div class="row full-width footer-links" data-equalizer="footer" data-equalizer-mq="small"> <div class="large-2 large-push-4 medium-3 small-6 columns" data-equalizer-watch="footer"> <h3> Further Information </h3> <a href="/apc"> Article Processing Charges </a> <a href="/about/payment"> Pay an Invoice </a> <a href="/openaccess"> Open Access Policy </a> <a href="/about/contact"> Contact MDPI </a> <a href="https://careers.mdpi.com" target="_blank" rel="noopener noreferrer"> Jobs at MDPI </a> </div> <div class="large-2 large-push-4 medium-3 small-6 columns" data-equalizer-watch="footer"> <h3> Guidelines </h3> <a href="/authors"> For Authors </a> <a href="/reviewers"> For Reviewers </a> <a href="/editors"> For Editors </a> <a href="/librarians"> For Librarians </a> <a href="/publishing_services"> For Publishers </a> <a href="/societies"> For Societies </a> <a href="/conference_organizers"> For Conference Organizers </a> </div> <div class="large-2 large-push-4 medium-3 small-6 columns"> <h3> MDPI Initiatives </h3> <a href="https://sciforum.net" target="_blank" rel="noopener noreferrer"> Sciforum </a> <a href="https://www.mdpi.com/books" target="_blank" rel="noopener noreferrer"> MDPI Books </a> <a href="https://www.preprints.org" target="_blank" rel="noopener noreferrer"> Preprints.org </a> <a href="https://www.scilit.net" target="_blank" rel="noopener noreferrer"> Scilit </a> <a href="https://sciprofiles.com?utm_source=mpdi.com&utm_medium=bottom_menu&utm_campaign=initiative" target="_blank" rel="noopener noreferrer"> SciProfiles </a> <a href="https://encyclopedia.pub" target="_blank" rel="noopener noreferrer"> Encyclopedia </a> <a href="https://jams.pub" target="_blank" rel="noopener noreferrer"> JAMS </a> <a href="/about/proceedings"> Proceedings Series </a> </div> <div class="large-2 large-push-4 medium-3 small-6 right-border-large-without columns UA_FooterFollowMDPI"> <h3> Follow MDPI </h3> <a href="https://www.linkedin.com/company/mdpi" target="_blank" rel="noopener noreferrer"> LinkedIn </a> <a href="https://www.facebook.com/MDPIOpenAccessPublishing" target="_blank" rel="noopener noreferrer"> Facebook </a> <a href="https://twitter.com/MDPIOpenAccess" target="_blank" rel="noopener noreferrer"> Twitter </a> </div> <div id="footer-subscribe" class="large-4 large-pull-8 medium-12 small-12 left-border-large columns"> <div class="footer-subscribe__container"> <img class="show-for-large-up" src="https://pub.mdpi-res.com/img/design/mdpi-pub-logo-white-small.png?71d18e5f805839ab?1732884643" alt="MDPI" title="MDPI Open Access Journals" style="height: 50px; margin-bottom: 10px;"> <form id="newsletter" method="POST" action="/subscribe"> <p> Subscribe to receive issue release notifications and newsletters from MDPI journals </p> <select multiple id="newsletter-journal" class="foundation-select" name="journals[]"> <option value="acoustics">Acoustics</option> <option value="amh">Acta Microbiologica Hellenica</option> <option value="actuators">Actuators</option> <option value="admsci">Administrative Sciences</option> <option value="adolescents">Adolescents</option> <option value="arm">Advances in Respiratory Medicine</option> <option value="aerobiology">Aerobiology</option> <option value="aerospace">Aerospace</option> <option value="agriculture">Agriculture</option> <option value="agriengineering">AgriEngineering</option> <option value="agrochemicals">Agrochemicals</option> <option value="agronomy">Agronomy</option> <option value="ai">AI</option> <option value="air">Air</option> <option value="algorithms">Algorithms</option> <option value="allergies">Allergies</option> <option value="alloys">Alloys</option> <option value="analytica">Analytica</option> <option value="analytics">Analytics</option> <option value="anatomia">Anatomia</option> <option value="anesthres">Anesthesia Research</option> <option value="animals">Animals</option> <option value="antibiotics">Antibiotics</option> <option value="antibodies">Antibodies</option> <option value="antioxidants">Antioxidants</option> <option value="applbiosci">Applied Biosciences</option> <option value="applmech">Applied Mechanics</option> <option value="applmicrobiol">Applied Microbiology</option> <option value="applnano">Applied Nano</option> <option value="applsci">Applied Sciences</option> <option value="asi">Applied System Innovation</option> <option value="appliedchem">AppliedChem</option> <option value="appliedmath">AppliedMath</option> <option value="aquacj">Aquaculture Journal</option> <option value="architecture">Architecture</option> <option value="arthropoda">Arthropoda</option> <option value="arts">Arts</option> <option value="astronomy">Astronomy</option> <option value="atmosphere">Atmosphere</option> <option value="atoms">Atoms</option> <option value="audiolres">Audiology Research</option> <option value="automation">Automation</option> <option value="axioms">Axioms</option> <option value="bacteria">Bacteria</option> <option value="batteries">Batteries</option> <option value="behavsci">Behavioral Sciences</option> <option value="beverages">Beverages</option> <option value="BDCC">Big Data and Cognitive Computing</option> <option value="biochem">BioChem</option> <option value="bioengineering">Bioengineering</option> <option value="biologics">Biologics</option> <option value="biology">Biology</option> <option value="blsf">Biology and Life Sciences Forum</option> <option value="biomass">Biomass</option> <option value="biomechanics">Biomechanics</option> <option value="biomed">BioMed</option> <option value="biomedicines">Biomedicines</option> <option value="biomedinformatics">BioMedInformatics</option> <option value="biomimetics">Biomimetics</option> <option value="biomolecules">Biomolecules</option> <option value="biophysica">Biophysica</option> <option value="biosensors">Biosensors</option> <option value="biotech">BioTech</option> <option value="birds">Birds</option> <option value="blockchains">Blockchains</option> <option value="brainsci">Brain Sciences</option> <option value="buildings">Buildings</option> <option value="businesses">Businesses</option> <option value="carbon">C</option> <option value="cancers">Cancers</option> <option value="cardiogenetics">Cardiogenetics</option> <option value="catalysts">Catalysts</option> <option value="cells">Cells</option> <option value="ceramics">Ceramics</option> <option value="challenges">Challenges</option> <option value="ChemEngineering">ChemEngineering</option> <option value="chemistry">Chemistry</option> <option value="chemproc">Chemistry Proceedings</option> <option value="chemosensors">Chemosensors</option> <option value="children">Children</option> <option value="chips">Chips</option> <option value="civileng">CivilEng</option> <option value="cleantechnol">Clean Technologies</option> <option value="climate">Climate</option> <option value="ctn">Clinical and Translational Neuroscience</option> <option value="clinbioenerg">Clinical Bioenergetics</option> <option value="clinpract">Clinics and Practice</option> <option value="clockssleep">Clocks & Sleep</option> <option value="coasts">Coasts</option> <option value="coatings">Coatings</option> <option value="colloids">Colloids and Interfaces</option> <option value="colorants">Colorants</option> <option value="commodities">Commodities</option> <option value="complications">Complications</option> <option value="compounds">Compounds</option> <option value="computation">Computation</option> <option value="csmf">Computer Sciences & Mathematics Forum</option> <option value="computers">Computers</option> <option value="condensedmatter">Condensed Matter</option> <option value="conservation">Conservation</option> <option value="constrmater">Construction Materials</option> <option value="cmd">Corrosion and Materials Degradation</option> <option value="cosmetics">Cosmetics</option> <option value="covid">COVID</option> <option value="crops">Crops</option> <option value="cryo">Cryo</option> <option value="cryptography">Cryptography</option> <option value="crystals">Crystals</option> <option value="cimb">Current Issues in Molecular Biology</option> <option value="curroncol">Current Oncology</option> <option value="dairy">Dairy</option> <option value="data">Data</option> <option value="dentistry">Dentistry Journal</option> <option value="dermato">Dermato</option> <option value="dermatopathology">Dermatopathology</option> <option value="designs">Designs</option> <option value="diabetology">Diabetology</option> <option value="diagnostics">Diagnostics</option> <option value="dietetics">Dietetics</option> <option value="digital">Digital</option> <option value="disabilities">Disabilities</option> <option value="diseases">Diseases</option> <option value="diversity">Diversity</option> <option value="dna">DNA</option> <option value="drones">Drones</option> <option value="ddc">Drugs and Drug Candidates</option> <option value="dynamics">Dynamics</option> <option value="earth">Earth</option> <option value="ecologies">Ecologies</option> <option value="econometrics">Econometrics</option> <option value="economies">Economies</option> <option value="education">Education Sciences</option> <option value="electricity">Electricity</option> <option value="electrochem">Electrochem</option> <option value="electronicmat">Electronic Materials</option> <option value="electronics">Electronics</option> <option value="ecm">Emergency Care and Medicine</option> <option value="encyclopedia">Encyclopedia</option> <option value="endocrines">Endocrines</option> <option value="energies">Energies</option> <option value="esa">Energy Storage and Applications</option> <option value="eng">Eng</option> <option value="engproc">Engineering Proceedings</option> <option value="entropy">Entropy</option> <option value="environsciproc">Environmental Sciences Proceedings</option> <option value="environments">Environments</option> <option value="epidemiologia">Epidemiologia</option> <option value="epigenomes">Epigenomes</option> <option value="ebj">European Burn Journal</option> <option value="ejihpe">European Journal of Investigation in Health, Psychology and Education</option> <option value="fermentation">Fermentation</option> <option value="fibers">Fibers</option> <option value="fintech">FinTech</option> <option value="fire">Fire</option> <option value="fishes">Fishes</option> <option value="fluids">Fluids</option> <option value="foods">Foods</option> <option value="forecasting">Forecasting</option> <option value="forensicsci">Forensic Sciences</option> <option value="forests">Forests</option> <option value="fossstud">Fossil Studies</option> <option value="foundations">Foundations</option> <option value="fractalfract">Fractal and Fractional</option> <option value="fuels">Fuels</option> <option value="future">Future</option> <option value="futureinternet">Future Internet</option> <option value="futurepharmacol">Future Pharmacology</option> <option value="futuretransp">Future Transportation</option> <option value="galaxies">Galaxies</option> <option value="games">Games</option> <option value="gases">Gases</option> <option value="gastroent">Gastroenterology Insights</option> <option value="gastrointestdisord">Gastrointestinal Disorders</option> <option value="gastronomy">Gastronomy</option> <option value="gels">Gels</option> <option value="genealogy">Genealogy</option> <option value="genes">Genes</option> <option value="geographies">Geographies</option> <option value="geohazards">GeoHazards</option> <option value="geomatics">Geomatics</option> <option value="geometry">Geometry</option> <option value="geosciences">Geosciences</option> <option value="geotechnics">Geotechnics</option> <option value="geriatrics">Geriatrics</option> <option value="glacies">Glacies</option> <option value="gucdd">Gout, Urate, and Crystal Deposition Disease</option> <option value="grasses">Grasses</option> <option value="hardware">Hardware</option> <option value="healthcare">Healthcare</option> <option value="hearts">Hearts</option> <option value="hemato">Hemato</option> <option value="hematolrep">Hematology Reports</option> <option value="heritage">Heritage</option> <option value="histories">Histories</option> <option value="horticulturae">Horticulturae</option> <option value="hospitals">Hospitals</option> <option value="humanities">Humanities</option> <option value="humans">Humans</option> <option value="hydrobiology">Hydrobiology</option> <option value="hydrogen">Hydrogen</option> <option value="hydrology">Hydrology</option> <option value="hygiene">Hygiene</option> <option value="immuno">Immuno</option> <option value="idr">Infectious Disease Reports</option> <option value="informatics">Informatics</option> <option value="information">Information</option> <option value="infrastructures">Infrastructures</option> <option value="inorganics">Inorganics</option> <option value="insects">Insects</option> <option value="instruments">Instruments</option> <option value="iic">Intelligent Infrastructure and Construction</option> <option value="ijerph">International Journal of Environmental Research and Public Health</option> <option value="ijfs">International Journal of Financial Studies</option> <option value="ijms">International Journal of Molecular Sciences</option> <option value="IJNS">International Journal of Neonatal Screening</option> <option value="ijpb">International Journal of Plant Biology</option> <option value="ijt">International Journal of Topology</option> <option value="ijtm">International Journal of Translational Medicine</option> <option value="ijtpp">International Journal of Turbomachinery, Propulsion and Power</option> <option value="ime">International Medical Education</option> <option value="inventions">Inventions</option> <option value="IoT">IoT</option> <option value="ijgi">ISPRS International Journal of Geo-Information</option> <option value="J">J</option> <option value="jal">Journal of Ageing and Longevity</option> <option value="jcdd">Journal of Cardiovascular Development and Disease</option> <option value="jcto">Journal of Clinical & Translational Ophthalmology</option> <option value="jcm">Journal of Clinical Medicine</option> <option value="jcs">Journal of Composites Science</option> <option value="jcp">Journal of Cybersecurity and Privacy</option> <option value="jdad">Journal of Dementia and Alzheimer's Disease</option> <option value="jdb">Journal of Developmental Biology</option> <option value="jeta">Journal of Experimental and Theoretical Analyses</option> <option value="jfb">Journal of Functional Biomaterials</option> <option value="jfmk">Journal of Functional Morphology and Kinesiology</option> <option value="jof">Journal of Fungi</option> <option value="jimaging">Journal of Imaging</option> <option value="jintelligence">Journal of Intelligence</option> <option value="jlpea">Journal of Low Power Electronics and Applications</option> <option value="jmmp">Journal of Manufacturing and Materials Processing</option> <option value="jmse">Journal of Marine Science and Engineering</option> <option value="jmahp">Journal of Market Access & Health Policy</option> <option value="jmp">Journal of Molecular Pathology</option> <option value="jnt">Journal of Nanotheranostics</option> <option value="jne">Journal of Nuclear Engineering</option> <option value="ohbm">Journal of Otorhinolaryngology, Hearing and Balance Medicine</option> <option value="jop">Journal of Parks</option> <option value="jpm">Journal of Personalized Medicine</option> <option value="jpbi">Journal of Pharmaceutical and BioTech Industry</option> <option value="jor">Journal of Respiration</option> <option value="jrfm">Journal of Risk and Financial Management</option> <option value="jsan">Journal of Sensor and Actuator Networks</option> <option value="joma">Journal of the Oman Medical Association</option> <option value="jtaer">Journal of Theoretical and Applied Electronic Commerce Research</option> <option value="jvd">Journal of Vascular Diseases</option> <option value="jox">Journal of Xenobiotics</option> <option value="jzbg">Journal of Zoological and Botanical Gardens</option> <option value="journalmedia">Journalism and Media</option> <option value="kidneydial">Kidney and Dialysis</option> <option value="kinasesphosphatases">Kinases and Phosphatases</option> <option value="knowledge">Knowledge</option> <option value="labmed">LabMed</option> <option value="laboratories">Laboratories</option> <option value="land">Land</option> <option value="languages">Languages</option> <option value="laws">Laws</option> <option value="life">Life</option> <option value="limnolrev">Limnological Review</option> <option value="lipidology">Lipidology</option> <option value="liquids">Liquids</option> <option value="literature">Literature</option> <option value="livers">Livers</option> <option value="logics">Logics</option> <option value="logistics">Logistics</option> <option value="lubricants">Lubricants</option> <option value="lymphatics">Lymphatics</option> <option value="make">Machine Learning and Knowledge Extraction</option> <option value="machines">Machines</option> <option value="macromol">Macromol</option> <option value="magnetism">Magnetism</option> <option value="magnetochemistry">Magnetochemistry</option> <option value="marinedrugs">Marine Drugs</option> <option value="materials">Materials</option> <option value="materproc">Materials Proceedings</option> <option value="mca">Mathematical and Computational Applications</option> <option value="mathematics">Mathematics</option> <option value="medsci">Medical Sciences</option> <option value="msf">Medical Sciences Forum</option> <option value="medicina">Medicina</option> <option value="medicines">Medicines</option> <option value="membranes">Membranes</option> <option value="merits">Merits</option> <option value="metabolites">Metabolites</option> <option value="metals">Metals</option> <option value="meteorology">Meteorology</option> <option value="methane">Methane</option> <option value="mps">Methods and Protocols</option> <option value="metrics">Metrics</option> <option value="metrology">Metrology</option> <option value="micro">Micro</option> <option value="microbiolres">Microbiology Research</option> <option value="micromachines">Micromachines</option> <option value="microorganisms">Microorganisms</option> <option value="microplastics">Microplastics</option> <option value="minerals">Minerals</option> <option value="mining">Mining</option> <option value="modelling">Modelling</option> <option value="mmphys">Modern Mathematical Physics</option> <option value="molbank">Molbank</option> <option value="molecules">Molecules</option> <option value="mti">Multimodal Technologies and Interaction</option> <option value="muscles">Muscles</option> <option value="nanoenergyadv">Nanoenergy Advances</option> <option value="nanomanufacturing">Nanomanufacturing</option> <option value="nanomaterials">Nanomaterials</option> <option value="ndt">NDT</option> <option value="network">Network</option> <option value="neuroglia">Neuroglia</option> <option value="neurolint">Neurology International</option> <option value="neurosci">NeuroSci</option> <option value="nitrogen">Nitrogen</option> <option value="ncrna">Non-Coding RNA</option> <option value="nursrep">Nursing Reports</option> <option value="nutraceuticals">Nutraceuticals</option> <option value="nutrients">Nutrients</option> <option value="obesities">Obesities</option> <option value="oceans">Oceans</option> <option value="onco">Onco</option> <option value="optics">Optics</option> <option value="oral">Oral</option> <option value="organics">Organics</option> <option value="organoids">Organoids</option> <option value="osteology">Osteology</option> <option value="oxygen">Oxygen</option> <option value="parasitologia">Parasitologia</option> <option value="particles">Particles</option> <option value="pathogens">Pathogens</option> <option value="pathophysiology">Pathophysiology</option> <option value="pediatrrep">Pediatric Reports</option> <option value="pets">Pets</option> <option value="pharmaceuticals">Pharmaceuticals</option> <option value="pharmaceutics">Pharmaceutics</option> <option value="pharmacoepidemiology">Pharmacoepidemiology</option> <option value="pharmacy">Pharmacy</option> <option value="philosophies">Philosophies</option> <option value="photochem">Photochem</option> <option value="photonics">Photonics</option> <option value="phycology">Phycology</option> <option value="physchem">Physchem</option> <option value="psf">Physical Sciences Forum</option> <option value="physics">Physics</option> <option value="physiologia">Physiologia</option> <option value="plants">Plants</option> <option value="plasma">Plasma</option> <option value="platforms">Platforms</option> <option value="pollutants">Pollutants</option> <option value="polymers">Polymers</option> <option value="polysaccharides">Polysaccharides</option> <option value="populations">Populations</option> <option value="poultry">Poultry</option> <option value="powders">Powders</option> <option value="proceedings">Proceedings</option> <option value="processes">Processes</option> <option value="prosthesis">Prosthesis</option> <option value="proteomes">Proteomes</option> <option value="psychiatryint">Psychiatry International</option> <option value="psychoactives">Psychoactives</option> <option value="psycholint">Psychology International</option> <option value="publications">Publications</option> <option value="qubs">Quantum Beam Science</option> <option value="quantumrep">Quantum Reports</option> <option value="quaternary">Quaternary</option> <option value="radiation">Radiation</option> <option value="reactions">Reactions</option> <option value="realestate">Real Estate</option> <option value="receptors">Receptors</option> <option value="recycling">Recycling</option> <option value="rsee">Regional Science and Environmental Economics</option> <option value="religions">Religions</option> <option value="remotesensing">Remote Sensing</option> <option value="reports">Reports</option> <option value="reprodmed">Reproductive Medicine</option> <option value="resources">Resources</option> <option value="rheumato">Rheumato</option> <option value="risks">Risks</option> <option value="robotics">Robotics</option> <option value="ruminants">Ruminants</option> <option value="safety">Safety</option> <option value="sci">Sci</option> <option value="scipharm">Scientia Pharmaceutica</option> <option value="sclerosis">Sclerosis</option> <option value="seeds">Seeds</option> <option value="sensors">Sensors</option> <option value="separations">Separations</option> <option value="sexes">Sexes</option> <option value="signals">Signals</option> <option value="sinusitis">Sinusitis</option> <option value="smartcities">Smart Cities</option> <option value="socsci">Social Sciences</option> <option value="siuj">Société Internationale d’Urologie Journal</option> <option value="societies">Societies</option> <option value="software">Software</option> <option value="soilsystems">Soil Systems</option> <option value="solar">Solar</option> <option value="solids">Solids</option> <option value="spectroscj">Spectroscopy Journal</option> <option value="sports">Sports</option> <option value="standards">Standards</option> <option value="stats">Stats</option> <option value="stresses">Stresses</option> <option value="surfaces">Surfaces</option> <option value="surgeries">Surgeries</option> <option value="std">Surgical Techniques Development</option> <option value="sustainability">Sustainability</option> <option value="suschem">Sustainable Chemistry</option> <option value="symmetry">Symmetry</option> <option value="synbio">SynBio</option> <option value="systems">Systems</option> <option value="targets">Targets</option> <option value="taxonomy">Taxonomy</option> <option value="technologies">Technologies</option> <option value="telecom">Telecom</option> <option value="textiles">Textiles</option> <option value="thalassrep">Thalassemia Reports</option> <option value="therapeutics">Therapeutics</option> <option value="thermo">Thermo</option> <option value="timespace">Time and Space</option> <option value="tomography">Tomography</option> <option value="tourismhosp">Tourism and Hospitality</option> <option value="toxics">Toxics</option> <option value="toxins">Toxins</option> <option value="transplantology">Transplantology</option> <option value="traumacare">Trauma Care</option> <option value="higheredu">Trends in Higher Education</option> <option value="tropicalmed">Tropical Medicine and Infectious Disease</option> <option value="universe">Universe</option> <option value="urbansci">Urban Science</option> <option value="uro">Uro</option> <option value="vaccines">Vaccines</option> <option value="vehicles">Vehicles</option> <option value="venereology">Venereology</option> <option value="vetsci">Veterinary Sciences</option> <option value="vibration">Vibration</option> <option value="virtualworlds">Virtual Worlds</option> <option value="viruses">Viruses</option> <option value="vision">Vision</option> <option value="waste">Waste</option> <option value="water">Water</option> <option value="wild">Wild</option> <option value="wind">Wind</option> <option value="women">Women</option> <option value="world">World</option> <option value="wevj">World Electric Vehicle Journal</option> <option value="youth">Youth</option> <option value="zoonoticdis">Zoonotic Diseases</option> </select> <input name="email" type="email" placeholder="Enter your email address..." required="required" /> <button class="genericCaptcha button button--dark UA_FooterNewsletterSubscribeButton" type="submit">Subscribe</button> </form> </div> </div> </div> <div id="footer-copyright"> <div class="row"> <div class="columns large-6 medium-6 small-12 text-left"> © 1996-2024 MDPI (Basel, Switzerland) unless otherwise stated </div> <div class="columns large-6 medium-6 small-12 small-text-left medium-text-right large-text-right"> <a data-dropdown="drop-view-disclaimer" aria-controls="drop-view-disclaimer" aria-expanded="false" data-options="align:top; is_hover:true; hover_timeout:2000;"> Disclaimer </a> <div id="drop-view-disclaimer" class="f-dropdown label__btn__dropdown label__btn__dropdown--wide text-left" data-dropdown-content aria-hidden="true" tabindex="-1"> Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. </div> <a href="/about/terms-and-conditions"> Terms and Conditions </a> <a href="/about/privacy"> Privacy Policy </a> </div> </div> </div> </div> <div id="cookie-notification" class="js-allow-cookies" style="display: none;"> <div class="columns large-10 medium-10 small-12"> We use cookies on our website to ensure you get the best experience.<br class="show-for-medium-up"/> Read more about our cookies <a href="/about/privacy">here</a>. </div> <div class="columns large-2 medium-2 small-12 small-only-text-left text-right"> <a class="button button--default" href="/accept_cookies">Accept</a> </div> </div> </div> <div id="main-share-modal" class="reveal-modal reveal-modal-new reveal-modal-new--small" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 style="margin: 0;">Share Link</h2> </div> <div class="small-12 columns"> <div class="social-media-links UA_ShareModalLinks" style="text-align: left;"> <a href="/cdn-cgi/l/email-protection#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" title="Email"> <i class="fa fa-envelope-square" style="font-size: 30px;"></i> </a> <a href="https://twitter.com/intent/tweet?text=Bioprofiling+TS%2FA+Murine+Mammary+Cancer+for+a+Functional+Precision+Experimental+Model&hashtags=mdpicancers&url=https%3A%2F%2Fwww.mdpi.com%2F583284&via=Cancers_MDPI" onclick="windowOpen(this.href,600,800); return false" title="Twitter" target="_blank" rel="noopener noreferrer"> <i class="fa fa-twitter-x-square" style="font-size: 30px;"></i> </a> <a href=" http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.mdpi.com%2F583284&title=Bioprofiling%20TS%2FA%20Murine%20Mammary%20Cancer%20for%20a%20Functional%20Precision%20Experimental%20Model%26source%3Dhttps%3A%2F%2Fwww.mdpi.com%26summary%3D%20The%20TS%2FA%20cell%20line%20was%20established%20in%201983%20from%20a%20spontaneous%20mammary%20tumor%20arisen%20in%20an%20inbred%20BALB%2Fc%20female%20mouse.%20Its%20features%20%28heterogeneity%2C%20low%20immunogenicity%20and%20metastatic%20ability%29%20rendered%20the%20TS%2FA%20cell%20line%20suitable%20as%20a%20preclinical%20model%20%5B...%5D" onclick="windowOpen(this.href,600,800); return false" title="LinkedIn" target="_blank" rel="noopener noreferrer"> <i class="fa fa-linkedin-square" style="font-size: 30px;"></i> </a> <a href="https://www.facebook.com/sharer.php?u=https://www.mdpi.com/583284" title="facebook" target="_blank" rel="noopener noreferrer"> <i class="fa fa-facebook-square" style="font-size: 30px;"></i> </a> <a href="javascript:void(0);" title="Wechat" data-reveal-id="weixin-share-modal"> <i class="fa fa-weixin-square" style="font-size: 26px;"></i> </a> <a href="http://www.reddit.com/submit?url=https://www.mdpi.com/583284" title="Reddit" target="_blank" rel="noopener noreferrer"> <i class="fa fa-reddit-square" style="font-size: 30px;"></i> </a> <a href="http://www.mendeley.com/import/?url=https://www.mdpi.com/583284" title="Mendeley" target="_blank" rel="noopener noreferrer"> <i class="fa fa-mendeley-square" style="font-size: 30px;"></i> </a> <a href="http://www.citeulike.org/posturl?url=https://www.mdpi.com/583284" title="CiteULike" target="_blank" rel="noopener noreferrer"> <i class="fa fa-citeulike-square" style="font-size: 30px;"></i> </a> </div> </div> <div class="small-9 columns"> <input id="js-clipboard-text" type="text" readonly value="https://www.mdpi.com/583284" /> </div> <div class="small-3 columns text-left"> <a class="button button--color js-clipboard-copy" data-clipboard-target="#js-clipboard-text">Copy</a> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <div id="weixin-share-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="weixin-share-modal-title" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 id="weixin-share-modal-title" style="margin: 0;">Share</h2> </div> <div class="small-12 columns"> <div class="weixin-qr-code-section"> <?xml version="1.0" standalone="no"?> <!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd"> <svg width="300" height="300" version="1.1" xmlns="http://www.w3.org/2000/svg"> <desc>https://www.mdpi.com/583284</desc> <g id="elements" fill="black" stroke="none"> <rect x="0" y="0" width="12" height="12" /> <rect x="12" y="0" width="12" height="12" /> <rect x="24" y="0" width="12" height="12" /> <rect x="36" y="0" width="12" height="12" /> <rect x="48" y="0" width="12" height="12" /> <rect x="60" y="0" width="12" height="12" /> <rect x="72" y="0" width="12" height="12" /> <rect x="96" y="0" width="12" height="12" /> <rect x="108" y="0" width="12" height="12" /> <rect x="120" y="0" width="12" height="12" /> <rect x="144" y="0" width="12" height="12" /> <rect x="156" y="0" width="12" height="12" /> <rect x="168" y="0" width="12" height="12" /> <rect x="180" y="0" width="12" height="12" /> <rect x="192" y="0" width="12" height="12" /> <rect x="216" y="0" width="12" height="12" /> <rect x="228" y="0" width="12" height="12" /> <rect x="240" y="0" width="12" height="12" /> <rect x="252" y="0" width="12" height="12" /> <rect x="264" y="0" width="12" height="12" /> <rect x="276" y="0" width="12" height="12" /> <rect x="288" y="0" width="12" height="12" /> <rect x="0" y="12" width="12" height="12" /> <rect x="72" y="12" width="12" height="12" /> <rect x="96" y="12" width="12" height="12" /> <rect x="108" y="12" width="12" height="12" /> <rect x="120" y="12" width="12" height="12" /> <rect x="168" y="12" width="12" height="12" /> <rect x="216" y="12" width="12" height="12" /> <rect x="288" y="12" width="12" height="12" /> <rect x="0" y="24" width="12" height="12" /> <rect x="24" y="24" width="12" height="12" /> <rect x="36" y="24" width="12" height="12" /> <rect x="48" y="24" width="12" height="12" /> <rect x="72" y="24" width="12" height="12" /> <rect x="96" y="24" width="12" height="12" /> <rect x="120" y="24" width="12" height="12" /> <rect x="132" y="24" width="12" height="12" /> <rect x="168" y="24" width="12" height="12" /> <rect x="216" y="24" width="12" height="12" /> <rect x="240" y="24" width="12" height="12" /> <rect x="252" y="24" width="12" height="12" /> <rect x="264" y="24" width="12" height="12" /> <rect x="288" y="24" width="12" height="12" /> <rect x="0" y="36" width="12" height="12" /> <rect x="24" y="36" width="12" height="12" /> <rect x="36" y="36" width="12" height="12" /> <rect x="48" y="36" width="12" height="12" /> <rect x="72" y="36" width="12" height="12" /> <rect x="96" y="36" width="12" height="12" /> <rect x="108" y="36" width="12" height="12" /> <rect x="132" y="36" width="12" height="12" /> <rect x="156" y="36" width="12" height="12" /> <rect x="168" y="36" width="12" height="12" /> <rect x="192" y="36" width="12" height="12" /> <rect x="216" y="36" width="12" height="12" /> <rect x="240" y="36" width="12" height="12" /> <rect x="252" y="36" width="12" height="12" /> <rect x="264" y="36" width="12" height="12" /> <rect x="288" y="36" width="12" height="12" /> <rect x="0" y="48" width="12" height="12" /> <rect x="24" y="48" width="12" height="12" /> <rect x="36" y="48" width="12" height="12" /> <rect x="48" y="48" width="12" height="12" /> <rect x="72" y="48" width="12" height="12" /> <rect x="168" y="48" width="12" height="12" /> <rect x="180" y="48" width="12" height="12" /> <rect x="216" y="48" width="12" height="12" /> <rect x="240" y="48" width="12" height="12" /> <rect x="252" y="48" width="12" height="12" /> <rect x="264" y="48" width="12" height="12" /> <rect x="288" y="48" width="12" height="12" /> <rect x="0" y="60" width="12" height="12" /> <rect x="72" y="60" width="12" height="12" /> <rect x="96" y="60" width="12" height="12" /> <rect x="132" y="60" width="12" height="12" /> <rect x="144" y="60" width="12" height="12" /> <rect x="192" y="60" width="12" height="12" /> <rect x="216" y="60" width="12" height="12" /> <rect x="288" y="60" width="12" height="12" /> <rect x="0" y="72" width="12" height="12" /> <rect x="12" y="72" width="12" height="12" /> <rect x="24" y="72" width="12" height="12" /> <rect x="36" y="72" width="12" height="12" /> <rect x="48" y="72" width="12" height="12" /> <rect x="60" y="72" width="12" height="12" /> <rect x="72" y="72" width="12" height="12" /> <rect x="96" y="72" width="12" height="12" /> <rect x="120" y="72" width="12" height="12" /> <rect x="144" y="72" width="12" height="12" /> <rect x="168" y="72" width="12" height="12" /> <rect x="192" y="72" width="12" height="12" /> <rect x="216" y="72" width="12" height="12" /> <rect x="228" y="72" width="12" height="12" /> <rect x="240" y="72" width="12" height="12" /> <rect x="252" y="72" width="12" height="12" /> <rect x="264" y="72" width="12" height="12" /> <rect x="276" y="72" width="12" height="12" /> <rect x="288" y="72" width="12" height="12" /> <rect x="108" y="84" width="12" height="12" /> <rect x="144" y="84" width="12" height="12" /> <rect x="168" y="84" width="12" height="12" /> <rect x="180" y="84" width="12" height="12" /> <rect x="192" y="84" width="12" height="12" /> <rect x="0" y="96" width="12" height="12" /> <rect x="12" y="96" width="12" height="12" /> <rect x="48" y="96" width="12" height="12" /> <rect x="60" y="96" width="12" height="12" /> <rect x="72" y="96" width="12" height="12" /> <rect x="132" y="96" width="12" height="12" /> <rect x="144" y="96" width="12" height="12" /> <rect x="180" y="96" width="12" height="12" /> <rect x="228" y="96" width="12" height="12" /> <rect x="252" y="96" width="12" height="12" /> <rect x="264" y="96" width="12" height="12" /> <rect x="276" y="96" width="12" height="12" /> <rect x="288" y="96" width="12" height="12" /> <rect x="0" y="108" width="12" height="12" /> <rect x="12" y="108" width="12" height="12" /> <rect x="48" y="108" width="12" height="12" /> <rect x="60" y="108" width="12" height="12" /> <rect x="84" y="108" width="12" height="12" /> <rect x="96" y="108" width="12" height="12" /> <rect x="108" y="108" width="12" height="12" /> <rect x="120" y="108" width="12" height="12" /> <rect x="144" y="108" width="12" height="12" /> <rect x="168" y="108" width="12" height="12" /> <rect x="180" y="108" width="12" height="12" /> <rect x="192" y="108" width="12" height="12" /> <rect x="204" y="108" width="12" height="12" /> <rect x="240" y="108" width="12" height="12" /> <rect x="252" y="108" width="12" height="12" /> <rect x="276" y="108" width="12" height="12" /> <rect x="12" y="120" width="12" height="12" /> <rect x="24" y="120" width="12" height="12" /> <rect x="60" y="120" width="12" height="12" /> <rect x="72" y="120" width="12" height="12" /> <rect x="84" y="120" width="12" height="12" /> <rect x="132" y="120" width="12" height="12" /> <rect x="168" y="120" width="12" height="12" /> <rect x="180" y="120" width="12" height="12" /> <rect x="192" y="120" width="12" height="12" /> <rect x="228" y="120" width="12" height="12" /> <rect x="240" y="120" width="12" height="12" /> <rect x="252" y="120" width="12" height="12" /> <rect x="264" y="120" width="12" height="12" /> <rect x="12" y="132" width="12" height="12" /> <rect x="24" y="132" width="12" height="12" /> <rect x="36" y="132" width="12" height="12" /> <rect x="48" y="132" width="12" height="12" /> <rect x="84" y="132" width="12" height="12" /> <rect x="96" y="132" width="12" height="12" /> <rect x="120" y="132" width="12" height="12" /> <rect x="132" y="132" width="12" height="12" /> <rect x="144" y="132" width="12" height="12" /> <rect x="168" y="132" width="12" height="12" /> <rect x="180" y="132" width="12" height="12" /> <rect x="192" y="132" width="12" height="12" /> <rect x="216" y="132" width="12" height="12" /> <rect x="228" y="132" width="12" height="12" /> <rect x="264" y="132" width="12" height="12" /> <rect x="276" y="132" width="12" height="12" /> <rect x="0" y="144" width="12" height="12" /> <rect x="24" y="144" width="12" height="12" /> <rect x="48" y="144" width="12" height="12" /> <rect x="60" y="144" width="12" height="12" /> <rect x="72" y="144" width="12" height="12" /> <rect x="120" y="144" width="12" height="12" /> <rect x="168" y="144" width="12" height="12" /> <rect x="192" y="144" width="12" height="12" /> <rect x="204" y="144" width="12" height="12" /> <rect x="216" y="144" width="12" height="12" /> <rect x="252" y="144" width="12" height="12" /> <rect x="264" y="144" width="12" height="12" /> <rect x="276" y="144" width="12" height="12" /> <rect x="288" y="144" width="12" height="12" /> <rect x="0" y="156" width="12" height="12" /> <rect x="36" y="156" width="12" height="12" /> <rect x="108" y="156" width="12" height="12" /> <rect x="132" y="156" width="12" height="12" /> <rect x="144" y="156" width="12" height="12" /> <rect x="168" y="156" width="12" height="12" /> <rect x="180" y="156" width="12" height="12" /> <rect x="192" y="156" width="12" height="12" /> <rect x="204" y="156" width="12" height="12" /> <rect x="240" y="156" width="12" height="12" /> <rect x="276" y="156" width="12" height="12" /> <rect x="24" y="168" width="12" height="12" /> <rect x="48" y="168" width="12" height="12" /> <rect x="60" y="168" width="12" height="12" /> <rect x="72" y="168" width="12" height="12" /> <rect x="108" y="168" width="12" height="12" /> <rect x="132" y="168" width="12" height="12" /> <rect x="156" y="168" width="12" height="12" /> <rect x="168" y="168" width="12" height="12" /> <rect x="180" y="168" width="12" height="12" /> <rect x="192" y="168" width="12" height="12" /> <rect x="228" y="168" width="12" height="12" /> <rect x="240" y="168" width="12" height="12" /> <rect x="252" y="168" width="12" height="12" /> <rect x="264" y="168" width="12" height="12" /> <rect x="36" y="180" width="12" height="12" /> <rect x="84" y="180" width="12" height="12" /> <rect x="96" y="180" width="12" height="12" /> <rect x="108" y="180" width="12" height="12" /> <rect x="132" y="180" width="12" height="12" /> <rect x="168" y="180" width="12" height="12" /> <rect x="180" y="180" width="12" height="12" /> <rect x="216" y="180" width="12" height="12" /> <rect x="228" y="180" width="12" height="12" /> <rect x="240" y="180" width="12" height="12" /> <rect x="264" y="180" width="12" height="12" /> <rect x="276" y="180" width="12" height="12" /> <rect x="0" y="192" width="12" height="12" /> <rect x="12" y="192" width="12" height="12" /> <rect x="24" y="192" width="12" height="12" /> <rect x="36" y="192" width="12" height="12" /> <rect x="60" y="192" width="12" height="12" /> <rect x="72" y="192" width="12" height="12" /> <rect x="84" y="192" width="12" height="12" /> <rect x="108" y="192" width="12" height="12" /> <rect x="132" y="192" width="12" height="12" /> <rect x="168" y="192" width="12" height="12" /> <rect x="192" y="192" width="12" height="12" /> <rect x="204" y="192" width="12" height="12" /> <rect x="216" y="192" width="12" height="12" /> <rect x="228" y="192" width="12" height="12" /> <rect x="240" y="192" width="12" height="12" /> <rect x="252" y="192" width="12" height="12" /> <rect x="264" y="192" width="12" height="12" /> <rect x="96" y="204" width="12" height="12" /> <rect x="132" y="204" width="12" height="12" /> <rect x="144" y="204" width="12" height="12" /> <rect x="156" y="204" width="12" height="12" /> <rect x="192" y="204" width="12" height="12" /> <rect x="240" y="204" width="12" height="12" /> <rect x="0" y="216" width="12" height="12" /> <rect x="12" y="216" width="12" height="12" /> <rect x="24" y="216" width="12" height="12" /> <rect x="36" y="216" width="12" height="12" /> <rect x="48" y="216" width="12" height="12" /> <rect x="60" y="216" width="12" height="12" /> <rect x="72" y="216" width="12" height="12" /> <rect x="108" y="216" width="12" height="12" /> <rect x="132" y="216" width="12" height="12" /> <rect x="168" y="216" width="12" height="12" /> <rect x="192" y="216" width="12" height="12" /> <rect x="216" y="216" width="12" height="12" /> <rect x="240" y="216" width="12" height="12" /> <rect x="0" y="228" width="12" height="12" /> <rect x="72" y="228" width="12" height="12" /> <rect x="96" y="228" width="12" height="12" /> <rect x="108" y="228" width="12" height="12" /> <rect x="120" y="228" width="12" height="12" /> <rect x="168" y="228" width="12" height="12" /> <rect x="192" y="228" width="12" height="12" /> <rect x="240" y="228" width="12" height="12" /> <rect x="252" y="228" width="12" height="12" /> <rect x="264" y="228" width="12" height="12" /> <rect x="288" y="228" width="12" height="12" /> <rect x="0" y="240" width="12" height="12" /> <rect x="24" y="240" width="12" height="12" /> <rect x="36" y="240" width="12" height="12" /> <rect x="48" y="240" width="12" height="12" /> <rect x="72" y="240" width="12" height="12" /> <rect x="96" y="240" width="12" height="12" /> <rect x="168" y="240" width="12" height="12" /> <rect x="192" y="240" width="12" height="12" /> <rect x="204" y="240" width="12" height="12" /> <rect x="216" y="240" width="12" height="12" /> <rect x="228" y="240" width="12" height="12" /> <rect x="240" y="240" width="12" height="12" /> <rect x="252" y="240" width="12" height="12" /> <rect x="264" y="240" width="12" height="12" /> <rect x="0" y="252" width="12" height="12" /> <rect x="24" y="252" width="12" height="12" /> <rect x="36" y="252" width="12" height="12" /> <rect x="48" y="252" width="12" height="12" /> <rect x="72" y="252" width="12" height="12" /> <rect x="120" y="252" width="12" height="12" /> <rect x="132" y="252" width="12" height="12" /> <rect x="144" y="252" width="12" height="12" /> <rect x="180" y="252" width="12" height="12" /> <rect x="216" y="252" width="12" height="12" /> <rect x="228" y="252" width="12" height="12" /> <rect x="264" y="252" width="12" height="12" /> <rect x="276" y="252" width="12" height="12" /> <rect x="288" y="252" width="12" height="12" /> <rect x="0" y="264" width="12" height="12" /> <rect x="24" y="264" width="12" height="12" /> <rect x="36" y="264" width="12" height="12" /> <rect x="48" y="264" width="12" height="12" /> <rect x="72" y="264" width="12" height="12" /> <rect x="108" y="264" width="12" height="12" /> <rect x="132" y="264" width="12" height="12" /> <rect x="144" y="264" width="12" height="12" /> <rect x="204" y="264" width="12" height="12" /> <rect x="216" y="264" width="12" height="12" /> <rect x="252" y="264" width="12" height="12" /> <rect x="276" y="264" width="12" height="12" /> <rect x="0" y="276" width="12" height="12" /> <rect x="72" y="276" width="12" height="12" /> <rect x="96" y="276" width="12" height="12" /> <rect x="180" y="276" width="12" height="12" /> <rect x="216" y="276" width="12" height="12" /> <rect x="228" y="276" width="12" height="12" /> <rect x="240" y="276" width="12" height="12" /> <rect x="252" y="276" width="12" height="12" /> <rect x="264" y="276" width="12" height="12" /> <rect x="276" y="276" width="12" height="12" /> <rect x="0" y="288" width="12" height="12" /> <rect x="12" y="288" width="12" height="12" /> <rect x="24" y="288" width="12" height="12" /> <rect x="36" y="288" width="12" height="12" /> <rect x="48" y="288" width="12" height="12" /> <rect x="60" y="288" width="12" height="12" /> <rect x="72" y="288" width="12" height="12" /> <rect x="96" y="288" width="12" height="12" /> <rect x="120" y="288" width="12" height="12" /> <rect x="168" y="288" width="12" height="12" /> <rect x="180" y="288" width="12" height="12" /> <rect x="264" y="288" width="12" height="12" /> <rect x="276" y="288" width="12" height="12" /> <rect x="288" y="288" width="12" height="12" /> </g> </svg> </div> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <a href="#" class="back-to-top"><span class="show-for-medium-up">Back to Top</span><span class="show-for-small">Top</span></a> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script src="https://pub.mdpi-res.com/assets/js/modernizr-2.8.3.min.js?5227e0738f7f421d?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/jquery-1.12.4.min.js?4f252523d4af0b47?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/foundation-5.5.3.min.js?6b2ec41c18b29054?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/foundation-5.5.3.equalizer.min.js?0f6c549b75ec554c?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/jquery.multiselect.js?0edd3998731d1091?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/jquery.cycle2.min.js?63413052928f97ee?1732884643"></script> <script> // old browser fix - this way the console log rows won't throw (silent) errors in browsers not supporting console log if (!window.console) window.console = {}; if (!window.console.log) window.console.log = function () { }; var currentJournalNameSystem = "cancers"; $(document).ready(function() { $('select.foundation-select').multiselect({ search: true, minHeight: 130, maxHeight: 130, }); $(document).foundation({ orbit: { timer_speed: 4000, }, reveal: { animation: 'fadeAndPop', animation_speed: 100, } }); $(".chosen-select").each(function(element) { var maxSelected = (undefined !== $(this).data('maxselectedoptions') ? $(this).data('maxselectedoptions') : 100); $(this).on('chosen:ready', function(event, data) { var select = $(data.chosen.form_field); if (select.attr('id') === 'journal-browser-volume') { $(data.chosen.dropdown).addClass('UI_JournalBrowser_Volume_Options'); } if (select.attr('id') === 'journal-browser-issue') { $(data.chosen.dropdown).addClass('UI_JournalBrowser_Issue_Options'); } }).chosen({ display_disabled_options: false, disable_search_threshold: 7, max_selected_options: maxSelected, width: "100%" }); }); $(".toEncode").each(function(e) { var oldHref = $(this).attr("href"); var newHref = oldHref.replace('.botdefense.please.enable.javascript.','@'); $(this).attr("href", newHref); if (!$(this).hasClass("emailCaptcha")) { $(this).html(newHref.replace('mailto:', '')); } $(this).removeClass("visibility-hidden"); }); $(document).on('opened.fndtn.reveal', '[data-reveal]', function() { $(document).foundation('equalizer', 'reflow'); }); // fix the images that have tag height / width defined // otherwise the default foundation styles overwrite the tag definitions $("img").each(function() { if ($(this).attr('width') != undefined || $(this).attr('height') != undefined) { $(this).addClass("img-fixed"); } }); $("#basic_search, #advanced_search").submit(function(e) { var searchArguments = false; $(this).find("input,select").not("#search,.search-button").each(function() { if (undefined === $(this).val() || "" === $(this).val()) { $(this).attr('name', null); } else { $(this).attr('name'); searchArguments = true; } }); if (!searchArguments) { window.location = $(this).attr('action'); return false; } }); $(".hide-show-desktop-option").click(function(e) { e.preventDefault(); var parentDiv = $(this).closest("div"); $.ajax({ url: $(this).attr('href'), success: function(msg) { parentDiv.removeClass().hide(); } }); }); $(".generic-toggleable-header").click(function(e) { $(this).toggleClass("active"); $(this).next(".generic-toggleable-content").toggleClass("active"); }); /* * handle whole row as a link if the row contains only one visible link */ $("table.new tr").hover(function() { if ($(this).find("td:visible a").length == 1) { $(this).addClass("single-link"); } }, function() { $(this).removeClass("single-link"); }); $("table.new:not(.table-of-tables)").on("click", "tr.single-link", function(e) { var target = $(e.target); if (!e.ctrlKey && !target.is("a")) { $(this).find("td:visible a")[0].click(); } }); $(document).on("click", ".custom-accordion-for-small-screen-link", function(e) { if ($(this).closest("#basic_search").length > 0) { if ($(".search-container__advanced").first().is(":visible")) { openAdvanced() } } if (Foundation.utils.is_small_only()) { if ($(this).hasClass("active")) { $(this).removeClass("active"); $(this).next(".custom-accordion-for-small-screen-content").addClass("show-for-medium-up"); } else { $(this).addClass("active"); $(this).next(".custom-accordion-for-small-screen-content").removeClass("show-for-medium-up"); $(document).foundation('orbit', 'reflow'); } } if (undefined !== $(this).data("callback")) { var customCallback = $(this).data("callback"); func = window[customCallback]; func(); } }); $(document).on("click", ".js-open-small-search", function(e) { e.preventDefault(); $(this).toggleClass("active").closest(".tab-bar").toggleClass("active"); $(".search-container").toggleClass("hide-for-small-down"); }); $(document).on("click", ".js-open-menu", function(e) { $(".search-container").addClass("hide-for-small-down"); }); $(window).on('resize', function() { recalculate_main_browser_position(); recalculate_responsive_moving_containers(); }); updateSearchLabelVisibilities(); recalculate_main_browser_position(); recalculate_responsive_moving_containers(); if (window.document.documentMode == 11) { $("<link/>", { rel: "stylesheet", type: "text/css", href: "https://fonts.googleapis.com/icon?family=Material+Icons"}).appendTo("head"); } }); function recalculate_main_browser_position() { if (Foundation.utils.is_small_only()) { if ($("#js-main-top-container").parent("#js-large-main-top-container").length > 0) { $("#js-main-top-container").appendTo($("#js-small-main-top-container")); } } else { if ($("#js-main-top-container").parent("#js-small-main-top-container").length > 0) { $("#js-main-top-container").appendTo($("#js-large-main-top-container")); } } } function recalculate_responsive_moving_containers() { $(".responsive-moving-container.large").each(function() { var previousParent = $(".responsive-moving-container.active[data-id='"+$(this).data("id")+"']"); var movingContent = previousParent.html(); if (Foundation.utils.is_small_only()) { var currentParent = $(".responsive-moving-container.small[data-id='"+$(this).data("id")+"']"); } else if (Foundation.utils.is_medium_only()) { var currentParent = $(".responsive-moving-container.medium[data-id='"+$(this).data("id")+"']"); } else { var currentParent = $(".responsive-moving-container.large[data-id='"+$(this).data("id")+"']"); } if (previousParent.attr("class") !== currentParent.attr("class")) { currentParent.html(movingContent); previousParent.html(); currentParent.addClass("active"); previousParent.removeClass("active"); } }); } // cookies allowed is checked from a) local storage and b) from server separately so that the footer bar doesn't // get included in the custom page caches function checkCookiesAllowed() { var cookiesEnabled = localStorage.getItem("mdpi_cookies_enabled"); if (null === cookiesEnabled) { $.ajax({ url: "/ajax_cookie_value/mdpi_cookies_accepted", success: function(data) { if (data.value) { localStorage.setItem("mdpi_cookies_enabled", true); checkDisplaySurvey(); } else { $(".js-allow-cookies").show(); } } }); } else { checkDisplaySurvey(); } } function checkDisplaySurvey() { } window.addEventListener('CookiebotOnAccept', function (e) { var CookieDate = new Date; if (Cookiebot.consent.preferences) { CookieDate.setFullYear(CookieDate.getFullYear() + 1); document.cookie = "mdpi_layout_type_v2=mobile; path=/; expires=" + CookieDate.toUTCString() + ";"; $(".js-toggle-desktop-layout-link").css("display", "inline-block"); } }, false); window.addEventListener('CookiebotOnDecline', function (e) { if (!Cookiebot.consent.preferences) { $(".js-toggle-desktop-layout-link").hide(); if ("" === "desktop") { window.location = "/toggle_desktop_layout_cookie"; } } }, false); var hash = $(location).attr('hash'); if ("#share" === hash) { if (1 === $("#main-share-modal").length) { $('#main-share-modal').foundation('reveal', 'open'); } } </script> <script src="https://pub.mdpi-res.com/assets/js/lib.js?f8d3d71b3a772f9d?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/mdpi.js?c267ce58392b15da?1732884643"></script> <script>var banners_url = 'https://serve.mdpi.com';</script> <script type='text/javascript' src='https://pub.mdpi-res.com/assets/js/ifvisible.min.js?c621d19ecb761212?1732884643'></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/affix.js?ac4ea55275297c15?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/clipboard.min.js?3f3688138a1b9fc4?1732884643"></script> <script type="text/javascript"> $(document).ready(function() { var helpFunctions = $(".middle-column__help__fixed"); var leftColumnAffix = $(".left-column__fixed"); var middleColumn = $("#middle-column"); var clone = null; helpFunctions.affix({ offset: { top: function() { return middleColumn.offset().top - 8 - (Foundation.utils.is_medium_only() ? 30 : 0); }, bottom: function() { return $("#footer").innerHeight() + 74 + (Foundation.utils.is_medium_only() ? 0 : 0); } } }); if (leftColumnAffix.length > 0) { clone = leftColumnAffix.clone(); clone.addClass("left-column__fixed__affix"); clone.insertBefore(leftColumnAffix); clone.css('width', leftColumnAffix.outerWidth() + 50); clone.affix({ offset: { top: function() { return leftColumnAffix.offset().top - 30 - (Foundation.utils.is_medium_only() ? 50 : 0); }, bottom: function() { return $("#footer").innerHeight() + 92 + (Foundation.utils.is_medium_only() ? 0 : 0); } } }); } $(window).on("resize", function() { if (clone !== null) { clone.css('width', leftColumnAffix.outerWidth() + 50); } }); new ClipboardJS('.js-clipboard-copy'); }); </script> <script src="https://pub.mdpi-res.com/assets/js/jquery-ui-1.13.2.min.js?1e2047978946a1d2?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/slick.min.js?d5a61c749e44e471?1732884643"></script> <script> $(document).ready(function() { $(".link-article-menu").click(function(e) { e.preventDefault(); $(this).find('span').toggle(); $(this).next("div").toggleClass("active"); }); $(".js-similarity-related-articles").click(function(e) { e.preventDefault(); if ('' !== $('#recommended-articles-modal').attr('data-url')) { $('#recommended-articles-modal').foundation('reveal', 'open', $('#recommended-articles-modal').attr('data-url')); } }); $.ajax({ url: "/article/291642/similarity-related/show-link", success: function(result) { if (result.show) { $('#recommended-articles-modal').attr('data-url', result.link); $('.js-article-similarity-container').show(); } } }); $(document).on('opened.fndtn.reveal', '[data-reveal]', function() { var modal = $(this); if (modal.attr('id') === "author-biographies-modal") { modal.find('.multiple-items').slick({ slidesToShow: 1, nextArrow: '<a class="slick-next" href="#"><i class="material-icons">chevron_right</i></a>', prevArrow: '<a class="slick-prev" href="#"><i class="material-icons">chevron_left</i></a>', slidesToScroll: 1, draggable: false, }); modal.find('.multiple-items').slick('refresh'); } }); }); </script> <script> $(document).ready(function() { $(document).on('keyup', function (e) { if (e.keyCode == 27) { var hElem = $(this).find(".annotator-adder"); if (hElem.length){ hElem.css({'visibility':'hidden'}); } else { document.querySelector("hypothesis-adder").shadowRoot.querySelector(".annotator-adder").style.visibility = "hidden"; } } }); }); </script> <script> window.hypothesisConfig = function () { return { sidebarAppUrl: 'https://commenting.mdpi.com/app.html', showHighlights: 'whenSidebarOpen' , openSidebar: false , assetRoot: 'https://commentingres.mdpi.com/hypothesis', services: [{ apiUrl: 'https://commenting.mdpi.com/api/', authority: 'mdpi', grantToken: '', doi: '10.3390/cancers11121889' }], }; }; </script> <script async id="hypothesis_frame"></script> <script type="text/javascript"> if (-1 !== window.location.href.indexOf("?src=")) { window.history.replaceState({}, '', `${location.pathname}`); } $(document).ready(function() { var scifeedCounter = 0; var search = window.location.search; var mathjaxReady = false; // late image file loading $("img[data-lsrc]").each(function() { $(this).attr("src", $(this).data("lsrc")); }); // late mathjax initialization var head = document.getElementsByTagName("head")[0]; var script = document.createElement("script"); script.type = "text/x-mathjax-config"; script[(window.opera ? "innerHTML" : "text")] = "MathJax.Hub.processSectionDelay = 0;\n" + "MathJax.Hub.Config({\n" + " \"menuSettings\": {\n" + " CHTMLpreview: false\n" + " },\n" + " \"CHTML-preview\":{\n" + " disabled: true\n" + " },\n" + " \"HTML-CSS\": {\n" + " scale: 90,\n" + " availableFonts: [],\n" + " preferredFont: null,\n" + " preferredFonts: null,\n" + " webFont:\"Gyre-Pagella\",\n" + " imageFont:'TeX',\n" + " undefinedFamily:\"'Arial Unicode MS',serif\",\n" + " linebreaks: { automatic: false }\n" + " },\n" + " \"TeX\": {\n" + " extensions: ['noErrors.js'],\n" + " noErrors: {\n" + " inlineDelimiters: [\"\",\"\"],\n" + " multiLine: true,\n" + " style: {\n" + " 'font-size': '90%',\n" + " 'text-align': 'left',\n" + " 'color': 'black',\n" + " 'padding': '1px 3px',\n" + " 'border': '1px solid'\n" + " }\n" + " }\n" + " }\n" + "});\n" + "MathJax.Hub.Register.StartupHook('End', function() {\n" + " refreshMathjaxWidths();\n" + " mathjaxReady = true;\n" + "});\n" + "MathJax.Hub.Startup.signal.Interest(function (message) {\n" + " if (message == 'End') {\n" + " var hypoLink = document.getElementById('hypothesis_frame');\n" + " if (null !== hypoLink) {\n" + " hypoLink.setAttribute('src', 'https://commenting.mdpi.com/embed.js');\n" + " }\n" + " }\n" + "});"; head.appendChild(script); script = document.createElement("script"); script.type = "text/javascript"; script.src = "https://pub.mdpi-res.com/bundles/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"; head.appendChild(script); // article version checker if (0 === search.indexOf('?type=check_update&version=')) { $.ajax({ url: "/2072-6694/11/12/1889" + "/versioncheck" + search, success: function(result) { $(".js-check-update-container").html(result); } }); } $('#feed_option').click(function() { // tracker if ($('#scifeed_clicked').length<1) { $(this).append('<span style="display:none" id="scifeed_clicked">done</span>'); } $('#feed_data').toggle('slide', { direction: 'up'}, '1000'); // slideToggle(700); OR toggle(700) $("#scifeed_error_msg").html('').hide(); $("#scifeed_notice_msg").html('').hide(); }); $('#feed_option').click(function(event) { setTimeout(function(){ var captchaSection = $("#captchaSection"); captchaSection.removeClass('ui-helper-hidden').find('input').prop('disabled', false); // var img = captchaSection.find('img'); // img.attr('src', img.data('url') + "?" + (new Date()).getTime()); // $(".captcha_reload").trigger("click"); var img = document.getElementById('gregwar_captcha_scifeed'); img.src = '/generate-captcha/gcb_captcha?n=' + (new Date()).getTime(); },800); }); $(document).on('click', '.split_feeds', function() { var name = $( this ).attr('name'); var flag = 1 - ($(this).is(":checked")*1); $('.split_feeds').each(function (index) { if ($( this ).attr('name') !== name) { $(this)[0].checked = flag; } }); }); $(document).on('click', '#scifeed_submit, #scifeed_submit1', function(event) { event.preventDefault(); $(".captcha_reload").trigger("click"); $("#scifeed_error_msg").html(""); $("#scifeed_error_msg").hide(); }); $(document).on('click', '.subscription_toggle', function(event) { if ($(this).val() === 'Create SciFeed' && $('#scifeed_hidden_flag').length>0) { event.preventDefault(); // alert('Here there would be a captcha because user is not logged in'); var captchaSection = $("#captchaSection"); if (captchaSection.hasClass('ui-helper-hidden')) { captchaSection.removeClass('ui-helper-hidden').find('input').prop('disabled', false); var img = captchaSection.find('img'); img.attr('src', img.data('url') + "?" + (new Date()).getTime()); $("#reloadCaptcha").trigger("click"); } } }); $(document).on('click', '.scifeed_msg', function(){ $(this).hide(); }); $(document).on('click', '.article-scilit-search', function(e) { e.preventDefault(); var data = $(".article-scilit-search-data").val(); var dataArray = data.split(';').map(function(keyword) { return "(\"" + keyword.trim() + "\")"; }); var searchQuery = dataArray.join(" OR "); var searchUrl = encodeURI("https://www.scilit.net/articles/search?q="+ searchQuery + "&advanced=1&highlight=1"); var win = window.open(searchUrl, '_blank'); if (win) { win.focus(); } else { window.location(searchUrl); } }); display_stats(); citedCount(); follow_goto(); // Select the node that will be observed for mutations const targetNodes = document.getElementsByClassName('hypothesis-count-container'); // Options for the observer (which mutations to observe) const config = { attributes: false, childList: true, subtree: false }; // Callback function to execute when mutations are observed const callback = function(mutationList, observer) { for(const mutation of mutationList) { if (mutation.type === 'childList') { let node = $(mutation.target); if (parseInt(node.html()) > 0) { node.show(); } } } }; // Create an observer instance linked to the callback function const observer = new MutationObserver(callback); // Start observing the target node for configured mutations for(const targetNode of targetNodes) { observer.observe(targetNode, config); } // Select the node that will be observed for mutations const mathjaxTargetNode = document.getElementById('middle-column'); // Callback function to execute when mutations are observed const mathjaxCallback = function(mutationList, observer) { if (mathjaxReady && typeof(MathJax) !== 'undefined') { refreshMathjaxWidths(); } }; // Create an observer instance linked to the callback function const mathjaxObserver = new ResizeObserver(mathjaxCallback); // Start observing the target node for configured mutations mathjaxObserver.observe(mathjaxTargetNode); }); /* END $(document).ready */ function refreshMathjaxWidths() { let width = ($('.html-body').width()*0.9) + "px"; $('.MathJax_Display').css('max-width', width); $('.MJXc-display').css('max-width', width); } function sendScifeedFrom(form) { if (!$('#scifeed_email').val().trim()) { // empty email alert('Please, provide an email for subscribe to this scifeed'); return false; } else if (!$('#captchaSection').hasClass('ui-helper-hidden') && !$('#captchaSection').find('input').val().trim()) { // empty captcha alert('Please, fill the captcha field.'); return false; } else if( ((($('#scifeed_form').find('input:checkbox:checked').length)-($('#split_feeds:checked').length))<1) || ($('#scifeed_kwd_txt').length < 0 && !$('#scifeed_kwd_txt').val().trim()) || ($('#scifeed_author_txt').length<0 &&!$('#scifeed_author_txt').val().trim()) ) { alert('You did not select anything to subscribe'); return false; } else if(($('#scifeed_form').find('input:checkbox:checked').length)-($('#split_feeds2:checked').length)<1){ alert("You did not select anything to subscribe"); return false; } else { var url = $('#scifeed_subscribe_url').html(); var formData = $(form).serializeArray(); $.post(url, formData).done(function (data) { if (JSON.parse(data)) { $('.scifeed_msg').hide(); var res = JSON.parse(data); var successFeeds = 0; var errorFeeds = 0; if (res) { $('.scifeed_msg').html(''); $.each(res, function (index, val) { if (val) { if (val.error) { errorFeeds++; $("#scifeed_error_msg").append(index+' - '+val.error+'<br>'); } if (val.notice) // for successful feed creation { successFeeds++; // $("#scifeed_notice_msg").append(index+' - '+val.notice+'<br>'); $("#scifeed_notice_msg").append('<li>'+index+'</li>'); } } }); if (successFeeds>0) { text = $('#scifeed_notice_msg').html(); text = 'The following feed'+(successFeeds>1?'s have':' has')+ ' been sucessfully created:<br><ul>'+ text + '</ul>' +($('#scifeed_hidden_flag').length>0 ? 'You are not logged in, so you probably need to validate '+ (successFeeds>1?'them':' it')+'.<br>' :'' ) +'Please check your email'+(successFeeds>1?'s':'')+' for more details.'; //(successFeeds>1?' for each of them':'')+'.<br>'; $("#scifeed_notice_msg").html(text); $("#scifeed_notice_msg").show(); } if (errorFeeds>0) { $("#scifeed_error_msg").show();; } } $("#feed_data").hide(); } }); } } function follow_goto() { var hashStr = location.hash.replace("#",""); if(typeof hashStr !== 'undefined') { if( hashStr == 'supplementary') { document.getElementById('suppl_id').scrollIntoView(); } if( hashStr == 'citedby') { document.getElementById('cited_id').scrollIntoView(); } } } function cited() { $("#framed_div").toggle('fast', function(){ if ($(this).css('display') != 'none') { var loaded = document.getElementById("loaded"); if(loaded.innerHTML == "No") { // Load Xref result var container = document.getElementById("framed_div"); // This replace the content container.innerHTML = "<img src=\"https://pub.mdpi-res.com/img/loading_circle.gif?9a82694213036313?1732884643\" height=\"20\" width=\"20\" alt=\"Processing...\" style=\"vertical-align:middle; margin-right:0.6em;\">"; var url = "/citedby/10.3390%252Fcancers11121889/23"; $.post(url, function(result) { if (result.success) { container.innerHTML = result.view; } loaded.innerHTML = "Yes"; }); } } return true; // for not going at the beginning of the page... }) return true; // for not going at the beginning of the page... } function detect_device() { // Added by Bastien (18/08/2014): based on the http://detectmobilebrowsers.com/ detector var check = false; (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows (ce|phone)|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4)))check = true})(navigator.userAgent||navigator.vendor||window.opera); return check; } function display_stats(){ $("#article_stats_div").toggle(); return false; } /* * Cited By Scopus */ function citedCount(){ $("#framed_div_cited_count").toggle('fast', function(){ if ($(this).css('display') != 'none') { var loaded = document.getElementById("loaded_cite_count"); // to load only once the result! if(loaded.innerHTML == "No") { // Load Xref result var d = document.getElementById("framed_div_cited_count"); // This replace the content d.innerHTML = "<img src=\"https://pub.mdpi-res.com/img/loading_circle.gif?9a82694213036313?1732884643\" height=\"20\" width=\"20\" alt=\"Processing...\" style=\"vertical-align:middle; margin-right:0.6em;\">"; $.ajax({ method : "POST", url : "/cite-count/10.3390%252Fcancers11121889", success : function(data) { if (data.succ) { d.innerHTML = data.view; loaded.innerHTML = "Yes"; follow_goto(); } } }); } } // end else return true; // for not going at the beginning of the page... }) return true; // for not going at the beginning of the page... } </script><script type="text/javascript" src="https://pub.mdpi-res.com/assets/js/third-party/highcharts/highcharts.js?bdd06f45e34c33df?1732884643"></script><script type="text/javascript" src="https://pub.mdpi-res.com/assets/js/third-party/highcharts/modules/exporting.js?944dc938d06de3a8?1732884643"></script><script type="text/javascript" defer="defer"> var advancedStatsData; var selectedStatsType = "abstract"; $(function(){ var countWrapper = $('#counts-wrapper'); $('#author_stats_id #type_links a').on('click', function(e) { e.preventDefault(); selectedStatsType = $(this).data('type'); $('#article_advanced_stats').vectorMap('set', 'values', advancedStatsData[selectedStatsType]); $('#advanced_stats_max').html(advancedStatsData[selectedStatsType].max); $('#type_links a').removeClass('active'); $(this).addClass('active'); }); $.get('/2072-6694/11/12/1889/stats', function (result) { if (!result.success) { return; } // process article metrics part in left column var viewNumber = countWrapper.find(".view-number"); viewNumber.html(result.metrics.views); viewNumber.parent().toggleClass("count-div--grey", result.metrics.views == 0); var downloadNumber = countWrapper.find(".download-number"); downloadNumber.html(result.metrics.downloads); downloadNumber.parent().toggleClass("count-div--grey", result.metrics.downloads == 0); var citationsNumber = countWrapper.find(".citations-number"); citationsNumber.html(result.metrics.citations); citationsNumber.parent().toggleClass("count-div--grey", result.metrics.citations == 0); if (result.metrics.views > 0 || result.metrics.downloads > 0 || result.metrics.citations > 0) { countWrapper.find("#js-counts-wrapper__views, #js-counts-wrapper__downloads").addClass("visible").show(); if (result.metrics.citations > 0) { countWrapper.find('.citations-number').html(result.metrics.citations).show(); countWrapper.find("#js-counts-wrapper__citations").addClass("visible").show(); } else { countWrapper.find("#js-counts-wrapper__citations").remove(); } $("[data-id='article-counters']").removeClass("hidden"); } if (result.metrics.altmetrics_score > 0) { $("#js-altmetrics-donut").show(); } // process view chart in main column var jsondata = result.chart; var series = new Array(); $.each(jsondata.elements, function(i, element) { var dataValues = new Array(); $.each(element.values, function(i, value) { dataValues.push(new Array(value.tip, value.value)); }); series[i] = {name: element.text, data:dataValues}; }); Highcharts.setOptions({ chart: { style: { fontFamily: 'Arial,sans-serif' } } }); $('#article_stats_swf').highcharts({ chart: { type: 'line', width: $("#tabs").width() //* 0.91 }, credits: { enabled: false }, exporting: { enabled: true }, title: { text: jsondata.title.text, x: -20 //center }, xAxis: { categories: jsondata.x_axis.labels.labels, offset: jsondata.x_axis.offset, labels:{ step: jsondata.x_axis.labels.steps, rotation: 30 } }, yAxis: { max: jsondata.y_axis.max, min: jsondata.y_axis.min, offset: jsondata.y_axis.offset, labels: { steps: jsondata.y_axis.steps }, title: { enabled: false } }, tooltip: { formatter: function (){ return this.key.replace("#val#", this.y); } }, legend: { align: 'top', itemDistance: 50 }, series: series }); }); $('#supplement_link').click(function() { document.getElementById('suppl_id').scrollIntoView(); }); $('#stats_link').click(function() { document.getElementById('stats_id').scrollIntoView(); }); // open mol viewer for molbank special supplementary files $('.showJmol').click(function(e) { e.preventDefault(); var jmolModal = $("#jmolModal"); var url = "/article/291642/jsmol_viewer/__supplementary_id__"; url = url.replace(/__supplementary_id__/g, $(this).data('index')); $('#jsmol-content').attr('src', url); jmolModal.find(".content").html($(this).data('description')); jmolModal.foundation("reveal", "open"); }); }); !function() { "use strict"; function e(e) { try { if ("undefined" == typeof console) return; "error"in console ? console.error(e) : console.log(e) } catch (e) {} } function t(e) { return d.innerHTML = '<a href="' + e.replace(/"/g, """) + '"></a>', d.childNodes[0].getAttribute("href") || "" } function n(n, c) { var o = ""; var k = parseInt(n.substr(c + 4, 2), 16); for (var i = c; i < n.length; i += 2) { if (i != c + 4) { var s = parseInt(n.substr(i, 2), 16) ^ k; o += String.fromCharCode(s); } } try { o = decodeURIComponent(escape(o)); } catch (error) { console.error(error); } return t(o); } function c(t) { for (var r = t.querySelectorAll("a"), c = 0; c < r.length; c++) try { var o = r[c] , a = o.href.indexOf(l); a > -1 && (o.href = "mailto:" + n(o.href, a + l.length)) } catch (i) { e(i) } } function o(t) { for (var r = t.querySelectorAll(u), c = 0; c < r.length; c++) try { var o = r[c] , a = o.parentNode , i = o.getAttribute(f); if (i) { var l = n(i, 0) , d = document.createTextNode(l); a.replaceChild(d, o) } } catch (h) { e(h) } } function a(t) { for (var r = t.querySelectorAll("template"), n = 0; n < r.length; n++) try { i(r[n].content) } catch (c) { e(c) } } function i(t) { try { c(t), o(t), a(t) } catch (r) { e(r) } } var l = "/cnd-cgi/l/email-protection#" , u = ".__cf_email__" , f = "data-cfemail" , d = document.createElement("div"); i(document), function() { var e = document.currentScript || document.scripts[document.scripts.length - 1]; e.parentNode.removeChild(e) }() }(); </script><script type="text/javascript"> function setCookie(cname, cvalue, ctime) { ctime = (typeof ctime === 'undefined') ? 10*365*24*60*60*1000 : ctime; // default => 10 years var d = new Date(); d.setTime(d.getTime() + ctime); // ==> 1 hour = 60*60*1000 var expires = "expires="+d.toUTCString(); document.cookie = cname + "=" + cvalue + "; " + expires +"; path=/"; } function getCookie(cname) { var name = cname + "="; var ca = document.cookie.split(';'); for(var i=0; i<ca.length; i++) { var c = ca[i]; while (c.charAt(0)==' ') c = c.substring(1); if (c.indexOf(name) == 0) return c.substring(name.length, c.length); } return ""; } </script><script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script><script> $(document).ready(function() { if ($("#js-similarity-related-data").length > 0) { $.ajax({ url: '/article/291642/similarity-related', success: function(response) { $("#js-similarity-related-data").html(response); $("#js-related-articles-menu").show(); $(document).foundation('tab', 'reflow'); MathJax.Hub.Queue(["Typeset", MathJax.Hub]); } }); } }); </script><link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/jquery-ui-1.10.4.custom.min.css?80647d88647bf347?1732884643"><link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/magnific-popup.min.css?04d343e036f8eecd?1732884643"><script type="text/javascript" src="https://pub.mdpi-res.com/assets/js/magnific-popup.min.js?2be3d9e7dc569146?1732884643"></script><script> $(function() { $(".js-show-more-academic-editors").on("click", function(e) { e.preventDefault(); $(this).hide(); $(".academic-editor-container").removeClass("hidden"); }); }); </script> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/vmap/jqvmap.min.css?126a06688aa11c13?1732884643"> <script src="https://pub.mdpi-res.com/assets/js/vmap/jquery.vmap.min.js?935f68d33bdd88a1?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/vmap/jquery.vmap.world.js?16677403c0e1bef1?1732884643"></script> <script> function updateSlick() { $('.multiple-items').slick('setPosition'); } $(document).ready(function() { $('.multiple-items').slick({ slidesToShow: 1, nextArrow: '<a class="slick-next" href="#"><i class="material-icons">chevron_right</i></a>', prevArrow: '<a class="slick-prev" href="#"><i class="material-icons">chevron_left</i></a>', slidesToScroll: 1, responsive: [ { breakpoint: 1024, settings: { slidesToShow: 1, slidesToScroll: 1, } }, { breakpoint: 600, settings: { slidesToShow: 1, slidesToScroll: 1, } }, { breakpoint: 480, settings: { slidesToShow: 1, slidesToScroll: 1, } } ] }); $('.multiple-items').show(); $(document).on('click', '.reviewReportSelector', function(e) { let path = $(this).attr('data-path'); handleReviews(path, $(this)); }); $(document).on('click', '.viewReviewReports', function(e) { let versionOne = $('#versionTab_1'); if (!versionOne.hasClass('activeTab')) { let path = $(this).attr('data-path'); handleReviews(path, versionOne); } location.href = "#reviewReports"; }); $(document).on('click', '.reviewersResponse, .authorResponse', function(e) { let version = $(this).attr('data-version'); let targetVersion = $('#versionTab_' + version); if (!targetVersion.hasClass('activeTab')) { let path = targetVersion.attr('data-path'); handleReviews(path, targetVersion); } location.href = $(this).attr('data-link'); }); $(document).on('click', '.tab', function (e) { e.preventDefault(); $('.tab').removeClass('activeTab'); $(this).addClass('activeTab') $('.tab').each(function() { $(this).closest('.tab-title').removeClass('active'); }); $(this).closest('.tab-title').addClass('active') }); }); function handleReviews(path, target) { $.ajax({ url: path, context: this, success: function (data) { $('.activeTab').removeClass('activeTab'); target.addClass('activeTab'); $('#reviewSection').html(data.view); }, error: function (xhr, ajaxOptions, thrownError) { console.log(xhr.status); console.log(thrownError); } }); } </script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/affix.js?v1?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/storage.js?e9b262d3a3476d25?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/jquery-scrollspy.js?09cbaec0dbb35a67?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/magnific-popup.js?4a09c18460afb26c?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/underscore.js?f893e294cde60c24?1732884643"></script> <script type="text/javascript"> $('document').ready(function(){ $("#left-column").addClass("show-for-large-up"); $("#middle-column").removeClass("medium-9").removeClass("left-bordered").addClass("medium-12"); $(window).on('resize scroll', function() { /* if ($('.button--drop-down').isInViewport($(".top-bar").outerHeight())) { */ if ($('.button--drop-down').isInViewport()) { $("#js-button-download").hide(); } else { $("#js-button-download").show(); } }); }); $(document).on('DOMNodeInserted', function(e) { var element = $(e.target); if (element.hasClass('menu') && element.hasClass('html-nav') ) { element.addClass("side-menu-ul"); } }); </script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/articles.js?5118449d9ad8913a?1732884643"></script> <script> repositionOpenSideBar = function() { $('#left-column').addClass("show-for-large-up show-for-medium-up").show(); $('#middle-column').removeClass('large-12').removeClass('medium-12'); $('#middle-column').addClass('large-9'); } repositionCloseSideBar = function() { $('#left-column').removeClass("show-for-large-up show-for-medium-up").hide(); $('#middle-column').removeClass('large-9'); $('#middle-column').addClass('large-12').addClass('medium-12'); } </script> <!--[if lt IE 9]> <script src="https://pub.mdpi-res.com/assets/js/ie8/ie8.js?6eef8fcbc831f5bd?1732884643"></script> <script src="https://pub.mdpi-res.com/assets/js/ie8/jquery.xdomainrequest.min.js?a945caca315782b0?1732884643"></script> <![endif]--> <!-- Twitter universal website tag code --> <script type="text/plain" data-cookieconsent="marketing"> !function(e,t,n,s,u,a){e.twq||(s=e.twq=function(){s.exe?s.exe.apply(s,arguments):s.queue.push(arguments); },s.version='1.1',s.queue=[],u=t.createElement(n),u.async=!0,u.src='//static.ads-twitter.com/uwt.js', a=t.getElementsByTagName(n)[0],a.parentNode.insertBefore(u,a))}(window,document,'script'); // Insert Twitter Pixel ID and Standard Event data below twq('init','o2pip'); twq('track','PageView'); </script> <!-- End Twitter universal website tag code --> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'8ebda5422ee6ce3f',t:'MTczMzE2NjkyNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html>